UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934 (Amendment No.     )

 

Filed by the Registrant

Filed by a Party other than the Registrant

Check the appropriate box:

Preliminary Proxy Statement

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material Pursuant to §240.14a-12

Marchex, Inc.

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

No fee required.

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

1)

Title of each class of securities to which transaction applies:

 

 

2)

Aggregate number of securities to which transaction applies:

 

 

3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

 

4)

Proposed maximum aggregate value of transaction:

 

 

5)

Total fee paid:

 

Fee paid previously with preliminary materials.

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

1)

Amount Previously Paid:

 

 

2)

Form, Schedule or Registration Statement No.:

 

 

3)

Filing Party:

 

 

4)

Date Filed:

 

 

 


 

July 10, 2017

Dear Stockholders of Marchex, Inc.,

We cordially invite you to attend our 2017 Annual Meeting of Stockholders. The Annual Meeting will be held on Monday, August 21, 2017, at 10:00 AM Pacific Time at Marchex, Inc., 520 Pike Street, 1211 Building Conference Center, 12th floor, Seattle Washington.

At this year’s Annual Meeting, the agenda will be as follows:

Agenda Item

Board Recommendation

Proposal One

To elect four (4) individuals to serve on our Board of Directors for the ensuing year and until their successors are elected

FOR

Proposal Two

To ratify the appointment of Moss Adams LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017

FOR

Proposal Three

To approve the adoption of an amendment to our amended and restated bylaws to provide that the courts located within the State of Delaware will serve as the exclusive forum for the adjudication of certain legal disputes

FOR

Proposal Four

To approve, by a non-binding advisory vote, the compensation paid to our named executive officers

FOR

Proposal Five

To select, by a non-binding advisory vote, the frequency at which stockholders will be asked to approve the compensation paid to our named executive officers

FOR

Proposal Six

To reapprove provisions of the 2012 Stock Incentive Plan to enable the Company to deduct in full certain plan-related compensation under Section 162(m) of the Internal Revenue Code of 1986, as amended

FOR

For our 2017 Annual Meeting, we have elected to use the Internet as our primary means of providing our proxy materials to stockholders. Consequently, most stockholders will not receive paper copies of our proxy materials. We will instead send to our stockholders a Notice of Internet Availability of Proxy Materials. The Notice of Internet Availability of Proxy Materials contains instructions on how to access our proxy statement and our Annual Report on Form 10-K for the fiscal year ended December 31, 2016, which contains, among other things, our 2016 audited consolidated financial statements. The Notice of Internet Availability of Proxy Materials also includes instructions on how you can vote using the Internet, and how you can request and receive, free of charge, a printed copy of our proxy materials, including our 2016 Annual Report, the Notice of Annual Meeting, our proxy statement and a proxy card. The electronic delivery of our proxy materials will reduce our printing and mailing costs and minimize the environmental impact of the proxy materials.

The ability to have your vote counted at the Annual Meeting is an important stockholder right. Regardless of the number of shares you hold, and whether or not you plan to attend the Annual Meeting, we hope that you will promptly cast your vote.

Thank you for your ongoing support and continued interest in Marchex, Inc.

Sincerely,

Marchex, Inc.

Ethan Caldwell

General Counsel, Secretary and member of the

Office of the CEO

 


 

Marchex, Inc.

520 Pike Street, Suite 2000

Seattle, Washington 98101

NOTICE OF 2017 ANNUALSPECIAL MEETING OF STOCKHOLDERS

To Be Held at 10:00 a.m. Pacific Time on Monday, August 21, 2017

Dear Stockholders of Marchex, Inc.:

The 2017 AnnualOn behalf of the Board of Directors (the “Board”) of Marchex, Inc. (the “Company”), you are cordially invited to attend a Special Meeting of Stockholders (the “Annual Meeting”Special Meeting) of Marchex, Inc., a Delaware corporation (“Marchex”), willto be held exclusively online via live audio webcast on Monday, August 21, 2017,October 1, 2020, at 10:00 AM, Pacific Time,Time. The Company has decided to hold this meeting exclusively online and not in a physical location given the ongoing public health impacts of the COVID-19 pandemic and the importance of the health and safety of the Company’s directors, officers, employees and stockholders. There will not be a physical meeting location, and the Company’s stockholders will not be able to attend the Special Meeting in person. The Special Meeting can be accessed by visiting www.meetingcenter.io/240872478 (the “Meeting Website”), where stockholders will be able to listen to the meeting, submit questions and vote online.

Information Concerning Solicitation and Voting

The Board is soliciting proxies for the Special Meeting to be held on October 1, 2020. The accompanying proxy statement (the “Proxy Statement”) contains information for you to consider when deciding how to vote on the matters brought before the Special Meeting.

Voting materials, which include the Proxy Statement and the Proxy Card, are being mailed to stockholders on or about     , 2020. The executive office of our Company is located atMarchex, Inc., 520 Pike Street, 1211 Building Conference Center, 12th floor,Suite 2000, Seattle, Washington 98101.

As previously announced, on August 7, 2020, the Company (the “Seller”) and Archenia, Inc. (the “Purchaser”), entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”), pursuant to which, and upon the terms and subject to the conditions thereof, the Purchaser will acquire the Seller’s (i) advertising network for businesses that drive sales through inbound phone calls (the “Call Marketplace Product”), (ii) advertising solution for small business resellers to sell call advertising, search marketing and other lead generation products through their existing sales channels to their small business advertisers (the “Local Leads Product”), and (iii) related business operations and certain other assets including an equity interest in Uproar.car Corporation (“Uproar,” and together with the Call Marketplace Product and the Local Leads Product, the “Business”), and assume certain liabilities of the Seller (the “Transaction”).  

We do not believe that the sale of the Business, under Delaware law, would be deemed a sale of all, or substantially all, of our assets, to the Purchaser on the terms and subject to the conditions set forth in the Asset Purchase Agreement, but we are seeking stockholder approval regarding the sale of the Business because the special committee of the Board comprised solely of independent directors of the Company (the “Special Committee”), along with the full Board, in conjunction with the Purchaser, considered the action appropriate, and strongly desire the input of the Company’s stockholders, given the historical significance of the Business, and given that Russell C. Horowitz, Co-CEO of the Seller, and Michael Arends, Co-CEO and Chief Financial Officer of the Seller, are the controlling stockholders of the Purchaser.

As consideration for the Business, Purchaser has agreed to pay us (a) $2.25 million in cash; (b) contingent consideration based on revenue from the Call Marketplace Product (once cumulative revenues exceed $140.0 million post transaction, 2.5% of incremental revenues net of direct variable costs for a 24-month period), the Local Leads Product (once cumulative revenues exceed $6.0 million post transaction, 15% of


incremental revenues net of direct variable costs), and the Purchaser’s total business (once annual revenues exceed $53.0 million in any of calendar years 2021, 2022 and 2023, 0.25% of incremental revenues); (c) contingent consideration for any sale of the Purchaser (if sold for greater than $11.1 million within 24-months following purposes as more fully describedclosing, 30% of incremental proceeds); (d) shares of Class B common stock in the accompanying proxy statement:Purchaser equal to a 10% equity interest at closing; and (e) the cancellation of Company stock options for 1.5 million shares currently held by Messrs. Horowitz and Arends. Messrs. Horowitz and Arends will remain in their current executive officer positions with the Company with no change in their roles or duties. While Messrs. Horowitz and Arends are the controlling stockholders of the Purchaser, they have advised the Company that they will not have executive officer positions with Purchaser. Seller and Purchaser have also agreed to enter into a support services agreement pursuant to which Seller, following the closing of the transaction, will provide services to Purchaser on a cost-plus 5% basis, with minimum payments to the Company of $3.5 million in the first year following closing, and $1.5 million in the second year following closing (with the second year minimum payment subject to a minimum revenue threshold of Purchaser for such year).

At the Special Meeting, stockholders will be asked to:

 

1.

To elect four (4) individuals to serve on our Board of Directors forApprove the ensuing yearTransaction, the Asset Purchase Agreement and until their successors are elected;the other transactions and ancillary documents contemplated by the Asset Purchase Agreement (the “Related Agreements”) (the “Asset Sale Proposal”);

 

2.

To ratifyApprove a proposal to adjourn or postpone the appointment of Moss Adams LLP (“Moss Adams”) as our independent registered public accounting firmSpecial Meeting, if necessary or appropriate, for the fiscal year ending December 31, 2017;purpose of soliciting additional votes for the approval of the Asset Sale Proposal (the “Adjournment Proposal”); and

 

3.

To approve the adoption of an amendment to our amended and restated bylaws to provide that the courts located within the State of Delaware will serve as the exclusive forum for the adjudication of certain legal disputes;

4.

To approve, by a non-binding advisory vote, the compensation paid to our named executive officers;

5.

To select, by a non-binding advisory vote, the frequency at which stockholders will be asked to approve the compensation paid to our named executive officers;

6.

To reapprove provisions of the 2012 Stock Incentive Plan to enable the Company to deduct in full certain plan-related compensation under Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”); and

7.

To transact anyTransact such other business that may properly come before the annual meeting and any adjournment or postponement thereof.meeting.

OurStockholders are referred to the Proxy Statement for more detailed information with respect to the matters to be considered at the Special Meeting. After careful consideration, the Board, in reliance on the recommendation from the Special Committee, has unanimously determined that the Transaction, the Asset Purchase Agreement and the Related Agreements are fair, advisable to and in the best interests of Directorsthe Company and its stockholders and recommends a vote FOR items 1, 2, 3, 4that you vote:

“FOR” the Asset Sale Proposal (Proposal One);

“FOR” the Adjournment Proposal (Proposal Two); and 6 and THREE YEARS for item 5.

in the proxy holder’s best judgment as to any other matters that may properly come before the Special Meeting.

All stockholders are invited to join the Special Meeting via the Meeting Website. The Board of Directors of Marchex has fixed the close of business on June 27, 2017 asAugust 10, 2020 is the record date for the Annual Meeting. Onlydetermining stockholders of record on the record date are entitled to notice of, and to vote at, the AnnualSpecial Meeting. Further information regarding voting rightsConsequently, only stockholders whose names appear on our books as owning our Class A common stock and Class B common stock at the mattersclose of business on August 10, 2020 will be entitled to be voted upon is presented innotice of, and to vote at, the accompanying proxy statement.Special Meeting and any adjournment or postponement thereof.

 


Your vote is important

YOUR VOTE AND PARTICIPATION IN THE COMPANY’S AFFAIRS ARE IMPORTANT.Whether or not

If your shares are registered in your name, even if you plan to attendjoin the AnnualSpecial Meeting pleasevia the Meeting Website or any adjournment or postponement of the Special Meeting, we request that you vote by telephone or Internet, by following the voting procedures described in the Notice of Internet Availability of Proxy Materials. If you received printed proxy materials and wish to vote by mail,or promptly complete, date and sign the enclosed proxy card and return it in the accompanying envelope.

If your shares are held in the name of a broker, bank or other nominee, and you receive notice of the Special Meeting through your broker, bank or other nominee, please vote or complete and return the materials in accordance with the instructions provided to you by such broker, bank or other nominee or contact your broker, bank or other nominee directly in order to obtain a proxy issued to you by your nominee holder to participate in the Special Meeting and submit your vote through the Meeting Website. Failure to do so may result in your shares not being eligible to be voted by proxy at the Special Meeting.

The Proxy Statement contains important information concerning the Special Meeting, the Transaction, the Asset Purchase Agreement and the Related Agreements, including information as to how to cast your vote. We appreciateencourage you to read the Proxy Statement, the Asset Purchase Agreement and the other annex to the Proxy Statement carefully and in their entirety.

The Asset Sale Proposal must be approved by both (a) stockholders representing a majority of the voting power of all issued and outstanding Class A common stock and Class B common stock entitled to vote at the Special Meeting (treated as a single class) and (b) stockholders representing a majority of the voting power of all issued and outstanding Class A common stock and Class B common stock entitled to vote at the Special Meeting (treated as a single class), disregarding stock owned by Russell C. Horowitz and Michael Arends. Therefore, if you do not vote by proxy or join the Special Meeting and submit a vote via the Meeting Website or, if you hold your continued supportshares in “street name,” properly instruct your broker, bank or other nominee with respect to voting your shares, it will have the same effect as if you voted “AGAINST” the Asset Sale Proposal.

Your vote is important. Please complete, sign, date and promptly return the proxy card in the enclosed envelope, so that your shares will be represented whether or not you join the Special Meeting via the Meeting Website.  Returning a proxy card will not deprive you of Marchex.your right to join the Special Meeting and vote your shares via the Meeting Website.

 

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE SPECIAL MEETING TO BE HELD ON OCTOBER 1, 2020:

THIS NOTICE OF SPECIAL MEETING, PROXY STATEMENT AND PROXY CARD ARE AVAILABLE AT www.investorvote.com/MCHX.

By order of the Board of Directors

Ethan Caldwell

General Counsel, Secretary and member of the

Office of the CEO  

Seattle, Washington

July 10, 2017


TABLE OF CONTENTS

Dated:               , 2020

Page

Proxy Statement General Information

1

Cautionary Note Regarding Forward-Looking Statements

4

Security Ownership of Certain Beneficial Owners and Management

5

Proposal One-Election of Directors

7

Corporate Governance

9

Proposal Two-Ratification of Appointment of Independent Registered Public Accounting Firm

13

Independent Registered Accounting Firm Fees

14

Audit Committee Report

15

Proposal Three-Adoption of an Amendment to Our Amended and Restated Bylaws to Provide That the Courts Located Within the State of Delaware Will Serve as the Exclusive Forum for the Adjudication of Certain Legal Disputes

16

Additional Information Relating to Our Executive Officers and Directors

18

Executive Officers

18

Compensation Discussion and Analysis

18

Compensation Committee Report

23

Summary Compensation Table

24

2016 Grants of Plan Based Awards

26

Outstanding Equity Awards at 2016 Fiscal Year End

27

Option Exercises and Stock Vested During 2016

28

Potential Payments Upon Termination or Change in Control

28

Procedures for Review and Approval of Related Person Transactions

34

Compensation of Directors

34

Equity Compensation Plans

36

Proposal Four-Advisory Vote on Executive Compensation

38

Proposal Five-Advisory Vote on Frequency of Advisory Vote on Executive Compensation

39

Proposal Six-Reapproval of Certain Provisions of the 2012 Stock Incentive Plan

40

Section 16(a) Beneficial Ownership Reporting Compliance

45

Stockholder Proposals for 2018 Annual Meeting

45

Annual Report 2016 on Form 10-K

45

Appendix A: Marchex, Inc. 2012 Stock Incentive Plan

A-1

 

Michelle Paterniti

Seattle, Washington

General Counsel and Secretary

 

 

 

 


 

 

 

PROXY STATEMENT

2017 ANNUAL MEETING OF STOCKHOLDERS

AUGUST 21, 2017

GENERAL INFORMATIONSpecial Meeting of Stockholders

 

This proxy statement (this “Proxy Statement”) is being provided to solicit proxies on behalf of the Board of Directors of Marchex, Inc. for use at the 2017 AnnualSpecial Meeting of Stockholders to be held on August 21, 2017,October 1, 2020, at 10:00 AM Pacific Time, at Marchex, Inc., 520 Pike Street, 1211 Building Conference Center, 12th Floor, Seattle, Washington,via the Internet, and at any adjournment or postponement thereof. We expect

All references in this Proxy Statement to:

“Marchex,” the “Company,” “Seller,” “we,” “us,” or “our” refer to first make this proxy statement available,Marchex, Inc.;

“Purchaser” refers to Archenia, Inc.;

the “Asset Purchase Agreement” refers to the Asset Purchase Agreement, dated as of August 7, 2020, by and between the Company and Purchaser;

the “Transaction” refers to the sale of the Business, as contemplated by the Asset Purchase Agreement, together with the Related Agreements and the other transactions contemplated thereby;

the “Call Marketplace Product” refers to our advertising network for businesses that drive sales through inbound phone calls;

the “Local Leads Product” refers to our Annual Reportadvertising solution for small business resellers to sell call advertising, search marketing and other lead generation products through their existing sales channels to their small business advertisers;

the fiscal year ended December 31, 2016,“Business” refers to the Call Marketplace Product, the Local Leads Product and related business operations and certain other assets including an equity interest in Uproar.car Corporation (“Uproar”); and

the “Related Agreements” refers to the Support Services Agreement, Subscription Agreement, Bill of Sale, Assignment and Assumption Agreement, Domain Name Assignment Agreement, Trademark Assignment and Transfer Agreement and Patent Assignment Agreement, all of which are exhibits to the Asset Purchase Agreement.

Capitalized terms used but not defined elsewhere in this Proxy Statement shall have the meanings set forth in the Asset Purchase Agreement.

Neither the Securities and Exchange Commission nor any other regulatory agency has approved or disapproved of the Transaction, passed upon the merits or fairness of the Transaction, or passed upon the adequacy or accuracy of this Proxy Statement. Any representation to the contrary is a criminal offense.

The Proxy Statement is dated               , 2020 and is first being mailed to stockholders on approximately July 10, 2017.or about               , 2020.


TABLE OF CONTENTS

SUMMARY TERM SHEET

1

QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING

10

RISK FACTORS

17

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

20

THE SPECIAL MEETING

21

Time, Date and Place

21

Purpose of the Special Meeting

21

Recommendation of Our Board

21

Record Date and Voting Power

22

Quorum

22

Required Vote

22

Voting by Stockholders

23

Abstentions

24

Broker Non-Votes

24

Failure to Vote

24

Revocability of Proxies

25

Adjournments

25

Solicitation of Proxies

25

Questions and Additional Information

25

PROPOSAL ONE: ASSET SALE PROPOSAL

26

Information about the Parties

26

General Description of the Transaction

26

Consideration for the Transaction

27

Background of the Transaction

27

Reasons for the Transaction and Recommendation of Our Board

31

Opinion of the Financial Advisor to the Company

33

Summary of Material Financial Analysis

36

General

38

Use of Proceeds and Future Operations

39

No Appraisal or Dissenters’ Rights

39

Regulatory Matters

39

Material U.S. Federal Income Tax Consequences

39

Anticipated Accounting Treatment

40


The Company’s Business following the Transaction

40

SEC Reporting

43

ASSET PURCHASE AGREEMENT

44

Purchase and Sale of Assets

44

Assumption of Liabilities

46

Consideration

46

Representations and Warranties

47

Covenants

48

Closing Conditions

49

Indemnification

50

Termination of the Asset Purchase Agreement

50

Transaction Costs

50

Governing Law

51

INTERESTS OF RELATED PARTIES IN THE TRANSACTION

52

FINANCIAL INFORMATION

53

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

54

PROPOSAL TWO: ADJOURNMENT PROPOSAL

56

STOCKHOLDER PROPOSALS FOR
2021 ANNUAL MEETING OF STOCKHOLDERS

57

HOUSEHOLDING OF PROXY MATERIALS

58

OTHER MATTERS

58

WHERE YOU CAN FIND MORE INFORMATION

59

INCORPORATION BY REFERENCE

59

INDEX TO FINANCIAL STATEMENTS

F-1

ANNEX A
ASSET PURCHASE AGREEMENT

ANNEX B
OPINION OF OUR FINANCIAL ADVISOR

B-1


SUMMARY TERM SHEET

This summary highlights selected information contained elsewhere in this Proxy Statement and may not contain all the information that is important to you with respect to the Transaction, the Asset Purchase Agreement, the Related Agreements and the other matters being considered at the Special Meeting of the Company’s stockholders to which this Proxy Statement relates. We urge you to read carefully the remainder of this Proxy Statement, including the attached annexes, and the other documents to which we have referred you. For additional information on the Company, see the section entitled “Where You Can Find More Information” beginning on page 56. We have included page references in this summary to direct you to a more complete description of the topics presented below.

Information about the Parties (see page 26)

The Company

We are a call analytics company that helps businesses connect, drive, measure, and convert callers into customers. We provide products and services for businesses of all sizes that depend on consumer phone calls or texts to drive sales. Our principal offices areanalytics technology can facilitate call quality and texting, analyze calls and measure the outcomes of calls. We also deliver performance-based, pay-for-call advertising across numerous mobile and online publishers to connect consumers with businesses over the phone.

We were incorporated in 2003 under the laws of the State of Delaware. Our executive office is located at 520 Pike Street, Suite 2000, Seattle, Washington 98101. Our telephone number is (206) 331-3300. Our website is www.marchex.com. The information contained on our website is not incorporated into this Proxy Statement.

In this proxy statement,Our Class B common stock is listed on The NASDAQ Global Select Market under the ticker symbol “MCHX.”

Purchaser

Archenia, Inc. provides adverting marketing services and lead generation.  It was incorporated in 2020 under the laws of the State of Delaware.

The Asset Purchase Agreement (see page 43 and Annex A)

On August 7, 2020, we referentered into the Asset Purchase Agreement with Purchaser pursuant to Marchex, Inc. as Marchex, we, us or the Company.

Internet Availability of Annual Meeting Materials

Under rules adopted by the Securities and Exchange Commission, or SEC,which we have electedagreed to provide accesssell to our proxy materials over the Internet. Accordingly, we are sending a Notice of Internet Availability of Proxy Materials, orPurchaser the Notice,Business, subject to our stockholders of record. All stockholders will havecertain conditions, including the ability to access the proxy materials on the website referred to in the Notice or to request to receive a printed setapproval of the proxy materials. Instructions on how to accessTransaction by stockholders at the proxy materials over the Internet or to requestSpecial Meeting representing (a) a printed copy may be found in the Notice. You will not receive a printed copymajority of the proxy materials unless you request one in the manner set forth in the Notice. This permits us to conserve natural resourcesvoting power of all issued and reduces our printing costs, while giving stockholders a convenientoutstanding Class A common stock and efficient way to access our proxy materials and vote their shares.

We intend to mail the Notice on or about July 10, 2017 to all stockholders of recordClass B common stock entitled to vote at the Annual Meeting.Special Meeting (treated as a single class) and (b) a majority of the voting power of all issued and outstanding Class A common stock and Class B common stock entitled to vote at the Special Meeting (treated as a single class), disregarding stock owned by Russell C. Horowitz and Michael Arends (the approval in clause (b), the “Majority of the Minority Vote,” and together with the approval in clause (a), “Stockholder Approval”).  We are seeking the Majority of the Minority Vote because a special committee (the “Special Committee”) of our board of directors (the “Board”) comprised solely of independent directors, in conjunction with the Purchaser, determined that doing so was appropriate given that Messrs. Horowitz and Arends are the controlling stockholders of the Purchaser. Under the terms of the Asset Purchase Agreement, we will retain certain specified assets, including all of our cash and cash equivalents, bank accounts (other than the Uproar bank account), certain contracts that are not expressly assumed by Purchaser, all intellectual property owned by us other than intellectual property primarily related to the Business, and certain other assets specified in


the Asset Purchase Agreement, and will also retain certain specified liabilities, including all liabilities with respect to taxes related to the Business arising before the closing of the Transaction, and certain other liabilities specified in the Asset Purchase Agreement.

Who MayA copy of the Asset Purchase Agreement is attached as Annex A to this Proxy Statement. You are encouraged to read the Asset Purchase Agreement carefully and in its entirety.

The Company’s Business Following the Transaction (see page 40)

Following the Transaction, we will continue to operate and manage our call analyticsbusiness, through which we provide various analytics and solutions products (the “Analytics and Solutions Products”) via our platforms to enterprises that depend on inbound phone calls to drive sales, appointments and reservations. Marketers can use these platforms to understand which marketing channels, advertisements, search keywords, or other digital marketing advertising formats are driving calls to their business, allowing them to optimize their advertising expenditures across media channels. The Analytics and Solutions Products also include technology that can extract data and insights about what is happening during a call and measures the outcome of calls and return on investment. The platform also includes technology that can block robocalls, telemarketers and spam calls to help save businesses time and expense. The Analytics and Solutions Products data can integrate directly into third-party marketer workflows such as Salesforce, Eloqua, Adobe, Google Search, Kenshoo, Marin Software, Facebook and Instagram, in addition to other marketing dashboards and tools. Advertisers pay us a fee for each call/text or call/text related data element they receive from calls or texts, including call-based ads we distribute through our sources of call distribution or for each phone number tracked based on pre-negotiated rates.

For further information regarding our platform, including our Analytics and Solutions Products, see “Proposal One: Asset Sale Proposal – The Company’s Business Following the Transaction.

Consideration for the Business (see page 27)

As consideration for the sale of the Business, Purchaser has agreed to pay us (a) $2.25 million in cash (the “Base Cash Payment Amount”); (b) contingent consideration based on revenue from the Call Marketplace Product (once cumulative revenues exceed $140.0 million post transaction, 2.5% of incremental revenues net of direct variable costs for a 24-month period), the Local Leads Product (once cumulative revenues exceed $6.0 million post transaction, 15% of incremental revenues net of direct variable costs), and the Purchaser’s total business (once annual revenues exceed $53.0 million in any of calendar years 2021, 2022 and 2023, 0.25% of incremental revenues); (c) contingent consideration for any sale of the Purchaser (if sold for greater than $11.1 million within 24-months following closing, 30% of incremental proceeds) ((b) and (c) collectively, the “Contingent Consideration”); (d) shares of Class B common stock in the Purchaser equal to a 10% equity interest at closing (the “Equity Consideration”); and (e) the cancellation of Company stock options for 1.5 million shares currently held by Russell C. Horowitz and Michael Arends.


Special Meeting (see page 21)

Date, Time and Place

The Board is soliciting proxies for the Special Meeting to be held on Thursday, October 1, 2020, at 10:00 AM Pacific Time virtually via the Internet. The Company has decided to hold this meeting exclusively via the Internet and not in a physical location given the ongoing public health impacts of the COVID-19 pandemic and the importance of the health and safety of the Company’s directors, officers, employees and stockholders. There will not be a physical meeting location, and the Company’s stockholders will not be able to attend the Special Meeting in person. The Special Meeting can be accessed by visiting www.meetingcenter.io/240872478 (the “Meeting Website”), where stockholders will be able to listen to the meeting, submit questions and vote online.

Purpose

At our Special Meeting, stockholders will act upon the matters outlined in the notice, including the following:

a proposal to approve the Transaction, the Asset Purchase Agreement and the Related Agreements (the “Asset Sale Proposal”);

a proposal to adjourn or postpone the Special Meeting, if necessary or appropriate, for the purpose of soliciting additional votes for the approval of the Asset Sale Proposal (the “Adjournment Proposal”); and

transact such other business that may properly come before the meeting.

Obtaining Stockholder Approval is a condition for the Transaction to occur. If the Company does not obtain Stockholder Approval, the Transaction will not occur.

Stockholders Entitled to Notice and to Vote

Only holders of record of our Class A common stock and holders of record of our special votingClass B common stock, at the close of business on June 27, 2017, or the August 10, 2020 (the “Record Date”), will be entitled to notice of, and to vote at, the AnnualSpecial Meeting. On the Record Date, 5,056,1364,660,927 shares of Class A common stock and 38,284,25439,896,634 shares of Class B common stock were issued and outstanding. Each share of Class A common stock is entitled to twenty-five (25) votes at the AnnualSpecial Meeting and each share of Class B common stock is entitled to one (1) vote at the AnnualSpecial Meeting. Holders of Class A common stock and Class B common stock will vote together as a single class on all matters that come before the AnnualSpecial Meeting; accordingly, throughout this proxy statement we refer generally to our outstanding Class A common stock and Class B common stock together as our "Common Stock."Common Stock.”

What Constitutes a Quorum

Stockholders may not take action at the AnnualSpecial Meeting unless there is a quorum present at the meeting. The presence, in personvia the Meeting Website or by proxy, of a majority of the voting power of the outstanding shares of Common Stock entitled to vote as of the close of business on the Record Date constitutes a quorum. Abstentions and broker non-votes will count toward establishing a quorum. Broker non-votes occur when brokers holding shares in street name for beneficial owners do not receive instructions from the beneficial owners about how to vote the shares. An abstention occurs when a stockholder withholds such stockholder's vote by checking the "abstain"“abstain” box on the proxy card, or similarly elects to abstain via the


Internet voting. Under the rules that govern brokers who are voting with respect to shares held in street name, brokers have the discretion to vote such shares on routine matters, including the ratification of appointment of independent registered accounting firm.

Distinction between Holding Shares as a Stockholder of Record and as a Beneficial Owner


Some of our stockholders hold their shares through a broker, trustee, or other nominee rather than directly in their own name. As summarized below, there are some distinctions between shares held of record and those shares owned beneficially.

Stockholder of Record. If your shares are registered directly in your name with our transfer agent, Computershare Trust Company, N.A. (“Computershare”), then you are considered, with respect to those shares, the “stockholder of record.” As the stockholder of record, you have the right to grant your voting proxy directly to us or to a third party, or to vote while virtually participating in the Special Meeting.

Beneficial Owner. If your shares are held in a brokerage account, by a trustee or by another nominee, then you are considered the “beneficial owner” of those shares. As the beneficial owner of those shares, you have the right to direct your broker, trustee, or nominee how to vote and you also are invited to join the Special Meeting via the Meeting Website. However, because a beneficial owner is not the stockholder of record, you may not vote these shares while participating in the Special Meeting via the Meeting Website unless you obtain a “legal proxy” from the broker, trustee or nominee that holds your shares, giving you the right to vote the shares while participating in Special Meeting via the Meeting Website.

If you are not a stockholder of record, please understand that we do not know that you are a stockholder, or how many shares you own.

Required Vote Required

For Proposal One,: Under applicable law the approval of the Asset Sale Proposal requires the affirmative vote of (a) a majority of the voting power of all issued and our current bylaws,outstanding Class A common stock and Class B common stock entitled to vote at the four (4) director candidates who receiveSpecial Meeting (treated as a single class) and (b) a majority of the greatest numbervoting power of votes cast forall issued and outstanding Class A common stock and Class B common stock entitled to vote at the electionSpecial Meeting (treated as a single class), disregarding stock owned by Russell C. Horowitz and Michael Arends (“the “Majority of directors by sharesthe Minority Vote”) as of the close of business on the Record Date present in personvia the Meeting Website or represented by proxy and entitled to vote shall be elected directors.proxy.

For Proposal Two,: The ratification regardless of whether a quorum is present at the appointment of Moss Adams as our independent registered public accounting firm requiresSpecial Meeting, the affirmative vote of a majority of the votesvoting power cast by stockholders present via the Meeting Website or represented by proxy at the Annual Meeting.Special Meeting constitutes approval.

Proposal Three: The adoption of an amendmentAbstentions and broker non-votes are counted to our amended and restated bylaws to provide that the courts located within the State of Delaware will serve as the exclusive forum for the adjudication of certain legal disputes requires the affirmative vote ofdetermine whether a majority of the votes castquorum is present at the Annual Meeting.

Proposal Four: The advisorySpecial Meeting but are not counted as a vote on the compensation paid to our named executive officers requires the affirmative votein favor of or against a majority of the votes cast at the Annual Meeting.

Proposal FiveThe advisory vote on the frequency of the vote on the compensation paid to our named executive officers will be determined by a plurality of the votes cast.

Proposal Six: The reapproval of certain provision of the 2012 Stock Incentive Plan requires the affirmative vote of a majority of the votes cast at the Annual Meeting.

particular matter.

Voting Process

SharesYour vote is very important to us and we hope that are properly votedyou will join the Special Meeting via the Meeting Website. However, whether or for whichnot you plan to join the Special Meeting via the Meeting Website, please vote by proxy cards are properly executed and returned will be voted at the Annual Meeting in accordance with the directions giveninstructions on your proxy card or in the absencevoting instruction card (from your broker, bank or other nominee). Below are descriptions of directions, will be voted "FOR" Proposals No. 1, 2, 3, 4, and 6 and “Three Years” for Proposal 5.

It is not expected that any other matters will be brought before the Annual Meeting. If, however, other matters are properly presented, the persons named as proxies will vote in accordance with their discretion with respect to such matters.

The manner in which your shares may be voted depends on how your shares are held. If you are the record holder of your shares, meaning you appear as the holder of your shares on the records of our stock transfer agent, you may vote thoseyour shares via the Internet,depending on whether or if you request a printed copy of the proxy materials, via a proxy card for voting those shares included with the printed proxy materials. If you own shares in street name, meaningnot you are a stockholder of record or a beneficial owner with your shares held through a bank or brokerage firm, you may instead receive a voting instruction form with this proxy statement that you may use to instruct your bank or brokerage firm how to vote your shares.owner.


Voting on the InternetStockholders of Record

You can vote your shares via the Internet by following the instructions in the Notice.

By Proxy via the Internet. Registered stockholders can vote your shares via the Internet at www.investorvote.com/MCHX. Please have your proxy card in hand when going online and follow the online instructions. Stockholders that vote by Internet must bear all costs associated with electronic access, including Internet access fees. Internet voting by proxy for registered stockholders is available up until 5:00 PM, Pacific Time, on September 30, 2020.  The Internet proxy voting procedures are designed to authenticate your identity and to allow you to vote your shares and confirm your voting instructions have been properly recorded. If you vote by proxy via the Internet, you do not need to complete and mail a proxy card. We encourage you to vote your shares by proxy via the Internet even if you plan to join the Special Meeting via the Meeting Website.

By Telephone. Registered stockholders also may vote by telephone calling 1-866-641-4276 (toll-free) and using any touch-tone telephone to transmit their votes up to 5:00 PM, Pacific Time, on September 30, 2020. Please have your proxy card in hand when you call and then follow the instructions. The control number necessary to vote your shares and confirm your voting instructions have been properly recorded. If you vote via the Internet, you do not need to complete and mail a proxy card. We encourage you to vote your shares via the Internet even if you plan to attend the Annual Meeting.

Voting by Mail

Youtelephone can vote your shares by mail by requesting a printed copy of the proxy materials sent to your address. When you receive the proxy materials, you may fill out the proxy card enclosed therein and return it per the instructionsbe found on the card. By signing and returning theenclosed proxy card according to the instructions provided, you are enabling the individuals named on the proxy card, known as "proxies," to vote your shares at the Annual Meeting in the manner you indicate. If you request a printed copy of the proxy materials, we encourage you to sign and return the proxy card even if you plan to attend the Annual Meeting.



Voting by Telephone

You may be able to vote by telephone. If so, instructions are included with your Notice.card. If you vote by telephone, you do not need to complete and mail your proxy card.

AttendanceBy Mail. Registered stockholders may vote your shares by signing, dating and Votingmailing the enclosed proxy card using the enclosed postage pre-paid envelope.  We strongly encourage you, however, to consider using the Internet or telephone voting options described above because these voting methods are faster and less costly than voting by mailing your signed and dated proxy card. If you vote via the Internet or telephone, you do not need to mail your proxy card.

By Virtually Participating in the Special Meeting. If you are the record holder of your shares, you may join the Special Meeting and submit a vote via the Meeting Website by joining as a “Stockholder” by entering the control number found on your proxy card or notice, or email you previously received and following the instructions on the Meeting Website. The password for the meeting is MCHX2020. If you own your stock in street name, you may join the Special Meeting via the Meeting Website, but in order to submit a vote of your shares via the Meeting Website during the Special Meeting, you must register in advance to attend the Special Meeting. To register you must submit proof of your proxy power (legal proxy) reflecting your Marchex holdings along with your name and email address to Computershare. Requests for registration must be labeled as “Legal Proxy” and be received no later than 5:00 p.m., Pacific Time, on September 24, 2020. You will receive a confirmation email from Computershare of your registration. Requests for registration should be directed to Computershare by email at the following address:

o

Forward the email from your broker, or attach an image of your legal proxy, to legalproxy@computershare.com

Beneficial Owners

If your shares are held of record in the name of a bank, broker or other nominee you should follow the separate instructions that the nominee provides to you. Although most banks and brokers now offer Internet and telephone voting, availability and specific processes will depend on their voting arrangements.


If your shares are held of record in the name of your bank, broker or other nominee and you would like to submit a vote during your participation in the Special Meeting, you must you must register in advance to attend the Special Meeting. You also must submit proof of your proxy power (legal proxy) from your bank, broker or other nominee reflecting your Marchex holdings along with your name and email address to Computershare by email at the Annual Meetingemail address legalproxy@computershare.com. Requests for registration must be labeled “Legal Proxy” and be received no later than 5:00 p.m., Eastern Time, on September 24, 2020. You will receive a confirmation email from Computershare of your registration.

Treatment of Voting Instructions

If you are the record holder ofprovide specific voting instructions, your shares you may attend the Annual Meeting and vote in person. You will be required to present a form of photo identification for admission to the Annual Meeting. voted as instructed.

If you ownhold shares as the stockholder of record and provide a proxy without giving specific voting instructions, then your stockshares will be voted in street name, youaccordance with the recommendation of the Board (in reliance on the recommendation from the Special Committee) set forth below.

You may attend the Annual Meeting in person provided that you present a form of photo identification and confirmation of ownership, such as a recent brokerage statementhave granted to your broker, trustee, or a letter from a bankother nominee discretionary voting authority over your account. Your broker, trustee, or broker, but in orderother nominee may be able to vote your shares atdepending on the Annual Meetingterms of the agreement you must obtain a "legal proxy" fromhave with your broker, trustee, or other nominee.

The persons identified as having the bank or brokerage firm that holds your shares. You should contact your bank or brokerage account representativeauthority to obtain a legal proxy.

Revocation

If you arevote the record holder of your shares, youproxies granted by the proxy card will have discretionary authority to vote, in their discretion, to the extent permitted by applicable law, on such other business as may revoke a previously granted proxy at any timeproperly come before the Annual Meeting by delivering to the Secretary of Marchex, Inc. a written notice of revocation or a duly executed proxy bearing a later date or by attending the AnnualSpecial Meeting and voting in person. Any stockholder owning shares in street name may changeany postponement or revoke previously given voting instructions by contactingadjournment. The Board is not aware of any other matters that are likely to be brought before the bank or brokerage firm holding the shares or by obtaining a legal proxy from such bank or brokerage firm and voting in person at the AnnualSpecial Meeting. Your personal attendance at the Annual Meeting does not revoke your proxy. Your last vote, prior to or at the Annual Meeting, is the vote that will be counted.

Householding

The SEC permits companies to send a single Notice, and for those stockholders that elect to receive a paper copy of proxy materials in the mail one copy of this proxy statement, together with our Annual Report for the fiscal year ended December 31, 2016, to any household at which two or more stockholders reside, unless contrary instructions have been received, but only if we provide advance notice and follow certain procedures. In such cases, each stockholder continues to receive a separate Notice, and for those stockholders that elect to receive a paper copy of proxy materials in the mail, one copy of our fiscal 2016 Annual Report and this proxy statement. This householding process reduces the volume of duplicate information and reduces printing and mailing expenses.

We have not instituted householding for stockholders of record; however, certain brokerage firms may have instituted householding for beneficial owners of our Common Stock held through brokerage firms. If your family has multiple accounts holding our Common Stock, you may have already received householding notification from your broker. Please contact your broker directly if you have any questions or require additional copies of the Notice, our fiscal 2016 Annual Report and this proxy statement. The broker will arrange for delivery of a separate copy of the Notice, and, if so requested, a separate copy of these proxy materials promptly upon your written or oral request. You may decide at any time to revoke your decision to household, and thereby receive multiple copies.

Solicitation of Proxies

We pay the cost of soliciting proxies for the Special Meeting, and we have engaged Georgeson LLC, a proxy solicitation firm, to assist in the solicitation of proxies for the Special Meeting and will pay Georgeson LLC an estimated fee of $8,500, plus reimbursement of reasonable out of pocket expenses. We solicit by mail, telephone, personal contact and electronic means and arrangements are made with brokerage houses and other custodians, nominees and fiduciaries to send notices, and if requested, other proxy materials, to beneficial owners. Upon request, we will reimburse them for their reasonable expenses. In addition, our directors, officers and employees may solicit proxies, either personally or by telephone, facsimile or written or electronic mail. Stockholders are requested to return their proxies without delay.

Recommendation of Our Board (see page 21)

After careful consideration, our Board (in reliance on the recommendation from the Special Committee) unanimously recommends that you vote:

Proposal One - FOR the Asset Sale Proposal; and

Proposal Two - FOR the Adjournment Proposal.

In reaching its decision to approve the Transaction, the Asset Purchase Agreement and the Related Agreements and to recommend that you vote in the manner noted above, our Board considered a wide range of factors relating to the Transaction, the Asset Purchase Agreement and the Related Agreements.  These factors included, among others, the Company’s prior unsuccessful efforts to sell the Call Marketplace Product and the Local Leads Product, the significant customer concentration without long term contracts, the revenue and contribution variability of the Business, the lower margin profile of the Call Marketplace


Product, and the lower trading multiples generally associated with the Business, the Special Committee’s unanimous approval of the Transaction, the value of the consideration to be received, and the financial analysis and fairness opinion of the financial advisor retained by the Special Committee summarized under “Opinion of the Financial Advisor to the Company.  . For more information on these factors, other factors considered, and the Special Committee process, see “Proposal One: Asset Sale Proposal – Reasons for the Transaction and Recommendation of Our Board.”

Opinion of the Financial Advisor to the Company (see page 34)

On August 7, 2020, ROTH Capital Partners, LLC (“ROTH”) rendered its oral opinion to the Special Committee and the full Board (which was subsequently confirmed in writing by delivery of ROTH’s written opinion addressed to the Board dated the same date) as to, as of August 7, 2020, the fairness, from a financial point of view, to the Company of the consideration to be received by Seller in the Transaction pursuant to the Asset Purchase Agreement in exchange for the Business, subject to certain liabilities of Seller as described in the Asset Purchase Agreement to be assumed by Purchaser in the Transaction (the “Assumed Liabilities”).

ROTH’s opinion was directed to the Special Committee and the Board (in its capacity as such), and only addressed the fairness, from a financial point of view, to the Company of the consideration to be received by Seller in exchange for the Business subject to the Assumed Liabilities in the Transaction pursuant to the Asset Purchase Agreement and did not address any other aspect or implication of the Transaction, any Related Agreement or any other agreement, arrangement or understanding entered into in connection therewith or otherwise. The summary of ROTH’s opinion in this Proxy Statement is qualified in its entirety by reference to the full text of its written opinion, which is included as Annex B to this Proxy Statement and describes the procedures followed, assumptions made, qualifications and limitations on the review undertaken and other matters considered by ROTH in connection with the preparation of its opinion. However, neither ROTH’s written opinion nor the summary of its opinion and the related analyses set forth in this Proxy Statement is intended to be, and they do not constitute, a recommendation to the Board, any security holder of the Company or any other person as to how such person should vote or act with respect to any matter relating to the Transaction or otherwise.

Use of Proceeds and Future Operations (see page 38)

The Company, and not its stockholders, will receive the proceeds from the Transaction. The Company plans to use the proceeds for working capital and general corporate purposes, in connection with its continued business of providing Analytics and Solutions Products. While the Company may possibly use some proceeds to repurchase outstanding shares of its Class B common stock in the Tender Offer (as defined in “Proposal One: Asset Sale Proposal—Background of the Transaction”), the Company does not believe it must consummate the Transaction in order to proceed with the Tender Offer.  Our Board will evaluate alternatives for the use of the cash proceeds to be received at closing to continue to maximize stockholder value with a goal of returning value to our stockholders. The amounts and timing of our actual expenditures, however, will depend upon numerous factors, and we may find it necessary or advisable to use portions of the proceeds from the Transaction for different or presently non-contemplated purposes.

Expected Timing of the Transaction (see page 42)

We expect to complete the Transaction promptly following the Special Meeting if we obtain Stockholder Approval and the various other conditions to closing are satisfied or waived. However, the Transaction may not be completed as currently anticipated. Certain factors, including factors outside of our control and the control of Purchaser, could result in the Transaction being delayed or not occurring at all.


Covenants (see page 47)

Pursuant to the Asset Purchase Agreement, the Company has agreed to certain covenants with respect to, among other things, the following:

the payment of any transfer taxes (as defined in the Asset Purchase Agreement) applicable to the sale of the Business;

confidentiality and non-disparagement;

non-competition with respect to Purchaser’s business;

employment by Purchaser of certain Company employees; and

delivery of required consents related to the Transaction.

Closing Conditions (see page 48)

The completion of the Transaction is dependent upon the satisfaction of a number of conditions, including:

all consents, approvals, orders or authorizations of, or registrations, declarations or filings with, all Governmental Authorities required in connection with the execution, delivery or performance hereof shall have been obtained or made;

the parties shall have performed in all material respects all covenants and agreements required to be performed by each of them at or prior to the closing;

receipt of Stockholder Approval, including the Majority of the Minority Approval;

receipt of the written consents (or waivers with respect thereto) as described in Schedule 4 of the Asset Purchase Agreement;

delivery of the various Related Agreements; and

no occurrence of any Material Adverse Effect, which generally refers to a change, event, effect or occurrence that is or may be reasonably likely to be materially adverse to the financial condition, results of operations, properties, assets or liabilities or prospects of the Business or the Assets taken as a whole, subject to certain exclusions relating to general economic, political, industry, or financial conditions, acts of war, changes in laws or accounting rules, and the Transaction.

Indemnification (see page 48)

Under certain circumstances specified in the Asset Purchase Agreement, the Company and Purchaser have agreed to indemnify each other for certain losses.


Termination of the Asset Purchase Agreement (see page 49)

The Asset Purchase Agreement may be terminated:

in writing by mutual consent of the Parties; or

by written notice from a Party to the other Party, in the event of such other Party’s material failure to perform or uncured material breach of the Agreement.

In the event of termination, the Asset Purchase Agreement will become void without liability on the part of any Party or its officers, directors or stockholders (with certain limited exceptions).

No Appraisal or Dissenters’ Rights (see page 38)

No appraisal rights or dissenters’ rights are available to our stockholders under Delaware law or our certificate of incorporation or bylaws, each as amended to date, in connection with the Transaction.

Risk Factors (see page 17)

In evaluating the Asset Sale Proposal, in addition to the other information provided elsewhere in this Proxy Statement and the annexes hereto, you should carefully consider the risk factors relating to the Transaction and our future operations, as well as the risk factors contained in the other filings the Company makes from time to time with the Securities and Exchange Commission (the “SEC”).



QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING

The following questions and answers are intended to briefly address commonly asked questions as they pertain to the Special Meeting, the Asset Purchase Agreement and the Transaction. These questions and answers may not address all questions that may be important to you as a stockholder. Please refer to the “Summary Term Sheet” and the more detailed information contained elsewhere in this Proxy Statement and the annexes to this Proxy Statement, each of which you should read carefully.

WHAT IS A PROXY?

A proxy is another person that you legally designate to vote your stock. If you designate someone as your proxy in a written document, that document is also called a “proxy” or a “proxy card.” If you are a street name holder, you must obtain a proxy from your broker, bank or other nominee in order to vote your shares during your virtual participation in the Special Meeting.

WHAT IS A PROXY STATEMENT?

A proxy statement is a document that regulations of the SEC require that we give to you when we ask you to sign a proxy card to vote your stock at the Special Meeting.

WHO IS SOLICITING YOUR VOTE?

The Board is soliciting your vote for the Special Meeting being held on October 1, 2020, at 10:00 AM Pacific Time, virtually via the Internet. The Company has decided to hold this meeting exclusively via the Internet and not in a physical location given the ongoing public health impacts of the COVID-19 pandemic and the importance of the health and safety of the Company’s directors, officers, employees and stockholders. There will not be a physical meeting location, and the Company’s stockholders will not be able to attend the Special Meeting in person. The Special Meeting can be accessed by Meeting Website, where stockholders will be able to listen to the meeting, submit questions and vote online.

WHAT WILL YOU BE VOTING ON?

At the Special Meeting, the Company’s stockholders will consider: (1) approval of the Transaction, the Asset Purchase Agreement and the Related Agreements; (2) approval of a proposal to adjourn or postpone the Special Meeting, if necessary or appropriate, for the purposes of soliciting additional votes for the approval of the Asset Sale Proposal; and (3) any other matters which may properly come before the meeting.

WHAT IS THE ASSET SALE PROPOSAL (PROPOSAL ONE)?

The Asset Sale Proposal is a proposal to sell the Business to Purchaser pursuant to the terms, and subject to certain conditions, of the Asset Purchase Agreement. Following the closing of the Transaction, we will continue to operate and manage our call analytics business, through which we provide the Analytics and Solutions Products.


WILL OUR CLASS B COMMON STOCK STILL BE PUBLICLY TRADED IF THE TRANSACTION IS COMPLETED?

Yes.  Our Class B common stock is currently traded on The NASDAQ Global Select Market under the ticker symbol “MCHX,” which we do not expect to change following the completion of the Transaction. It is not possible to predict the trading price of our Class B common stock following the closing of the Transaction. Accordingly, you may find it more difficult to dispose of your shares of Class B common stock, and you may not be able to sell some or all of your shares of Class B common stock when you desire. See “Risk Factors” for a further discussion of some of these risks.

DID THE SPECIAL COMMITTEE AND THE BOARD APPROVE THE TRANSACTION, ASSET PURCHASE AGREEMENT AND THE RELATED AGREEMENTS?

Yes. The Special Committee and the full Board (a) determined that the Transaction, the Asset Purchase Agreement, the Related Agreements and the other transactions contemplated thereby are fair, advisable to and in the best interests of the Company and its stockholders, and (b) approved the execution and delivery of the Asset Purchase Agreement, the Related Agreements and such other agreements necessary or appropriate to consummate the Transaction.  The full Board has recommended that the Company’s stockholders approve the Transaction, the Asset Purchase Agreement and the Related Agreements.

WHY DID THE SPECIAL COMMITTEE AND THE BOARD APPROVE THE TRANSACTION?

In reaching its decision to approve the Transaction, the Asset Purchase Agreement and the Related Agreements and to recommend that you vote in the manner noted above, our Board considered a wide range of factors relating to the Transaction, the Asset Purchase Agreement and the Related Agreements.  These factors included, among others, the Company’s prior unsuccessful efforts to sell the Call Marketplace Product and the Local Leads Product, the significant customer concentration without long term contracts, the revenue and contribution variability of the Business, the lower margin profile of the Call Marketplace Product, and the lower trading multiples generally associated with the Business, the Special Committee’s unanimous approval of the Transaction, the value of the consideration to be received, and the financial analysis and fairness opinion of the financial advisor retained by the Special Committee summarized under “Opinion of the Financial Advisor to the Company.  For more information on these factors, other factors considered, and the Special Committee process, see “Proposal One: Asset Sale Proposal – Reasons for the Transaction and Recommendation of Our Board.”

WHAT HAPPENS IF THE ASSET SALE PROPOSAL (PROPOSAL ONE) IS NOT APPROVED?

If stockholders do not approve the Asset Sale Proposal, the Transaction will not occur. Instead, the Company will retain the assets and liabilities proposed to be sold in the Transaction and will not receive the Base Cash Payment Amount, the Equity Consideration, or the Contingent Consideration. Further, the options held by Russell C. Horowitz and Michael Arends would not be cancelled.

IF THE ASSET SALE PROPOSAL (PROPOSAL ONE) IS APPROVED, WHEN WILL THE TRANSACTION CLOSE?

We currently anticipate that the Transaction will close promptly after the Special Meeting if the Asset Sale Proposal is approved, subject to the satisfaction or waiver of the closing conditions discussed elsewhere in this Proxy Statement.


WHAT IS THE ADJOURNMENT PROPOSAL (PROPOSAL TWO)?

The Adjournment Proposal is a proposal to adjourn or postpone the Special Meeting, if necessary or appropriate, to allow us to solicit additional votes for the approval of the Asset Sale Proposal.

WHAT ARE THE BOARD’S RECOMMENDATIONS ON HOW I SHOULD VOTE MY SHARES?

The Board (in reliance on the recommendation from the Special Committee) unanimously recommends that you vote your shares as follows:

Proposal One - FOR the Asset Sale Proposal; and

Proposal Two - FOR the Adjournment Proposal.

WHAT IS THE RECORD DATE AND WHAT DOES IT MEAN?

The Record Date to determine the stockholders entitled to notice of and to vote at the Special Meeting is the close of business on August 10, 2020. The Record Date was established by the Board as required by Delaware law. On the Record Date, 4,660,927 shares of Class A common stock and 39,896,634 shares of Class B common stock were issued and outstanding.

HOW MANY VOTES DO STOCKHOLDERS HAVE?

Each share of Class A common stock is entitled to twenty-five (25) votes at the Special Meeting and each share of Class B common stock is entitled to one (1) vote at the Special Meeting. Holders of Class A common stock and Class B common stock will vote together as a single class on all matters that come before the Special Meeting.  There is no cumulative voting.

HOW MANY VOTES MUST BE PRESENT TO HOLD THE MEETING?

The presence, via the Meeting Website or by proxy, of a majority of the voting power of the outstanding shares of Common Stock entitled to vote as of the close of business on the Record Date constitutes a quorum. Abstentions and broker non-votes will count toward establishing a quorum. Broker non-votes occur when brokers holding shares in street name for beneficial owners do not receive instructions from the beneficial owners about how to vote the shares.

HOW MAY I VOTE MY SHARES?

You can vote either during virtual participation in the Special Meeting or by proxy without joining the Special Meeting via the Meeting Website. We urge you to vote by proxy even if you plan to join the Special Meeting via the Meeting Website so that we will know as soon as possible that enough votes will be present for us to hold the meeting.


(a) How may I vote my shares while virtually participating in the meeting?

If your shares are registered directly in your name with our transfer agent, Computershare, on the Record Date, you are considered, with respect to those shares, the stockholder of record, and the proxy materials and proxy card are being sent directly to you by the Company. As the stockholder of record, you may participate virtually in the Special Meeting and submit a vote through the Meeting Website by visiting the Meeting Website, joining as a “Stockholder” by entering the control number found on your proxy card or notice, or email you previously received and following the instructions on the Meeting Website. The password for the meeting is MCHX2020.

If your shares are held in a brokerage account or by another nominee, you are considered the beneficial owner of shares held in street name, and the proxy materials are being forwarded to you together with a voting instruction card. If you own your stock in street name, you may attend the Special Meeting and vote your shares via the Meeting Website, but you must obtain a legal proxy from the bank or brokerage firm that holds your shares. You should contact your bank or brokerage account representative to obtain a legal proxy. Once you have the legal proxy, you must register to attend the Special Meeting by providing a copy of that legal proxy to Computershare along with your name and email address. Requests for registration must be labeled as “Legal Proxy” and be received no later than 5:00 p.m., Pacific Time, on September 24, 2020. You will receive a confirmation email from Computershare of your registration. Requests for registration should be directed to Computershare by email at the following address: legalproxy@computershare.com.

(b) How can I vote my shares without virtually participating in the meeting?

Whether you hold shares directly as a registered stockholder of record or beneficially in street name, you may vote without participating in the Special Meeting. You may vote by granting a proxy or, for shares held in street name, by submitting voting instructions to your broker or nominee. In most cases, you will be able to do this by telephone, by using the Internet or by mail. Please refer to the summary instructions included with proxy materials and on your proxy card. For shares held in street name, the voting instruction card will be included in the materials forwarded by the broker or nominee. If you have telephone or Internet access, you may submit your proxy by following the instructions with your proxy materials and on your proxy card. You may submit your proxy by mail by signing your proxy card or, for shares held in street name, by following the voting instructions with your proxy materials and on your proxy card. You may submit your proxy by mail by signing your proxy card or, for shares held in street name, by following the voting instruction card included in the materials forwarded by your stockbroker or nominee and mailing it in the enclosed, postage paid envelope. If you provide specific voting instructions, your shares will be voted as you have instructed.

WHAT IF I DO NOT SPECIFY HOW I WANT MY SHARES VOTED?

If you are a record holder who returns a completed proxy card that does not specify how you want to vote your shares on one or more proposals, the designated proxies will vote your shares for each proposal as to which you provide no voting instructions, and such shares will be voted in the following manner:

Proposal One - FOR the Asset Sale Proposal; and

Proposal Two - FOR the Adjournment Proposal.

If you are a “street name” holder and do not provide voting instructions on one or more proposals, your bank, broker or other nominee may be able to vote those shares.


HOW MANY VOTES ARE NEEDED TO APPROVE EACH PROPOSAL?

For Proposal One, the approval of the Asset Sale Proposal requires the affirmative vote of (a) a majority of the voting power of all issued and outstanding Class A common stock and Class B common stock entitled to vote at the Special Meeting (treated as a single class) and (b) a majority of the voting power of all issued and outstanding Class A common stock and Class B common stock entitled to vote at the Special Meeting (treated as a single class), disregarding stock owned by Russell C. Horowitz and Michael Arends (“the “Majority of the Minority Vote”), as of the close of business on the Record Date present via the Meeting Website or represented by proxy. Stockholders may vote “for”, “against” or “abstain” for the Asset Sale Proposal. If you “abstain” from voting on the Asset Sale Proposal, your abstention will have the same effect as a vote “against” the Asset Sale Proposal.

For Proposal Two, regardless of whether a quorum is present at the Special Meeting, the affirmative vote of a majority of the voting power cast by stockholders present via the Meeting Website or represented by proxy at the Special Meeting constitutes approval.

WHAT IS THE QUORUM REQUIREMENT?

A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if a majority of the voting power of the outstanding shares of Common Stock entitled to vote as of the close of business on the Record Date is present at the Special Meeting via the Meeting Website or represented by proxy. On the Record Date, 4,660,927 shares of Class A common stock and 39,896,634 shares of Class B common stock were issued and outstanding. Thus, 78,209,905 votes must be present via the Meeting Website or represented by proxy at the Special Meeting to have a quorum.

Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you participate virtually in the Special Meeting. Abstentions and broker non-votes will be counted towards the quorum requirement. If there is no quorum, the holders of a majority of shares of Common Stock present via the Meeting Website or represented by proxy may adjourn the Special Meeting to another date.

CAN I CHANGE MY VOTE?

If you are the record holder of your shares, you may revoke a previously granted proxy at any time before the Special Meeting by delivering to the Secretary of Marchex, Inc. a written notice of revocation or a duly executed proxy bearing a later date or by virtually participating in Special Meeting and submitting  your votes through the Meeting Website. Any stockholder owning shares in street name may change or revoke previously given voting instructions by contacting the bank or brokerage firm holding the shares or by obtaining a legal proxy from such bank or brokerage firm and voting in person at the Special Meeting. Your presence at the Special Meeting via the Meeting Website does not revoke your proxy. Your last vote, prior to or at the Special Meeting, is the vote that will be counted.

WHAT IF I VOTE “ABSTAIN”?

A vote to “abstain” on any matter indicates that your shares will not be voted for such matter and will have the effect of a vote against the proposal. Abstentions are considered as being present for quorum purposes.


IF I HOLD SHARES THROUGH A BROKER OR OTHER NOMINEE, CAN MY SHARES BE VOTED IF I DO NOT INSTRUCT MY BROKER OR OTHER NOMINEE OR MAKE ARRANGEMENTS TO ATTEND THE SPECIAL MEETING?

No.  If you hold your shares through a broker or other nominee, you must instruct it how to vote those shares at the Special Meeting, or else make arrangement to with your broker or other nominee to attend the Special Meeting.  A “broker non-vote” occur when a nominee holding shares for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power for that particular item and has not received instructions from the beneficial owner. Broker non-votes count for quorum purposes but not for voting purposes. If you have neither instructed your broker or other nominee, nor made arrangements with your broker or other nominee to virtually participate in the Special Meeting and virtually vote your shares, your shares will not be voted.

WHAT HAPPENS IF THE MEETING IS POSTPONED OR ADJOURNED?

Your proxy will still be valid and may be voted at the postponed or adjourned meeting. You will still be able to change or revoke your proxy until it is actually voted.

WHAT IS HOUSEHOLDING OF SPECIAL MEETING MATERIALS?

The SEC permits companies to send a single copy of proxy materials to any household at which two or more stockholders reside, unless contrary instructions have been received, but only if we provide advance notice and follow certain procedures. This householding process reduces the volume of duplicate information and reduces printing and mailing expenses.

We have not instituted householding for stockholders of record; however, certain brokerage firms may have instituted householding for beneficial owners of our Common Stock held through brokerage firms. If your family has multiple accounts holding our Common Stock, you may have already received householding notification from your broker. Please contact your broker directly if you have any questions or require additional copies of our fiscal 2019 Annual Meeting.Report or this proxy statement. The broker will arrange for delivery of separate copies of these proxy materials promptly upon your written or oral request. You may decide at any time to revoke your decision to household, and thereby receive multiple copies.

WHAT SHOULD I DO IF I RECEIVE MORE THAN ONE SET OF VOTING MATERIALS?

You may receive more than one set of voting materials, including multiple copies of the Notice of Special Meeting or this Proxy Statement and multiple proxy cards or voting instruction cards. For example, if you hold your shares in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account in which you hold shares. Similarly, if you are a stockholder of record and hold shares in a brokerage account, you will receive a notice for shares held in your name and a notice or voting instruction card for shares held in street name. Please follow the directions provided in the notice and each additional notice or voting instruction card you receive to ensure that all your shares are voted.

DO STOCKHOLDERS HAVE DISSENTER’S RIGHTS?

Stockholders do not have dissenter’s rights with respect to any of the proposals being voted on.

WILL I RECEIVE ANY PROCEEDS FROM THE TRANSACTION?

No. The Company, and not its stockholders, will receive the proceeds from the Transaction.


HOW WILL THE COMPANY USE THE PROCEEDS FROM THE TRANSACTION?

The Company plans to use the proceeds for working capital and general corporate purposes, in connection with its continued business of providing Analytics and Solutions Products. While the Company may possibly use some proceeds to repurchase outstanding shares of its Class B common stock in the Tender Offer, the Company does not believe it must consummate the Transaction in order to proceed with the Tender Offer.  Our Board will evaluate alternatives for the use of the cash proceeds to be received at closing to commercialize the foregoing business segments and to continue to maximize stockholder value with a goal of returning value to our stockholders. The amounts and timing of our actual expenditures, however, will depend upon numerous factors, and we may find it necessary or advisable to use portions of the proceeds from the Transaction for different or presently non-contemplated purposes.

WHAT ARE THE U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE TRANSACTION TO U.S. STOCKHOLDERS?

The Transaction is a corporate action. Our stockholders will not realize any gain or loss for U.S. federal income tax purposes as a result of the Transaction. See “Proposal One: Asset Sale Proposal – Material U.S. Federal Income Tax Consequences.”

WHAT ARE THE SOLICITATION EXPENSES AND WHO PAYS THE COST OF THIS PROXY SOLICITATION?

We pay the cost of soliciting proxies for the Special Meeting, and we have engaged Georgeson LLC, a proxy solicitation firm, to assist in the solicitation of proxies for the Special Meeting and will pay Georgeson LLC an estimated fee of $8,500, plus reimbursement of reasonable out of pocket. We solicit by mail, telephone, personal contact and electronic means and arrangements are made with brokerage houses and other custodians, nominees and fiduciaries to send Notices, and if requested, other proxy materials, to beneficial owners. Upon request, we will reimburse them for their reasonable expenses. In addition, our directors, officers and employees may solicit proxies, either personally or by telephone, facsimile or written or electronic mail. Stockholders are requested to return their proxies without delay.

WHERE CAN I FIND VOTING RESULTS?

The Company expects to publish the voting results in a Current Report on Form 8‑K, which it expects to file with the SEC within four business days following the Special Meeting.

WHO CAN HELP ANSWER MY QUESTIONS?

The information provided above in this “Question and Answer” format is for your convenience only and is merely a summary of the information contained in this Proxy Statement. We urge you to carefully read this entire Proxy Statement, including the documents we refer to herein. If you have any questions, need additional material, or require assistance in voting your shares, please feel free to contact Computershare. Stockholders may call Computershare toll-free at 1-800-368-5948.



RISK FACTORS

Risks Related to the Transaction

The announcement and pendency of the Transaction, whether or not consummated, may adversely affect our business.

The announcement and pendency of the Transaction, whether or not consummated, may adversely affect the trading price of our Class B common stock, our business or our relationships with customers, suppliers and employees. In addition, pending the completion of the Transaction, we may be unable to attract and retain key personnel and the focus and attention of our management and employee resources may be diverted from operational matters during the pendency of the Transaction.

We cannot be sure if or when the Transaction will be completed.

The closing of the Transaction is subject to the satisfaction or waiver of various conditions, including Stockholder Approval. The closing conditions set forth in the Asset Purchase Agreement may not be satisfied. If we are unable to satisfy the closing conditions in Purchaser’s favor or if other mutual closing conditions are not satisfied, Purchaser will not be obligated to complete the Transaction. In the event that the Transaction is not completed, the announcement of the termination of the Asset Purchase Agreement may adversely affect the trading price of our Class B common stock, our business and operations or our relationships with customers, suppliers and employees.  Any delay in completing the Transaction may significantly reduce the benefits that the Company expects to achieve if it successfully completes the Transaction within the expected timeframe.

In addition, if the Transaction is not completed, our Board, in discharging its fiduciary obligations to our stockholders, may evaluate other strategic alternatives that may be available, which alternatives may not be as favorable to the Company and our stockholders as the Transaction. We may be unable to locate credible purchasers, resulting in our continuing to offer and sell our Call Marketplace Product and the Local Leads Product, which face significant customer concentration without long term contracts, and revenue and contribution variability of the Business.  Continuing to offer and sell the Call Marketplace Product, which has a lower margin profile than our Analytics and Solutions Products, may also result in lower trading multiples than we might achieve if we only offered and sold Analytics and Solutions Products.

The Asset Purchase Agreement limits our ability to pursue alternatives to the Transaction.

The Asset Purchase Agreement contains provisions that make it more difficult for us to sell our assets or engage in another type of acquisition transaction with a party other than Purchaser, even if that party were prepared to pay consideration with a higher value than the consideration to be paid by Purchaser. These provisions could also discourage a third party that might have an interest in acquiring all of, or substantially all of, our assets or our Class B common stock from considering or proposing such an acquisition.

Our stockholders should assume that they will not receive any of the proceeds of the Transaction.

The proceeds from the Transaction will be paid directly to the Company and not our stockholders. As discussed elsewhere in this Proxy Statement, our Board will evaluate different alternatives for the use of the proceeds from the Transaction. The Company intends to use substantially all of the proceeds for working capital and general corporate purposes in connection its continued business of providing Analytics and Solutions Products.  The Board does not currently expect to declare a special dividend of any such proceeds to our stockholders.  While the Company may possibly use some proceeds to repurchase outstanding shares of its Class B common stock in the Tender Offer, the Company does not believe it must consummate the


CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This proxy statement contains “forward-looking statements” withinTransaction in order to proceed with the meaningTender Offer.  The Tender Offer may not proceed, and no stockholder should approve the Transaction with any expectation that so voting will increase the likelihood of the U.S. Private Securities Litigation Reform Actstockholder being able to receive any consideration in the Tender Offer.

We will incur significant expenses in connection with the Transaction, regardless of 1995,whether the Transaction is completed.

We expect to incur significant expenses related to the Transaction. These expenses include, but are not limited to, financial advisory and opinion fees and expenses, legal fees, accounting fees and expenses, certain employee expenses, filing fees, printing expenses and other related fees and expenses. Many of these expenses will be payable by us regardless of whether the Transaction is completed.

The opinion obtained by the Company from its financial advisor does not and will not reflect changes in circumstances subsequent to the date of the Asset Purchase Agreement.

On August 7, 2020, ROTH rendered its oral opinion to the Special Committee and the full Board (which was subsequently confirmed in writing by delivery of ROTH’s written opinion addressed to the Board dated the same date) as to, as of August 7, 2020, the fairness, from a financial point of view, to the Company of the consideration to be received by Seller in the Transaction pursuant to the Asset Purchase Agreement in exchange for the Business, subject to the Assumed Liabilities.

Although the Company believes there have been no material changes in the matters and conditions considered by ROTH in rendering its fairness opinion and no material changes are anticipated to occur prior to the Special Meeting, changes in the operations and prospects of the Company, general market and economic conditions and other factors that may be beyond the control of the Company, and on which the opinion was based, may alter the value of assets by the time the Transaction is completed. The opinion rendered by ROTH does not speak to the time when the Transaction will be completed. For a more complete description of the opinion rendered by ROTH, see “Opinion of the Financial Advisor to the Company” and the full text of the opinion contained in Annex B to this Proxy Statement.

Our Executive Chairman and certain executive officers may have interests in the Transaction other than, or in addition to, the interests of our stockholders generally.

Our Executive Chairman and certain executive officers may have interests in the Transaction that are different from, or are in addition to, the interests of our stockholders generally.  The Company entered into the Asset Purchase Agreement with Archenia, Inc., of which Russell C. Horowitz, our Executive Chairman and Co-CEO of the Company, and Michael Arends, Co-CEO and Chief Financial Officer of the Company, are the controlling stockholders. Accordingly, all of the rights and obligations of Purchaser under the Asset Purchase Agreement indirectly affect the interests of Messrs. Horowitz and Arends, including the obligations to the pay the consideration to the Company.  In addition to paying the Base Cash Payment Amount at closing, Purchaser has agreed to pay the Company the Contingent Consideration based on revenues from the Call Marketplace Product, from the Local Leads Product and of Purchaser, in each case assuming certain thresholds are met.  Pursuant to the Support Services Agreement to be entered at closing, Purchaser will agree to pay the Company for certain services we provide to Purchaser at the Company’s cost plus 5%, with a minimum of $3.5 million in the first year following closing and $1.5 million in the second year following closing (with the second year minimum payment subject to a numberminimum revenue threshold of Purchaser for such year).  Whether and to what extent the payments in connection with the Contingent Consideration and the Support Services Agreement are made to the Company may be influenced by the future business performance, accounting decisions and reporting of Purchaser.  In addition, Messrs Horowitz and Arends enjoy certain rights to indemnification from the Company in the event it breaches the Asset Purchase Agreement.


Risks Related to Our Future Operations

Our operations will be less diversified and we will have reduced sources of revenue following the Transaction, which may negatively impact the value and liquidity of our Class B common stock.

Upon the closing of the Transaction, the scope of our operations will be reduced in that our sources of revenue will be limited to our Analytics and Solutions Products, without our Call Marketplace Product, Local Leads Product or other assets and operations comprising the Business. We may not be able to secure additional sources of revenue or to grow our remaining business following the closing of the Transaction, which could negatively impact the value and liquidity of our Class B common stock.

We have discretion in the use of the proceeds from the Transaction and may not use them effectively.

If the Transaction is consummated, the Company will receive the proceeds from the Transaction. The Company plans to use the proceeds for working capital and other general corporate purposes in connection with its continued business of providing Analytics and Solutions Products. Our management will have broad discretion in the application of the proceeds from the Transaction and could spend the proceeds in ways that do not improve our results of operations or enhance the value of our Class B common stock. The failure by our management to apply these funds effectively could result in financial losses that could have a material adverse effect on our business and cause the price of our Class B common stock to decline. Pending their use, we may invest the proceeds in a manner that does not produce income or that loses value. Although our Board will evaluate various alternatives regarding the use of the proceeds from the Transaction, it has made no decision with respect to the specific use of proceeds other than as described above and has not committed to making any such decision by a particular date. This uncertainty may negatively impact the value and liquidity of our Class B common stock.

We may be subject to securities litigation, which is expensive and could divert our attention.

We may be subject to securities litigation in connection with the Transaction, including possible regulatory action or class action lawsuits. Litigation is frequently initiated in connection with merger and acquisition transactions, particularly those involving insiders. Regulatory inquiries and litigation are complex and could result in substantial costs, divert our management's attention and resources, and harm our business, financial condition and results of operations.


CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Certain statements included in this proxy statement contain forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this proxy statement, including, but not limited to, statementsincluded herein regarding ourthe consummation of the Transaction, the satisfaction of the revenue thresholds for the Contingent Consideration, and the Company’s strategy, future operating results,operations, future financial position, prospects,future revenues, other financial guidance (including the financial projections provided to Roth in connection with its fairness opinion), acquisitions, and business strategy, expectations regarding our growth and the growth of the industry in which we operate, anddispositions, projected costs, prospects, plans and objectives of management for future operations are forward-looking statements. Without limitingThe Company may not actually achieve the foregoing, the words “anticipates”, “believes”, “could”, “estimates”, “expects”, “intends”, “may”, “plans”, “seeks” and other similar language, whetherplans, intentions, or expectations disclosed in the negative or affirmative, are intended to identifyits forward-looking statements althoughand you should not allplace undue reliance on the Company’s forward-looking statements contain these identifying words. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actualstatements. Actual results or events could differ materially from those anticipatedthe plans, intentions and expectations disclosed in thesethe forward-looking statements the Company makes due to a number of important factors including but not limited to:

the occurrence of any event, change or other circumstances that could give rise to the termination of the Asset Purchase Agreement;

our stockholders failing to approve the Asset Sale Proposal;

the failure of one or more conditions to the closing of the Transaction to be satisfied or waived by the applicable party;

an increase in the amount of costs, fees, expenses and other charges related to the Asset Purchase Agreement or Transaction;

risks arising from the diversion of management’s attention from our ongoing business operations;

risks associated with our ability to identify and realize business opportunities following the Transaction;

failure of Purchaser to meet revenue thresholds for the Contingent Consideration;

general economic and business conditions, such as product demand, order cancellations and delays, and competition;

changes in the Company’s business strategy or development plans;

the continuing impact of the COVID-19 pandemic on the general economy, the Company’s customers and on the Company’s business, operations, employees and financial condition; and

the other factors discussed under the heading “Risk Factors” in this Proxy Statement and the other filings we make with the SEC from time to time.

Most of these factors are beyond our ability to predict or control. Any of these factors, or a resultcombination of various factors. Importantthese factors, could materially affect our future financial condition or results of operations and the ultimate accuracy of our forward-looking statements. There also are other factors that we may not describe (generally because we currently do not perceive them to be material) that could cause actual results to differ materially from those in theseour expectations.

We expressly disclaim any obligation to update or revise any forward-looking statements, are discussed in the “Risk Factors”, “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, and “Quantitative and Qualitative Disclosures About Market Risk” sections in our filings with the Securities and Exchange Commission. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. We therefore caution you against relying on any of these forward-looking statements. Also, any forward-looking statement made by us in this proxy statement speaks only as of the date of this proxy statement. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developmentsevents or otherwise, except as may be required by law.


THE SPECIAL MEETING

Time, Date and Place

The Special Meeting is scheduled to be held on Thursday, October 1, 2020, at 10:00 AM Pacific Time virtually via the Internet. The Company has decided to hold this meeting exclusively via the Internet and not in a physical location given the ongoing public health impacts of the COVID-19 pandemic and the importance of the health and safety of the Company’s directors, officers, employees and stockholders. There will not be a physical meeting location, and the Company’s stockholders will not be able to attend the Special Meeting in person. The Special Meeting can be accessed by visiting MeetingWebsite, where stockholders will be able to listen to the meeting, submit questions and vote online.

Purpose of the Special Meeting

At our Special Meeting, stockholders will act upon the matters outlined in the notice, including the following:

the Asset Sale Proposal; and

the Adjournment Proposal

Other than the proposals noted above, we do not expect a vote to be taken on any other matters at the Special Meeting or any adjournment or postponement thereof. However, if any other matters are properly presented at the Special Meeting or any adjournment or postponement thereof for consideration, the holders of the proxies solicited by this Proxy Statement will have discretion to vote on such matters in accordance with applicable law and their judgment.

Recommendation of Our Board

After careful consideration, our Board (in reliance on the recommendation from the Special Committee) unanimously recommends that you vote:

Proposal One - FOR the Asset Sale Proposal; and

Proposal Two - FOR the Adjournment Proposal.

In reaching its decision to recommend that you vote in the manner noted above, our Board considered a wide range of factors relating to the Transaction, the Asset Purchase Agreement and the Related Agreements. These factors included, among others, the Company’s prior unsuccessful efforts to sell the Call Marketplace Product and the Local Leads Product, the significant customer concentration without long term contracts, the revenue and contribution variability of the Business, the lower margin profile of the Call Marketplace Product, and the lower trading multiples generally associated with the Business, the Special Committee’s unanimous approval of the Transaction, the value of the consideration to be received, and the fairness opinion of the financial advisor retained by the Special Committee summarized under “Opinion of the Financial Advisor to the Company.” For more information on these factors (including the Special Committee process), see “Proposal One: Asset Sale Proposal – Reasons for the Transaction and Recommendation of Our Board.”


Record Date and Voting Power

Only holders of record of our Class A common stock and Class B common stock, at the close of business on August 10, 2020, or the Record Date, will be entitled to notice of, and to vote at, the Special Meeting. On the Record Date, 4,660,927 shares of Class A common stock and 39,896,634 shares of Class B common stock were issued and outstanding. Each share of Class A common stock is entitled to twenty-five (25) votes at the Special Meeting and each share of Class B common stock is entitled to one (1) vote at the Special Meeting. Holders of Class A common stock and Class B common stock will vote together as a single class on all matters that come before the Special Meeting. No other shares of Common Stock were outstanding on the Record Date.

Quorum

The presence, via the Meeting Website or by proxy, of a majority of the voting power of the outstanding shares of Common Stock entitled to vote as of the close of business on the Record Date constitutes a quorum. Abstentions and broker non-votes will count toward establishing a quorum. Broker non-votes occur when brokers holding shares in street name for beneficial owners do not receive instructions from the beneficial owners about how to vote the shares. An abstention occurs when a stockholder withholds such stockholder's vote by checking the "abstain" box on the proxy card, or similarly elects to abstain via the Internet voting. Under the rules that govern brokers who are voting with respect to shares held in street name, brokers have the discretion to vote such shares on routine matters, including the ratification of appointment of independent registered accounting firm. However, even if a quorum does not exist, pursuant to the Adjournment Proposal, a majority of the shares on Common Stock present, in person or by proxy, at the Special Meeting may act to postpone or adjourn the Special Meeting to another place, date and time.

Once a share of Common Stock is represented by presence via the Meeting Website or by proxy at the Special Meeting, it will be counted for purposes of determining whether a quorum exists at the Special Meeting and any adjournment or postponement of the Special Meeting. However, if a new record date is set for the adjourned or postponed Special Meeting, a new quorum will have to be established. For purposes of determining the presence of a quorum, abstentions will be counted as present at the Special Meeting.

Required Vote

Proposal One: Asset Sale Proposal

The approval of the Asset Sale Proposal requires the affirmative vote of (a) a majority of the voting power of all issued and outstanding Class A common stock and Class B common stock entitled to vote at the Special Meeting (treated as a single class) and (b) a majority of the voting power of all issued and outstanding Class A common stock and Class B common stock entitled to vote at the Special Meeting (treated as a single class), disregarding stock owned by Russell C. Horowitz and Michael Arends (“the “Majority of the Minority Vote”), as of the close of business on the Record Date present via the Meeting Website or represented by proxy. Stockholders may vote “for”, “against” or “abstain” for the Asset Sale Proposal. If you “abstain” from voting on the Asset Sale Proposal, your abstention will have the same effect as a vote “against” the Asset Sale Proposal.

Proposal Two: Adjournment Proposal

The Adjournment Proposal will be approved, regardless of whether a quorum is present at the Special Meeting, by the affirmative vote of a majority of the voting power cast by stockholders present via the Meeting Website or represented by proxy at the Special Meeting.


Holders of our Common Stock may vote “FOR,” “AGAINST” or “ABSTAIN” with respect to the Adjournment Proposal.

Abstentions and broker non-votes are counted to determine whether a quorum is present at the Special Meeting but are not counted as a vote in favor of or against a particular matter.

Voting by Stockholders

Your vote is very important to us and we hope that you will participate in the Special Meeting virtually. However, whether or not you plan to participate in the Special Meeting virtually, please vote by proxy in accordance with the instructions on your proxy card or voting instruction card (from your broker, bank or other nominee). Below are descriptions of how you may vote your shares depending on whether or not you are a stockholder of record or a beneficial owner.

Stockholders of Record

By Internet. Registered stockholders may vote on the Internet at www.investorvote.com/MCHX. Please have your proxy card in hand when going online and follow the online instructions. Stockholders that vote by Internet must bear all costs associated with electronic access, including Internet access fees. Internet voting for registered stockholders is available up until 5:00 PM, Pacific Time, on September 30, 2020, the day before the Special Meeting. The Internet voting procedures are designed to authenticate each stockholder by use of a control number to allow stockholders to vote their shares and to confirm that their instructions have been properly recorded. The control number can be found on the enclosed proxy card.

By Mail. Registered stockholders may vote their shares by signing, dating and mailing the enclosed proxy card using the enclosed postage pre-paid envelope. We strongly encourage you, however, to consider using the Internet or telephone voting options described below because these voting methods are faster and less costly than voting by mailing your signed and dated proxy card. If you vote via the Internet or telephone, you do not need to mail your proxy card.

By Telephone. Registered stockholders also may vote by telephone by calling 1-866-641-4276 (toll-free) and using any touch-tone telephone to transmit their votes up to 5:00 PM, Pacific Time, on September 30, 2020, the day before the Special Meeting. Please have your proxy card in hand when you call and then follow the instructions. The control number necessary to vote your shares by telephone can be found on the enclosed proxy card.

By Virtually Participating in the Special Meeting. If you are the record holder of your shares, you may join the Special Meeting and submit a vote via the Meeting Website by joining as a “Stockholder” by entering the control number found on your proxy card or notice, or email you previously received and following the instructions on the Meeting Website. The password for the meeting is MCHX2020. If you own your stock in street name, you may join the Special Meeting via the Meeting Website, but in order to submit a vote of your shares via the Meeting Website during the Special Meeting, you must register in advance to attend the Special Meeting. To register you must submit proof of your proxy power (legal proxy) reflecting your Marchex holdings along with your name and email address to Computershare. Requests for registration must be labeled as “Legal Proxy” and be received no later than 5:00 p.m., Eastern Time, on September 24, 2020. You will receive a confirmation email from Computershare of your registration. Requests for registration should be directed to Computershare by email at the following address: legalproxy@computershare.com.


Beneficial Owners

If your shares are held of record in the name of a bank, broker or other nominee you should follow the separate instructions that the nominee provides to you. Although most banks and brokers now offer Internet and telephone voting, availability and specific processes will depend on their voting arrangements.

If your shares are held of record in the name of your bank, broker or other nominee and you would like to submit a vote during your participation in the Special Meeting, you must you must register in advance to attend the Special Meeting. You also must submit proof of your proxy power (legal proxy) from your bank, broker or other nominee reflecting your Marchex holdings along with your name and email address to Computershare by email at the email address legalproxy@computershare.com. Requests for registration must be labeled “Legal Proxy” and be received no later than 5:00 p.m., Eastern Time, on September 24, 2020. You will receive a confirmation email from Computershare of your registration.

Abstentions

Abstentions will have the same effect as a vote “AGAINST” the Asset Sale Proposal.

Abstentions will have no effect on the outcome of the Adjournment Proposal.

For purposes of determining the presence of a quorum, abstentions will be counted as present at the Special Meeting.

Broker Non-Votes

Brokers, banks or other nominees who hold shares in “street name” for their customers have authority to vote those shares on “routine” proposals when they have not received instructions from the beneficial owners of such shares. However, brokers, banks or other nominees do not have the authority to vote shares they hold for their customers on “non-routine” proposals when they have not received instructions from the beneficial owners of such shares.

Broker non-votes occur when shares are held in “street name” through a broker, bank or other intermediary on behalf of a beneficial owner, and the broker submits a proxy but does not vote for a matter because the broker has not received voting instructions from the beneficial owner and (i) the broker does not have discretionary voting authority on the matter or (ii) the broker chooses not to vote on a matter for which it has discretionary voting authority. The Asset Sale Proposal and the Adjournment Proposal are considered “non-routine” matters. Therefore, if you do not provide voting instructions to your broker regarding the Asset Sale Proposal or the Adjournment Proposal, your broker will not be permitted to exercise voting authority to vote your shares on such proposals and will result in a broker non-vote.

Failure to Vote

If you are a stockholder of record and you do not vote at the Special Meeting by submitting a vote through the Meeting Website or properly return your proxy card or vote over the Internet or by phone, your shares will not be voted at the Special Meeting, will not be counted as present via the Meeting Website or by proxy at the Special Meeting and will not be counted for purposes of determining whether a quorum exists.

As discussed above, brokers, banks and other nominees do not have discretionary voting authority with respect the Asset Sale Proposal. Accordingly, if you are the beneficial owner of shares held in “street name” and you do not issue voting instructions to your broker, bank or other nominee with respect to the Asset Sale Proposal, your shares will not be voted at the Special Meeting and will not be deemed present for any purpose at the Special Meeting related to such proposals, including for purposes of determining whether a quorum exists.


A failure to vote will have the same effect as a vote “AGAINST” the approval of the Asset Sale Proposal but will have no effect on the outcome of the Adjournment Proposal.

Revocability of Proxies

A stockholder of record who has given a proxy may revoke it at any time prior to its exercise at the Special Meeting by (i) giving written notice of revocation to our Secretary, (ii) properly submitting a duly executed proxy bearing a later date, or (iii) appearing in person at the Special Meeting and voting in person.

If you are the beneficial owner of shares held through a broker, trustee, or other nominee, you must follow the specific instructions provided to you by your broker, trustee, or other nominee to change or revoke any instructions you already have provided to your broker, trustee, or other nominee.

Attendance at the Special Meeting via the Meeting Website, in and of itself, will not constitute a revocation of a proxy.

Adjournments

The Special Meeting may be adjourned for any purpose, including for the purpose of obtaining a quorum or soliciting additional votes if there are insufficient votes to authorize the Asset Sale Proposal. Any adjournment may be made without notice (if the adjournment is not for more than 30 days and a new record date is not fixed for the adjourned meeting), by an announcement made at the Special Meeting of the time, date and place of the adjourned meeting. Any adjournment will allow stockholders of record who have already sent in proxies to revoke them at any time prior to their use at the Special Meeting, as adjourned.

Solicitation of Proxies

Our Board is soliciting proxies for the Special Meeting to be held on October 1, 2020, at 10:00 AM Pacific Time, virtually via the Internet. The Company has decided to hold this meeting exclusively via the Internet and not in a physical location given the ongoing public health impacts of the COVID-19 pandemic and the importance of the health and safety of the Company’s directors, officers, employees and stockholders. There will not be a physical meeting location, and the Company’s stockholders will not be able to attend the Special Meeting in person. The Special Meeting can be accessed by visiting Meeting Website, where stockholders will be able to listen to the meeting, submit questions and vote online. This Proxy Statement contains important information for you to consider when deciding how to vote on the matters brought before the Special Meeting.

We will bear the expense of soliciting proxies and we have engaged Georgeson LLC, a proxy solicitation firm, to assist in the solicitation of proxies for the Special Meeting and will pay Georgeson LLC an estimated fee of $8,500, plus reimbursement of reasonable out of pocket expenses. We will reimburse banks, brokers and other custodians, nominees and fiduciaries for reasonable charges and expenses incurred in forwarding soliciting materials to their clients. We may conduct further solicitation personally or telephonically through our directors, officers, and employees, none of whom will receive additional compensation for assisting with the solicitation.

Questions and Additional Information

If you have any questions, need additional material, or require assistance in voting your shares, please feel free to contact Computershare. Stockholders may call Computershare toll-free at 1-800-368-5948.


PROPOSAL ONE: ASSET SALE PROPOSAL

Information about the Parties

The Company

We are a call analytics company that helps businesses connect, drive, measure, and convert callers into customers. We provide products and services for businesses of all sizes that depend on consumer phone calls or texts to drive sales. Our analytics technology can facilitate call quality and texting, analyze calls and measure the outcomes of calls. We also deliver performance-based, pay-for-call advertising across numerous mobile and online publishers to connect consumers with businesses over the phone.

We were incorporated in 2003 under the laws of the State of Delaware. Our executive office is located at 520 Pike Street, Suite 2000, Seattle, Washington 98101. Our telephone number is (206) 331-3300. Our website is www.marchex.com.

Our Class B common stock is listed on The NASDAQ Global Select Market under the ticker symbol “MCHX.”

Purchaser

Archenia, Inc. provides adverting marketing services and lead generation.  It was incorporated in 2020 under the laws of the State of Delaware.

General Description of the Transaction

On August 7, 2020, we entered into an Asset Purchase Agreement with Purchaser pursuant to which, and upon the terms and subject to the conditions thereof, the Purchaser will acquire our (i) advertising network for businesses that drive sales through inbound phone calls (the “Call Marketplace Product”), (ii) advertising solution for small business resellers to sell call advertising, search marketing and other lead generation products through their existing sales channels to their small business advertisers (the “Local Leads Product”), and (iii) related business operations and certain other assets including an equity interest in Uproar.car Corporation (“Uproar,” and together with the Call Marketplace Product and the Local Leads Product, the “Business”), and will assume certain liabilities of the Company. We also agreed to enter into a support services agreement pursuant to which we, following the closing of the transaction, will provide services to Purchaser on a cost-plus 5% basis, with minimum payments to the Company of $3.5 million in the first year following closing, and $1.5 million in the second year following closing (with the second year minimum payment subject to a minimum revenue threshold of Purchaser for such year).

We do not believe that the sale of the Business, under Delaware law, would be deemed a sale of all, or substantially all, of our assets, to the Purchaser on the terms and subject to the conditions set forth in the Asset Purchase Agreement, but we are seeking stockholder approval regarding the sale of the Business because the special committee of the Board comprised solely of independent directors of the Company (the “Special Committee”), along with the full Board, in conjunction with the Purchaser, considered the action appropriate, and strongly desire the input of the Company’s stockholders, given the historical significance of the various lines of business that comprise the Business, and given that Russell C. Horowitz, Co-CEO of the Seller, and Michael Arends, Co-CEO and Chief Financial Officer of the Seller, are the controlling stockholders of the Purchaser.

We are retaining and will continue to operate and manage our business through which we provide Analytics and Solutions Products following the closing of the Transaction.


For more information on the above, please see “—Asset Purchase Agreement – Purchase and Sale of Assets” and “—Asset Purchase Agreement – Assumption and Transfer of Liabilities.”

A copy of the Asset Purchase Agreement is attached as Annex A to this Proxy Statement. You are encouraged to read the Asset Purchase Agreement carefully and in its entirety.

Consideration for the Transaction

As consideration for the Transaction, Purchaser has agreed to pay us (a) the Base Cash Payment Amount plus (b) the Equity Consideration plus (c) the Contingent Consideration plus (d) the cancellation of Company stock options for 1.5 million shares currently held by Russell C. Horowitz and Michael Arends.

Background of the Transaction

The Board and senior management of the Company, with the assistance of the Company’s outside legal and financial advisors, regularly review the Company’s long-term strategic plan with the goal of maximizing stockholder value. From time to time, the Board has explored the disposition of some of the Company’s product lines to focus on its Analytics and Solutions Products, which it views as its core operations with the greatest long-term market potential, as well as other strategic transactions.

In 2018, the Board determined it was in the best interest of the Company and its stockholders to attempt to sell the Call Marketplace Product given its significant customer concentration without long term contracts and revenue and contribution variability, to streamline the Company’s operations, improve efficiency in its other product lines and focus on its Analytics and Solutions Products as its core operations with the greater long-term market potential. However, the Company was unable to identify any credible buyer, and the planned disposition was abandoned.

In May 2020, preliminary discussions among members of the Board, including Co-CEO Russell C. Horowitz, resumed about the potential sale of the Business, with the prospect of a potential offer from certain members of the management team. In addition to allowing the Company to focus on its Analytics and Solutions Products, a potential sale of the Business could inject cash to support operations and enable the Company to defray certain costs amid the significant economic uncertainty associated with COVID-19, which had created financial distress for certain of the Company’s distribution partners, reseller partners and agencies, service providers and suppliers.  Preliminary discussions about a potential sale of the Business continued into June 2020.

On June 5, 2020, the Board formed the Special Committee to consider any offer received from certain members of the management team for a potential transaction, including to negotiate its terms and to make a recommendation to the Board regarding it.  Such members of the management team continued to preliminarily consider whether to move forward with making an offer, the relevant assets, accounting and tax issues, and related matters.  

On June 11, 2020, at a meeting of the Board, management reviewed high level strategic considerations regarding the potential divestiture by the Company of the Business.

On June 12, 2020, to assist in considering a potential transaction, the Special Committee retained DLA Piper LLP (US) (“DLA Piper”) as its independent legal counsel and ROTH as its financial advisor.

In addition, in connection with its ongoing consideration of strategic transactions, the Board and management began to preliminarily consider the possibility of a tender offer pursuant to which the Company would repurchase shares of its Class B common stock. On July 8, 2020, at a meeting of the Board,


management updated the directors (including each member of the Special Committee) on the anticipated timing for any potential offer and related transaction, including a discussion of the performance of the Business, customer concentration and volatility considerations.  The discussion also included the general economic framework for a potential transaction, including management’s initial thoughts regarding potential elements to provide for shared opportunity and risk and an ongoing support services agreement which would enable the Company to defray certain costs.

On July 23, 2020, the Special Committee met to discuss the status of management’s consideration of a potential transaction, including the role of the Special Committee, the expected structure of any offer from the management team, the desired assets and liabilities of the Business, and related accounting considerations.

Later that day, Purchaser provided to the Special Committee a preliminary non-binding proposal to acquire the Business, including Jingle Networks, Inc. and a portion of the Company’s equity ownership interest in Uproar.car Corporation such that the Company would retain 19.9% ownership of Uproar for a purchase price of (i) $2.0 million in net cash, (ii) the cancellation of options to purchase 1.5 million shares of Class B common stock held by the Messrs. Horowitz and Arends, (iii) contingent consideration in the form of 15% of Purchaser’s net revenue from local leads products in excess of $7.0 million, 2.5% of Purchaser’s net revenue from call marketplace products in excess of $140.0 million, and a royalty of 0.25% of Purchaser’s annual revenues in excess of $55.0 million in the three years after closing; and (iv) if Purchaser is sold in the 24-months following closing for at least $11.1 million, contingent consideration in the form of 10% of incremental proceeds above such amount.  The proposal also contemplated the Company owning 19.9% of the equity in Purchaser, an escrow of the consideration Purchaser would pay to the Company, a support services agreement by which the Company would provide certain services to Purchaser at cost plus five percent, and a binding customary exclusivity period.

On July 24, 2020, the Special Committee and its advisors at DLA Piper and ROTH met to discuss the proposal received on July 23, 2020.  The Special Committee discussed the cash consideration and the need for additional detail regarding the Business proposed to be purchased, the model and calculations regarding the contingent consideration, and the options to be cancelled as part of the consideration. On July 25, 2020, the Special Committee responded through counsel to Purchaser by requesting additional information regarding these matters.  The Special Committee also noted that it may not be willing to grant the Purchaser exclusivity for a sale of the Business and will require that the closing of any transaction be contingent upon approval of a majority of the Company’s disinterested stockholders which counsel to Purchaser indicated was also an important factor to the Purchaser.

On July 28, 2020, Purchaser provided to the Special Committee additional detail regarding the Business proposed to be purchased, the contingent consideration (indicating it would supplementally provide certain financial information and calculations), and the options to be cancelled as part of the consideration.  Purchaser also indicated its willingness to agree to exclusivity in these circumstances with a provision that the parties would work together in good faith to determine an appropriate response to any third party inquiry or proposal regarding the Business, and confirmed that Purchaser was in agreement that closing of any transaction would be contingent upon approval of a majority of the Company’s disinterested stockholders.

On July 29, 2020, Purchaser provided to the Special Committee certain financial information and calculations to clarify the contingent consideration payable under the proposed net revenue sharing arrangements and royalty.  Through telephone calls with counsel, Purchaser also communicated certain flexibility in the consideration structure to address accounting considerations.


On July 30, 2020, the Special Committee and its advisors at DLA Piper and ROTH met to discuss the additional financial information and calculations related to the contingent consideration.  The Special Committee also discussed how to respond to Purchaser’s offer, focusing on the importance of the cash consideration and ensuring minimum service amounts under the Support Services Agreement.  The Special Committee instructed its counsel to prepare a draft response to Purchaser for the Special Committee’s further consideration.

On July 31, 2020, the Special Committee and its advisors at DLA Piper met to discuss the draft response.  Following the meeting, the Special Committee responded through counsel to Purchaser’s offer that the Special Committee was willing to move forward with the transaction, provided that the cash component of the consideration increase to $2.25 million, the Company’s equity interest in Purchaser decrease to 10%, Purchaser commits to minimum services of at least $4.0 million in the first year and $2.0 million in the second year, and the contingent consideration to the Company in the event of a sale of Purchaser increase to 40%. Through counsel, the parties also discussed the nature of the escrow referenced in the original offer.

On August 1, 2020, Purchaser submitted a revised offer letter, retaining the terms of its original offer except that Purchaser would increase the net cash consideration to $2.25 million, decrease the Company’s equity ownership in Purchaser to 10%, commit to minimum services of at least $3.5 million in the first year and (if Purchaser has at least $38 million in revenue in the second year) $1.5 million in the second year, reduce the thresholds for the Company to receive contingent consideration to $6.0 million in revenue from local leads products and to $53.0 million in Purchaser’s revenue, and increase the contingent consideration in the event of the sale of Purchaser to 30% of the proceeds above $11.1 million. The revised offer also eliminated the requirement to escrow any of the consideration Purchaser would pay to the Company, added the condition that a majority of the Company’s disinterested stockholders approve the transaction and retained the provision for binding exclusivity.

On August 1, 2020, the Special Committee met to consider the revised offer.  Following discussion, including the feedback of its financial advisor regarding the economic terms, the Special Committee determined to accept the general terms of the offer.  The Special Committee instructed its counsel to communicate the same to Purchaser and to move forward with the preparation of a definitive asset purchase agreement.

Over the course of the week, the Special Committee and Purchaser exchanged drafts of the Asset Purchase Agreement, the schedules thereto, the Support Services Agreement and other ancillary agreements (collectively, “Transaction Documents”). Substantially all correspondence, telephone calls and other interactions regarding the Transaction Documents and transactions contemplated thereby were conducted through counsel.  Although such interactions occurred multiple times each day, the most notable interactions consisted of the following:

On August 1, 2020, the Special Committee provided Purchaser a draft of the Asset Purchase Agreement.

On August 3, 2020, Purchaser provided the Special Committee a draft of the Support Services Agreement.

On August 4, 2020, Purchaser provided to the Special Committee comments regarding the Asset Purchase Agreement, which among other things addressed the class and measurement date of the 10% of Purchaser common stock the Company would receive, the net revenue definition associated with the contingent consideration, the shares in Uproar being transferred, the transfer of employees to Purchaser, a limited indemnity structure, and the absence of a Company material adverse effect as a closing condition.


On August 4, 2020, the Special Committee provided to Purchaser comments to the Support Services Agreement, which among other things added default interest in the event Purchaser does not timely pay the Company and clarified that the minimum amounts of services may not be changed without Company consent.  The Special Committee also provided drafts of assignments of trademarks, patents and domain names, a bill of sale, and an assignment and assumption agreement.

On August 5, 2020, Purchaser provided to the Special Committee comments regarding the Support Services Agreement, which mainly reduced the level of default interest.  Purchaser also confirmed that it had no comments on the assignments of trademarks, patents and domain names, bill of sale, and assignment and assumption agreement.

On August 5, 2020, the Special Committee provided to Purchaser comments regarding the Asset Purchase Agreement, which mainly clarified Purchaser’s reporting obligations associated with the contingent consideration, added covenants relating to transferred employees and contracts requiring consent, and set forth a 12-month indemnification capped at $2.25 million as the exclusive remedy for claims under the Asset Purchase Agreement.

On August 6, 2020, the Special Committee provided to Purchaser a Subscription Agreement for the equity in Purchaser the Company would receive at closing.  It also provided a compromise on the level of default interest in the Support Services Agreement. Later that day, Purchaser confirmed it had no comments on the subscription agreement or the revised Support Services Agreement.

On August 6, 2020, Purchaser provided to the Special Committee comments on the Asset Purchase Agreement, which among other things reduced to 10% the equity the Company would retain in Uproar and eliminated language relating to the Company’s ability to consider alternative proposals.  Purchaser also provided to the Special Committee the schedules contemplated by the Asset Purchase Agreement together with an explanation for how they were prepared, including the knowledge employees who prepared them and the role of third-party advisors to the Company.

On August 6, 2020, the Special Committee provided to Purchaser a revised Asset Purchase Agreement intended to finalize all outstanding issues, including to provide for reasonable cooperation in the event of an alternative proposal.  The Special Committee confirmed to Purchaser that the Special Committee did not expect to have comments on the schedules.  The parties confirmed to each other that they did not have further comments on any of the Transaction Documents.

On August 7, 2020, the Special Committee and then the Board met to consider and approve the Transaction Documents and the Transaction.  Supporting materials were circulated prior to the meetings, including the substantially final version of the Transaction Documents and ROTH’s financial analyses relating to Business and a draft of its opinion as to the fairness, from a financial point of view, to the Company of the consideration to be received by the Company for the Business.

At the Special Committee meeting, representatives of DLA Piper summarized the terms of the Transaction Documents.  ROTH then confirmed to the Special Committee that it was prepared to deliver a fairness opinion to the Board.  Following discussion, the Special Committee approved the Transaction and the Transaction Documents, and it recommended that the Board do the same.  The Special Committee directed counsel to circulate a written consent of the Special Committee to formalize such approvals.  


A meeting of the Board was then convened.  Following a summary of the Transaction and the Transaction Documents by representatives of DLA Piper, the Board requested that ROTH review and discuss its financial analyses with respect to the Business and the proposed Transaction. Thereafter, at the request of the Board, ROTH orally delivered its opinion to the Board (which was subsequently confirmed in writing by delivery of ROTH’s written opinion addressed to the Board, dated August 7, 2020), as to the fairness, from a financial point of view, to the Company of the consideration to be received by the Company for the Business.  Following discussion, the Board approved the Transaction and the Transaction Documents.  The Board directed counsel to circulate a written consent of the Board to formalize such approvals.

Later that day, the Company and Purchaser finalized and then executed the Asset Purchase Agreement.

Also on August 7, 2020, the Audit Committee of the Board met to consider the financial results for the second quarter of 2020.  The Board and management also discussed the possibility of a joint tender offer with Edenbrook Capital, LLC, a large stockholder of the Company, and a consensus regarding the basic economic terms and timeline for a potential joint tender offer was reached on August 8, 2020 (the “Tender Offer”).

On August 10, 2020, the Company announced the Transaction and the execution of the Transaction Documents, its financial results for the second quarter of 2020, and the intent to conduct the Tender Offer.

Reasons for the Transaction and Recommendation of Our Board

In reaching its decision to approve the Asset Purchase Agreement and the Transaction, and to recommend that our stockholders vote to approve the Asset Sale Proposal, the Board consulted with management and outside financial and legal advisors. The Board considered a wide range of factors relating to the Asset Purchase Agreement and the proposed Transaction, many of which the Board believed supported its decision, including the following:

the Company’s previous effort to sell the Call Marketplace Product and Local Leads Product, which were unsuccessful because the Company was unable to identify any credible buyer;

the Board’s determination that it was in the best interests of the Company and its stockholders to dispose of the Business given its significant customer concentration without long term contracts, revenue and contribution variability, to streamline the Company’s operations, improve efficiency in its other product lines, and focus on its Analytics and Solutions Products as its core operations with the greater long-term market potential;

the lower margin profiles for the Call Marketplace Product, and the lower trading multiples it believes analysts and investors generally ascribe to businesses selling such products, each as compared to the margin profiles for the Analytics Solutions and Products and the trading multiples it believes analysts and investors generally ascribe to businesses selling such products;

the Special Committee’s negotiation of, and unanimous approval of the Transaction, the Asset Purchase Agreement and the Related Agreements and its recommendation that the Board approve and adopt the same;

the value of the consideration to be received by us pursuant to the Asset Purchase Agreement;


our Board’s belief that the Transaction was more favorable to our stockholders than any other alternative reasonably available to the Company and our stockholders, including the alternatives of retaining the Call Marketplace Product and the Local Leads Product, based upon:

o

the Board’s knowledge of the current and prospective environment in which the Company operates, the competitive environment, the Company’s overall strategic position, and the challenges attendant to improving the Company’s financial performance in order to maximize stockholder value and the likely effect of these factors on the Company’s sustainability as a public company and strategic options; and

o

the Board’s understanding of our business, operations, management, financial condition, earnings and prospects.

the consideration we receive in the Transaction would provide us with cash to provide liquidity and certainty of value to the Company immediately upon the closing of the Transaction, through the cash payment for services under the Support Services Agreement, and through the prospect of future cash from the Contingent Consideration;

the Transaction provides more liquid forms of working capital without diluting existing stockholders;

the financial analysis reviewed by ROTH with the Board as well as the oral opinion of ROTH rendered to the Board on August 7, 2020 (which was subsequently confirmed in writing by delivery of ROTH’s written opinion addressed to the Board dated August 7, 2020), as to, as of such date, the fairness, from a financial point of view, to the Company of the consideration to be received by Seller in exchange for the Business subject to the Assumed Liabilities in the Transaction pursuant to the Asset Purchase Agreement;

the anticipated time to close the Transaction and the risk that if we did not accept Purchaser’s offer at the time that we did, the Board might not have had another opportunity to do so;

the Transaction will be subject to the approval of both (a) stockholders representing a majority of the voting power of all issued and outstanding Class A common stock and Class B common stock entitled to vote at the Special Meeting (treated as a single class) and (b) stockholders representing a majority of the voting power of all issued and outstanding Class A common stock and Class B common stock entitled to vote at the Special Meeting (treated as a single class), disregarding stock owned by Russell C. Horowitz and Michael Arends;

The Company will have an equity interest in the Purchaser and along with the Contingent Consideration potentially benefit from any future revenue of the Business; and

the terms of the Asset Purchase Agreement were negotiated at arms-length and believed by our Board to be fair to us and our stockholders.

Our Board also considered and balanced against the potential benefits of the Transaction a number of potentially adverse factors concerning the Transaction, including the following:

the conditions placed on our ability to solicit or respond to Acquisition Proposals as described under “Proposal One: Asset Sale Proposal – Asset Purchase Agreement - Covenants - No Solicitation”;


the interests of certain of our executive officers in the Transaction, which may be different from, or in addition to, the interests of our stockholders generally, including the potential for future conflicts in connection with the Contingent Consideration and payments committed to us under the Support Services Agreement, and the potential adverse impact of the cancellation of Company stock options for 1.5 million shares currently held by Messrs. Horowitz and Arends;

the risk that all conditions to the parties’ obligations to complete the Transaction may not be satisfied or waived, and as a result, it is possible that the Transaction could be delayed or might not be completed;

the risks and costs to the Company if the Transaction does not close, including the diversion of management and employee attention, potential employee attrition and the potential effect on business and customer relationships;

the risk of disruption to our business and customer reaction as a result of the public announcement of the Transaction; and

the risk that accompanies being a public company with relatively low revenues while we continue to try to grow our other areas of business without the potential income associated with the Business.

The foregoing discussion of the factors considered by our Board is not intended to be exhaustive, but it does set forth the principal factors considered by the Board. The Board collectively reached the conclusion to approve the Transaction and the Transaction Documents in light of the various factors described above, as well as other factors that the Board felt were appropriate. In view of the wide variety of factors considered by the Board in connection with its evaluation of the Transaction and the complexity of these matters, the Board did not consider it practical, and did not attempt, to quantify, rank or otherwise assign relative weights to the specific factors it considered in reaching its decision. Rather, the Board made its recommendation based on the totality of the information presented to, and the investigation conducted by, the Board. In considering the factors discussed above, individual directors may have given different weights to different factors.

After evaluating these factors and consulting with its outside legal counsel and financial advisor, all members of the Board approved Transaction and the Transaction Documents and determined that the Transaction is advisable, fair to and in the best interests of the Company and our stockholders.

Accordingly, our Board (in reliance on the recommendation from the Special Committee) recommends that stockholders vote “FOR” the Asset Sale Proposal.

Opinion of the Financial Advisor to the Company

Pursuant to an engagement letter, dated June 10, 2020, the Special Committee retained ROTH to render an opinion to the Special Committee as to the fairness, from a financial point of view, of the aggregate amount to be paid for the Assets (the “Purchase Price”) to be received by the Company.

On August 7, 2020, ROTH rendered its oral opinion, subsequently confirmed in writing, to the Special Committee that, as of such date, and based upon and subject to the various assumptions made, procedures followed, matters considered and qualifications and limitations set forth in the opinion, the Purchase Price to be received by the Company in the Transaction is fair, from a financial point of view, to the Company.

The full text of ROTH’s written opinion, dated August 7, 2020, is attached to this proxy statement as Annex B and is incorporated by reference herein. Stockholders of the Company are urged to read


the entire opinion carefully and in its entirety to learn about the assumptions made, procedures followed, matters considered and limitations on the scope of the review undertaken by ROTH in rendering its opinion. The analysis performed by ROTH should be viewed in its entirety; none of the methods of analysis should be viewed in isolation when reaching a conclusion on whether the consideration was fair. The opinion addresses only the fairness of the Transaction consideration, from a financial point of view, to the Company, as of the date of the opinion, and does not address the merits of the Company’s underlying business decision to proceed with or effect the Transaction or the likelihood of consummation of the Transaction. ROTH expressed no opinion or recommendation to the Special Committee whether the Company should proceed with the Transaction.  ROTH’s opinion was directed to the Special Committee in connection with its consideration of the Transaction and was not intended to be, and does not constitute, a recommendation to any stockholder as to how such stockholder should vote with respect to the Transaction or any other matter.

In arriving at its opinion, ROTH:

i)

reviewed certain publicly available financial and other business information of the Business;

ii)

reviewed certain financial projections prepared, and furnished to us, by the management of the Business (the “Financial Projections”) and conducted discussions with members of senior management concerning the Financial Projections;

iii)

discussed the past and current operations, financial condition and the prospects of the Business with senior executives of the Seller;

iv)

participated in certain discussions with representatives of the Special Committee and its legal advisors;

v)

reviewed the Asset Purchase Agreement;

vi)

reviewed the Support Services Agreement between Seller and Purchaser; and

vii)

performed such other analyses, including detailed financial analyses and modeling, and reviewed such other information and considered such other factors as we have deemed appropriate for purposes of evaluating the proposed Transaction and arriving at an opinion.

For purposes of rendering its opinion, ROTH relied upon and assumed, without assuming liability or responsibility for independent verification, the accuracy and completeness of all information that was publicly available or was furnished, or otherwise made available, to ROTH or discussed with or reviewed by or for ROTH. ROTH further assumed that the forecasted financial information provided, including the Financial Projections, was prepared on a reasonable basis in accordance with industry practice, and that management of the Company was not aware of any information or facts that would make any information provided to ROTH incomplete or misleading. Without limiting the generality of the foregoing, for the purpose of the opinion, ROTH assumed that with respect to financial forecasts, estimates and other forward-looking information reviewed by ROTH, that such information was reasonably prepared based on assumptions reflecting the best currently available estimates and judgments of the management of the Company as to the expected future results of operations and financial condition of the Business. ROTH expressed no opinion as to any such financial forecasts, estimates or forward-looking information or the assumptions on which they were based.  With respect to the financial forecasts provided to and examined


by ROTH, ROTH noted that projecting future results of any company, partnership, venture, or asset is inherently subject to uncertainty.

In connection with its opinion, ROTH assumed and relied upon, without independent verification, the accuracy and completeness of all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by ROTH.  ROTH’s opinion did not address any legal, regulatory, tax or accounting issues.  

In arriving at its opinion, ROTH assumed that the executed Asset Purchase Agreement and Support Services Agreement (collectively, the “Agreements”) would be in all material respects identical to the Agreements reviewed by ROTH. ROTH relied upon and assumed, without independent verification, that (i) the representations and warranties of all parties set forth in the Agreements and all related documents and instruments that are referred to therein are true and correct in all material respects, (ii) each party to the Agreements will fully and timely perform, in all material respects, all of the covenants and agreements required to be performed by such party, (iii) the Transaction will be consummated pursuant to the terms of the Agreements without amendments thereto, and (iv) all conditions to the consummation of the Transaction will be satisfied without waiver by any party of any conditions or obligations thereunder. Additionally, ROTH assumed that all the necessary regulatory approvals and consents required for the Transaction, including the approval of the stockholders of the Company, would be obtained in a manner that would not adversely affect the Company or the contemplated benefits of the Transaction.

In arriving at its opinion, ROTH did not perform any appraisals or valuations of any specific assets or liabilities (fixed, contingent or other) of the Company or the Business, and were not furnished or provided with any such appraisals or valuations.  Without limiting the generality of the foregoing, ROTH did not undertake any independent analysis of any pending or threatened litigation, regulatory action, possible unasserted claims or other contingent liabilities, to which the Company or any of its affiliates was a party or may be subject, and at the direction of the Special Committee of the Board of Directors of the Company and with its consent, ROTH’s opinion made no assumption concerning, and therefore did not consider, the possible assertion of claims, outcomes or damages arising out of any such matters.

ROTH’s opinion was necessarily based upon the information available to ROTH and facts and circumstances as they existed and were subject to evaluation on the date thereof; events occurring after the date thereof could materially affect the assumptions used in preparing the opinion. ROTH did not undertake to reaffirm or revise the opinion or otherwise comment upon any events occurring after the date thereof and ROTH expressly disclaimed any undertaking or obligation to advise any person of any change in any fact or matter affecting its opinion of which it become aware after the date thereof.


Summary of Material Financial Analysis

The following is a summary of the material financial analysis performed by ROTH and reviewed by the Special Committee in connection with ROTH’s opinion relating to the Transaction and does not purport to be a complete description of the financial analyses performed by ROTH. The rendering of an opinion is a complex analytic process involving various determinations as to the most appropriate and relevant methods of financial analysis and the application of those methods to the particular circumstances. Therefore, this summary does not purport to be a complete description of the analyses performed by ROTH or of its presentation to the Special Committee on August 7, 2020. Some of the summaries of the financial analyses include information presented in tabular format. In order to fully understand ROTH’s financial analysis, the tables must be read together with the text of each summary, as the tables alone do not constitute a complete description of the financial analysis. Considering the data below without considering the full narrative description of the financial analysis, including the methodology and assumptions underlying the analysis, could create a misleading or incomplete view of ROTH’s financial analysis.

In performing its analysis, ROTH made numerous assumptions with respect to industry performance, general business and economic conditions and other matters, many of which are beyond the control of the Company or any other parties to the Asset Purchase Agreement. ROTH does not assume any responsibility if future results are materially different from those discussed. Any estimates contained in these analyses are not necessarily indicative of actual values or predictive of future results or values, which may be significantly more or less favorable than as set forth below.

Due to the declining revenue and profitability of the Business and an indication from management of the Company that the Company would likely close the Business when it no longer has a positive cash contribution, ROTH did not believe that standard operating valuation and going concern methodologies were applicable.  ROTH therefore applied a net present value analysis to determine an implied equity value for the Business.

ROTH also analyzed the revenue related contingent considerations in the Transaction and, based on discussions with management, ROTH did not believe it was likely that any of such contingent consideration triggers would be achieved in the necessary timeframes to generate additional consideration, including the consideration related to the Call Marketplace Threshold Amount, Local Leads Threshold Amount or Aggregate Revenue Threshold Amount. ROTH therefore did not ascribe any value to any revenue related contingent consideration.  In addition, given the uncertainty of any future sale of the Business by Purchaser or the timing or amount that may be received therefor, ROTH did not ascribe any value to the Sale Transaction Contingent Consideration.

Present Value of Cash Flow Analysis. ROTH performed an analysis of the net present value of cash flows of the Business by calculating ranges of the estimated net present value of the unlevered, after-tax free cash flows attributable to the Company that the Company is forecasted to generate from July 1, 2020 through fiscal year 2022. All of the information used in ROTH’s analysis was based on publicly available sources and the financial projections provided by the Company’s management, which are summarized in the tables


below. The following tables set forth the free cash flows and calculations used in ROTH’s analysis.  Management of the Company indicated that EBITDA was equal to cash flow.

Notes:

All values in millions USD

Financial projections provided by management

EBITDA represents income (loss) before interest, income taxes, depreciation, amortization, stock compensation expense, impairment of intangible assets, goodwill and acquisition related costs (benefit), and foreign government paycheck assistance subsidies; NOPAT represents net operating profit (loss) after tax; D&A represents depreciation and amortization; Capex represents capital expenditures; NWC represents net working capital; PV represents present value; WACC represents weighted average cost of capital; and EV represents enterprise value

Valuation assumes $0M in net debt, 0x terminal value, $0 capex, change in NWC is 5% the change in revenue, and valuation date of July 1, 2020

Transaction Equity Value equals the cash consideration of $2.25 million / 90% of the Business acquired by the Purchaser

In performing its net present value of cash flow analysis, ROTH calculated ranges of the estimated present values of the Company’s unlevered, after-tax free cash flows attributable to the Company that the Company forecasted to generate from July 1, 2020 through fiscal year 2022 by applying discount rates ranging from 12.2% to 22.2%, reflecting ROTH’s estimates of the Company’s cost of capital.  

ROTH then deducted the present value of the shut down costs for the Business to determine a range of implied equity values of the Company. The net present value of cash flow analysis implied a range of equity values for the Business of $1.8 million to $1.9 million.  


ROTH noted that the Transaction implied equity value of the Business of $2.5 million was above the high end of the range of the implied equity value of the Business based on the net present value cash flow analysis.

General 

The summary set forth above does not contain a complete description of the analysis performed by ROTH, but it does summarize the material analysis performed by ROTH in rendering its opinion. The preparation of a fairness opinion is a complex process and is not necessarily susceptible to partial analysis or summary description. ROTH believes that its analysis and the summary set forth above must be considered as a whole and that selecting portions of its analysis or of the summary, without considering the analysis as a whole or all of the factors included in its analysis, would create an incomplete view of the processes underlying the analyses set forth in the ROTH opinion. In arriving at its opinion, ROTH considered the results of all of its analyses and did not attribute any particular weight to any factor or analysis. Instead, ROTH made its determination as to fairness on the basis of its experience and financial judgment after considering the results of all of its analyses. The fact that any specific analysis has been referred to in the summary above is not meant to indicate that this analysis was given greater weight than any other analysis. In addition, the range of valuations described above should not be taken to be ROTH’s view of the actual value of the Company.

As described above, ROTH’s opinion was only one of many factors considered by the Special Committee and the Board in making its determination to approve the Transaction. ROTH was not requested to and did not solicit any expressions of interest from any other parties with respect to the Business.

ROTH is a full-service securities firm engaged in securities trading and brokerage activities, as well as providing investment banking and other financial services.  In the past two years, no material relationship existed between the Company and/or its affiliates and ROTH and/or its affiliates pursuant to which compensation was received by ROTH or its affiliates as a result of such relationship.  In the ordinary course of business, ROTH and its affiliates may acquire, hold or sell, for it and its affiliates’ own accounts and for the accounts of customers, equity, debt and other securities and financial instruments (including bank loans and other obligations) of the Company and the other parties to the Transaction, and, accordingly, may at any time hold a long or a short position in such securities.  In addition, ROTH and its affiliates may in the future provide investment banking and other financial services to the parties of the Transaction for which ROTH would expect to receive compensation.

ROTH is acting as financial advisor to the Special Committee in connection with the Transaction. Pursuant to its engagement letter with ROTH, the Company has agreed to pay ROTH a fixed fee upon the delivery of its fairness opinion to the Special Committee. The fairness opinion fee is not contingent upon the Transaction closing. The fee was determined by ROTH and proposed to the Special Committee. In addition, the Company has agreed to indemnify ROTH for certain liabilities that may arise out of its engagement by the Special Committee and the rendering of ROTH’s opinion.


Use of Proceeds and Future Operations

The Company, and not its stockholders, will receive the proceeds from the Transaction. The Company plans to use the proceeds for working capital and general corporate purposes, in connection with its continued business of providing Analytics and Solutions Products. While the Company may possibly use some proceeds to repurchase outstanding shares of its Class B common stock in the Tender Offer, the Company does not believe it must consummate the Transaction in order to proceed with the Tender Offer. Our Board will evaluate alternatives for the use of the cash proceeds to be received at closing to continue to maximize stockholder value with a goal of returning value to our stockholders. The amounts and timing of our actual expenditures, however, will depend upon numerous factors, and we may find it necessary or advisable to use portions of the proceeds from the Transaction for different or presently non-contemplated purposes.

No Appraisal or Dissenters’ Rights

No appraisal or dissenters’ rights are available to our stockholders under Delaware law or under our certificate of incorporation or bylaws in connection with the Transaction.

Regulatory Matters

We are unaware of any material federal, state or foreign regulatory requirements or approvals required for the execution of the Asset Purchase Agreement or completion of the Transaction.

Material U.S. Federal Income Tax Consequences

The following discussion is a general summary of the anticipated material U.S. federal income tax consequences of the Transaction. The following discussion is based upon the Internal Revenue Code (the “Code”), its legislative history, currently applicable and proposed Treasury Regulations under the Code and published rulings and decisions, all as currently in effect as of the date of this Proxy Statement, and all of which are subject to change, possibly with retroactive effect. Tax consequences under state, local and non-U.S. laws, or federal laws other than those pertaining to income tax, are not addressed in this Proxy Statement. No rulings have been requested or received from the Internal Revenue Service (the “IRS”) as to the tax consequences of the Transaction and there is no intent to seek any such ruling. Accordingly, the IRS may challenge the tax treatment of the Transaction discussed below and, if it does challenge the tax treatment, it may be successful.

Purchaser is a corporation newly formed for purposes of acquiring the Assets.  In connection with the transfer of the Assets, Purchaser will be issuing shares of Class B Common Stock of Purchaser, in addition to the Base Cash Payment Amount, the contingent consideration (if any), and the assumption of the Assumed Liabilities.  The Transaction will be treated for U.S. federal income tax purposes as a transaction described in Section 351 of the Code upon which we will not recognize loss, but we will recognize gain, but not in excess of the amount of money received plus the fair market value of other property, if any, received. Under applicable IRS guidance, the amount of gain we recognize with respect to each particular Asset is determined by allocating the aggregate consideration among the transferred Assets in proportion to the relative fair market values of the Assets, and the amount of gain realized with respect to each Asset will be measured by the difference between the consideration allocable to such Asset and our tax basis in that Asset, without netting of losses against gain. Unrecognized loss would generally be preserved in the tax basis of the Equity Consideration.  Our basis in our Assets is generally equal to their cost, as adjusted for certain items, such as depreciation. The gain will be ordinary income or capital gain depending on the nature of the transferred Assets.  Because the contingent consideration may be received after the close of the taxable year in which the Transaction occurs, we may choose to report eligible gain using the installment method of accounting. We do not expect any additional gain under Section 357(c) of the Code because the


amount of Assumed Liabilities are not expected to exceed the tax basis in the Assets.  To the extent the Transaction results in us recognizing gain for U.S. federal income tax purposes, our available net operating loss carryforwards are expected to offset the majority of the gain. It is anticipated that we will pay an immaterial amount of tax on the gain recognized from the Transaction.  Our tax basis in the Equity Consideration will generally equal the tax basis of the transferred Assets, decreased by the amount of money and fair market value of any property received and increased by any gain recognized.

Anticipated Accounting Treatment

Marchex prepares its financial statements in accordance with accounting principles generally accepted in the United States of America, which is referred to as GAAP. Marchex expects to deconsolidate the Marchex Carve Out (as further defined) upon closing of the Transaction and record the equity interest in the Purchaser, received as part of the Transaction consideration, as an equity method investment on its consolidated balance sheet. Contingent consideration that meets the definition of a derivative and does not qualify for a scope exception for derivative accounting treatment will be measured at fair value on Marchex’s consolidated balance sheet.  Other contingent consideration will be recognized, if appropriate, when the contingency is resolved.  Stock option awards cancelled as part of the Transaction currently have an unamortized expense balance.  Marchex is evaluating the accounting treatment for these cancellations and expects stock-based compensation expense to increase upon closing of the Transaction.

The Company’s Business following the Transaction

If the Transaction is completed, we will no longer operate and manage the Call Marketplace Product or the Local Leads Product. However, we will continue to operate and manage our call analytics business, through which we provide various Analytics and Solutions Products via our platforms to enterprises that depend on inbound phone calls to drive sales, appointments and reservations. Marketers can use these platforms to understand which marketing channels, advertisements, search keywords, or other digital marketing advertising formats are driving calls to their business, allowing them to optimize their advertising expenditures across media channels. The Analytics and Solutions Products also include technology that can extract data and insights about what is happening during a call and measures the outcome of calls and return on investment. The platform also includes technology that can block robocalls, telemarketers and spam calls to help save businesses time and expense. The Analytics and Solutions Products data can integrate directly into third-party marketer workflows such as Salesforce, Eloqua, Adobe, Google Search, Kenshoo, Marin Software, Facebook and Instagram, in addition to other marketing dashboards and tools. Advertisers pay us a fee for each call/text or call/text related data element they receive from calls or texts, including call-based ads we distribute through our sources of call distribution or for each phone number tracked based on pre-negotiated rates.

Our primary product offerings are:

Marchex Speech Analytics. Marchex Speech Analytics is a product that can enable actionable insights for enterprise, mid-sized and small businesses, helping them understand what is happening on inbound calls from consumers to their business. Marchex Speech Analytics leverages our proprietary and patent pending speech recognition technology. Marchex Speech Analytics incorporates machine and deep learning algorithms and AI-powered conversation analysis functionality that can give customers strategic, real-time visibility into company performance in customer interactions. Marchex Speech Analytics includes customizable dashboards and visual analytics to make it easier for marketers, salespeople and call center teams to realize actionable insights across a growing amount of call data. According to a February 2018 MarketsandMarkets report, the speech analytics market is expected to grow from $941 million in 2017 to $2.2 billion by 2022.


Text Analytics and Communications. With the acquisitions of Sonar Technologies, Inc. in December 2019, as well as SITA Laboratories, Inc. (d/b/a Callcap) and Telmetrics, Inc. in November 2018, Marchex enables businesses to send and receive text/SMS messages with customers. In addition, we can provide insights for businesses on text and messaging interactions and offer customized text engagement solutions to improve the customer experience and accelerate the sales process. According to a 2018 study by Mobilesquared, there were 1.67 trillion applications to consumer SMS messages globally with the number expected to rise to 2.8 trillion by 2022. According to a 2017 study from Listrak, 75% of consumers prefer offers from businesses delivered via text and business offers delivered via SMS text marketing had a 97% read-rate.

Call Monitoring. Marchex provides businesses the ability to have an unbiased view into every inbound or outbound call, from providing a call recording, to offering services to create customized call performance scorecards, both of which can help businesses learn more about their customers and enhance service quality and customer satisfaction. Through these services, businesses can customize the insights they want in order to improve business practices and to grow faster.

Marchex Sales Edge. Launched in 2019, Marchex Sales Edge incorporates artificial intelligence-based functionality within the product suite that can help enable businesses to understand customer conversations in phone calls and via text, in real-time and at scale, and can help enable businesses to learn how to optimize the sales process in order to take the right actions to win more business. These solutions can arm businesses with the data-driven intelligence they need to deliver on-demand and personalized customer experiences. Marchex Sales Edge products include:

o

Marchex Sales Edge Rescue. Marchex Sales Rescue combines Marchex artificial intelligence and machine learning with conversational call monitoring and scoring services and can alert businesses when potential buyers hang up without making an appointment or purchase, or when certain calls did not meet the business’ sales or customer service standards. Marchex Sales Rescue can identify in real-time when potential high-value customer prospects engaged in conversations with sales representatives are mishandled in any number of ways and can give businesses the opportunity to re-engage immediately to capture these potentially lost opportunities, as well as avoid undesired customer experiences.  It can give businesses a more complete picture of the in-bound opportunities they are missing, while also measuring the effectiveness and impact of capturing those opportunities through outbound engagement.

o

Marchex Sales Edge Enterprise. Marchex Sales Edge Enterprise is a product for corporate managers that can provide conversation performance insights and trends across a brand or network of distributed business locations. The conversational data analyses can provide critical sales insights that can help enterprises boost outcomes across national and regional sales organizations.

o

Marchex Sales Edge Local. Marchex Sales Edge Local is expected to be available in the latter part of 2020 and is a product for business location managers that analyze phone conversations. Marchex Sales Edge Local can provide performance insights and prioritize leads using intelligent lead scoring and integrating with existing workflows and tools companies use each day, like Salesforce Sales Cloud CRM. This product can help companies grow their business at each location by prioritizing their best leads, while arming them with tools they can use to train their sales teams.

Marchex Omnichannel Analytics Cloud. Marchex Omnichannel Analytics Cloud leverages the call analytics platform and can provide a single source to marketers to see which media channels


are driving phone calls across search, display, video, site, and social media. Our Omnichannel Analytics Cloud products include:

o

Marchex Search Analytics. Marchex Search Analytics is a product for search marketers that can drive phone calls from search campaigns. Marchex Search Analytics can attribute inbound phone calls made from paid search ads and landing pages to a keyword. The platform can deliver this data as well as data about call outcomes directly into search management platforms like Google Search and Kenshoo. According to a June 2016 BIA Kelsey report, mobile calls represent 60% of inbound calls to businesses in 2016. This equals 85 billion global mobile calls annually, a figure that is projected to grow to 169 billion calls by 2020.

o

Marchex Display and Video Analytics. Marchex Display and Video Analytics is a product for marketers that buy digital display advertising. Marchex Display and Video Analytics can measure the influence that display advertising has on inbound phone calls so that marketers can better attribute their return on advertising spend for inbound phone calls and delivers this data to marketers in a reporting dashboard. According to a January 2019 eMarketer report, US advertisers are expected to spend nearly $68 billion in 2019 on display advertising.

o

Marchex Site Analytics. Marchex Site Analytics is a product for marketers that can drive phone calls from websites. Marchex Site Analytics can identify which websites are driving calls and provides actionable insights to help marketers understand the customer’s journey to their website, what drove them to call, and can enable marketers to better optimize both online and offline.

o

Marchex Social Analytics. Marchex Social Analytics is a product for marketers that buy social media advertising. Marchex Social Analytics can help measure the influence social media advertising has on inbound calls from platforms like Facebook or Instagram so marketers can see which posts are working. According to Statista, global social media is forecasted to grow from $76 billion in 2018 to $125 billion by 2023.

Marchex Audience Targeting.Marchex Audience Targeting leverages call data to automatically build unique audience segments for display and social media platforms. Marchex Audience Targeting can help marketers target high intent audiences with their display campaigns and fine-tune campaigns to specific audience segments that are most likely to convert to customers, or can find new segments and opportunities that have not been targeted before.

SEC Reporting

Our SEC reporting obligations as a public company will not be affected as a result of the closing of the Transaction.

Expected Timing of the Transaction

We expect to complete the Transaction promptly following the Special Meeting if we obtain Stockholder Approval and the various other conditions to closing are satisfied or waived. However, the Transaction may not be completed as currently anticipated. Certain factors, including factors outside of our control and the control of Purchaser, could result in the Transaction being delayed or not occurring at all.



ASSET PURCHASE AGREEMENT

The following discussion sets forth the principal terms of the Asset Purchase Agreement, a copy of which is attached as Annex A to this Proxy Statement and is incorporated herein by reference. The rights and obligations of the parties are governed by the express terms and conditions of the Asset Purchase Agreement and not by this discussion, which is summary in nature. This discussion is not complete and is qualified in its entirety by reference to the complete text of the Asset Purchase Agreement. All capitalized terms used but not defined herein shall have the meanings set forth in the Asset Purchase Agreement. You are encouraged to read the Asset Purchase Agreement carefully and in its entirety, as well as this Proxy Statement and any documents included herewith, before making any decisions regarding the proposals being brought before the Special Meeting.

Purchase and Sale of Assets

Purchased Assets

Upon the terms and subject to the conditions of the Asset Purchase Agreement, Seller has agreed to sell to Purchaser, and Purchaser has agreed to purchase from Seller (i) the following assets, properties and rights of Seller, to the extent that such assets, properties and rights exist as of the Closing Date and primarily relate to the Business, and (ii) 3,500,000 shares of Series A Preferred Stock held by Seller in Uproar (the “Uproar Shares”), with Seller retaining an equity interest in Uproar equal to 10% of Uproar’s outstanding capital stock (the “Retained Uproar Equity”) (collectively, the “Assets”), free and clear of all liens, claims, pledges, mortgages, restrictions, security interests and encumbrances of any kind, nature and description (“Liens”):

(a)

all accounts or notes receivable of the Business;

(b)

all inventory, including office and other supplies of the Business;

(c)

all contracts set forth on Schedule 1 to the Asset Purchase Agreement (the “Assumed Contracts”);

(d)

all Intellectual Property Assets set forth on Schedule 2 to the Asset Purchase Agreement (the “Intellectual Property Assets”) and Intellectual Property primarily related to the Business;

(e)

all fixed assets, equipment, furnishings, computer hardware, fixtures and other tangible personal property (the “Tangible Personal Property”);

(f)

all Permits of the Business;

(g)

all prepaid expenses, credits, advance payments, security, deposits, charges, sums and fees to the extent related to any of the Assets;

(h)

all of Seller’s rights under warranties, indemnities and all similar rights against third parties to the extent related to any of the Assets;


(i)

originals, or where not available, copies, of all books and records, including books of account ledgers and general, financial and accounting records, equipment maintenance files, customer lists, customer purchasing histories, price lists, distribution lists, supplier lists, production data, quality control records and procedures, customer complaints and inquiry files, research and development files, records and data (including all correspondence with any Governmental Authority), sales material and records, strategic plans, internal financial statements and marketing and promotional surveys, material and research, that relate to the Business or the Assets;

(j)

all goodwill associated with any of the assets described in the foregoing clauses;

(k)

all shares of capital stock held by Seller in Jingle Networks, Inc., a Delaware corporation; and

(l)

the Uproar bank account held by Seller.

Excluded Assets

Under the terms of the Asset Purchase Agreement, other than the Assets mentioned above, all other assets or properties of Seller will be excluded from the Assets (the “Excluded Assets”). This includes:

(a)

all cash and cash equivalents, bank accounts and securities of Seller (including the remaining shares held by Seller in Uproar);

(b)

all contracts that are not Assumed Contracts and not related to the Business;

(c)

all Intellectual Property other than the Intellectual Property Assets;

(d)

the corporate seals, organizational documents, minute books, stock books, Tax Returns, books of account or other records having to do with the corporate organization of Seller, all employee-related or employee benefit-related files or records, and any other books and records which Seller is prohibited from disclosing or transferring to Purchaser under applicable Law and is required by applicable Law to retain;

(e)

all insurance policies of Seller and all rights to applicable claims and proceeds thereunder;

(f)

all Benefit Plans and trusts or other assets attributable thereto;

(g)

all Tax assets (including duty and Tax refunds and prepayments) of Seller or any of its Affiliates unless they specifically relate to the Business;

(h)

all rights to any action, suit or claim of any nature available to or being pursued by Seller, whether arising by way of counterclaim or otherwise;

(i)

all assets, properties and rights primarily used by Seller in its business other than the Business; and

(j)

the rights which accrue or will accrue to Seller under the Asset Purchase Agreement.


Assumption of Liabilities

Assumed Liabilities

Upon the terms and subject to the conditions of the Asset Purchase Agreement, Purchaser has agreed to assume any and all liabilities and obligations of Seller arising out of or relating to the Business or the Assets on or after the Closing, other than the Excluded Liabilities (referred to in this discussion as the “Assumed Liabilities”), including, without limitation, the following:

(k)

all trade accounts payable of Seller to third parties in connection with the Business that remain unpaid as of the Closing Date;

(l)

all liabilities and obligations arising under or related to the Assumed Contracts on or after the Closing;

(m)

all liabilities and obligations for Taxes related to the Business, the Assets or the Assumed Liabilities for any taxable period ending after the Closing Date; and

(n)

all other liabilities and obligations arising out of or relating to Purchaser’s ownership or operation of the Business and the Assets on or after the Closing.

Excluded Liabilities

Under the terms of the Asset Purchase Agreement, Purchaser will not assume and will not be responsible to pay, perform or discharge any of the following liabilities or obligations of Seller (referred to in this discussion as the “Excluded Liabilities”):

(o)

any liabilities or obligations arising out of or relating to Seller’s ownership or operation of the Business and the Assets prior to the Closing Date;

(p)

any liabilities or obligations relating to or arising out of the Excluded Assets; and

(q)

any liabilities or obligations for (i) Taxes related to the Business, the Assets or the Assumed Liabilities for any taxable period ending on or prior to the Closing Date and (ii) any other Taxes of Seller for any taxable period.

Consideration

As consideration for the sale of the Business, Purchaser has agreed to pay us (a) $2.25 million in cash (the “Base Cash Payment Amount”); (b) the Contingent Consideration (as further described below); (c) shares of Class B common stock in the Purchaser equal to a 10% equity interest at closing (the “Equity Consideration”); and (d) the cancellation of Company stock options for 1.5 million shares currently held by Russell C. Horowitz and Michael Arends.


Contingent Consideration

Call Marketplace Revenue. If, at any time following the Closing Date, Purchaser’s cumulative Revenue from the Call Marketplace Product exceeds One Hundred and Forty Million Dollars ($140,000,000) (the “Call Marketplace Threshold Amount”), then Purchaser will pay us an amount equal to 2.5% of all of Purchaser’s Net Revenue generated from such Revenue exceeding the Call Marketplace Threshold Amount beginning on the date the Call Marketplace Threshold Amount is achieved and ending on the date that is two years following such date (the “Call Marketplace Contingent Consideration”).

Local Leads Revenue. If, at any time following the Closing Date, Purchaser’s cumulative Revenue of the Local Leads Product exceeds Six Million Dollars ($6,000,000) (the “Local Leads Threshold Amount”), then Purchaser will pay us 15% of all of Purchaser’s Net Revenue generated from such Revenue exceeding the Local Leads Threshold Amount beginning on the date the Local Leads Threshold Amount is achieved and continuing for so long as the Local Leads Product may be sold (the “Local Leads Contingent Consideration”).

Purchaser’s Aggregate Revenue.  If Purchaser’s aggregate Revenue exceeds Fifty-Three Million Dollars ($53,000,000) (the “Aggregate Revenue Threshold Amount”) in any of the calendar years 2021, 2022, or 2023, then Purchaser will pay us an amount equal to 0.25% of all of Purchaser’s Revenue exceeding the Aggregate Revenue Threshold Amount for such calendar year (the “Aggregate Revenue Contingent Consideration”).

Sale Transaction Contingent Consideration. If (i) Purchaser undergoes a Sale Transaction within twenty-four (24) months following the Closing Date, and (ii) the purchase price for the Sale Transaction is in excess of Eleven Million One Hundred Eleven Thousand One Hundred Eleven Dollars ($11,111,111) (the “Sale Transaction Contingent Consideration Threshold Amount”), then, in addition to our pro rata share of the consideration paid pursuant to such Sale Transaction, Purchaser will pay us an additional amount equal to 30% of the distributable proceeds exceeding the Sale Transaction Contingent Consideration Threshold Amount pursuant to the Sale Transaction (the “Sale Transaction Contingent Consideration”). Purchaser will pay us the Sale Transaction Consideration at the time the consideration paid pursuant to such Sale Transaction is distributed.  

Representations and Warranties

The Agreement contains a number of representations and warranties made by the Seller and Purchaser. The statements embodied in those representations and warranties were made for purposes of the Agreement between the parties and are subject to qualifications and limitations agreed to by the parties in connection with negotiating the terms of the Agreement. Certain representations and warranties were made as of August 7, 2020, may be subject to contractual standards of materiality different from those generally applicable to stockholders or which may have been used for the purpose of allocating risk between the parties rather than establishing matters of fact. Accordingly, you should not rely on the representations and warranties as characterizations of the actual state of facts because they are qualified as described above. Moreover, information concerning the subject matter of the representations and warranties may have changed since August 7, 2020, and these changes may or may not be fully reflected in the Seller’s or Purchaser’s public disclosures. The Agreement should not be read alone, but should instead be read in conjunction with the other information regarding the Seller and Purchaser that is contained in this Proxy Statement, as well as in the filings that the Seller will make and has made with the SEC. The representations and warranties contained in the Agreement may or may not have been accurate as of the date they were made, and we make no assertion herein that they are accurate as of the date of this Proxy Statement.


Seller Representations and Warranties

In the Agreement, the Seller has made a number of representations and warranties that are subject, in some cases, to specified exceptions and qualifications contained in the Agreement. These representations and warranties relate to, among other things:

our corporation organization;

our corporate authority to enter into the Agreement and each of the Seller Ancillary Agreements, the validity and enforceability of such agreements and the Board’s approval and recommendation;

the absence of conflicts with our charter documents, applicable law or certain contracts as a result of the execution, delivery and performance by us of the Agreement and the Seller Ancillary Agreements;

litigation;

compliance with laws;

Assumed Contracts;

title to Tangible Personal Property and the sufficiency of the Assets for the continued conduct of the Business after the Closing in substantially the same manner as conducted prior to the Closing;

taxes; and

the accuracy of statements in this Proxy Statement.

Purchaser Representations and Warranties

Purchaser’s representations and warranties relate to, among other things:

its organization;

its corporate authority to enter into the Agreement and each of the Purchaser Ancillary Agreements, the validity and enforceability of such agreements;

access to information regarding the Business; and

acknowledgement regarding Seller making no representations or warranties as to the Assets or the business except as set forth in the Agreement.

Covenants

No Solicitation of Transactions

As part of the Transaction, we agreed that we will not directly or indirectly, through any officer, director, stockholder or agent, initiate, solicit or encourage (including by way of furnishing non-public information or assistance), or enter into negotiations of any type, directly or indirectly, or enter into a confidentiality agreement, letter of intent or purchase agreement, merger agreement or other similar agreement with any Person other than Purchaser with respect to a sale of all or any substantial portion of the Assets, or a merger,


consolidation, business combination, sale of all or any substantial portion of the capital stock of Seller or the liquidation or similar extraordinary transaction with respect to Seller. We also agreed that we will notify Purchaser orally (within one Business Day) and in writing (as promptly as practicable) of all relevant terms of any inquiry or proposal by a third party to do any of the foregoing that we may receive relating to any of such matters, and that notwithstanding anything to the contrary the Parties will work together in good faith to determine an appropriate response to any such inquiry or proposal.

Transfer Taxes

We will pay any Transfer Taxes incurred as a result of the Transaction.

Restrictive Covenants

Confidentiality. We agreed to hold in confidence at all times following signing the Agreement all Confidential Information and to not disclose, publish or make use of Confidential Information at any time following signing without the prior written consent of Purchaser.

Non-Competition. We agreed that we will not, during the Restricted Period, in any manner, directly or indirectly or by assisting any other Person, engage in or assist others in engaging in any business or activity that competes with the Business or the Purchaser Business in the Territory.

Non-Disparagement.  Each party agreed that, during the Restricted Period, neither it nor its affiliates will, directly or indirectly, make any derogatory or disparaging statement or communication regarding the other Party or any of the other Party’s affiliates or the Business or any of their respective employees.

Stockholders Meeting

We are required, as promptly as reasonably practicable to (i) file this Proxy Statement with the SEC, and (ii) hold a meeting of stockholders for the purposes of obtaining the requisite stockholder approval and the Majority of the Minority Vote following the effectiveness of this Proxy Statement. We are required to cooperate and consult with Purchaser in connection with the preparation of this Proxy Statement.

Closing Conditions

The respective obligations of the Parties to effect the Transaction are subject to satisfaction (or waiver by Purchaser and the Seller, if permitted by law) at or prior to the closing of the following conditions:

all consents and filings with Governmental Authorities shall have been obtained or made;

each Party shall have performed in all material respects all covenants and agreements required to be performed at or prior to the Closing;

the Majority of Minority Vote is obtained;

Seller shall have obtained and delivered to Purchaser the written consents (or waivers with respect thereto) as described on Schedule 4 to the Asset Purchase Agreement;

the various Ancillary Agreements are executed and delivered; and


no Material Adverse Effect shall have occurred, which generally refers to a change, event, effect or occurrence that is or may be reasonably likely to be materially adverse to the financial condition, results of operations, properties, assets or liabilities or prospects of the Business or the Assets taken as a whole, subject to certain exclusions relating to general economic, political, industry, or financial conditions, acts of war, changes in laws or accounting rules, and the Transaction.

Indemnification

Each Party will indemnify, defend, and hold the other party harmless from, against, and in respect of, and will compensate and reimburse the other party for, any and all losses (“Losses”) incurred, arising out of or relating to (i) any breach or inaccuracy of any representation or warranty made by such Party in the Asset Purchase Agreement, or (ii) any breach of any covenant, agreement or undertaking made by such Party in the Asset Purchase Agreement. Claims for indemnification may be made through the date 12 months following the closing of the Transaction. Losses in respect of a claim for indemnification shall be reduced by the amount of any insurance proceeds actually received by the indemnified party with respect to such matter, and an indemnified party shall act in good faith and in a commercially reasonable manner to mitigate any Losses they may suffer as a result of an allowable claim for indemnification. Neither Party shall be required to pay an aggregate amount in excess of the Base Cash Payment Amount in respect of any Losses suffered by the other Party. The foregoing indemnification provision is the sole and exclusive remedy with respect to any and all claims under the Asset Purchase Agreement (except for fraudulent, criminal or intentional misconduct).

Termination of the Asset Purchase Agreement

The Asset Purchase Agreement may be terminated:

in writing by mutual consent of the Parties;

by written notice from Seller to Purchaser, in the event Purchaser (i) fails to perform in any material respect any of its agreements contained therein required to be performed by it at or prior to the Closing or (ii) materially breaches any of its representations and warranties contained therein, which failure or breach is not cured within ten days following Seller having notified Purchaser of their intent to terminate the Asset Purchase Agreement; or

by written notice from Purchaser to Seller, in the event Seller (i) fails to perform in any material respect any of its agreements contained therein required to be performed by it at or prior to the Closing or (ii) materially breaches any of its representations and warranties contained therein, which failure or breach is not cured within ten days following Purchaser having notified Seller of its intent to terminate the Asset Purchase Agreement.

In the event of termination of the Asset Purchase Agreement, the Asset Purchase Agreement will become void without liability on the part of any Party or its officers, directors or stockholders (with certain limited exceptions).

Transaction Costs

Except as otherwise provided in the Agreement, all fees and expenses incurred in connection with the Agreement and the transactions contemplated thereby will be paid by the party incurring such fees or expenses, whether or not the Transaction is consummated.


Governing Law

The Asset Purchase Agreement is governed by Delaware law.

Support Services Agreement

At the closing of the Transaction, the Parties have agreed to enter into the Support Services Agreement, pursuant to which Purchaser will agree to pay the Company for certain services we provide to Purchaser.  These services may include information technology, human resources, accounting, legal, technology operations (comprising physical and logical monitoring and maintenance of data centers), contracts administration, and other general and administrative services.  Purchaser will pay the Company its cost plus 5%, with a minimum of $3.5 million in the first year following closing and $1.5 million in the second year following closing (with the second year minimum payment subject to a minimum revenue threshold of Purchaser for such year).


INTERESTS OF RELATED PARTIES IN THE TRANSACTION

As previously described in this Proxy Statement, the Company entered into the Asset Purchase Agreement with Archenia, Inc., of which Russell C. Horowitz, Co-CEO of the Company, and Michael Arends, Co-CEO and Chief Financial Officer of the Company, are the controlling stockholders. Accordingly, all of the rights and obligations of Purchaser under the Asset Purchase Agreement indirectly affect the interests of Messrs. Horowitz and Arends, including the obligations to the pay the consideration to the Company.  In addition to paying the Base Cash Payment Amount at closing, Purchaser has agreed to pay the Company the Contingent Consideration based on revenues from the Call Marketplace Product, from the Local Leads Product and of Purchaser, in each case assuming certain thresholds are met.  Pursuant to the Support Services Agreement to be entered at closing, Purchaser will agree to pay the Company for certain services we provide to Purchaser at the Company’s cost plus 5%, with a minimum of $3.5 million in the first year following closing and $1.5 million in the second year following closing (with the second year minimum payment subject to a minimum revenue threshold of Purchaser for such year).  Whether and to what extent the payments in connection with the Contingent Consideration and the Support Services Agreement are made to the Company may be influenced by the future business performance, accounting decisions and reporting of Purchaser.  In addition, Messrs Horowitz and Arends enjoy certain rights to indemnification from the Company in the event it breaches the Asset Purchase Agreement.

In light of these different or additional interests, the Board formed the Special Committee, comprised solely of independent directors of the Company, to consider and negotiate the terms of the Transaction and to ensure the terms were fair, advisable to and in the best interests of the Company and its stockholders. On August 7, 2020, the Special Committee approved the Transaction and recommended that the Board do the same.


FINANCIAL INFORMATION

Consolidated Financial Statements of Marchex

Marchex’s audited consolidated financial statements as of and for the fiscal years ended December 31, 2019 and 2018, and the notes thereto, are contained in our annual report on Form 10-K that is incorporated by reference into this Proxy Statement.  Marchex’s unaudited condensed consolidated financial statements as of and for the fiscal quarters ended March 31, 2020 and June 30, 2020, and the notes thereto, are contained in our quarterly reports on Form 10-Q that are incorporated by reference into this Proxy Statement.  

Unaudited Pro Forma Consolidated Financial Information

Marchex has prepared unaudited pro forma consolidated financial information and notes thereto for Marchex, which begin on page F-2. The unaudited pro forma consolidated financial information has been prepared from Marchex’s historical consolidated financial statements and give effect to the Transactions. There can be no assurance that the Transaction will be consummated. The unaudited pro forma consolidated financial statements should be read in conjunction with the historical financial statements of Marchex and the notes thereto.

The definitive proxy statement will be updated with unaudited pro forma balance sheet information as of June 30, 2020 and unaudited pro forma statement of operations information for the 6-month period ended June 30, 2020.

Unaudited Special Purpose Combined Financial Statements for Marchex Carve Out

Unaudited special purpose combined financial statements and notes thereto for Marchex Carve Out are provided beginning on page F-8. The unaudited special purpose combined balance sheets were prepared as of December 31, 2018, December 31, 2019, and March 31, 2020. Unaudited special purpose combined statements of operation and cash flows were prepared for the years ended December 31, 2018 and 2019, and for the three-month periods ended March 31, 2020.

The definitive proxy statement will be updated for an unaudited special purpose combined balance sheet as of June 30, 2020, and unaudited special purpose combined statements of operations and cash flows for the 6-month period ended June 30, 2019 and 2020.


SECURITY OWNERSHIP OF CERTAIN BENEFICIALBENEFICIAL OWNERS AND MANAGEMENT

To the Company’s knowledge, the following table sets forth information regarding the beneficial ownership of our Class A common stock and Class B common stock as of June 27, 2017August 10, 2020 by:

each person (or group of affiliated persons) who is known by us to own beneficially more than 5% of the outstanding shares of our Class A common stock or Class B common stock;

each of our directors and nominees for director;

each of our current “named executive officers listedofficers” (as defined in the “Summary Compensation Table” (“NEOs”)Regulation S-K Item 402); and

all of our current directors, nominees for director and executive officers as a group.

Percentage of beneficial ownership is based on 5,056,1364,660,927 shares of our Class A common stock and 38,284,25439,896,634 shares of our Class B common stock outstanding as of June 27, 2017.August 10, 2020. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, shares of common stock subject to options or restricted stock units held by that person that are currently exercisable or exercisable or issuable upon vesting within 60 days of June 27, 2017,August 10, 2020, are deemed outstanding. These shares are not, however, deemed outstanding for the purposes of computing the percentage ownership of any other person. Except as otherwise noted below, the address for each beneficial owner listed below is c/o Marchex, Inc., 520 Pike Street, Suite 2000, Seattle, Washington 98101.

 

Shares Beneficially Owned

 

 

% Total

 

 

 

Class A Common Stock

 

 

Class B Common Stock

 

 

Voting

 

Name and, as appropriate, Address of Beneficial Owner

 

Shares

 

 

%

 

 

Shares

 

 

%

 

 

Power (1)

 

5% Security Holders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Prescott Group Capital Management, LLC (2)

 

 

 

 

 

 

 

 

4,298,949

 

 

 

11.2

 

 

 

2.6

 

1924 South Utica, Suite 1120

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tulsa, OK  74104-6529

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Edenbrook Capital, LLC (3)

 

 

 

 

 

 

 

 

3,063,187

 

 

 

8.0

 

 

 

1.9

 

2 Depot Plaza

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bedford Hills, NY 10507

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BlackRock, Inc. (4)

 

 

 

 

 

 

 

 

2,406,080

 

 

 

6.3

 

 

 

1.5

 

55 East 52nd Street

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

New York, NY 10022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Named Executive Officers and Directors:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Michael Arends (5)

 

 

 

 

 

 

 

 

1,079,337

 

 

 

2.8

 

 

*

 

Ethan Caldwell (6)

 

 

395,209

 

 

 

7.8

 

 

 

1,042,439

 

 

 

2.7

 

 

 

6.3

 

Dennis Cline (7)

 

 

 

 

 

 

 

 

191,246

 

 

*

 

 

*

 

Anne Devereux-Mills (8)

 

 

 

 

 

 

 

 

301,846

 

 

*

 

 

*

 

Nicolas J. Hanauer (9)

 

 

 

 

 

 

 

 

2,634,411

 

 

 

6.8

 

 

 

1.4

 

Russell C. Horowitz (10)

 

 

4,660,927

 

 

 

92.2

 

 

 

1,054,404

 

 

 

2.7

 

 

 

70.9

 

Ian Morris (11)

 

 

 

 

 

 

 

 

144,942

 

 

*

 

 

*

 

Gary Nafus (12)

 

 

 

 

 

 

 

 

113,124

 

 

*

 

 

*

 

M. Wayne Wisehart (13)

 

 

 

 

 

 

 

 

237,131

 

 

*

 

 

*

 

All directors and executive officers as a group (9 persons) (14)

 

 

5,056,136

 

 

 

100.0

 

 

 

6,798,880

 

 

 

16.8

 

 

 

79.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Except as indicated in the footnotes below and except as subject to community property laws where applicable, the persons named in the table abovebelow have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them.

 

 

Shares Beneficially Owned

 

 

% Total

 

 

 

Class A Common Stock

 

 

Class B Common Stock

 

 

Voting

 

Name and, as appropriate, Address of Beneficial Owner

 

Shares

 

 

%

 

 

Shares

 

 

%

 

 

Power (1)

 

5% Security Holders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Edenbrook Capital, LLC (2)

 

 

 

 

 

 

 

 

7,796,796

 

 

 

19.5

 

 

 

5.0

 

116 Radio Circle

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mount Kisco, NY 10549

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Renaissance Technologies LLC (3)

 

 

 

 

 

 

 

 

2,587,172

 

 

 

6.5

 

 

 

1.7

 

800 Third Avenue

New York, NY 10022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Harbert Discovery Fund, LP (4)

 

 

 

 

 

 

 

 

2,235,065

 

 

 

5.6

 

 

 

1.4

 

2100 Third Avenue North, Suite 600

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Birmingham, AL 35203

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Named Executive Officers and Directors:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Michael Arends (5)

 

 

 

 

 

 

 

 

1,505,631

 

 

 

3.7

 

 

 

*

 

Dennis Cline (6)

 

 

 

 

 

 

 

 

170,260

 

 

*

 

 

*

 

Donald Cogsville (7)

 

 

 

 

 

 

 

 

48,123

 

 

 

*

 

 

 

*

 

Russell C. Horowitz (8)

 

 

4,660,927

 

 

 

100.0

 

 

 

1,143,480

 

 

 

2.8

 

 

 

74.9

 

M. Wayne Wisehart (9)

 

 

 

 

 

 

 

 

286,145

 

 

*

 

 

*

 

All directors and executive officers as a group (5 persons) (10)

 

 

4,660,927

 

 

 

100.0

 

 

 

3,153,639

 

 

 

7.7

 

 

 

75.7

 

 

*

Beneficial ownership or total voting power, as the case may be, representing less than one percent.

(1)

Percentage of voting power represents voting power with respect to shares of our Class A common stock and Class B common stock, as a single class. Each holder of Class A common stock shall be entitled to 25 votes per share of Class A common stock and each holder of Class B common stock shall be entitled to 1 vote per share of


Class B common stock on all matters submitted to a vote of stockholders, except as may otherwise be required by law. The Class A common stock is convertible at any time by the holder into shares of Class B common stock on a share-for-share basis.



(2)

Based on the most recently available Schedule 13G/13D/A filed with the SEC on February 10, 2017July 22, 2020 by Prescott GroupEdenbrook Capital, Management, L.L.C.LLC (“Prescott”Edenbrook), an investment advisormanager to certain private investment funds on its behalf; on behalf of Jonathan Brolin (“Brolin”), an individual; and on behalf of Prescott Group Aggressive Small Cap, L.P.Edenbrook Long Only Value Fund, LP (“Edenbrook Fund”). Edenbrook and Prescott Group Aggressive Small Cap II, L.P. (collectively, the “Small Cap Funds”) and Phil Frohlich (“Frohlich”). Prescott and Frohlich,Brolin each report beneficial ownership of 4,298,9497,796,796 shares of our Class B common stock, and soleshared voting and sole dispositive power as to 4,298,9497,796,796 shares of our Class B common stock. With respect to Small Cap Funds, each reportEdenbrook Long Only Value Fund, LP reports beneficial ownership of 4,298,9497,796,796 shares of our Class B common stock, and shared voting and shared dispositive power as to 6,788,133 shares of 4,298,949.our Class B common stock.

(3)

Based on the most recently available Schedule 13D13G/A filed with the SEC on February 9, 201713, 2020 by Edenbrook Capital,Renaissance Technologies LLC (“Edenbrook”("Renaissance"), an investment manager to certain private investment fundsadvisor on its behalf and on behalf of Jonathan Brolin (“Brolin”Renaissance Technologies Holdings Corporation ("Renaissance Holdings Corporation"), whose address is 2 Depot Plaza, Bedford Hills, New York, an individual. Edenbrook. Renaissance and BrolinRenaissance Holdings Corporation each report beneficial ownership of 3,063,1872,587172 shares of our Class B common stock, sole voting power as to 2,417,857 shares of our Class B common stock, sole dispositive power as to 2,589,840 shares of our Class B common stock and shared voting and dispositive power as to 3,063,1876,332 shares of our Class B common stock.

(4)

Based on the most recently available Schedule 13G/A13D filed with the SEC on January 25, 2017March 12, 2020 by BlackRock, Inc. (“BlackRock”), a parent holding company/control person, on its behalf and for the benefit of the following BlackRock direct and/or indirect subsidiaries: BlackRock Advisors, LLC, BlackRock Asset Management Canada Limited, BlackRockHarbert Discovery Fund, LP; Harbert Discovery Fund GP, LLC; Harbert Fund Advisors, Blackrock Institutional Trust Company, N.A., Blackrock International Limited, Blackrock InvestmentInc.; Harbert Management LLCCorporation; Jack Bryant; Kenan Lucas; and Blackrock Financial Management, Inc. (collectively, the “BlackRock Subsidiaries”). BlackRock reportsRaymond Harbert report beneficial ownership of 2,406,080 shares of our Class B common stock, with sole voting power of 2,267,2852,235,065 shares of our Class B common stock and soleshared voting and dispositive power of 2,406,080with respect to 2,235,065 shares of our Class B common stock. BlackRock reports that the BlackRock Subsidiaries have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of our Class B common stock, and that no one of the BlackRock Subsidiaries has an interest greater than five percent (5%) of our total outstanding common shares.

(5)

Includes: (1) 165,000239,250 shares of restricted stock subject to vesting; (2) 483,483678,277 shares of our Class B common stock subject to options that are currently exercisable or exercisable within 60 days of June 27, 2017;August 10, 2020; (3) 10,500 shares of our Class B common stock held by the Nicole Marie Arends 2003 Trust for the benefit of Nicole Marie Arends, the daughter of Mr. Arends, for which shares Mr. Arends disclaims beneficial ownership; (4) 18,100 shares of Class B common stock held in an Individual Retirement Account for the benefit of Mr. Arends; and (5) 6,500 shares of Class B common stock held in an Individual Retirement Account for the benefit of Diana Arends, Mr. Arends’ wife.

(6)

Includes: (1) 189,25022,500 shares of restricted stock subject to vesting; and (2) 504,43715,000 shares of our Class B common stock subject to options that are currently exercisable or exercisable within 60 days of June 27, 2017.

(7)

Includes: (1)August 10, 2020; (3) 28,500 shares of our Class B common stock held by DMC Investments, LLC, a limited liability company of which Mr. Cline is the managing member; and (2)(4) 10,000 shares of our Class B common stock held by the Colburn Cline Trust for the benefit of Colburn Cline, the son of Mr. Cline, for which shares Mr. Cline disclaims beneficial ownership.

(8)(7)

Includes 112,500Includes: (1) 22,500 shares of restricted stock subject to vesting.

(9)

Includes 300,000vesting; and (2) 17,500 shares of our Class B common stock subject to options that are currently exercisable.exercisable or exercisable within 60 days of August 10, 2020.

(10)(8)

Includes: (1) 4,660,927 shares of our Class A common stock held by MARRCH Investments, LLC; (2) 778,000261,500 shares of restricted stock subject to vesting; (3) 579,062 shares of our Class B common stock subject to options that are currently exercisable;exercisable or exercisable within 60 days of August 10, 2020; and (3)(4) 5,000 shares of Class B common stock held in an Individual Retirement Account for the benefit of Mr. Horowitz. Mr. Horowitz is the managing member of MARRCH Investments, LLC and, as such, may be deemed to exercise voting and investment power over the shares held by all of these entities.this entity.  

(11)(9)

Includes 91,38322,500 shares of restricted stock subject to vesting; and (2) 25,000 shares of Class B common stock subject to options that are currently exercisable or exercisable within 60 days of August 10, 2020.

(10)

Includes an aggregate of: (1) 4,660,927 shares of our Class A common stock; (2) 1,838,800 shares of our Class B common stock which includes 20,500 shares for which beneficial ownership has been disclaimed; and (3) 1,314,839 shares of our Class B common stock subject to options that are currently exercisable or exercisable within 60 days of June 27, 2017.August 10, 2020.

(12)

Includes 103,124 shares of our Class B common stock subject to options that are currently exercisable. Mr. Nafus resigned effective March 31, 2017 as Chief Revenue Officer and as a member of the office of the CEO and in connection with his employment termination, any unvested restricted stock and unvested options were forfeited. Mr. Nafus has 90 days from his employment termination date to exercise any vested options.

(13)

Includes 40,000 shares of our Class B common stock subject to options that are currently exercisable.

(14)

Includes an aggregate of: (1) 5,056,136 shares of our Class A common stock; (2) 4,498,453 shares of our Class B common stock which includes 20,500 shares for which beneficial ownership has been disclaimed; and (3) 2,300,427 shares of our Class B common stock subject to options that are currently exercisable or exercisable within 60 days of June 27, 2017.



PROPOSAL ONE—ELECTION OF DIRECTORS

(Item 1 on Proxy Card)

The Board of Directors currently consists of five (5) individuals, three (3) of whom have been nominated for election at the Annual Meeting along with Russell C. Horowitz, who previously served as a director of the Company. Directors are elected to hold office until the next annual meeting of stockholders and until their respective successors have been elected and qualified. The names and the respective ages of the four (4) nominees as of June 27, 2017 are set forth below:

Name

Age

Position

Director Since

Dennis Cline (1)(2)

56

Director

May 2003

Anne Devereux-Mills (2)(3)

55

Chairman of the Board of Directors

October 2006

Russell C. Horowitz

51

Consultant and member of the office of the CEO

M. Wayne Wisehart (1)(3)

71

Director

November 2008

(1)

Member of the Audit Committee.

(2)

Member of the Nominating and Governance Committee.

(3)

Member of the Compensation Committee.

Set forth below is a description of the business experience of each current director, including a discussion of the specific experience, qualifications, attributes and skills that led our Board of Directors to conclude that those individuals should serve as our directors.

Dennis Cline. Mr. Cline has served as a member of our Board of Directors since May 2003. Since 2013, Mr. Cline has served on the board of advisors of Blackstratus, a provider of security information event management products and services. Previously, Mr. Cline served on the board of directors of TraceSecurity, a provider of cloud-based security solutions, from 2003 to 2015. From 2004 to 2006, Mr. Cline served as Chief Executive Officer and Executive Chairman of netForensics, a provider of security event information management. Prior to joining netForensics as its Chief Executive Officer, Mr. Cline was Managing Partner of DMC Investments, a firm he founded in 2000, which provides capital and consulting services to technology companies. From 1988 to 2000, Mr. Cline was the CEO of DirectWeb, a provider of computer hardware and Internet access for consumers. Prior to DirectWeb, Mr. Cline was a senior executive at Network Associates, a provider of computer security solutions. Mr. Cline received his J.D. from Rutgers School of Law and his B.A. from Rutgers University. Mr. Cline brings extensive governance, marketing, sales and broad management expertise to the board.

Anne Devereux-Mills. Ms. Devereux-Mills has served as a member of our Board of Directors since October 2006 and as Chairman of our Board Directors since October 2016. With over 25 years of experience in the marketing and advertising industries. Ms. Devereux-Mills now serves as the Chief Strategy Officer and a member of the Board of Directors of Lantern, a mobile technology provider for mental health and wellness programs. Prior to these current roles, Ms. Devereux-Mills served as Chairman of LLNS, a division of Omnicom Group Inc. (NYSE: OMC) from May 2006 to April 2012 and served as Chief Executive Officer of LLNS from May 2006 to September 2010. LLNS is a leading healthcare communications agency. Prior to joining LLNS, from February 2003 to May 2006, Ms. Devereux-Mills was the Chief Integration Officer as well as Managing Director of all health-related assignments within BBDO New York, an advertising agency. Before joining BBDO New York, from April 2002 to February 2003, Ms. Devereux-Mills was President of Dugan Valva Contess, an independent communications agency. From January 1996 to April 2002, Ms. Devereux-Mills was President and Founder of Consumer Healthworks which then became Merkley Newman Harty Healthworks, one of the first agencies to specialize in direct-to-consumer advertising for healthcare brands. Ms. Devereux-Mills received a B.A. degree from Wellesley College. Ms. Devereux-Mills brings extensive marketing and advertising expertise to the board.

Russell C. Horowitz. Mr. Horowitz is a founder of our Company and has served as a consultant to the Company since May of 2016 and as a member of the office of the CEO since October 2016.  Prior to these roles, Mr. Horowitz served as Executive Director from February 2015 to May 2016 and as CEO, Treasurer and Chairman of the Board from inception to February 2015.   Mr. Horowitz was previously a founder of Go2Net, a provider of online services to merchants and consumers, including merchant Web hosting, online payment authorization technology, and Web search and directory services. He served as its Chairman and Chief Executive Officer from its inception in February 1996 until its merger with InfoSpace in October 2000, at which time Mr. Horowitz served as the Vice Chairman and President of the combined company through the merger integration process. Additionally, Mr. Horowitz served as the Chief Financial Officer of Go2Net from its inception until May 2000. Prior to Go2Net, Mr. Horowitz served as the Chief Executive Officer and a director of Xanthus Management, LLC, the general partner of Xanthus Capital, a merchant bank focused on investments in early-stage companies, and was a founder and Chief Financial Officer of Active Apparel Group, now Everlast Worldwide. Mr. Horowitz received a B.A. in Economics from Columbia College of Columbia University. Mr. Horowitz brings historic knowledge and continuity together with extensive operational and industry expertise to the board.


M. Wayne Wisehart. Mr. Wisehart has served as a member of our Board of Directors since November 2008. From February 2010 to November 2010, Mr. Wisehart served as interim Chief Financial Officer for All Star Directories, a publisher of online and career school directories. Mr. Wisehart previously served as the Chief Financial Officer of aQuantive, Inc. (formerly Avenue A Media, Inc.), a leading global digital marketing company, which was acquired by Microsoft in August 2007. Prior to aQuantive, Mr. Wisehart served as Chief Financial Officer of Western Wireless Corporation, a cellular phone service provider, which was acquired by Alltel in August 2005. Mr. Wisehart also served as the Chief Financial Officer from 2000 to 2002 of iNNERHOST, Inc., a Web hosting service’s company, as President and Chief Executive Officer from 1999 to 2000 of TeleDirect International Inc., a company that provide customer interaction systems, and as the President and Chief Executive Officer from 1997 to 1998 of Price Communications Wireless. Mr. Wisehart also serves on the Board of Directors of Centri Technology, Inc. Mr. Wisehart received a B.S. degree in Business from the University of Missouri-St. Louis. Mr. Wisehart brings extensive financial and accounting expertise to the board.

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE ELECTION OF THE NOMINEES LISTED ABOVE TO THE BOARD OF DIRECTORS.



CORPORATE GOVERNANCE

Board Independence

The Board of Directors determined that each of the members of the board is an independent director in accordance with NASDAQ listing standards.

Committees and Meeting Attendance

The Board of Directors has an Audit Committee, a Compensation Committee and a Nominating and Governance Committee. Each of these committees operates under a written charter adopted by the board. Copies of these charters are available on our website at www.marchex.com. The Board of Directors held nine meetings and took action by written consent on five occasions during the fiscal year ended December 31, 2016. Each of the standing committees of the board held the number of meetings indicated below. During the last fiscal year, each of our directors attended at least 75% of the total number of meetings of the board and committees of the board on which such director served during that period. We encourage director representation at our annual meetings of stockholders. Our former Executive Chairman, current Chairman and Chair of our Audit Committee attended last year’s annual meeting.

The following table sets forth the three standing committees of the board, the members of each committee, the number of meetings held by each committee, and the number of committee actions taken by written consent during the 2016 fiscal period:

Name of Director

Audit

Compensation

Nominating and Governance

Dennis Cline

Member

 

Member

Anne Devereux-Mills

 

Member

Chair

Nicolas Hanauer

 

 

 

Ian Morris

Member

Chair

Member

M. Wayne Wisehart

Chair

Member

 

Number of Meetings

8

7

4

Action by Written Consent

2

7

0

During 2016, the following directors served on committees for portions of the year: Mr. Hanauer served on the Nominating and Governance Committee through May 12, 2016. Effective May 13, 2016, Mr. Morris was appointed to serve as a member of the Nominating and Governance Committee.

Audit Committee

The Audit Committee is currently comprised of Messrs. Cline, Morris and Wisehart (Chair). Each of the members of the Audit Committee is independent for purposes of the NASDAQ listing standards as they apply to Audit Committee members. Messrs. Cline and Wisehart are Audit Committee financial experts, as defined in the rules of the Securities and Exchange Commission. The Audit Committee operates under a charter that is available on our website at www.marchex.com. The functions of the Audit Committee include reviewing, with the Company’s independent registered public accounting firm, the scope and timing of the independent registered public accounting firm’s services, the independent registered public accounting firm’s report on the Company’s consolidated financial statements and internal control over financial reporting following completion of the Company’s audits, and the Company’s internal accounting and financial control policies and procedures, and making annual recommendations to the Board of Directors for the appointment of independent registered public accounting firm for the ensuing year. The Audit Committee held eight meetings and took action by written consent on two occasions during the fiscal year ended December 31, 2016. Additional information regarding the Audit Committee is set forth in the Audit Committee Report below.

Compensation Committee

The Compensation Committee is currently comprised of Messrs. Morris (Chair) and Wisehart and Ms. Devereux-Mills. Each of the members of the Compensation Committee is independent for purposes of the NASDAQ listing standards. The Compensation Committee operates under a charter that is available on our website at www.marchex.com. The Compensation Committee held seven meetings and took action by written consent on seven occasions during the fiscal year ended December 31, 2016.



The purpose of the Compensation Committee is to assist the Board of Directors in carrying out its responsibilities with respect to: (i) overseeing the Company’s compensation policies and practices; (ii) reviewing and approving annual compensation and compensation procedures for the Company’s executive officers; and (iii) overseeing and recommending director compensation to the Board of Directors. More specifically, the Compensation Committee’s responsibilities include overseeing the Company’s general compensation structure, policies and programs, and assessing whether the Company’s compensation structure establishes appropriate incentives for management and employees; making recommendations to the Board of Directors with respect to, and administering, the Company’s incentive compensation and equity-based compensation plans, including the Company’s stock option plan and employee stock purchase plan; reviewing and approving compensation procedures for the Company’s executive officers; recommending to the independent directors for approval the compensation of the Chief Executive Officer based on relevant corporate goals and objectives and the Board of Directors’ performance evaluation of the Chief Executive Officer; and reviewing and recommending to the Board of Directors for approval the compensation of executive officers other than the Chief Executive Officer; reviewing and recommending to the Board of Directors employment, retention, restricted stock and severance agreements for executive officers, including change in control provisions, plans or agreements; reviewing the compensation of directors for service on the Board of Directors and its committees. Regarding most compensation matters, including executive and director compensation, the Company’s management provides recommendations to the Compensation Committee. The Compensation Committee has delegated its authority to grant equity and other awards under the Company’s stock incentive plan to eligible employees who are not executive officers to the Stock Option Grant Subcommittee within certain pre-approved limits. The Stock Option Grant Subcommittee currently consists of Messrs. Arends, and Caldwell and such committee regularly reports any grants made to the Compensation Committee.

Nominating and Governance Committee

The Nominating and Governance Committee is currently comprised of Messrs. Cline and Morris and Ms. Devereux-Mills (Chair). Each of the members of the Nominating and Governance Committee is independent for purposes of the NASDAQ listing standards. The Nominating and Governance Committee operates under a charter that is available on our website at www.marchex.com. The Nominating and Governance Committee identifies individuals qualified to become board members, recommends to the board those persons to be nominated for election to our board at the annual meeting of stockholders, develops and recommends to the board a set of corporate governance principles applicable to the Company and oversees the annual evaluation of the board. The Nominating and Governance Committee held four meetings during the fiscal year ended December 31, 2016.

Nomination of Directors

The Nominating and Governance Committee may use third party executive search firms to help identify prospective director nominees. The Nominating and Governance Committee has not established specific minimum age, education, experience, or skill requirements for potential members, but, in general, expects that qualified candidates will have high-level managerial experience in a relatively complex organization or be accustomed to dealing with complex problems, and will be able to represent the interests of the stockholders as a whole rather than special interest groups or constituencies. The Nominating and Governance Committee considers each candidate’s character, integrity, judgment, skills, background, experience of particular relevance to the Company, ability to work well with others and time available to devote to board activities, among other factors. The Nominating and Governance Committee also considers the interplay of a candidate’s background and expertise with that of other board members, and the extent to which a candidate may be a desirable addition to any committee of the board. The Nominating and Governance Committee uses the same process for evaluating all nominees, regardless of the original source of the nomination.

The Nominating and Governance Committee also focuses on issues of diversity, such as diversity of gender, race and national origin, education, professional experience and differences in viewpoints and skills. The Nominating and Governance Committee does not assign specific weights to particular criteria. Rather, the Board of Directors believes that the backgrounds and qualifications of the directors, considered as a group, should provide a significant composite mix of experience, knowledge and abilities that will allow the board to fulfill its responsibilities. The Nominating and Governance Committee believes that it is essential that the board members represent diverse viewpoints. The Nominating and Governance Committee’s goal is to assemble a board that brings to the Company a variety of perspectives and skills derived from high quality business and professional experience.

Our evaluations of potential directors include, among other things, an assessment of a candidate’s background and credentials, personal interviews, and discussions with appropriate references. Once we have selected appropriate candidates, we present them to the full board for election if a vacancy occurs or is created by an increase in the size of the board during the course of the year, or for nomination if the director is to be first elected by stockholders.



Marchex stockholders may recommend individuals to the Nominating and Governance Committee for consideration as potential director candidates by submitting their names and appropriate supporting background and biographical information to: Marchex, Inc., 520 Pike Street, Suite 2000, Seattle, Washington 98101, Attention: General Counsel. The recommendation must include any relevant information, including the candidate’s name, home and business contact information, detailed biographical data and qualifications, and information regarding any relationships between the candidate and the Company within the last three years. Acceptance of a recommendation does not mean that the committee will ultimately nominate the recommended candidate.

Code of Conduct and Code of Ethics

The Company has adopted a code of conduct applicable to each of the Company’s officers, directors and employees, and a code of ethics applicable to the Company’s Chief Executive Officer, Chief Financial Officer and the Company’s senior financial officers, as contemplated by Section 406 of the Sarbanes-Oxley Act of 2002 and both codes are available on our website at www.marchex.com.

Corporate Governance Guidelines

The Board of Directors has adopted corporate governance guidelines to ensure effective corporate governance which are available on our website at www.marchex.com.

Board Leadership Structure

The Board of Directors does not have a specific policy regarding the separation of the roles of Chief Executive Officer and Chairman of the Board as the board believes it is in the best interest of the Company to make that determination based on the position and direction of the Company and the membership of the board. The Board of Directors is responsible for the control and direction of the Company.

The Board of Directors is currently comprised of independent members, as independence is defined under the NASDAQ Listing Standards. The leadership structure of the Company has varied over time as the demands of the business, the composition of the Board, and the ranks of our senior executives have changed, and the Board has utilized this flexibility to establish the most appropriate structure at any given time. From our inception, until February of 2015, we combined the roles of Chairman of the Board and Chief Executive Officer, but in February of 2015 we began to operate with an Executive Chairman of the Board separate from the Chief Executive Officer. In October 2016, Anne Devereux-Mills was appointed Chairman of the Board of Directors and an office of the CEO was established subject to oversight by Ms. Devereux-Mills following the resignation of our then Chief Executive Officer.

We have experienced recent turnover in certain senior executives, and currently the duties and responsibilities of the chief executive officer are performed by the Office of the CEO consisting of Michael Arends (Chief Financial Officer), Ethan Caldwell (Chief Administrative Officer, General Counsel and Secretary), and Russell C. Horowitz (currently a consultant to the Company and previously Chief Executive Officer and Chairman of the Board) and subject to oversight by our Chairman, Anne Devereux-Mills. We are assessing our current and future senior leadership needs, although we may not be successful in finding or hiring suitable additional senior leadership.

Board’s Role in Risk Management

The Board of Directors, as a whole and also at the committee level, is responsible for oversight of our risk assessment and management process. Management is responsible for the Company’s day-to-day risk management activities. The Audit Committee periodically reviews risks and exposures associated with financial matters and financial reporting, the Compensation Committee oversees risks relating to compensation programs and policies, and the Nominating and Governance Committee oversees risks associated with Board and corporate governance matters. Furthermore, the Board of Directors periodically reviews risk management matters, including as part of its ongoing corporate strategy review, and is apprised of particular risk management matters in connection with its general oversight and approval of corporate matters.

Board Effectiveness

The Board of Directors performs an annual self-assessment to evaluate its effectiveness in fulfilling its obligations.


Executive Session

The corporate governance guidelines provide that the Company’s independent directors shall meet regularly (not less than two times per year) in executive session at which only the Company’s independent directors shall be present. The independent directors met in executive session four times during the fiscal year ended December 31, 2016.

Compensation Committee Interlocks and Insider Participation

None of the members of the Compensation Committee during 2016, are or have been an officer or employee of the Company. No member of the Compensation Committee had any relationship with the Company requiring disclosure under Item 404 of Regulation S-K. During fiscal year 2016, none of the Company’s executive officers served on the Compensation Committee (or its equivalent) or Board of Directors of another entity any of whose executive officers served on the Company’s Compensation Committee or Board of Directors.

Communications with Directors

The Board of Directors provides a process for Marchex stockholders to send communications to the Board of Directors. Any stockholder who desires to contact the Board of Directors may do so by writing to: Marchex, Inc., 520 Pike Street, Suite 2000, Seattle, Washington 98101, Attention: Ethan Caldwell, Secretary. Communications received by mail will be screened by the Secretary for appropriateness before either forwarding to or notifying the members of the Board of Directors of receipt of a communication.



PROPOSAL TWO—RATIFICATION OF APPOINTMENT OF INDEPENDENT

REGISTERED PUBLIC ACCOUNTING FIRM

(Item 3 on Proxy Card)

KPMG LLP (“KPMG”) served as our independent registered public accounting firm for the fiscal year ended December 31, 2016 (“fiscal 2016”) and audited our consolidated financial statements for fiscal 2016 and prior years. On June 23, 2017, following a review process undertaken by the Audit Committee, the Audit Committee approved the selection of Moss Adams to serve as our independent registered public accounting firm for the fiscal year ended December 31, 2017. At the same time, the Audit Committee approved the dismissal of KPMG, effective as of June 23, 2017. Stockholder ratification of the selection of Moss Adams as Marchex’s independent registered public accounting firm is not required by Marchex’s bylaws, Delaware corporate law or otherwise. Notwithstanding the foregoing, the Board of Directors has elected to seek such ratification as a matter of good corporate practice. Should the stockholders fail to ratify the selection of Moss Adams as our independent registered public accounting firm, the Board of Directors will consider whether to retain Moss Adams for the year ended December 31, 2017 and will consider the appointment of another independent registered public accounting firm.  

KPMG's reports on the Company’s financial statements for the fiscal years ended December 31, 2015 and 2016 did not contain an adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles. During the Company’s two most recent fiscal years ended 2015 and  2016 and through June 23, 2017, the date of KPMG's dismissal, we had no disagreements (as defined in Item 304 of Regulation S-K) with KPMG on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to KPMG's satisfaction, would have caused it to make reference to the subject matter of the disagreements in connection with any opinion to the subject matter of the disagreement. Furthermore, during the period of KPMG’s retention, there were no reportable events of the type described in Item 304(a)(1)(v) of Regulation S-K.

The change in independent registered accounting firm was disclosed in the Company's Current Report on Form 8-K filed with the SEC on June 28, 2017. A copy of KPMG’s letter, dated June 28, 2017, stating its agreement with the statements made therein as it pertains to KPMG in the Form 8-K was included as an exhibit to such Form 8-K filing.

During the two most recent fiscal years ended December 31, 2015 and 2016, and through June 23, 2017, neither the Company nor anyone on the Company’s behalf consulted Moss Adams regarding either (i) the application of accounting principles to a specified transaction regarding the Company, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report nor oral advice was provided to the Company that was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was the subject of a disagreement (as that term is defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) or a “reportable event” (as that term is defined in Item 304(a)(1)(v) of Regulation S-K).

Representatives of KPMG and Moss Adams are expected to be present at the Annual Meeting in order to respond to appropriate questions and to make any other statement deemed appropriate.

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE “FOR” RATIFICATION OF THE APPOINTMENT OF MOSS ADAMS LLP.



INDEPENDENT REGISTERED ACCOUNTING FIRM FEES

Accounting Fees and Services

During fiscal years 2015 and 2016, we retained KPMG to provide professional services in the following categories and amounts:

  

2015

 

2016

 

Fee Category

($)

 

($)

 

Audit Fees

 

962,000

 

 

914,000

 

Tax Fees

 

88,000

 

 

88,000

 

Total All Fees

 

1,050,000

 

 

1,002,000

 

Tax fees” consist of fees for professional services for tax return preparation and consultation on matters related to, state and local tax considerations and tax credits.

The Audit Committee has considered whether the provision of non-audit services is compatible with maintaining the independence of KPMG and has concluded that it is.

The Audit Committee pre-approved 100% of the 2015 and the 2016 KPMG services and fees above pursuant to the pre-approval policy described below.

Policy on Pre-Approval by Audit Committee of Services Performed by Independent Registered Public Accounting Firm

The policy of the Audit Committee is to pre-approve all audit and permissible non-audit services to be performed by the independent registered public accounting firm during the fiscal year. The Audit Committee pre-approves services by authorizing specific projects within the categories outlined above, subject to the budget for each category. The Audit Committee’s charter delegates to its chairman the authority to address any requests for pre-approval of services between Audit Committee meetings, and the chairman must report any pre-approval decisions to the Audit Committee at its next scheduled meeting.



AUDIT COMMITTEE REPORT

The information contained in this report shall not be deemed to be “soliciting material” or “filed” or incorporated by reference in future filings with the U.S. Securities and Exchange Commission, or subject to the liabilities of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that we specifically request that it be treated as soliciting material or specifically incorporate it by reference into a document filed under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

We reviewed Marchex’s audited financial statements for the fiscal year ended December 31, 2016 and discussed these financial statements with Marchex’s management, including a discussion of the quality, not just the acceptability, of the accounting principles, the reasonableness of significant judgments and the clarity of disclosures in the financial statements. Marchex’s management is responsible for Marchex’s financial reporting process, including its system of internal controls, and for the preparation of consolidated financial statements in accordance with generally accepted accounting principles. Marchex’s independent registered public accounting firm, KPMG LLP (“KPMG”), is responsible for performing an independent audit of Marchex’s financial statements in accordance with standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”) and issuing a report on those financial statements and issuing a report on the effectiveness of Marchex’s internal control over financial reporting as of the end of the fiscal year. Our responsibility is to monitor and review these processes. We also reviewed and discussed with KPMG the audited financial statements and the matters required by SEC Regulation S-X Rule 2-07 and Auditing Standard No. 1301, Communications with Audit Committees.

KPMG provided us with the written disclosures and the letter required by PCAOB Ethics and Independence Rule 3526, Communications with Audit Committees Concerning Independence. This rule requires independent registered public accounting firms annually to disclose in writing all relationships that in the independent registered public accounting firm’s professional opinion may reasonably be thought to bear on independence, to confirm their independence and to engage in a discussion of independence. In addition to engaging in this discussion with KPMG regarding its independence, we also considered whether KPMG’s provision of other, non-audit related services to Marchex is compatible with maintaining KPMG’s independence.

Based on our discussions with management and KPMG, and our review of information provided by management and KPMG, we recommended to the Marchex Board of Directors that the audited financial statements be included in Marchex’s Annual Report on Form 10-K for the year ended December 31, 2016.

Respectfully submitted,

THE AUDIT COMMITTEE

Dennis Cline

Ian Morris

M. Wayne Wisehart, Chair



PROPOSAL THREE—TWO: ADJ ADOPTION OF AN AMENDMENT TO OUR AMENDED AND RESTATED BYLAWS TOOURNMENT PROPOSALPROVIDE THAT THE COURTS LOCATED WITHIN THE STATE OF DELAWAREWILL SERVEAS THE EXCLUSIVE FORUM FOR THE ADJUDICATION OFCERTAIN LEGAL DISPUTES

(Item 2 on Proxy Card)

We are asking stockholdersyou to approve an amendment (the "Amendment")a proposal to our Amended and Restated Bylaws (the "Bylaws") that, if adopted, would result in the courts located within the State of Delaware serving as the exclusive forum for the adjudication of certain legal actions involving us. Specifically, if this proposal is approved by our stockholders, the Bylaws will be amended to insert a new provision as Article 15 to the Bylaws and to make appropriate conforming changes, including the re-designation of current Article 15 (Amendments) as Article 16. The text of the new Article 15 is as follows:

EXCLUSIVE FORUM FOR ADJUDICATION OF DISPUTES

Unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any current or former Director, Officer or other employee of the Corporation to the Corporation or the Corporation’s stockholders, (iii) any action asserting a claim arising pursuant to any provision of the DGCL, or (iv) any action asserting a claim governed by the internal affairs doctrine shall be a state or federal court located within the State of Delaware (a "Chosen Court"), in all cases subject to the Chosen Court having personal jurisdiction over the indispensable parties named as defendants. Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this By-Law.

The Board of Directors believes that adopting the Amendment is in the best interests of the Company and its stockholders for the following reasons:

The Amendment provides that all intra-corporate disputes will be litigated in the State of Delaware, where we are incorporated and whose law governs those disputes;

The Delaware courts have developed considerable expertise in dealing with corporate law issues, as well as a substantial and influential body of case law construing Delaware’s corporate law and long-standing precedent regarding corporate governance;

The Amendment will help us avoid multiple lawsuits in multiple jurisdictions relating to such disputes, thus saving the significant costs and effort in addressing cases brought in multiple jurisdictions;

The Amendment will reduce the risk that the outcome of cases in multiple jurisdictions could be inconsistent, even though each jurisdiction purports to follow Delaware law;

The Amendment will only regulate the forum where our stockholders may file claims relating to the specified intra-corporate disputes; it does not restrict the ability of our stockholders to bring such claims, nor does it affect the remedies available if such claims are ultimately successful;

We will retain the ability to consent to an alternative forum in appropriate circumstances where we determine that our interests and those of our stockholders are best served by permitting a particular dispute to proceed in a forum other than Delaware; and

The Amendment is not being proposed in anticipation of any specific litigation or transaction.

The Board of Directors is seeking stockholder approval for this exclusive forum bylaw based on the following:

The Board of Directors’ belief that such a provision is in the best interest of our stockholders; and

The Board of Directors’ own determination that the approval of stockholders is desirable on this issue.



The Board of Directors is increasingly concerned about the harm to us that can occur, and has occurred, as a result of lawyer-driven stockholder derivative litigation filed purportedly on our behalf against our current and former officers and directors. Such cases may be filed in the state court where the defendant company is headquartered or whereapprove one or more adjournments of the individual defendants resides, rather thanSpecial Meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to approve the state whereAsset Sale Proposal at the company is incorporated, thus requiring a court less familiar with the lawstime of the state of incorporation to interpret and apply those laws. Multiple stockholder derivative actions involving the same or very similar allegations can be filed in multiple jurisdictions, requiring defendants to expend significant resources to attempt to coordinate and defend nearly identical actions in multiple courts. We have been subjected to just such stockholder derivative actions in 2015 and 2016, when seven stockholder derivative actions involving virtually identical allegations were filed in four different jurisdictions against us, the Board of Directors, and current and former officers. In order to defend these actions, we are required to undertake significant legal costs to avoid duplicative litigation that threatens to result in inconsistent legal consequences for the defendants. The Board of Directors finds the costs arising from the multitude of nearly identical lawsuits, and the significant possibility that a court outside Delaware could misapply Delaware law to the Company's disadvantage, instructive and believes that the Amendment will help the Company avoid these risks in the future.

The Board of Directors is also aware that certain proxy advisors, and even some institutional holders, take the view that they will not support an exclusive forum clause until the company requesting it can show it already has suffered material harm as a result of multiple stockholder suits filed in different jurisdictions regarding the same matter. The Board of Directors believes that it is more prudent and in the best interests of stockholders to take preventive measures before the Company and the interests of most of its stockholders are materially harmed by the increasing practice of the plaintiff’s bar to file claims in multiple jurisdictions. It is important to note that the Amendment is not being proposed in anticipation of or reaction to any specific litigation or transaction; rather, the Amendment is being proposed on a prospective basis to prevent potential future harm to the Company and its stockholders.

The Board of Directors is committed to good corporate governance practices. A description of our key corporate governance practices appears under "Corporate Governance" above.

After considering the foregoing, the Board of Directors believes the Amendment is in the best interests of the Company and its stockholders and recommends thatSpecial Meeting. If our stockholders approve the Amendment. If approved by ourAdjournment Proposal, we could adjourn the Special Meeting and any adjourned session of the Special Meeting and use the additional time to solicit additional proxies, including the solicitation of proxies from stockholders that have previously returned properly executed proxies voting against approval of the Amendment willAsset Sale Proposal. Among other things, approval of the Adjournment Proposal could mean that, even if we had received proxies representing a sufficient number of votes against approval of the Asset Purchase Agreement such that the Asset Sale Proposal would be immediately effective. Ifdefeated, we could adjourn the AmendmentSpecial Meeting without a vote on the approval of the Asset Purchase Agreement and seek to convince the holders of those shares to change their votes to votes in favor of approval of the Asset Purchase Agreement. Additionally, we may seek to adjourn the Special Meeting if a quorum is not approved,present at the BoardSpecial Meeting.

Regardless of Directors will reconsider whether a quorum is present at the Amendment is inSpecial Meeting, the best interestsaffirmative vote of the Company and its stockholders.

Vote Required

The affirmative voteholders of a majority of the voting power of the issued and outstanding shares of our Common Stock entitled to vote, present in personand voting, via the Meeting Website or represented by proxy at the AnnualSpecial Meeting, and entitled to vote is required to approve the Amendment.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" ADOPTION OF AN AMENDMENT TO OUR BYLAWS TO PROVIDE THAT THE COURTS LOCATED WITHIN THE STATE OF DELAWARE WILL SERVE AS THE EXCLUSIVE FORUM FOR THE ADJUDICATION OF CERTAIN LEGAL DISPUTES



ADDITIONAL INFORMATION RELATING TO OUR EXECUTIVE OFFICERS AND DIRECTORS

Executive Officers

Our executive officers, and their respective ages, as of June 27, 2017, are as follows:

Name

Age

Position

Michael Arends

46

Chief Financial Officer and member of the office of the CEO

Ethan Caldwell

48

Chief Administrative Officer, General Counsel, Secretary and member of the office of the CEO

Russell C. Horowitz

51

Consultant and member of the office of the CEO

Biographical information for Russell C. Horowitz who has been nominated as a director is set forth above (See “Proposal One – Election of Directors”) and biographical information for all other executive officers is set forth below.

Michael Arends. Mr. Arends has served as our Chief Financial Officer since May 2003 and as a member of the office of the CEO since October 2016. Prior to joining Marchex, Mr. Arends held various positions at KPMG since 1992, most recently as a Partner in KPMG’s Pacific Northwest Information, Communications and Entertainment assurance practice. Mr. Arends is a Certified Public Accountant and a Chartered Accountant and received a Bachelor of Commerce degree from the University of Alberta.

Ethan Caldwell. Mr. Caldwell is a founder of our Company and has served as our Chief Administrative Officer, General Counsel and Secretary since our inception in January 2003 and as a member of the office of the CEO since October 2016. Mr. Caldwell was previously Senior Vice President, General Counsel and Corporate Secretary of Go2Net, from November 1996, until its merger with InfoSpace through December 2000. Mr. Caldwell received his J.D. from the University of Maryland and his B.A. in Political Science from Occidental College.

Compensation Discussion and Analysis

The Role of Stockholder Say-On-Pay Votes

In May 2014, we held a stockholder advisory vote to approve the compensation of our named executive officers (the “say-on-pay proposal”). Our stockholders overwhelmingly approved the compensation of our named executive officers, with approximately 99% of stockholder votes cast in favor of the say-on-pay proposal. The Compensation Committee believes this affirms the stockholders’ support of our approach to executive compensation, and did not change its approach in 2015 or 2016.

The Compensation Committee will continue to consider the outcome of our say-on-pay votes, such as Proposal Four in this proxy statement, when making future compensation decisions for the named executive officers.

Overview

Our “named executive officers”, or “NEOs”, are:

Michael Arends

Chief Financial Officer and member of the office of the CEO

Ethan Caldwell

Chief Administrative Officer, General Counsel, Secretary and member of the office of the CEO

Gary Nafus

Former Chief Revenue Officer and former member of the office of the CEO, who ceased serving as an executive officer in March 2017

Russell C. Horowitz

Consultant and member of the office of the CEO

Peter Christothoulou

Former Chief Executive Officer, who ceased serving as an executive officer in October 2016

Ziad Ismail

Former Chief Product Officer, who ceased serving as an executive officer in September 2016

You can find detailed information regarding the compensation we paid to our NEOs in the tables that begin on page 25.

Our executive compensation programs are intended to serve two related goals:

Long-Term Retention of our Strong Management Team. We believe that our continued success depends on our ability to retain our experienced, complementary and dedicated management team. Although we always consider the ultimate interest of our stockholders in setting NEO compensation, we also must acknowledge that our executives face many career options and we therefore must provide strong incentives for them to continue to participate in our growth.



Long-Term Growth in Stockholder Value. We believe that management compensation packages should reflect as much as possible the risk and opportunity experienced by our stockholders. As a result, we strongly emphasize performance-based compensation arrangements which reward NEOs for contributions to our long-term growth and overall corporate success.

We believe that this long-term focus will appropriately reward our management team for performance that will most benefit our Company and stockholders. We think that a focus on shorter-term results could inappropriately over- or under-compensate our executives due to short-term fluctuations that do not as accurately reflect our corporate growth and the corresponding benefit to our stockholders.

Our “long-term” emphasis results in NEO compensation packages that are weighted significantly towards long-term equity grants, with a relatively low proportion of NEO compensation derived from cash salaries. Cash bonuses to our NEOs are generally paid only under our annual incentive plan, which ties such bonus payments directly to our annual corporate performance. The Compensation Committee separately awarded Mr. Nafus a cash bonus in the amount of $196,875 which was paid in October 2016 and $65,625 which was paid in January 2017 for 2016 performance of which $100,000 is subject to forfeiture in the event that Mr. Nafus voluntarily leaves Marchex prior to October 3, 2017 (other than for Good Reason) or if Mr. Nafus is terminated by Marchex for Cause prior to October 3, 2017. Mr. Nafus resigned as our Chief Revenue Officer and as a member of the office of the CEO effective March 31, 2017 and in connection with his employment termination, $100,000 of the 2016 performance bonus paid was forfeited.

The Compensation Committee is responsible for setting the compensation and benefits for our chief executive officer and our other executive officers, to determine distributions and grants of awards under our various stock and other incentive plans and to assume responsibility for all matters related to the foregoing. Meetings of the Compensation Committee are called by the chair of the committee and the chair sets the agenda for each committee meeting. In performing its responsibilities, the Compensation Committee typically invites, for all or a portion of each meeting, our chief executive officer and other members of management to its meetings. Our chief executive officer meets with the Compensation Committee on an ongoing basis to discuss the objectives and performance of Marchex’s NEOs. For compensation decisions relating to our executive officers, the Compensation Committee considers recommendations from our chief executive officer, our general counsel, our chief financial officer and our vice president of people services, who utilize various industry compensation surveys as part of our company wide annual compensation review process. After receipt and discussion of such recommendations with our chief executive officer, the Compensation Committee meets without our chief executive officer to ultimately determine the compensation packages for each of our executive officers. Our chief executive officer does not participate in deliberations regarding his own compensation.

In October 2016, Mr. Christothoulou resigned as our Chief Executive Officer and in connection therewith, we established an office of the CEO. We are assessing our current and future senior leadership needs, although we may not be successful in finding or hiring suitable additional senior leadership.

Role of a Compensation Consultant

The duties of any compensation consultant we engage are generally to evaluate executive compensation, perform an analysis on realized pay alignment with financial and stock performance, discuss general compensation trends, provide competitive market practice data and benchmarking, participate in the design and implementation of certain elements of the executive compensation program and assist our chief executive officer in developing compensation recommendations to present to the Compensation Committee for the executive officers other than himself. The Compensation Committee may accept, reject or modify any recommendations by compensation consultants or other outside advisors. The compensation consultant does not make specific recommendations on individual amounts for the executive officers or the independent directors, nor does the consultant determine the amount or form of executive and director compensation.

In February 2016, the Compensation Committee engaged Pearl Meyer & Partners, LLC (“Pearl Meyer”) as its independent compensation consultant. The Compensation Committee conducted an assessment of Pearl Meyer’s independence relative to standards prescribed by the SEC and determined that no conflicts existed. Historically, the Company has not used a compensation consultant for executive compensation matters.



NEO Compensation for 2016

Our Compensation Committee in reviewing our executive compensation packages assesses salary, salary history, the number and value of shares owned by our executives, prior equity grants and vesting and exercise history. The Compensation Committee also considers data regarding compensation paid at public media, internet and technology-based companies of comparable size to our Company and which could compete for the services of our NEOs. Although the compensation practices of our competitors instruct our review, we use that data only to gain perspective and do not “benchmark” our compensation to any particular level. The Compensation Committee consults with outside counsel in its review and for 2016 engaged a compensation consultant.

Competitive Positioning

To date, the Compensation Committee periodically reviews competitive data regarding compensation at various comparable peer companies. We do not benchmark compensation levels to fall within specific ranges compared to selected peer groups in our industry. We use the information developed by management and outside counsel using proxy data for peer group companies to gain a general understanding of current compensation practices. In this regard, in January of 2016, the Company provided Institutional Shareholder Services Inc. with the below suggested list of peer group companies for its reference:

1.Acxiom

2.Bankrate

3.Bazaarvoice, Inc.

4.comScore, Inc.

5.Constant Contact

6.Criteo

7.Limelight Networks, Inc.

8.LivePerson, Inc.

9.Market

10.MicroStrategy

11.New Relic

12.Neustar

13.Nielsen Holdings PLC

14.Rubicon Project

15.Shutterstock

16.Tableau Software

17.Tech Target, Inc.

18.Web.com

19.XO Group, Inc.

20.Yelp

Base Salary

The 2016 salaries shown in the Summary Compensation Table on page 25 were set by our Compensation Committee based on the compensation review discussed above, as well as a consideration of each NEO’s total compensation package including prior equity grants, exercise history, and existing stock ownership. Base salaries are a necessary part of our compensation program and provide executives with a fixed portion of pay that is not performance-based. Our goal is to provide competitive base pay levels. Historically, the Compensation Committee considered our desire to maintain cash remuneration as a relatively small portion of overall compensation. In addition, the Compensation Committee considered each NEO’s skills, experience, level of responsibility, performance and contribution to our Company. The Compensation Committee also took into account in conjunction with the NEO’s specific areas of responsibilities and objectives, each NEO’s contribution to the Company’s overall success as a member of the management team. The Compensation Committee considers the relative compensation levels among all the members of the management team to ensure the Company’s executive compensation programs are internally consistent and equitable. All salaries are reviewed at least annually and subject to future adjustment by the Compensation Committee. On April 21, 2016, the Compensation Committee, pursuant to its review of annual compensation for executive officers, approved revised annual NEO salaries effective April 21, 2016.

Equity Compensation

All of our employees and directors are eligible to receive options, shares of restricted stock, and/or restricted stock units under our 2012 Stock Incentive Plan (the “2012 Stock Plan”).

The Compensation Committee does not automatically grant equity to NEOs every year. The Compensation Committee take into account the various factors outlined in the discussion of base salary above as well as the Company’s financial performance and its impact on stockholder value and also analyzes existing NEO equity holdings and prior equity awards to take into account whether additional grants are appropriate and necessary to recalibrate the cash-equity balance of NEO compensation packages.


During 2016, the Compensation Committee granted our NEOs stock options for our Class B common stock and shares of restricted stock under the 2012 Stock Plan (both with time-based vesting), based on the compensation review discussed above. The Compensation Committee determined the size of each NEO’s equity grants based on a consideration of his existing stock ownership and outstanding equity grants awarded in prior years. Given their vesting schedules, we believe that these equity grants will help further motivate our management team to continue to focus on the long-term success of our business enterprise. You can find more information regarding these grants, including their vesting schedules, by referring to our Grant of Plan-Based Awards Table in 2016 on page 26 and Outstanding Equity Awards at 2016 Fiscal Year-End Table on page27. Such equity awards are subject to double-trigger change in control acceleration in certain circumstances. For more information on this acceleration provision, please refer to pages28-29.

Most equity awards for employees are tied to their annual performance reviews and are generally granted following the release of our third or fourth quarter financial results. We may occasionally make employee grants outside of that review process; such awards typically are granted as of the date the grant is approved. All new hire awards have a grant date set to correspond to the date of hire. All options have an exercise price set at the closing market price of our Class B common stock on the grant date.

Annual Incentive Plan

The Compensation Committee originally adopted our annual incentive plan in 2006 and as amended to date (the “Incentive Plan”) to motivate and reward key employees for enabling our Company to achieve specified corporate objectives together, to increase the competitiveness of our management compensation packages without increasing our fixed costs, and to align management compensation with key measures of our financial performance.

The Compensation Committee in its discretion determines the maximum amount available for award, in the aggregate, to all plan participants in light of the number of participants and the Company’s resources. The Compensation Committee also determines the participants in the pool. Eligibility determinations are based upon the Compensation Committee’s assessment of the importance of a participant’s role, together with such participant’s overall cash and equity compensation level. Finally, the Compensation Committee determines the measures of performance on which bonus awards are based, using any of the following as it determines in its sole discretion:

revenues;

pre-tax income;

adjusted operating income before amortization;

operating income before amortization;

operating income;

net earnings;

net income;

cash flow or funds from operations;

adjusted earnings per share;

earnings per share;

appreciation in the fair market value of our stock;

cost reduction or savings;

implementation of critical processes or projects; or

adjusted earnings before interest, taxes, depreciation and amortization, or adjusted earnings before any of them.

The Compensation Committee determined that for the 2016 fiscal period, a maximum of up to $2,396,000 would be available for award, in the aggregate, to all plan participants based upon the achievement of updated revenue and adjusted OIBA targets. The participants for the 2016 fiscal period and updated annual bonus targets were: Michael Arends ($217,500), Ethan Caldwell ($213,750), Peter Christothoulou ($285,000), Ziad Ismail ($156,750) and Gary Nafus ($325,000). Participants in the Incentive Plan would not receive a bonus if adjusted OIBA thresholds are were achieved, even if revenue targets were met. If all targets were met at the highest threshold, plan participants earned a maximum of $2,396,000 in the aggregate for the entire bonus pool. The target bonuses were a specified percentage of bonus targets (ranging from 35 to 200% based on performance target category) and were based on achieving specified revenue (new, existing and all revenue) and adjusted OIBA targets for the 2016 fiscal period.  Bonuses for 2016 were based on the following weighting: 25% from new revenue target attainment, 25% from existing revenue target attainment, 25% from all revenue target attainment and 25% from adjusted OIBA target attainment.


The Compensation Committee elected to use these revenues and adjusted OIBA targets because it believes that such targets most accurately reflect our growth and improvements in our corporate performance without the impact of certain non-cash and non-recurring expenses which the Company does not regard as ongoing costs of doing business. The Compensation Committee set a range of specific revenue and adjusted OIBA targets based on a review of our actual revenue and adjusted OIBA for the fiscal year ended December 31, 2015 and our budgeted revenue and adjusted OIBA for the 2016 fiscal year. At the low end of the range, the targets were intended to be difficult but realistic given our expectations regarding corporate performance. The high end of the range, intended to reflect “optimum” Company performance, were set significantly higher than our projected financial results and were considered “stretch” goals.

The Compensation Committee also has absolute discretion to award no bonuses at all even if the highest target is achieved. It is our intention that any such bonus payments would still constitute a relatively small percentage of our NEO compensation so that the bulk of their compensation package will remain dependent on our long-term growth. For 2016, the Compensation Committee did not award any bonuses under the Incentive Plan. The Compensation Committee separately awarded Mr. Nafus a cash bonus in the amount of $196,875 which was paid in October 2016 and $65,625 which was paid in January 2017 for 2016 performance of which $100,000 is subject to forfeiture in the event that Mr. Nafus voluntarily leaves Marchex prior to October 3, 2017 (other than for Good Reason) or if Mr. Nafus is terminated by Marchex for Cause prior to October 3, 2017. Mr. Nafus resigned as Chief Revenue Officer and as a member of the office of CEO effective March 31, 2017 and in connection with his employment termination, $100,000 of the 2016 performance bonus paid was forfeited.

Amended and Restated Executive Officer Employment Agreements

Effective on April 21, 2016, pursuant to the Compensation Committee’s review of long-term incentives and annual compensation for executive officers, we entered into Amended and Restated Executive Officer Employment Agreements with each of Messrs. Michael Arends, Ethan Caldwell, Peter Christothoulou, Ziad Ismail and Gary Nafus and which such agreements supersede any prior employment related agreements or offer letters, the terms of which are described in more detail under the heading “Potential Payments upon Termination or Change in Control” beginning on page 28 of this proxy statement.

Retention Agreements

We have entered into retention agreements with each of Messrs. Arends, Caldwell and Christothoulou (no longer in effect). In addition, the majority of our outstanding equity grants held by our executive officers will vest in full immediately upon any change in control.  These arrangements are described on page 30.

We believe it is appropriate to have these arrangements in place to promote our goal of the long-term retention of our management team. The Compensation Committee took into account the retention practices of our competitors in establishing the terms of such retention agreements.

Separation Agreements

In connection with the resignation of Messrs. Horowitz and Christothoulou from the Company, Messrs. Horowitz and Christothoulou each entered into separation agreements with the Company detailing the terms of their respective separation benefits at resignation, the terms of which are described in more detail under the heading “Potential Payments upon Termination or Change in Control” beginning on page 28 of this proxy statement.  

Risk Assessment of Compensation Policies and Practices

We believe our compensation policies and practices do not motivate imprudent risk taking. In this regard, we note the following: (i) our annual incentive compensation is based on balanced performance metrics that promote disciplined progress towards longer-term Company goals; (ii) we do not offer short-term incentives that might drive high-risk investments at the expense of long-term Company value; and (iii) our compensation programs are weighted towards offering long-term incentives that reward sustainable performance, especially when considering our executive share ownership. Accordingly, we believe that our compensation policies and practices do not create risks that are reasonably likely to have a material adverse effect on the Company.



COMPENSATION COMMITTEE REPORT

The information contained in this report shall not be deemed to be “soliciting material” or “filed” or incorporated by reference in future filings with the U.S. Securities and Exchange Commission, or subject to the liabilities of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that we specifically request that it be treated as soliciting material or specifically incorporate it by reference into a document filed under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

The Compensation Committee consists of Ian Morris (Chair), Anne Devereux-Mills and M. Wayne Wisehart. The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K with our management. Based on this review and discussion, the Compensation Committee recommended to our Board of Directors that the Compensation Discussion and Analysis be included in this proxy statement.

Respectfully submitted,

THE COMPENSATION COMMITTEE

Anne Devereux-Mills

Ian Morris, Chair

M. Wayne Wisehart



Summary Compensation Table (1)

The following table sets forth information concerning the compensation earned during the fiscal years ended December 31, 2014, 2015 and 2016, as applicable, by our NEOs:

Name and Principal Position

 

Year

 

Salary

($)

 

 

Bonus

($)

 

 

Stock Awards(3)

($)

 

 

Option Awards(4) ($)

 

 

Non-equity compensation ($)

 

 

All Other Compensation(2)

($)

 

 

Total

($)

 

Michael Arends

 

2016

 

 

286,959

 

 

 

 

 

 

510,000

 

 

 

304,200

 

 

 

 

 

 

11,315

 

 

 

1,112,474

 

Chief Financial Officer and member

 

2015

 

 

280,000

 

 

 

 

 

 

 

 

 

 

 

 

140,444

 

 

 

 

 

 

420,444

 

of the office of the CEO

 

2014

 

 

277,500

 

 

 

 

 

 

 

 

 

 

 

 

230,771

 

 

 

 

 

 

508,271

 

Ethan Caldwell

 

2016

 

 

275,875

 

 

 

 

 

 

510,000

 

 

 

304,200

 

 

 

 

 

 

 

 

 

1,090,075

 

Chief Administrative Officer, General

 

2015

 

 

255,000

 

 

 

 

 

 

 

 

 

 

 

 

140,444

 

 

 

 

 

 

395,444

 

Counsel, Secretary, and member

of the office of the CEO

 

2014

 

 

250,000

 

 

 

 

 

 

 

 

 

 

 

 

230,771

 

 

 

 

 

 

480,771

 

Gary Nafus (5)

 

2016

 

 

300,000

 

 

 

162,500

 

 

 

297,500

 

 

 

163,800

 

 

 

 

 

 

 

 

 

923,800

 

Chief Revenue Officer and member

of the office of the CEO

 

2015

 

 

88,636

 

 

 

104,000

 

 

 

897,750

 

 

 

618,750

 

 

 

 

 

 

 

 

 

1,709,136

 

Russell C. Horowitz (6)

 

2016

 

 

95,625

 

 

 

 

 

 

277,250

 

 

 

 

 

 

 

 

 

213,116

 

 

 

585,991

 

Consultant and member

 

2015

 

 

255,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

255,000

 

of the office of the CEO

 

2014

 

 

250,000

 

 

 

 

 

 

 

 

 

 

 

 

230,771

 

 

 

 

 

 

480,771

 

Former Executive Officers:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Peter Christothoulou (7)

 

2016

 

 

278,646

 

 

 

 

 

 

637,500

 

 

 

585,000

 

 

 

 

 

 

617,922

 

 

 

2,119,068

 

Former Chief Executive Officer

 

2015

 

 

255,000

 

 

 

 

 

 

 

 

 

 

 

 

140,444

 

 

 

 

 

 

395,444

 

 

 

2014

 

 

250,000

 

 

 

 

 

 

 

 

 

 

 

 

230,771

 

 

 

 

 

 

480,771

 

Ziad Ismail (8)

 

2016

 

 

203,207

 

 

 

7,500

 

 

 

531,250

 

 

 

351,000

 

 

 

 

 

 

26,185

 

 

 

1,119,142

 

Former Chief Product Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

Includes only those columns relating to compensation awarded to, earned by or paid to the NEOs in 2014, 2015 and 2016 except with respect to Messrs. Nafus and Ismail who were not NEO’s in 2014 and with respect to Mr. Ismail only, in 2015 as well.

(2)

Unless otherwise noted, the total of all perquisites and personal benefits of each NEO falls below the reportable amount for disclosure within this table. Mr. Arends’ amount in 2016 exceeded the reportable amount and includes the Company’s 401K matching contribution, auto allowance and life insurance premium.

(3)

These amounts do not reflect whether the NEO has actually realized or will realize a financial benefit from the awards (such as by vesting of a restricted stock award). Amounts represent the aggregate grant date fair value of restricted stock awards each year computed in accordance with FASB ASC 718, excluding the effect of estimated forfeitures.  For a more detailed discussion on the valuation model and assumptions used to calculate the fair value of each stock award, refer to note 6 to the consolidated financial statements contained in our 2016 Annual Report on Form 10-K filed on March 8, 2017.

(4)

These amounts do not reflect whether the NEO has actually realized or will realize a financial benefit from the awards (such as by exercising stock options). Amounts represent the aggregate grant date fair value of option awards each year computed in accordance with FASB ASC 718, excluding the effect of estimated forfeitures. The fair value of the shares underlying the option awards that vest based on time is estimated using the Black-Scholes option pricing model. For a more detailed discussion on the valuation model and assumptions used to calculate the fair value of each stock award, refer to note 6 to the consolidated financial statements contained in our 2016 Annual Report on Form 10-K filed on March 8, 2017.

(5)

Mr. Nafus joined Marchex as its Chief Revenue Officer in September of 2015. The Compensation Committee separately awarded Mr. Nafus a cash bonus in the amount of $196,875 which was paid in October 2016 and $65,625 which was paid in January 2017 for 2016 performance. Mr. Nafus resigned as Chief Revenue Officer and as a member of Marchex’s office of the CEO effective March 31, 2017 and in connection with his employment termination, 238,750 shares of unvested restricted stock, 241,876 unvested options and $100,000 of the 2016 bonus performance amount paid were forfeited.


(6)

On May 11, 2016, in connection with Mr. Horowitz’s resignation from the Board of Directors and his position as Executive Director, we entered into a separation agreement and release with Mr. Horowitz. Mr. Horowitz remained employed as Marchex’s Executive Director until May 12, 2016. From May 12, 2016 through the earlier of (i) May 12, 2017, or (ii) Marchex’s termination of the consulting period, Mr. Horowitz will provide consulting and advisory services from time to time and Marchex will pay Mr. Horowitz an annualized amount of $255,000 per year, payable in monthly installments in advance through May 12, 2017 for such services. Effective as of May 12, 2016, (i) vesting was accelerated in full on Mr. Horowitz’s existing equity awards, (ii) Marchex extended the period during which Mr. Horowitz may exercise any vested stock options through the remaining contractual term, and (iii) Mr. Horowitz was granted 100,000 shares of Marchex’s Class B common stock pursuant to the Company’s 2012 Stock Incentive Plan at a purchase price of $0.01 per share with quarterly vesting in equal amounts through May 12, 2017.

(7)

In October 2016, Mr. Christothoulou ceased serving as an executive officer and in connection therewith 150,000 shares of unvested restricted stock and 250,0000 unvested options granted were forfeited. Other compensation in 2016 were amounts related to Mr. Christothoulou’s separation agreement which includes $570,000 in total severance payment which were paid in two equal installments of $285,000 on October 3, 2016 and April 3, 2017, the Company’s portion of its share of medical, dental, vision insurance premiums under COBRA and accrued vacation totaling $44,572, and auto allowance of $3,350 while an employee of the Company.

(8)

In September 2016, Mr. Ismail ceased serving as an executive officer and in connection therewith all equity awards granted in April 2016 were forfeited. Other compensation in 2016 includes the Company’s 401K matching contribution and separation related payments including accrued vacation.



2016 Grants of Plan-Based Awards (1)

The following table sets forth certain information with respect to plan-based awards granted during the fiscal year ended December 31, 2016 to our NEOs:

 

 

 

Estimated Future Payouts Under Non-Equity Incentive Plan Awards (2)

 

 

Equity Grants

 

 

 

 

 

Name

 

Grant Date

 

Threshold

($)

 

 

Target

($)

 

 

Maximum

($)

 

 

All Other Stock Awards: Number of Shares of Stock or Units (#)

 

 

All Other Option Awards: Number of Securities Underlying Options

(#)

 

 

Exercise or Base Price of Option Awards

($)

 

 

Grant Date Fair Value of Stock and Option Awards(3)

($)

 

Michael Arends

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Annual Incentive Plan

 

1/1/2016

 

 

4,800

 

 

 

217,500

 

 

 

435,000

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Options

 

4/21/2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

130,000

 

 

 

4.26

 

 

 

304,200

 

Restricted Stock

 

4/21/2016

 

 

 

 

 

 

 

 

 

 

 

120,000

 

 

 

 

 

 

 

 

 

510,000

 

Ethan Caldwell

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Annual Incentive Plan

 

1/1/2016

 

 

4,700

 

 

 

213,750

 

 

 

427,500

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Options

 

4/21/2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

130,000

 

 

 

4.26

 

 

 

304,200

 

Restricted Stock

 

4/21/2016

 

 

 

 

 

 

 

 

 

 

 

120,000

 

 

 

 

 

 

 

 

 

510,000

 

Gary Nafus (4)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Annual Incentive Plan

 

1/1/2016

 

 

7,200

 

 

 

325,000

 

 

 

650,000

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Options

 

4/21/2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

70,000

 

 

 

4.26

 

 

 

163,800

 

Restricted Stock

 

4/21/2016

 

 

 

 

 

 

 

 

 

 

 

70,000

 

 

 

 

 

 

 

 

 

297,500

 

Russell C. Horowitz (5)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted Stock

 

5/12/2016

 

 

 

 

 

 

 

 

 

 

 

100,000

 

 

 

 

 

 

 

 

 

277,250

 

Former Executive Officers:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Peter Christothoulou (6)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Annual Incentive Plan

 

1/1/2016

 

 

6,300

 

 

 

285,000

 

 

 

570,000

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Options

 

4/21/2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

250,000

 

 

 

4.26

 

 

 

585,000

 

Restricted Stock

 

4/21/2016

 

 

 

 

 

 

 

 

 

 

 

150,000

 

 

 

 

 

 

 

 

 

637,500

 

Ziad Ismail (7)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Annual Incentive Plan

 

1/1/2016

 

 

3,500

 

 

 

156,750

 

 

 

313,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Options

 

4/21/2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

150,000

 

 

 

4.26

 

 

 

351,000

 

Restricted Stock

 

4/21/2016

 

 

 

 

 

 

 

 

 

 

 

125,000

 

 

 

 

 

 

 

 

 

531,250

 

(1)

Includes only those columns related to plan based awards granted during 2016. All other columns have been omitted.

(2)

For description, see Annual Incentive Plan on page 21. No amounts were paid for 2016.

(3)

These amounts represent the aggregate grant date fair value in accordance with FASB ACS Topic 718, excluding the effect of estimated forfeitures.  These amounts do not reflect whether the NEO has actually realized or will realize a financial benefit from the awards (such as by vesting in a restricted stock or exercising a stock option).  For a more detailed discussion on the valuation model and assumptions used to calculate the fair value of each stock award, refer to Note 6 to the consolidated financial statements contained in our 2016 Annual Report on Form 10-K filed on March 8, 2017.

(4)

Mr. Nafus resigned as Chief Revenue Officer and as a member of Marchex’s office of the CEO effective March 31, 2017 and in connection with his employment termination, all equity awards granted in April 2016 were forfeited.

(5)

In connection with Mr. Horowitz’s resignation from the Board of Directors and his position as Executive Director in May 2016, we entered into a separation agreement and release which included a grant of 100,000 shares with quarterly vesting in equal amounts through May 12, 2017.

(6)

In October 2016, Mr. Christothoulou resigned as Chief Executive Officer and in connection therewith 150,000 shares of unvested restricted stock and 250,0000 unvested options which were granted in April 2016 were forfeited.

(7)

In September 2016, Mr. Ismail resigned as Chief Product Officer and in connection therewith all equity awards granted in April 2016 were forfeited.



Outstanding Equity Awards at 2016 Fiscal Year-End (1)

The following table sets forth certain information with respect to the value of all unexercised options and unvested stock awards previously awarded to our NEOs as of December 31, 2016. Certain option and stock awards provide for accelerated vesting in full upon a change in control. For more information on these acceleration provisions, please refer to pages 28-29.

 

 

 

Option Awards

 

 

Stock Awards

 

Name

 

Grant Date

 

Number of Securities Underlying Unexercised Options

Exercisable

(#)

 

 

Number of Securities Underlying Unexercised Options Unexercisable (#)

 

 

Option Exercise Price

($)

 

 

Option

Expiration

Date

 

 

Number of

Shares or

Units of Stock

That Have Not

Vested

(#)

 

 

Market Value of Shares or Units of Stock That Have Not Vested(2)

($)

 

Michael Arends

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Options

 

8/12/2009

 

 

21,601

 

 

 

 

 

 

4.63

 

 

8/12/2019

 

 

 

 

 

 

 

Stock Options

 

5/11/2010

 

 

13,167

 

 

 

 

 

 

4.89

 

 

5/11/2020

 

 

 

 

 

 

 

Stock Options

 

12/20/2010

 

 

98,000

 

 

 

 

 

 

8.77

 

 

12/20/2020

 

 

 

 

 

 

 

Stock Options

 

12/20/2011

 

 

100,000

 

 

 

 

 

 

6.35

 

 

12/20/2021

 

 

 

 

 

 

 

Stock Options

 

12/20/2012

 

 

70,090

 

 

 

 

 

 

4.41

 

 

12/20/2022

 

 

 

 

 

 

 

Stock Options

 

12/20/2013

 

 

140,000

 

 

 

 

 

 

8.94

 

 

12/20/2023

 

 

 

 

 

 

 

Stock Options

 

4/21/2016

(3)

 

 

 

 

130,000

 

 

 

4.26

 

 

4/21/2026

 

 

 

 

 

 

 

Restricted Stock

 

4/21/2016

(4)

 

 

 

 

 

 

 

 

 

 

 

 

 

120,000

 

 

 

318,000

 

Ethan Caldwell

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Options

 

8/12/2009

 

 

100,000

 

 

 

 

 

 

4.63

 

 

8/12/2019

 

 

 

 

 

 

 

Stock Options

 

5/11/2010

 

 

76,500

 

 

 

 

 

 

4.89

 

 

5/11/2020

 

 

 

 

 

 

 

Stock Options

 

12/20/2010

 

 

62,000

 

 

 

 

 

 

8.77

 

 

12/20/2020

 

 

 

 

 

 

 

Stock Options

 

12/20/2011

 

 

70,000

 

 

 

 

 

 

6.35

 

 

12/20/2021

 

 

 

 

 

 

 

Stock Options

 

12/20/2012

 

 

85,000

 

 

 

 

 

 

4.41

 

 

12/20/2022

 

 

 

 

 

 

 

Restricted Stock

 

12/20/2012

(4)

 

 

 

 

 

 

 

 

 

 

 

 

 

10,500

 

 

 

27,825

 

Stock Options

 

12/20/2013

(3)

 

28,125

 

 

 

9,375

 

 

 

8.94

 

 

12/20/2023

 

 

 

 

 

 

 

Stock Options

 

12/20/2013

(5)

 

37,500

 

 

 

 

 

 

8.94

 

 

12/20/2023

 

 

 

 

 

 

 

Restricted Stock

 

12/20/2013

(4)

 

 

 

 

 

 

 

 

 

 

 

 

 

18,750

 

 

 

49,688

 

Stock Options

 

4/21/2016

(3)

 

 

 

 

130,000

 

 

 

4.26

 

 

4/21/2026

 

 

 

 

 

 

 

Restricted Stock

 

4/21/2016

(4)

 

 

 

 

 

 

 

 

 

 

 

 

 

120,000

 

 

 

318,000

 

Gary Nafus (6)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Options

 

9/15/2015

(3)

 

85,937

 

 

 

189,063

 

 

 

4.00

 

 

9/15/2025

 

 

 

 

 

 

 

Restricted Stock

 

9/15/2015

(4)

 

 

 

 

 

 

 

 

 

 

 

 

 

168,750

 

 

 

447,188

 

Stock Options

 

4/21/2016

(3)

 

 

 

 

70,000

 

 

 

4.26

 

 

4/21/2026

 

 

 

 

 

 

 

Restricted Stock

 

4/21/2016

(4)

 

 

 

 

 

 

 

 

 

 

 

 

 

70,000

 

 

 

185,500

 

Russell C. Horowitz (7)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Options

 

8/12/2009

 

 

150,000

 

 

 

 

 

 

4.63

 

 

8/12/2019

 

 

 

 

 

 

 

Stock Options

 

5/11/2010

 

 

182,500

 

 

 

 

 

 

4.89

 

 

5/11/2020

 

 

 

 

 

 

 

Stock Options

 

12/20/2010

 

 

137,000

 

 

 

 

 

 

8.77

 

 

12/20/2020

 

 

 

 

 

 

 

Stock Options

 

12/20/2011

 

 

116,000

 

 

 

 

 

 

6.35

 

 

12/20/2021

 

 

 

 

 

 

 

Stock Options

 

12/20/2012

 

 

117,500

 

 

 

 

 

 

4.41

 

 

12/20/2022

 

 

 

 

 

 

 

Stock Options

 

12/20/2013

 

 

75,000

 

 

 

 

 

 

8.94

 

 

12/20/2023

 

 

 

 

 

 

 

Restricted Stock

 

5/12/2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

50,000

 

 

 

132,500

 

(1)

Includes only those columns for which there are outstanding equity awards at December 31, 2016. All other columns have been omitted.

(2)

The market value of unvested stock awards is calculated by multiplying the number of unvested stock awards held by the applicable NEO by the closing price of our Class B common stock on December 31, 2016 of $3.65, as reported on the NASDAQ Global Select Market.

(3)

The option vests at the rate of 25% on the first anniversary of the grant date and 1/12 of the remainder vests quarterly thereafter in equal increments and with vesting in full of all such option shares in the event of a change in control.


(4)

The shares of restricted stock vest at the rate of 25% on each of the first, second, third, and fourth anniversaries, respectively, of the grant date with vesting in full upon a change in control. Except in the case of Mr. Caldwell, (i) remaining vests of 12/20/12 and 12/20/2013 were modified in December 2016 to vest on 12/20/2018 and in the event of termination for any reason prior to 12/2018, the remaining shares subject to vesting will become immediately vested upon such termination to the extent vested based on vesting schedule for such shares prior to amendment and subject to additional vesting to the extent applicable as provided in Mr. Caldwell’s employment agreement with the Company; and (ii) Mr. Caldwell’s 4/21/16 grant was modified in April 2017 to vest as follows: 60,000 shares on 12/20/2018, 30,000 shares each in 4/21/2019 and 4/21/2020 and in the event of termination for any reason prior to 12/20/2018, the 60,000 shares to vest on 12/20/18 will become immediately vested upon such termination with the remaining shares subject to vesting to the extent applicable as provided in Mr. Caldwell’s employment agreement with the Company.

(5)

The performance based options are fully vested as certain service and market conditions were satisfied.

(6)

Mr. Nafus resigned as Chief Revenue Officer and as a member of Marchex’s office of the CEO effective March 31, 2017, and in connection with his employment termination, 238,750 shares of unvested restricted stock and 241,876 unvested options were forfeited.

(7)

In connection with Mr. Horowitz’s resignation from the Board of Directors and his position as Executive Director in May 2016, we entered into a separation agreement and release which included a grant of 100,000 shares with quarterly vesting in equal amounts through May 12, 2017 and accelerated vesting in full of all existing equity awards.

Option Exercises and Stock Vested during 2016

The following table sets forth certain information concerning option exercises by our NEOs and vesting of our common stock held by them during the fiscal year ended December 31, 2016:

 

Option Awards

 

 

Stock Awards

 

Name

 

Number of Shares

Acquired on Exercise

(#)

 

 

Value

Realized

on Exercise(1)

($)

 

 

Number of

Shares

Acquired

on Vesting

(#)

 

 

Value

Realized on

Vesting (2)

($)

 

Gary Nafus

 

 

 

 

 

 

 

 

56,250

 

 

 

157,500

 

Russell C. Horowitz (3)

 

 

 

 

 

 

 

 

83,312

 

 

 

270,670

 

Former Executive Officers:

 

 

 

 

 

 

 

 

 

 

 

 

 

Peter Christothoulou (4)

 

 

 

 

 

 

 

 

190,187

 

 

 

523,014

 

Ziad Ismail (5)

 

 

 

 

 

 

 

 

66,250

 

 

 

290,888

 

(1)

The value realized on exercise is calculated as the difference between the actual sales price of the shares underlying the options exercised and the applicable exercise price of those options.

(2)

The value realized on vesting is calculated based on the closing sales price of the underlying stock on the NASDAQ Global Select Market on the vesting date.

(3)

In connection with Mr. Horowitz’s resignation in May 2016 from the Board of Directors, all Marchex equity including 33,312 of restricted stock were accelerated in full as of the resignation date. In addition, of the 100,000 shares of restricted stock granted to Mr. Horowitz in May 2016, 50,000 shares have vested as of December 31, 2016.

(4)

In connection with Mr. Christothoulou’s resignation in October 2016, 190,187 shares of restricted stock were accelerated as of the termination date.

(5)

Restricted stock and restricted stock units that vested prior to Mr. Ismail’s resignation in August 2016.

Potential Payments Upon Termination or Change in Control

Amended and Restated Executive Officer Employment Agreements

Effective on April 21, 2016, pursuant to the Compensation Committee’s review of long-term incentives and annual compensation for executive officers, we entered into Amended and Restated Executive Officer Employment Agreements with each of Messrs. Michael Arends, Ethan Caldwell, Peter Christothoulou, Ziad Ismail and Gary Nafus and which such agreements supersede any prior employment related agreements or offer letters.


The Amended and Restated Executive Officer Employment Agreements for each of Messrs. Arends, Caldwell and Christothoulou provide for the following: (i) that the excise tax gross-up provision contained in the Retention Agreements shall terminate and have no further force and effect, and (ii) in the event the Company terminates executive’s employment for any reason other than Cause, or executive terminates his employment for Good Reason (regardless of a Change in Control) and subject to executive’s execution of a release of claims, executive will be eligible to receive the following severance and related post-termination benefits: (a) a lump sum payment equal to one and one half (1.5) times (in the case Mr. Christothoulou) and one (1) times (in the case of Mr. Arends and Mr. Caldwell) executive’s then annual salary payable at the time of termination, unless the termination of executive’s employment occurs within 12 months following a Change in Control, in which case executive will receive the benefits under his Retention Agreement, (b) payment by the Company of its share of medical, dental and vision insurance premiums under COBRA (“Health Benefits”) for executive and executive’s dependents for the 12 month period following the separation date or such lesser period as executive remains eligible under COBRA, unless the termination of executive’s employment occurs within 12 months following a Change in Control, in which case executive will receive the benefits under executive’s Retention Agreement; and (c) an additional one and one half (1.5) years of time-based vesting (in the case of Mr. Christothoulou) and an additional one (1) year of time-based vesting (in the case of Mr. Arends and Mr. Caldwell) on any unvested options, restricted stock and restricted stock units as of the separation date. In the event that executive’s employment terminates due to death or disability, and subject to execution of a release of claims, executive will be eligible to receive the following severance and related post-termination benefits: (i)payment by the Company of Health Benefits for the 18 month period following the separation date or such lesser period as executive remains eligible under COBRA, and (ii) one hundred percent (100%) of all performance and time-based unvested options, restricted stock and restricted stock units will immediately vest upon executive’s separation date.  Additionally, one hundred percent (100%) of all performance and time based options, restricted stock and restricted stock units not already vested, shall become immediately vested upon the occurrence of both (a) a Change in Control, (b) followed by the first to occur of (i) a termination of executive’s employment by the Company or any successor thereto without Cause, (ii) a material diminution in the nature or scope of executive’s duties, responsibilities, authorities, powers or functions that constitutes Good Reason, or (iii) the twelve month anniversary of the occurrence of the Change in Control provided that executive then remains an employee of the Company or its successor (collectively, the “Double-Trigger Change in Control Acceleration”).

The Amended and Restated Executive Officer Employment Agreements for each of Messrs. Ismail and Nafus provide for the following: (i) in the event the Company terminates executive’s employment for any reason other than Cause) or executive terminates his employment for good reason and subject to executive’s execution of a release of claims, executive will be eligible to receive the following severance and related post-termination benefits: (a) a lump sum payment equal to one (1) times executive’s then annual salary payable at the time of termination, unless the termination of executive’s employment occurs within 12 months following a Change in Control, in which case executive will receive the benefits provided below; (b) payment by the Company of Health Benefits for executive and executive’s dependents for the 12 month period following the separation date or such lesser period as executive remains eligible under COBRA, unless the termination of executive’s employment occurs within 12 months following a Change in Control, in which case executive will receive the Heath Benefits for 18 months, and (c) an additional one (1) year of time-based vesting on any unvested options, restricted stock and restricted stock units as of the separation date. In the event that executive’s employment terminates due to death or disability, and subject to execution of a release of claims, executive will be eligible to receive the following severance and related post-termination benefits: (i) payment by the Company of Health Benefits for the 18 month period following the separation date or such lesser period as executive remains eligible under COBRA, and (ii) one hundred percent (100%) of all performance and time-based unvested options, restricted stock and restricted stock units will immediately vest upon executive’s separation date. Additionally, in the event of a Change in Control, then executive shall be entitled to a lump sum severance payment payable in cash equal to one (1) times the product of the executive’s Annual Salary plus the greater of the aggregate amount of any bonuses paid to or earned by executive with respect to the Company’s immediately prior fiscal year or executive’s pro rata portion of the aggregate bonus pool under the Incentive Plan for the then current fiscal year assuming achievement under the Incentive Plan of the maximum performance targets for such fiscal year, and Double-Trigger Change in Control Acceleration.

Mr. Ismail resigned as Chief Product Officer in September 2016. Mr. Christothoulou resigned as Chief Executive Officer in October 2016. Mr. Nafus resigned as Chief Revenue Officer and as a member of the office of the CEO effective March 31, 2017.


Restricted Stock and Restricted Stock Units Agreements

On December 20, 2013, we granted an aggregate of 347,500 shares of restricted stock under our 2012 Stock Plan to certain of our NEOs pursuant to a review by our Compensation Committee of equity incentives for NEOs. These awards are subject to certain conditions on vesting, but will vest in full upon the occurrence of both (a) a change in control, (b) followed by (i) a termination without cause of the executive officer’s employment by the Company or any successor thereto, (ii) a diminution in duties (as defined in such award agreements) with respect to the executive officer, or (iii) the 12-month anniversary of the occurrence of the change in control.

On September 15, 2015, in connection with his appointment as Chief Revenue Officer of the Company, we granted Mr. Nafus 225,000 shares of restricted stock under our 2012 Stock Plan with 25% of the total shares of restricted stock vesting on the first, second, third and fourth annual anniversaries of the grant date. The award will vest in full upon the occurrence of both (x) a change in control, (y) followed by the earliest to occur of: (i) a termination of Mr. Nafus’ service without cause by the Company or any successor thereto, (ii) a diminution in duties, or (iii) the 12-month anniversary of the occurrence of the change in control so long as Mr. Nafus’ service with the Company or any successor thereto is continuous from the grant date through such date.

On April 21, 2016, we granted an aggregate of 735,000 shares of restricted stock under our 2012 Stock Plan to our NEOs (including to our two former executive officers) pursuant to a review by our Compensation Committee of equity incentives for NEOs. These shares of restricted equity are subject to certain conditions on vesting as well as the Double-Trigger Change in Control Acceleration.

Option Agreements

On December 20, 2013, we granted an aggregate of 457,500 options under our 2012 Stock Plan to certain of our NEOs pursuant to a review by our Compensation Committee of equity incentives for NEOs. These options are subject to certain conditions on vesting, but will vest in full upon the occurrence of both (a) a change in control, (b) followed by, (i) a termination without cause of the executive officer’s employment by the Company or any successor thereto, (ii) a diminution in duties (as defined in such award agreements) with respect to the executive officer, or (iii) the 12-month anniversary of the occurrence of the change in control.

On September 15, 2015, in connection with his appointment as Chief Revenue Officer of the Company, we granted Mr. Nafus 275,000 options under our 2012 Stock Plan with 25% of the total option shares vesting on the first anniversary of the grant date and the remainder vesting quarterly thereafter over the next 3-year period in equal increments of 6.25% of the aggregate amount of such shares. The award will vest in full upon the occurrence of both (x) a change in control, (y) followed by the earliest to occur of: (i) a termination of Mr. Nafus’ service without cause by the Company or any successor thereto, (ii) a diminution in duties, or (iii) the 12-month anniversary of the occurrence of the change in control so long as Mr. Nafus’ service with the Company or any successor thereto is continuous from the grant date through such date.

On April 21, 2016, we granted an aggregate of 980,000 options under our 2012 Stock Plan to our NEOs (including to our two former executive officers) pursuant to a review by our Compensation Committee of equity incentives for NEOs. These options are subject to certain conditions on vesting as well as the Double-Trigger Change in Control Acceleration.

Retention Agreements

On October 2, 2006, we entered into retention agreements with each of Messrs. Arends, Caldwell and Christothoulou (no longer in effect), which provide that in the event of a change in control, each of Messrs. Arends, Caldwell and Christothoulou would be entitled to a lump sum payment equal to two times the amount calculated by adding (1) his annual salary at that time plus (2) the greater of (a) any bonus he earned with respect to the prior fiscal year, or (b) his pro rata portion of the aggregate bonus pool under our Incentive Plan for the current year assuming achievement under the Incentive Plan of the maximum performance targets for such year. With respect to Messrs. Arends, Caldwell and Christothoulou, if within twelve (12) months following a change in control: (1) the Company shall terminate his employment with the Company without cause, or (2) he shall voluntarily terminate such employment for good reason, the Company shall provide reimbursement of health care premiums for him and his dependents, for a period of eighteen (18) months from the date of his termination, to the extent that he is eligible for and elects continuation coverage under COBRA (provided that such reimbursement shall terminate upon commencement of new employment by an employer that offers health care coverage to its employees). In consideration for the Company’s willingness to enter into amended and restated employment agreements with each of Messrs. Arends, Caldwell and Christothoulou effective April 21, 2016, such executives relinquished the excise tax gross-up provision which was contained in the retention agreements.  


Separation Agreements

On October 3, 2016, in connection with Mr. Christothoulou’s resignation from his position as Chief Executive Officer, we entered into a separation agreement and release with Mr. Christothoulou. Mr. Christothoulou remained an employee of the Company through October 31, 2016. Mr. Christothoulou’s separation agreement with the Company provides for the following: (1) a cash payment equal to $285,000 payable on October 3, 2016 and a second cash payment equal to $285,000 payable on April 3, 2017 subject to performance of transition services in cooperation with the Company through such date, (2) payment by the Company of its share of medical, dental and vision insurance premiums under COBRA for Mr. Christothoulou and Mr. Christothoulou’s dependents for up to twelve (12) months following the termination date; and (3) an additional vesting of 190,187 shares of restricted stock and an additional vesting of 288,877 options held by Mr. Christothoulou as of October 31, 2016.

On May 11, 2016, in connection with Mr. Horowitz’s resignation from the Board of Directors and his position as Executive Director, we entered into a separation agreement and release with Mr. Horowitz. Mr. Horowitz remained employed as Marchex’s Executive Director until May 12, 2016. From May 12, 2016 through the earlier of (i) May 12, 2017, or (ii) Marchex’s termination of the consulting period, Mr. Horowitz will provide consulting and advisory services from time to time and Marchex will pay Mr. Horowitz an annualized amount of $255,000 per year, payable in monthly installments in advance through May 12, 2017 for such services. So long as Mr. Horowitz timely elects health benefits continuation under COBRA, Mr. Horowitz shall be entitled to receive payment by Marchex of Mr. Horowitz’s applicable premiums for such continuation coverage during the period commencing on May 12, 2016 and ending on the earliest to occur of (i) the eighteen (18) month anniversary of May 12, 2016, (ii) the expiration of Mr. Horowitz’s eligibility for benefits under COBRA, and (iii) the date on which Mr. Horowitz and his covered dependents become covered by health insurance through another source. Effective as of May 12, 2016, (i) vesting was accelerated in full on Mr. Horowitz’s existing equity awards, (ii) Marchex extended the period during which Mr. Horowitz may exercise any vested stock options through the remaining contractual term, and (iii) Mr. Horowitz was granted 100,000 shares of Marchex’s Class B common stock pursuant to the Company’s 2012 Stock Incentive Plan at a purchase price of $0.01 per share with quarterly vesting in equal amounts through May 12, 2017. On May 12, 2017, we entered into a first amendment to the agreement with Mr. Horowitz, which provides for the continuation of the consulting relationship beyond the original termination date of May 12, 2017 on a month to month basis.

The following table sets forth an estimate of the payments and benefits that would be received by each of our NEOs if a change in control of Marchex and/or termination of their employment had occurred on December 31, 2016. The amounts contained in the table for each continuing NEO are based the individual’s period of employment and compensation as of December 31, 2016 and, where applicable, the closing price of Marchex Class B common stock on December 31, 2016. The table presents estimates of incremental amounts that would become payable had a triggering event occurred on December 31, 2016 and does not include amounts that were earned and payable as of that date regardless of the occurrence of a triggering event. The table also sets forth the actual payments and benefits received or to be received by Messrs. Christothoulou, Horowitz and Ismail as a result of their cessation of employment prior to December 31, 2016. For our continuing NEOs, the actual amounts of payments and benefits that could be received can be determined only at the time of a triggering event, and are dependent upon the facts and circumstances then applicable.


Potential Payments upon Termination or Change in Control

 

Name

 

Change in Control

without Termination

of Employment (1)

($)

 

 

Change in Control

with Termination of

Employment without

Cause or Resignation

for Good Reason (2)

($)

 

 

Termination of

Employment

without Cause

or Resignation

for Good Reason

without Change

in Control (3)

($)

 

 

Termination

Due to Death

or Disability (4)

($)

 

 

Voluntary

Resignation (5)

($)

 

Michael Arends

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Salary and bonus payments

(6)

 

1,740,000

 

 

 

1,740,000

 

 

 

 

 

 

 

 

 

 

Severance payments

(7)

 

 

 

 

 

 

 

290,000

 

 

 

 

 

 

 

 

Value of accelerated option awards

(8)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Value of accelerated restricted stock awards

(9)

 

 

 

 

467,063

 

 

 

228,563

 

 

 

467,063

 

 

 

 

Health benefits

(10)

 

 

 

 

 

30,618

 

 

 

14,592

 

 

 

21,888

 

 

 

 

Life insurance death benefit

(11)

 

 

 

 

 

 

 

 

 

 

 

 

 

1,500,000

 

 

 

 

Total

 

 

1,740,000

 

 

 

2,237,681

 

 

 

533,155

 

 

 

1,988,951

 

 

 

 

Ethan Caldwell

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Salary and bonus payments

(6)

 

1,710,000

 

 

 

1,710,000

 

 

 

 

 

 

 

 

 

 

Severance payments

(7)

 

 

 

 

 

 

 

285,000

 

 

 

 

 

 

 

 

Value of accelerated option awards

(8)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Value of accelerated restricted stock awards

(9)

 

 

 

 

395,513

 

 

 

132,169

 

 

 

395,513

 

 

 

 

Health benefits

(10)

 

 

 

 

 

33,840

 

 

 

9,660

 

 

 

14,490

 

 

 

 

Total

 

 

1,710,000

 

 

 

2,139,353

 

 

 

426,829

 

 

 

410,003

 

 

 

 

Gary Nafus (14)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Salary and bonus payments

(6)

 

900,000

 

 

 

900,000

 

 

 

 

 

 

 

 

 

 

Severance payments

(7)

 

 

 

 

 

 

 

300,000

 

 

 

 

 

 

 

Value of accelerated option awards

(8)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Value of accelerated restricted stock awards

(9)

 

 

 

 

632,688

 

 

 

195,438

 

 

 

632,688

 

 

 

 

Health benefits

(10)

 

 

 

 

21,888

 

 

 

14,592

 

 

 

21,888

 

 

 

 

Total

 

 

900,000

 

 

 

1,554,576

 

 

 

510,030

 

 

 

654,576

 

 

 

 

 

Russell C. Horowitz

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Value of accelerated option awards

(8)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Value of accelerated restricted stock awards

(9)

 

 

 

 

 

 

 

 

 

 

 

 

 

124,920

 

Health benefits

(10)

 

 

 

 

 

 

 

 

 

 

 

 

 

37,782

 

Consulting services

(12)

 

 

 

 

 

 

 

 

 

 

 

 

 

255,000

 

Value of stock award for consulting services

(13)

 

 

 

 

 

 

 

 

 

 

 

 

 

375,000

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

792,702

 

Former Executive Officers:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Peter Christothoulou

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Severance payments

(7)

 

 

 

 

 

 

 

 

 

 

 

 

 

599,048

 

Value of accelerated option awards

(8)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Value of accelerated restricted stock awards

(9)

 

 

 

 

 

 

 

 

 

 

 

 

 

523,017

 

Health benefits

(10)

 

 

 

 

 

 

 

 

 

 

 

 

 

15,524

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,137,589

 

Ziad Ismail

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Severance payments

(7)

 

 

 

 

 

 

 

 

 

 

 

 

 

22,514

 

(1)

Amounts in the column headed “Change in Control without Termination of Employment” represent the payments and benefits that would be provided on a “single trigger” basis, meaning that they are triggered by the occurrence of a change in control of Marchex and are not conditioned on the NEO’s subsequent termination of employment.  These payments and benefits would be provided by the retention agreements described above to which Mr. Caldwell and Mr. Arends are parties, and by our employment agreement with Mr. Nafus.


(2)

Amounts in the column headed “Change in Control with Termination of Employment without Cause or Resignation for Good Reason” represent both the payments and benefits that would be provide on a “single trigger” basis contained in the first column and certain additional payments and benefits that would be provided on a “double trigger” basis, meaning that they are triggered if, within 12 months following a change in control of Marchex, the NEO’s employment is terminated without cause or the NEO resigns for good reason in accordance with our employment agreements with Messrs. Caldwell, Arends and Nafus.

(3)

Amounts in the column headed “Termination of Employment without Cause or Resignation for Good Reason without Change in Control” represent the payments and benefit that would be provided by our employment agreements with Messrs. Caldwell, Arends and Nafus upon their termination of employment without cause or resignation for good reason not occurring within 12 months following a change in control of Marchex.  All such payments and benefits are conditioned upon the NEO’s effective release of claims in favor of Marchex.

(4)

Amounts in the column headed “Termination Due to Death or Disability” represent the values of benefits that would be provided by our employment agreements with Messrs. Caldwell, Arends and Nafus in the event their employment with us terminates as a result of death or disability.  All such payments and benefits are conditioned upon the NEO’s release of claims in favor of Marchex.

(5)

Amounts in the column headed “Voluntary Resignation” reflect the actual values of payments and benefits provided or to be provided to Messrs. Christothoulou, Horowitz and Ismail in connection with their resignations from employment effective October 31, 2016, May 12, 2016 and September 30, 2016, respectively.  All such payments and benefits were conditioned upon the former employee’s effective release of claims in favor of Marchex.

(6)

Represents two times (one times in the case of Mr. Nafus) the sum of the NEO’s annual base salary as in effect on December 31, 2016 plus the greater of the bonus earned for the prior fiscal year or the bonus that would be earned for the current fiscal year assuming achievement of the applicable performance target at the maximum credited level.  For the year ended December 31, 2016, the bonus component included in the calculation of such payments is equal to 200% of the NEO’s annual base salary as in effect on December 31, 2016.

(7)

Represents one times the continuing NEO’s annual base salary as in effect on December 31, 2016. In accordance with his separation agreement, Mr. Christothoulou was entitled to severance payments of $285,000 on October 3, 2016 and $285,000 on April 3, 2017 subject to his provision of certain transition services to Marchex. In addition, Mr. Christothoulou also received accrued vacation of $29,048 as part of his separation agreement. Mr. Ismail received severance payments including accrued vacation pursuant to his separation agreement with Marchex.

(8)

Represents the intrinsic value of unvested stock options held by each NEO on December 31, 2016 whose vesting would be accelerated in the event of the NEO’s termination of without cause or resignation for good reason as follows: (a) 100% of unvested performance based and time based options if employment terminates within 12 months following a change in control and (b) one-year of additional vesting of unvested time based options if employment terminates other than within 12 months following a change in control. If employment terminates due to death or disability, the vesting of 100% of unvested performance based and time based options would be accelerated. The value of any accelerated stock option vesting would be the excess, if any, of the closing price per share of our Class B common stock on the NASDAQ Global Market over the exercise price of the option. For the purposes of this table, we have assumed an option vesting acceleration date of December 31, 2016. Because all options held by continuing NEOs on December 31, 2016 had exercise prices exceeding that day’s closing price of $2.65, they had no intrinsic value.  In accordance with their separation agreements and effective as of their separation dates, Mr. Christothoulou was entitled to accelerated vesting of one and one half years of his unvested options (288,877 options), all of which were then under water, and Mr. Horowitz was entitled to accelerated vesting of 100% of his unvested options, all of which were then under water. However, in accordance with his separation agreement, the options held by Mr. Horowitz will remain exercisable until their 10th anniversaries and may have intrinsic value in the future.

(9)

Represents the value of unvested restricted stock held by each NEO on December 31, 2016 whose vesting would be accelerated in the event of the NEO’s termination of without cause or resignation for good reason as follows: (a) 100% of unvested performance based and time based restricted stock if employment terminates within 12 months following a change in control and (b) one-year of additional vesting of unvested time based restricted stock if employment terminates other than within 12 months following a change in control.  If employment terminates due to death or disability, the vesting of 100% of unvested performance and time based restricted stock would be accelerated.  The value of any accelerated restricted stock vesting reflected in the table is based on the closing price of $2.65 per share of our Class B common stock on the NASDAQ Global Market on December 31, 2016. In accordance with their separation agreements and effective as of their separation dates, Mr. Christothoulou was entitled to accelerated vesting of one and one half years of his unvested time based restricted stock (190,187 shares), and Mr. Horowitz was entitled to accelerated vesting of 100% of his unvested restricted stock (33,312 shares) in which the accelerated values realized in the table is based on the closing price of $2.75 and $3.75, respectively, on their termination dates.


(10)

In accordance with our retention agreements with Messrs. Caldwell and Arends and our employment agreement with Mr. Nafus, each would be reimbursed for up to 18 months of health benefit continuation coverage under COBRA upon their termination of employment without cause or resignation for good reason within 12 months following a change in control of Marchex (reduced, in the case of Mr. Nafus, by the amount of any required employee premium contribution for health care benefits).  The amounts stated in the second column reflect the applicable premium cost for a period of 18 months.  Under our employment agreements with Messrs. Caldwell, Arends and Nafus, each continuing NEO would be eligible to receive up to 12 months of company-paid health benefit continuation coverage under COBRA, reduced by the amount of any required employee premium contribution for health care benefits, in the event of their termination of employment without cause or resignation for good reason not occurring within 12 months following a change in control.  The amounts stated in the third column reflect the applicable premium cost for a period of 12 months.  The amounts stated in the fourth column represent up to 18 months of company-paid health benefit continuation coverage under COBRA, reduced by the amount of any required employee premium contribution for health care benefits, to which Messrs. Caldwell, Arends and Nafus or their beneficiaries would be entitled upon their termination of employment due to disability or death in accordance with their employment agreements.  The amount stated for Mr. Christothoulou represents 12 months of company-paid health benefit continuation coverage under COBRA, reduced by the amount of any required employee premium contribution for health care benefits, to which Mr. Christothoulou is entitled in accordance with his separation agreement.  The amount stated for Mr. Horowitz represents 18 months of company-paid health benefit continuation coverage under COBRA, reduced by the amount of any required employee premium contribution for health care benefits, to which Mr. Horowitz is entitled in accordance with his separation agreement.

(11)

Represents the death benefit that would be paid to Mr. Arends’ beneficiaries pursuant to life insurance maintained by Marchex pursuant to our employment agreement with Mr. Arends.

(12)

Represents the aggregate fee payable to Mr. Horowitz in 12 monthly installments for consulting services to be rendered to Marchex by Mr. Horowitz through May 12, 2017 in accordance with his separation agreement.

(13)

Represents the value, based on the closing price of $3.75 per share of our common stock on the NASDAQ Global Market on May 12, 2016, of 100,000 shares of Marchex Class B common stock granted to Mr. Horowitz at a purchase price of $0.01 per share in accordance with his separation agreement. Such shares are subject to quarterly vesting over four quarters contingent upon Mr. Horowitz performance of consulting services for Marchex.

(14)

Mr. Nafus resigned as Chief Revenue Officer and as a member of Marchex’s office of the CEO effective March 31, 2017 and in connection with his employment termination, 238,750 of unvested restricted stock and 241,876 of unvested options were forfeited.

Procedures for Review and Approval of Related Person Transactions

Our Audit Committee is responsible under its charter for reviewing and approving in advance any proposed related party transactions which would require disclosure under Item 404(a) of Regulation S-K and reporting to the Board of Directors on any approved transactions. The Audit Committee is responsible for ensuring that such relationships are on terms commensurate with those that would be extended to an unrelated third party.

Compensation of Directors

The Compensation Committee is responsible for periodically reviewing and recommending to the Board of Directors the compensation of our independent directors. The following table summarizes compensation earned during 2016 by each of our directors except for Mr. Horowitz, whose compensation is reflected in the Summary Compensation Table and who did not receive additional compensation for his service on our Board of Directors through May of 2016:

2016 Director Compensation (1)

Name

 

Fees Earned

or Paid

in Cash

($)

 

 

Stock

Awards(2)

($)

 

 

Total

($)

 

Dennis Cline

 

 

32,000

 

 

 

124,658

 

 

 

156,658

 

Anne Devereux-Mills (3)

 

 

30,000

 

 

 

513,158

 

 

 

543,158

 

Nicolas J. Hanauer

 

 

 

 

 

139,620

 

 

 

139,620

 

Clark Kokich (4)

 

 

 

 

 

 

 

 

 

Ian Morris

 

 

 

 

 

166,549

 

 

 

166,549

 

M. Wayne Wisehart

 

 

 

 

 

164,554

 

 

 

164,554

 

(1)

Includes only those columns relating to compensation awarded to, earned by, or paid to non-employee directors for their services.


(2)

The amounts in the stock awards column reflect the aggregate grant fair value of stock awards granted to directors in 2016 in accordance with FASB ASC Topic 718. These amounts do not reflect whether the director has actually realized or will realize a financial benefit from the awards (such as by vesting in a restricted stock) except for Ms. Devereux Mills which includes the vested value of 25% of the restricted stock granted on October 5, 2016. See note 3 below for vesting details of Ms. Devereux-Mill’s October 5, 2016 grant.

(3)

In connection with Ms. Devereux-Mills’ appointment as Chairman of the Board of Directors of Marchex in October 2016, Marchex’s Compensation  awarded Ms. Devereux-Mills restricted stock under Marchex’s 2012 Stock Incentive Plan on October 5, 2016 (“Grant Date”) to purchase 150,000 shares of Marchex’s Class B common stock in her capacity as Chairman and at a purchase price of $0.01 per share, with 25% of the aggregate amount of such shares vesting on each of the Grant Date and the first, second and third annual anniversaries of the Grant Date (in each such case assuming continued service as Chairman on the applicable vesting date) and with accelerated vesting upon certain events as set forth in such restricted stock agreement.

(4)

In connection with Mr. Kokich’s appointment to the Board as Executive Chairman, Marchex’s Compensation Committee awarded Mr. Kokich restricted stock under Marchex’s 2012 Stock Incentive Plan on February 25, 2015 (“Grant Date”) to purchase 150,000 shares of Marchex’s Class B common stock in his capacity as Executive Chairman and at a purchase price of $0.01 per share, with 25% of the aggregate amount of such shares vesting on the first annual anniversary of the Grant Date and the remainder of such shares vesting quarterly thereafter over the next three (3) year period in equal increments of 6.25% of the aggregate amount of such shares (in each such case assuming continued service as Executive Chairman on the applicable vesting date) and with accelerated vesting upon certain events as set forth in such restricted stock agreement.  Upon Mr. Kokich’s resignation as Executive Chairman in October 2016, 56,250 shares of restricted stock were vested and 93,750 shares of restricted stock were forfeited upon such resignation. Mr. Kokich also received an annual salary of $60,000 as Executive Chairman.

The aggregate number of equity awards outstanding as of December 31, 2016 were:

Name

 

Stock Awards

(#)

 

 

Option Awards (#)

 

 

Total

 

Dennis Cline

 

 

34,436

 

 

 

 

 

 

34,436

 

Anne Devereux-Mills (3)

 

 

146,936

 

 

 

 

 

 

146,936

 

Nicolas J. Hanauer

 

 

38,569

 

 

 

300,000

 

 

 

338,569

 

Clark Kokich (4)

 

 

 

 

 

 

 

 

 

Ian Morris

 

 

46,008

 

 

 

146,215

 

 

 

192,223

 

M. Wayne Wisehart

 

 

45,457

 

 

 

40,000

 

 

 

85,457

 

In May 2016, based upon the elections of the individual directors and in accordance with Marchex’s previously announced non-employee director compensation policy: (i) the Company granted an aggregate of 198,906 shares of restricted stock to the non-employee directors pursuant to the Company’s 2012 Stock Plan which will vest in full on the earlier of May 13, 2017 or the date of the 2017 annual meeting of stockholders assuming continued service on the board during such period and with accelerated vesting in full upon a change in control, and (ii) will be paid an aggregate of $62,000 in total cash compensation for the fiscal year, in addition to reimbursement for reasonable out-of-pocket expenses they incur in attending board, committee, and company meetings. In October 2016, Ms. Devereux-Mills was granted an additional 150,000 shares of restricted stock in connection with her appointment to Chairman of the Board of Directors of Marchex. See note 3 above for details of Ms. Devereux-Mills’ October 2016 grant.



EQUITY COMPENSATION PLANS

Amended and Restated 2003 Stock Incentive Plan. Our 2003 Stock Incentive Plan, effective on March 30, 2004, was adopted by our Board of Directors and approved by our stockholders on March 30, 2004 (the “2003 Stock Plan”). The 2003 Stock Plan provides for the granting of shares of Class B common stock to employees, directors, and consultants of Marchex, its affiliates and strategic partners and provides for the following types of grants:

incentive stock options within the meaning of Section 422 of the Internal Revenue Code, sometimes known as ISOs;

non-statutory stock options, which are options not intended to qualify as ISOs, sometimes known as non-qualified options; and

right to purchase shares pursuant to restricted stock purchase agreements.

The 2003 Stock Plan was amended in May of 2010 to provide for grants of restricted stock units to eligible participants under the 2003 Stock Plan. No awards will be made under the 2003 Stock Plan after December 31, 2012 and the 2012 Stock Plan covers the anticipated balance of shares available under the 2003 Stock Plan.

2012 Stock Incentive Plan. Our 2012 Stock Incentive Plan, effective on April 2, 2012, was adopted by our Board of Directors and approved by our stockholders on May 4, 2012 (the “2012 Stock Plan”). The 2012 Stock Plan provides for the granting of shares of Class B common stock to employees, directors, and consultants of Marchex, its affiliates and strategic partners and provides for the following types of grants:

incentive stock options within the meaning of Section 422 of the Internal Revenue Code, sometimes known as ISOs;

non-statutory stock options, which are options not intended to qualify as ISOs, sometimes known as non-qualified options;

right to purchase shares pursuant to restricted stock purchase agreements; and

restricted stock units.

2014 Employee Stock Purchase Plan. Our 2014 employee stock purchase plan was adopted by our Board of Directors on March 8, 2013 and approved by our stockholders on May 3, 2013 (the “2014 Employee Stock Purchase Plan”). The 2014 Employee Stock Purchase Plan is intended to qualify under Section 423 of the Internal Revenue Code and permits eligible employees to purchase our Class B common stock for amounts up to 15% of their compensation in purchase periods under the plan. Under the 2014 Employee Stock Purchase Plan, no employee will be permitted to purchase stock worth more than $25,000 in any calendar year, valued as of the first day of each purchase period. We have authorized an aggregate of 225,000 shares of our Class B common stock for issuance under the 2014 Employee Stock Purchase Plan to participating employees. The 2014 Employee Stock Purchase Plan provides for purchase periods which shall be determined by the Board of Directors and the purchase price of shares of Class B common stock available under the purchase plan shall be equal to 95% of the closing price of the shares of Class B common stock on the last business day of each purchase period.



Equity Compensation Plan Information

The following table sets forth certain information regarding our Class B common stock that may be issued upon exercise of options, warrants and other rights under all of our existing equity compensation plans as of December 31, 2016:

Plan Category

 

Number of

shares to be

issued upon

exercise of

outstanding

options,

warrants

and rights

(#)

(a)

 

 

Weighted

average

exercise price

of outstanding

options,

warrants

and rights

($)

(b)

 

 

Number of

shares remaining

available for

future issuance

under equity

compensation

plans (excluding

shares reflected

in column (a)

(#)

(c)

 

Equity compensation plans approved by security holders:

 

 

 

 

 

 

 

 

 

 

 

 

2003 amended and restated stock incentive plan, as amended (1)

 

 

3,181,834

 

 

 

6.70

 

 

 

 

2012 stock incentive plan (2)

 

 

6,378,480

 

(3)

 

5.45

 

(4)

 

3,646,087

 

2014 employee stock purchase plan

 

 

 

 

 

 

 

 

156,029

 

Total

 

 

9,560,314

 

 

 

5.97

 

(4)

 

3,802,116

 

The weighted-average exercise price in column (b) is calculated based on outstanding stock options. It does not take into account shares issuable upon vesting of outstanding restricted stock units, which have no exercise price.

(1)

After December 31, 2013, no awards were made under the 2003 Stock Plan. Consists of stock options to purchase shares of our Class B common stock.

(2)

We have reserved 11,501,545 shares of Class B common stock for issuance under our 2012 Stock Plan, which includes an increase of 2,097,153 shares to the authorized number of shares available under the plan, which occurred on January 1, 2016.

(3)

Consists of stock options to purchase 4,496,050 shares of Class B common stock and restricted stock units representing the right to purchase 1,882,430 shares of our Class B common stock.

(4)

Calculated exclusive of outstanding restricted stock units.


PROPOSAL FOUR—ADVISORY VOTE ON EXECUTIVE COMPENSATION

(Item 4 on Proxy Card)

Introduction

The Dodd-Frank Wall Street Reform and Consumer Protection Act, enacted in July 2010, requires that we provide our stockholders with the opportunity to vote to approve, on a non-binding, advisory basis, the compensation of our NEOs as disclosed in this proxy statement in accordance with the compensation disclosure rules of the SEC.

As described in detail under the heading “Compensation Discussion and Analysis,” we believe that our continued success depends on our ability to retain our experienced, complementary and dedicated management team and we therefore provide strong incentives for them to continue to participate in our growth. We also believe that management compensation packages should reflect as much as possible the risk and opportunity experienced by our stockholders. As a result, we strongly emphasize performance-based compensation arrangements which reward NEOs for contributions to our long-term growth and overall corporate success. We believe that this long-term focus will appropriately reward our management team for performance that will most benefit our Company and stockholders.

We urge you to read the “Compensation Discussion and Analysis” section, the Summary Compensation Table and the related compensation tables and narrative in this proxy statement for additional details on our executive compensation, including our compensation philosophy and objectives and the 2016 compensation of our NEOs.

The vote on this resolution is not intended to address any specific element of compensation; rather the vote relates to the compensation of our NEOs, as described in this proxy statement in accordance with the compensation disclosure rules of the SEC.

Accordingly, we are asking you to vote on the adoption of the following resolution:

BE IT RESOLVED by the stockholders of Marchex, Inc., that the stockholders approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed pursuant to Item 402 of Regulation S-K in this proxy statement for the Company’s 2017 annual meeting.

As an advisory vote, this proposal is non-binding. Although the vote is non-binding, the Board of Directors and the Compensation Committee value the opinions of our stockholders, and will consider the outcome of the vote when making future compensation decisions for our NEOs.

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE “FOR” APPROVAL OF THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS.


PROPOSAL FIVE —ADVISORY VOTE ON FREQUENCY OF ADVISORY VOTE ON

EXECUTIVE COMPENSATION

(Item 5 on Proxy Card)

As described in Proposal Four above, the Company’s stockholders are being provided the opportunity to cast an advisory vote on the compensation of the Company’s NEOs.

The Dodd-Frank Wall Street Reform and Consumer Protection Act also provides that stockholders must be given the opportunity to vote, on a non-binding, advisory basis, for their preference as to how frequently the Company should seek future advisory votes on the compensation of its NEOs. In other words, how often a proposal similar to this year’s Proposal Four will be included in the matters to be voted on at each annual meeting. The choices available under the rules are every year, every other year, or every third year. Stockholders also may, if they wish, abstain from casting a vote on this proposal.

Our Board of Directors believes that stockholders should have the opportunity to vote on the compensation of the NEOs every three years, consistent with the Company’s long-term approach to executive compensation. While the Board and Compensation Committee regularly review compensation, with an in-depth review on an annual basis, the Company’s programs and policies are designed to enhance long-term growth and performance and incentivize our employees on a long-term basis. As discussed in the “Compensation Discussion and Analysis” section of this proxy statement, a majority of the total compensation for executives is in the form of equity awards. The Board of Directors believes that a vote every three years will foster a more long-term view of compensation. It would also give the Company sufficient time to engage with stockholders to better understand their views about the Company’s compensation programs and respond in a more effective manner.

Stockholders can already provide input to the Board of Directors on an annual or more frequent basis using other mechanisms such as by communicating directly with the Board of Directors or individual directors by sending letters or by speaking with them at the annual meeting of stockholders. While an annual vote on executive compensation will indicate whether stockholders have concerns about the Company’s compensation programs and policies, it would not provide specific information about stockholder views. An advisory vote occurring once every three years would permit our stockholders to observe and evaluate the impact of any changes to our executive compensation policies and practices that have occurred since the last advisory vote on executive compensation, including changes made in response to the outcome of a prior advisory vote on executive compensation.

The frequency option chosen by our stockholders for conducting future advisory votes on executive compensation is not a binding determination. However, the opinions expressed by stockholders in their vote on this proposal will be given due consideration by the Board of Directors and the Compensation Committee in making a determination as to the frequency of future advisory votes on executive compensation.

The proxy card provides stockholders with the opportunity to choose among four options (holding the vote every one, two or three years, or abstaining) and, therefore, stockholders will not be voting to approve or disapprove the recommendation of the Board of Directors. Please mark your proxy card to indicate your preference on this proposal or your abstention if you wish to abstain. If you submit your proxy but fail to indicate your preference, your shares will be treated as though you chose a frequency of three years on this proposal.

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS “THREE YEARS” AS THE DESIRED FREQUENCY FOR AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.


PROPOSAL SIX— REAPPROVAL OF CERTAIN PROVISIONS OF THE 2012 STOCK INCENTIVE PLAN

(Item 6 on Proxy Card)

Our stockholders previously approved our 2012 Stock Incentive Plan, under which employees, officers, directors and other individuals who provide bona fide services to us or for any of our affiliates, may be granted equity-based awards.  The stockholders now are being asked to reapprove certain provisions of the 2012 Stock Incentive Plan solely for the purpose of preserving our ability to deduct in full for federal income tax purposes the compensation recognized by certain of our executive officers in connection with certain awards that may be granted in the future under the 2012 Stock Incentive Plan.

Section 162(m) of the Internal Revenue Code limits a corporation’s income tax deduction for compensation paid to certain executive officers who are “covered employees” within the meaning of Section 162(m) to $1 million per person per year unless the compensation qualifies as “performance-based compensation.” In general, for compensation under the 2012 Stock Incentive Plan to qualify as “performance-based compensation,” certain material terms of the 2012 Stock Incentive Plan must be approved by our stockholders in a separate vote. Where, as in the case of the 2012 Stock Incentive Plan, the Compensation Committee has the authority to establish individual award performance goal targets after initial stockholder approval of the material terms of the performance goals, reapproval of the performance goals by the stockholders at least every five years is required to preserve the exemption from the federal income tax deduction limit under Section 162(m) for performance-based compensation. To preserve this exemption following the annual meeting, we are requesting our stockholders to reapprove the material terms of the performance goals under the 2012 Stock Incentive Plan.

Adjournment Proposal.

The Board of Directors believes that it is in the best interests of the Company and its stockholders to preservebe able to adjourn the ability of the Company to deduct in full compensation related to stock options, stock appreciation rights and other performance-based awards granted under the 2012 Stock Incentive Plan. Therefore, solelySpecial Meeting, if necessary or appropriate, for the purpose of qualifying such compensation as performance-based under Section 162(m), the stockholders are asked to reapprove the following provisionssoliciting additional proxies in respect of the 2012 Stock Incentive Plan:

All employees, officers, directors and other individuals who provide bona fide servicesproposal to or forapprove the Company and any affiliate ofAsset Purchase Agreement if there are insufficient votes to approve the Company are eligible to be granted stock options, stock appreciation rights, restricted or unrestricted stock awards, restricted stock units, performance awards, and other stock-based awards under the 2012 Stock Incentive Plan.

No participant may receive in any fiscal year under the 2012 Stock Incentive Plan awards which, in the aggregate, exceed 4,000,000 shares (subject to appropriate adjustment for stock splits, stock dividends, split-ups, recapitalizations, mergers, consolidations, business combinations, exchanges and similar changes to the Company’s capital structure).

The grant or vesting of certain awards intended to qualify as “performance-based” may be made subject to the attainment of performance goals relating to performance measures established in writing by the Compensation Committee.  “Performance Measures” mean criteria relating to any of the following, as it may apply to an individual, one or more business units, divisions or subsidiaries, or on a Company-wide basis, and in either absolute terms or relative to the performance of one or more comparable companies or an index covering multiple companies:

(i)

Earnings or Profitability Metrics: earnings/loss (gross, operating, net, or adjusted); earnings/loss before interest and taxes (“EBIT”); operating income before amortization (“OIBA”) and adjusted OIBA; earnings/loss before interest, taxes, depreciation and amortization (“EBITDA”) and adjusted EBITDA; profit margins; expense levels or ratios; as may be adjusted to eliminate the effect of any one or more of the following: interest expense, asset impairments, early extinguishment of debt, stock-based compensation expense, amortization of intangible assets from acquisitions, acquisition related costs, gain/loss on sales and disposals of intangible assets, lease incentives, costs to exit activities and other non-GAAP financial measures under Regulation G promulgated by the Securities and Exchange Commission;

(ii)

Return Metrics: return on investment, assets, equity or capital (total or invested);

(iii)

Cash Flow Metrics: operating cash flow; cash flow sufficient to achieve financial ratios or a specified cash balance; free cash flow; cash flow return on capital; net cash provided by operating activities; cash flow per share; working capital;

(iv)

Liquidity Metrics: capital raising; debt reduction; extension of maturity dates of outstanding debt; debt leverage (debt to capital, net debt-to-capital, debt-to-EBITDA or other liquidity ratios) or access to capital; debt ratings; total or net debt; other similar measures approved by the administrator;


(v)

Stock Price and Equity Metrics: return on stockholders’ equity; total stockholder return; stock price; stock price appreciation; market capitalization; earnings/loss per share (basic or diluted) (before or after taxes); price-to-earnings ratio; and

(vi)

Strategic and Operating Metrics: geographic footprint; revenue (gross, operating or net); new business or customer wins; market share; market penetration; growth in assets; key hires; management of employment practices and employee benefits; effective income tax rates; business expansion; acquisitions, divestitures, collaborations, licensing or joint ventures; financing; covenant compliance; resolution of significant litigation; and legal compliance or risk reduction.

While we believe that compensation provided by such awards under the 2012 Stock Incentive Plan generally will be deductible by the Company for federal income tax purposes, under certain circumstances, such as a change in control of the Company, compensation paid in settlement of certain awards may not qualify as performance-based.

Summary of the 2012 Stock Incentive Plan

The following summary of material terms of the 2012 Stock Incentive Plan is qualified in its entirety by the actual language of the 2012 Stock Incentive Plan, copy of which is set forth in Appendix A to this proxy statement.

Background and Purpose

We adopted the 2012 Stock Incentive Plan to promote long-term growth and profitability by providing key people with incentives to improve stockholder value of the Company and contribute to our growth and financial success, and enabling us to attract, retain and reward the best-available personnel.

Eligibility and Participation

Participation in the 2012 Stock Incentive Plan is open to all of our employees, officers, directors and other individuals who provide services to us or any of our affiliates, as the administrator of the 2012 Stock Incentive Plan may select from time to time. Our Compensation Committee serves as the administrator. The administrator may also grant awards to individuals in connection with their hiring, recruitment or other related circumstance before the date that the relevant individual first performs those services for us or any of our affiliates, however, no awards may vest or become exercisable and no shares may be issued before the individual commences performance of those services. As of the date of this proxy statement, five non-employee directors and approximately two hundred and twenty-three employees and other individuals providing services to the Company or any of its affiliates are eligible to participate in the 2012 Stock Incentive Plan.

Types of Awards

The 2012 Stock Incentive Plan provides for the grant of stock options, stock appreciation rights, stock awards, restricted stock units, performance awards and other stock-based awards, as each is described more fully below, which may be granted separately or in tandem with other awards. The administrator is responsible for determining the prices, expiration dates, and other material conditions governing the exercise of the awards granted under the 2012 Stock Incentive Plan. We may make or guarantee loans to assist award holders in the exercise of awards or to satisfy any withholding tax obligations arising from awards granted under the 2012 Stock Incentive Plan, to the extent permitted by law. Securities laws, however, preclude us from making or guaranteeing any such loans to our executive officers. Types of awards that may be granted under the 2012 Stock Incentive Plan include:

Stock Options. The administrator may grant tax-qualified incentive stock options, within the meaning of Section 422 of the Code, or nonqualified stock options. However, only employees of the Company or its subsidiaries may receive tax-qualified incentive stock options. All stock options must have an exercise price equal to or above the fair market value of our shares on the date of grant and a term of no longer than ten years. As of June 27, 2017, the fair market value of a share of our Class B common stock was $2.92 based upon the closing price as reported on the NASDAQ Global Select Market on such date. An option holder may pay the exercise price in cash or by broker-assisted cashless exercise or by any other means that the administrator approves or any combination of the foregoing.

Stock Appreciation Rights. The administrator may grant stock appreciation rights that entitle the holder to receive a payment in cash, shares or a combination of the foregoing, having an aggregate value that is equal to the excess (if any) on the date of exercise of the fair market value of the underlying shares on that date over the base price of the shares specified in the grant agreement. The base price per share specified in the grant agreement cannot be less than the lower of the fair market value of shares on the grant date or the exercise price of any tandem stock option award to which the stock appreciation right is related. No stock appreciation right may have a term longer than ten years’ duration.


Stock Awards. The administrator may grant stock awards in such amounts, on such terms and conditions and for such consideration (including no consideration or such minimum consideration as may be required by law), as the administrator determines. A stock award may be restricted or unrestricted and may be denominated in shares or other securities, stock-equivalent units, securities or debentures convertible into shares, or any combination of these. Stock awards may be paid in shares or other securities, cash or a combination of these.

Performance Awards. The administrator may grant stock-based awards that are “qualified performance-based compensation” within the meaning of Section 162(m) of the Code. The grant of, or lapse of restrictions with respect to, performance-based stock awards must be based upon one or more performance measures and objective performance targets to be attained relative to those performance measures as determined by the administrator. Performance targets may include minimum, maximum, intermediate and target levels of performance, with the size of the performance-based stock award or the lapse of restrictions based on the level of performance attained. The administrator is authorized to make adjustments to the method of calculating the attainment of performance measures or targets in recognition of extraordinary or non-recurring items, changes in tax laws, changes in generally accepted accounting principles or accounting policies, changes related to restructured or discontinued operations, the restatement of prior period financial results, or any other unusual, non-recurring gain or loss that is separately identified and quantified in our financial statements.

For this purpose, “performance measures” are those measures described in the Section 162(m) approval provisions above or as may be established by the Compensation Committee from time to time.

Shares Available Under the 2012 Stock Incentive Plan

The total number of shares of our common stock that may be issued with respect to awards granted under the 2012 Stock Incentive Plan will be 3,500,000, plus an automatic annual increase to be added on January 1 of each year equal to five percent (5%) of the total shares of common stock outstanding on such date (including for this purpose any shares of common stock issuable upon conversion of any outstanding capital stock of the Company). The total number of shares of common stock available for granting incentive stock options intended to qualify under Code section 422 under the 2012 Stock Incentive Plan will be 3,500,000, plus an automatic annual increase to be added on January 1 of each year beginning in 2013 and ending in 2022, equal to the lesser of (i) 2,000,000 shares of common stock or (ii) five percent (5%) of the total shares of common stock outstanding on such date (including for this purpose any shares of common stock issuable upon conversion of any outstanding capital stock of the Company) or (iii) such lesser number as determined by the Board.

If any award, or portion of an award, under the 2012 Stock Incentive Plan or the Company’s 2003 Amended and Restated Stock Incentive Plan (the “2003 Plan”) expires or terminates unexercised, becomes unexercisable, is settled in cash without delivery of shares of common stock, or is forfeited or otherwise terminated, surrendered or canceled as to any shares, or if any shares of common stock are repurchased by or surrendered to the Company in connection with any award (whether or not such surrendered shares were acquired pursuant to any award) under this 2012 Stock Incentive Plan or the 2003 Plan, or if any shares are withheld by the Company, the shares subject to such award and the repurchased, surrendered and withheld shares will thereafter be available for further awards under the 2012 Stock Incentive Plan; provided, however, that any such shares that are surrendered to or repurchased or withheld by the Company in connection with any award under this 2012 Stock Incentive Plan or the 2003 Plan or that are otherwise forfeited after issuance will not be available for purchase pursuant to incentive stock options intended to qualify under Code section 422.

The maximum number of shares of common stock subject to awards of any combination that may be granted during any one fiscal year of the Company to any one individual under this 2012 Stock Incentive Plan will be limited to 4,000,000 shares. Such per-individual limit will not be adjusted to effect a restoration of shares of common stock with respect to which the related sward is terminated, surrendered or canceled.

Each of the limits described above is adjusted to reflect any stock dividends, stock splits, split-ups, recapitalizations, mergers, consolidations, business combinations, exchanges of stock or anything similar. The shares to be issued under the 2012 Stock Incentive Plan are shares of authorized but unissued or reacquired shares or treasury shares, including shares we repurchase on the open market.

Adjustments to Awards

In the event of a stock dividend, stock split or reverse stock split affecting shares, the maximum number of shares for which awards may be granted under the 2012 Stock Incentive Plan and the maximum number of shares with respect to which awards may be granted during any one fiscal year to any individual, and the number of shares covered by and the exercise price and other terms of outstanding awards, will be adjusted to reflect such event without further action of our Board of Directors.


Except as stated above, in the event of any change affecting shares, the Company or its capitalization, by reason of a spin-off, split-up, dividend, recapitalization, merger, consolidation, or share exchange (other than any such change that is part of a transaction resulting in a “Change in Control” of the Company (as defined in the 2012 Stock Incentive Plan)), the administrator, in its discretion and without the consent of the holders of the awards, shall make appropriate adjustments to the maximum number and type of shares reserved for issue or with respect to which awards may be granted under the 2012 Stock Incentive Plan (in the aggregate, with respect to any individual during any one calendar year and with respect to which awards that are intended to be tax-qualified as incentive stock options under the Code); and any adjustments in outstanding awards, including, but not limited to, modifying the number, kind and price of securities subject to awards.

In the event of any transaction resulting in a Change in Control of the Company or if the Company is to be consolidated with or acquired by another entity in a merger, consolidation, private sale or sale of all or substantially all of the Company’s assets or otherwise (any of the foregoing, an “Acquisition”), the administrator of the 2012 Stock Incentive Plan or the board of directors of any entity assuming the obligations of the Company under the 2012 Stock Incentive Plan (the “Successor Board”), will, as to outstanding stock options, either (i) make appropriate provision for the continuation of such stock options by substituting on an equitable basis for the shares of common stock then subject to such stock options either the consideration payable with respect to the outstanding shares of common stock in connection with the Acquisition or securities of any successor or acquiring entity; or (ii) upon written notice to the holders, provide that all options must be exercised (to the extent then exercisable after taking into account any applicable acceleration of vesting) at the end of which period the options will terminate; or (iii) terminate all options in exchange for a cash payment equal to the excess of the fair market value of the shares subject to such options (to the extent then exercisable after taking into account any applicable acceleration of vesting) over the exercise price thereof.

With respect to outstanding awards other than stock options, the administrator of the 2012 Stock Incentive Plan or the Successor Board, will either (x) make appropriate provisions for the continuation of such awards by substituting on an equitable basis for the shares then subject to such awards either the consideration payable with respect to the outstanding shares of common stock in connection with the Acquisition or securities of any successor or acquiring entity; or (y) upon written notice to the holders, provide that all such awards must be accepted (to the extent then subject to acceptance) within a specified number of days of the date of such notice, at the end of which period the offer of the awards will terminate; or (z) terminate all such other awards in exchange for a cash payment equal to the excess of the fair market value of the shares subject to such awards (to the extent then vested after taking into account any applicable acceleration of vesting) over the base or purchase price thereof, if any. In addition, in the event of an Acquisition, the administrator may waive any or all Company repurchase rights with respect to outstanding awards.

Further, in the event that a “Change in Control” of the Company  occurs after a performance-based stock award has been granted but before completion of the applicable performance period, a pro rata portion of such award becomes payable (or a pro rata portion of the lapse restrictions lapses, as applicable) as of the date of the Change in Control to the extent otherwise earned on the basis of achievement of the pro rata portion of the performance measures and performance targets relating to the portion of the performance period completed as of the date of the Change in Control.

Without the consent of award holders, the administrator may make adjustments to the terms and conditions of, and the criteria included in, awards in recognition of unusual or non-recurring events affecting the Company, the financial statements of the Company or any affiliate, changes in applicable laws, regulations, or accounting principles, whenever the administrator determines that such adjustments are appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the 2012 Stock Incentive Plan.

Amendment and Termination

Our Board of Directors may terminate, amend or modify the 2012 Stock Incentive Plan or any portion of it at any time without stockholder approval, subject to such restrictions on amendments and modifications as may apply under applicable laws or listing rules.

Compliance with Securities Laws and Listing Rules

If at any time the administrator determines that delivery of our common stock under the 2012 Stock Incentive Plan would be unlawful under the laws of any applicable jurisdiction, or federal, state or foreign securities laws or violate the rule of the national exchange on which our common stock is then listed, the right to exercise an award or receive shares of common stock pursuant to an award will be suspended until the administrator determines such delivery would not violate such laws or rules.



Federal Income Tax Consequences

The following is a general summary of the federal income tax treatment of stock options, which are authorized for grant under the 2012 Stock Incentive Plan, based upon the provisions of the Code as of the date of this proxy statement. Non-U.S. residents should consult with their tax adviser regarding the specific tax consequences as a result of the grant of awards under the 2012 Stock Incentive Plan in their country of origin. This summary is not intended to be exhaustive and the exact tax consequences to any award holder depend upon his or her particular circumstances and other facts. 2012 Stock Incentive Plan participants should consult their tax advisor with respect to any state, local and non-U.S. tax considerations or relevant federal tax implications of options granted under the 2012 Stock Incentive Plan.

Incentive Stock Options. An option holder recognizes no taxable income for regular income tax purposes as a result of the grant or exercise of an incentive stock option that qualifies under Section 422 of the Code. Option holders who neither dispose of their shares within two years of the date that the option was granted or within one year following the exercise of the option, normally recognize a capital gain or loss on the sale of the shares equal to the difference, if any, between the sale price and the purchase price of the shares. If an option holder satisfies these holding periods, on the sale of the shares, we are not entitled to any deduction for federal income tax purposes. Where an option holder disposes of shares within two years after the date of grant of those options or within one year after the date of exercise (a “disqualifying disposition”), the difference between the fair market value of the shares on the exercise date and the option exercise price (which is not to exceed the gain realized on the sale, if the disposition is a transaction with respect to which a loss, if sustained, would be recognized) is taxed as ordinary incomeAsset Purchase Agreement at the time of disposition. Any gain in excess of that amount is a capital gain. If a loss is recognized, there is no ordinary income, and such loss is a capital loss. Any ordinary income recognized by the option holder on the disqualifying disposition of the shares generally results in a deduction by us for federal income tax purposes.

Nonqualified Stock Options. Options not designated or qualifying as incentive stock options are nonqualified stock options having no special tax status. An option holder generally recognizes no taxable income as a result of the grant of the option. On the exercise of a nonqualified stock option, the option holder normally recognizes ordinary income in the amount of the difference between the option exercise price and the fair market value of the shares on the exercise date. Where the option holder is an employee, such ordinary income generally is subject to withholding of income and employment taxes. On the sale of shares acquired by the exercise of a nonqualified stock option, any gain or loss (based on the difference between the sale price and the fair market value on the exercise date), is taxed as a capital gain or loss. No tax deduction is available to us with respect to the grant of a nonqualified stock option or the sale of the stock acquired pursuant to such grant. We should generally be entitled to a deduction equal to the amount of ordinary income recognized by the option holder as a result of the exercise of a nonqualified stock option.

Deductibility of Compensation. The Code allows publicly held corporations to deduct compensation that is in excess of $1 million paid to the corporation’s chief executive officer and or any of its three most highly compensated executive officers (other than the chief executive officer and the chief financial officer) if the compensation is payable solely based on the attainment of one or more performance goals and where certain statutory requirements are satisfied. It is intended that compensation arising from awards granted under the 2012 Stock Incentive Plan that are based on performance goals, and stock options and stock appreciation rights, are to be deductible by us as qualified performance-based compensation not subject to the $1 million limitation on deductibility under the Code. Despite this, we reserve the right to grant awards under the 2012 Stock Incentive Plan that do not result in qualified performance-based compensation and, as such, may not entitle us to a tax deduction.

Approval of this proposal requires the affirmative vote of a majority of the shares of the Company’s Class A common stock and Class B common stock present or represented by proxy and entitled to vote on this proposal.Special Meeting.

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE “FOR” APPROVAL OF THISTHE ADJOURNMENT PROPOSAL. IF NOT OTHERWISE SPECIFIED, PROXIES WILL BE VOTED “FOR” APPROVAL OF THIS PROPOSAL.


SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Securities Exchange Act of 1934 requires the Company’s directors, officers and persons who beneficially own more than 10% of a registered class of the Company’s equity securities to file with the SEC initial reports of ownership and reports of changes in ownership. Directors, officers and 10% stockholders are required by SEC regulations to furnish the Company with copies of all Section 16(a) reports they file.

Based solely on review of the copies of such reports the Company has received, or written representations that no other reports were required for those persons, the Company believes that its directors, officers and 10% stockholders complied with all applicable filing requirements during 2016.

STOCKHOLDER PROPOSALS FOR 2018
2021
ANNUAL MEETING OF STOCKHOLDERS

Stockholders are entitled to present proposals for action at a forthcoming meeting if they comply with the requirements of the proxy rules promulgated by the SEC. Proposals of stockholders of the Company intended to be presented for consideration at our 20182021 Annual Meeting of Stockholders must be received by the Company no later than March 12, 2018April 22, 2021 and must otherwise comply with the requirements of Rule 14a-814a‑8 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) in order that they may be considered for inclusion in the proxy statement and form of proxy relating to that meeting. Stockholder proposals should be addressed to the attention of the Company’s General Counsel, 520 Pike Street, Suite 2000, Seattle, Washington 98101. Stockholders who wish to present a proposal at our 20182021 Annual Meeting of Stockholders, other than one that will be included in our proxy materials, should send notice to the Company by June 22, 2018.August 2, 2021. If a stockholder proposal is not submitted by this date and it is properly brought before our 20182021 Annual Meeting of Stockholders, we may exercise voting discretion to vote the proxies that the Board of Directors solicits for our 20182021 Annual Meeting of Stockholders on such stockholder proposal in accordance with our best judgment. If a stockholder makes a timely notification, the people we name as proxies may still exercise discretionary voting authority under circumstances consistent with the proxy rules of the SEC. The corresponding proposal submission date for our 20172020 Annual Meeting of Stockholders was June 27, 2017.July 28, 2020. We have discretionary authority to vote the proxies that the Board of Directors solicits for our 20172020 Annual Meeting of Stockholders on any stockholder proposals properly brought before our 20172020 Annual Meeting of Stockholders with respect to which the Company was not notified by that date.


2016 ANNUAL REPORT ON FORM 10-K ANDHOUSEHOLDING OF PROXY MATERIALS

The SEC FILINGS

Our financial statementspermits companies to send a single Notice, and for those stockholders that elect to receive a paper copy of proxy materials in the mail one copy of this proxy statement, together with our Annual Report for the fiscal year ended December 31, 2016 are included2019, to any household at which two or more stockholders reside, unless contrary instructions have been received, but only if we provide advance notice and follow certain procedures. In such cases, each stockholder continues to receive a separate Notice, and for those stockholders that elect to receive a paper copy of proxy materials in the mail, one copy of our Annual Report on Form 10-K. Ourfiscal 2019 Annual Report and this proxy statementstatement. This householding process reduces the volume of duplicate information and reduces printing and mailing expenses.

We have not instituted householding for stockholders of record; however, certain brokerage firms may have instituted householding for beneficial owners of our Common Stock held through brokerage firms. If your family has multiple accounts holding our Common Stock, you may have already received householding notification from your broker. Please contact your broker directly if you have any questions or require additional copies of the Notice, our fiscal 2019 Annual Report and this proxy statement. The broker will arrange for delivery of a separate copy of the Notice, and, if so requested, a separate copy of these proxy materials promptly upon your written or oral request. You may decide at any time to revoke your decision to household, and thereby receive multiple copies.

OTHER MATTERS

The Board is not aware of any other matter other than those set forth in this Proxy Statement that will be presented for action at the Special Meeting. If other matters properly come before the Special Meeting, the persons appointed as proxies intend to vote the shares they represent in accordance with their best judgment in the interest of the Company.

WHETHER OR NOT YOU INTEND TO BE PRESENT AT THE SPECIAL MEETING, PLEASE COMPLETE, SIGN, DATE AND RETURN THE ENCLOSED PROXY AT YOUR EARLIEST CONVENIENCE.


WHERE YOU CAN FIND MORE INFORMATION

We are postedsubject to the information and reporting requirements of the Exchange Act, pursuant to which we file periodic reports, documents and other information with the SEC relating to our business, financial statements and other matters. These reports and other information may be accessed at www.sec.gov.  We also post the reports and other information we file with or furnish to the SEC on our website, at www.marchex.com (See Company-Investors-SEC Filings).

INCORPORATION BY REFERENCE

The SEC allows us to “incorporate by reference” into this Proxy Statement documents we have filed with the SEC. This means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be a part of this Proxy Statement. We incorporate by reference the following documents (each SEC File No. 000-50658):

our annual report on Form 10-K for the year ended December 31, 2019, as filed with the SEC on April 28, 2020;

our quarterly reports on Form 10-Q for the quarterly periods ended March 31, 2020 and June 30, 2020, as filed with the SEC on May 19, 2020 (amended on May 22, 2020) and August 10, 2020, respectively; and

our current reports on Form 8-K filed with the SEC on March 3, 2020, May 8, 2020 (two filings), May 11, 2020 (two filings, one amended May 15, 2020), and August 10, 2020 (two filings) (each File No. 000-50658).

We are availablenot, however, incorporating any documents or information that are deemed to be furnished and not filed in accordance with SEC rules and regulations.

You may obtain all documents we incorporate by reference through our website, www.marchex.com, and from the SEC at its website, at www.sec.gov.www.sec.gov. We will also provide to each person to whom a proxy statement is delivered, upon written or oral request, any document we incorporate by reference but do not deliver with this Proxy Statement.  You may also obtainrequest a copy of our Annual Report and this proxy statement without chargethese documents by sending a written request tocontacting us at Marchex, Investor Relations,Inc., 520 Pike Street, Suite 2000, Seattle, Washington 98101 or (206) 331‑3300.  If so requested, we will provide a copy of the incorporated filings at no cost within one (1) business day.

Any statement contained in a document incorporated by calling (206) 331-3300.reference into this Proxy Statement will be deemed to be modified or superseded for purposes of this Proxy Statement to the extent that a statement contained in this Proxy Statement modifies or supersedes the statement. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this Proxy Statement.

By order of the Board of Directors

Dated:               , 2020

Michelle Paterniti

General Counsel and Secretary


INDEX TO FINANCIAL STATEMENTS

UNAUDITED PRO FORMA CONDENSED FINANCIAL INFORMATION

F-2

UNAUDITED SPECIAL PURPOSE COMBINED FINANCIAL STATEMENTS OF MARCHEX CARVE OUT

F-11


APPENDIXUNAUDITED PRO FORMA CONDENSED FINANCIAL INFORMATION

The following unaudited pro forma condensed consolidated financial statements are derived from the historical consolidated financial statements of Marchex, Inc. (“Marchex” or the “Company”) as of and for the three months ended March 31, 2020, and for the years ended December 31, 2018 and 2019, which are incorporated by reference herein. The pro forma adjustments give effect to the disposal of the Marchex Carve Out, as described below.  

These unaudited pro forma condensed consolidated financial statements include adjustments to reflect the following:

the sale of all of Marchex’s interest in the Marchex Carve Out assets, liabilities, and operations;

the proceeds received from the sale, including a 10% equity interest in the entity purchasing the Marchex Carve Out;

the effects of the anticipated Support Services Agreement between Marchex and the Purchaser of Marchex Carve Out at the level of services expected during the first year of the Support Services Agreement term.

The unaudited pro forma consolidated balance sheet as of March 31, 2020, is presented to reflect adjustments Marchex’s balance sheet as if the Transaction were completed on March 31, 2020.  Marchex believes that the cash balance that ultimately will be transferred to the Purchaser at the closing of the Transaction will be significantly below the balance that existed as of March 31, 2020.  

The unaudited pro forma consolidated statements of operations for the three months ended March 31, 2020, and for the years ended December 31, 2019 and 2018 are presented as if the Transaction were completed on January 1, 2018.  The discontinued operations column in the pro forma consolidated statements of operations reflects the operations of Marchex Carve Out excluding any allocation of corporate overhead.  Pro Forma adjustments reflect aspects of the Support Services Agreement that are expected to be received by the Company for providing overhead-related services post Transaction.  Part of the Transaction consideration includes cancellation of stock-based awards, which have a total unamortized expense amount of approximately $350 thousand as of June 30, 2020.  No entries have been made to the pro forma statement of operations for the cancellations.

The following unaudited pro forma condensed consolidated financial statements should be read in conjunction with:

the accompanying notes to the unaudited pro forma consolidated financial statements;

the audited consolidated financial statements and accompanying notes of Marchex, Inc., incorporated by reference herein;

the special purpose combined financial statements of the Marchex Carve Out contained elsewhere in this proxy statement.

The unaudited pro forma condensed consolidated financial data has been presented for informational purposes only. The assumptions used and pro forma adjustments derived from such assumptions are based on currently available information, and the Company believes such assumptions are reasonable under the circumstances.  The pro forma data is not necessarily indicative of our results of operations or financial condition had the Transaction been completed on the dates assumed.  In addition, they are not necessarily indicative of our future results of operations or financial condition.



Marchex, Inc.

Unaudited Pro Forma Condensed Consolidated Balance Sheet

As of March 31, 2020
(in thousands)

 

 

Marchex, Inc.

Historical

 

 

Discontinued

Operations

 

 

Pro Forma

Adjustments

 

 

 

 

Marchex, Inc.

Pro Forma

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

40,312

 

 

$

(874

)

 

$

2,250

 

 

(a)

 

$

41,688

 

Accounts receivable, net

 

 

16,762

 

 

 

(10,129

)

 

g

 

 

 

 

 

6,633

 

Prepaid expenses and other current assets

 

 

2,097

 

 

 

(151

)

 

 

 

 

 

 

 

1,946

 

Total current assets

 

 

59,171

 

 

 

(11,154

)

 

 

2,250

 

 

 

 

 

50,267

 

Property and equipment, net

 

 

3,264

 

 

 

(77

)

 

 

 

 

 

 

 

 

3,187

 

Right-of-use lease asset

 

 

5,578

 

 

 

 

 

 

 

 

 

 

 

5,578

 

Other assets, net

 

 

1,096

 

 

 

 

 

 

120

 

 

(b)

 

 

1,216

 

Equity Investment

 

 

 

 

 

 

 

 

464

 

 

(c)

 

 

464

 

Goodwill

 

 

19,132

 

 

 

 

 

 

 

 

 

 

 

19,132

 

Intangible assets from acquisitions, net

 

 

11,820

 

 

 

 

 

 

 

 

 

 

 

11,820

 

Total assets

 

$

100,061

 

 

$

(11,231

)

 

$

2,834

 

 

 

 

$

91,664

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

7,476

 

 

$

(5,808

)

 

 

 

 

 

 

$

1,668

 

Accrued expenses and other current liabilities

 

 

7,223

 

 

 

(554

)

 

 

450

 

 

(d)

 

 

7,119

 

Current portion of acquisition related liabilities

 

 

642

 

 

 

 

 

 

 

 

 

 

 

642

 

Deferred revenue and deposits

 

 

1,380

 

 

 

(232

)

 

 

 

 

 

 

 

1,148

 

Lease liability, current

 

 

1,495

 

 

 

 

 

 

 

 

 

 

 

1,495

 

Total current liabilities

 

 

18,216

 

 

 

(6,594

)

 

 

450

 

 

 

 

 

12,072

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred tax liabilities

 

 

181

 

 

 

 

 

 

 

 

 

 

 

181

 

Lease liability, non-current

 

 

5,410

 

 

 

 

 

 

 

 

 

 

 

5,410

 

Non-current portion of acquisition-related liabilities

 

 

226

 

 

 

 

 

 

 

 

 

 

 

226

 

Total liabilities

 

 

24,033

 

 

 

(6,594

)

 

 

450

 

 

 

 

 

17,889

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders' equity

 

 

76,028

 

 

 

(4,637

)

 

 

2,384

 

 

(e)

 

 

73,775

 

Total liabilities and stockholders' equity

 

$

100,061

 

 

$

(11,231

)

 

$

2,834

 

 

 

 

$

91,664

 



Marchex, Inc.

Unaudited Pro Forma Consolidated Statement of Operations

For the three months ended March 31, 2020

(in thousands, except per share amounts)

 

 

Marchex,

Inc.

Historical

 

 

Discontinued

Operations

 

 

Pro Forma

Adjustments

 

 

 

 

Marchex,

Inc.

Pro Forma

 

Revenue

 

$

24,785

 

 

$

(12,778

)

 

 

 

 

 

 

 

$

12,007

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service costs (1)

 

 

14,498

 

 

 

(9,440

)

 

 

(50

)

 

(f)

 

 

5,008

 

Sales and marketing (1)

 

 

4,991

 

 

 

(1,038

)

 

 

(25

)

 

(f)

 

 

3,928

 

Product development (1)

 

 

6,043

 

 

 

(806

)

 

 

(25

)

 

(f)

 

 

5,212

 

General and administrative (1)

 

 

3,737

 

 

 

(172

)

 

 

(775

)

 

(f)

 

 

2,790

 

Amortization of intangible assets from acquisitions (2)

 

 

1,763

 

 

 

 

 

 

 

 

 

 

 

1,763

 

Acquisition and disposition-related costs (benefit)

 

 

(635

)

 

 

 

 

 

 

 

 

 

 

(635

)

Total operating expenses

 

 

30,397

 

 

 

(11,456

)

 

 

(875

)

 

 

 

 

18,066

 

Impairment of goodwill

 

 

(14,213

)

 

 

 

 

 

 

 

 

 

 

(14,213

)

Impairment of intangible assets from acquisitions

 

 

(5,903

)

 

 

 

 

 

 

 

 

 

 

(5,903

)

Income / (loss) from operations

 

 

(25,728

)

 

 

(1,322

)

 

 

875

 

 

 

 

 

(26,175

)

Other income

 

 

12

 

 

 

 

 

 

 

35

 

 

(g)

 

 

47

 

Interest income

 

 

98

 

 

 

 

 

 

 

 

 

98

 

Income / (loss) before provision for income taxes

 

 

(25,618

)

 

 

(1,322

)

 

 

910

 

 

 

 

 

(26,030

)

Income tax expense / (benefit)

 

 

(743

)

 

 

 

 

 

(h)

 

 

(743

)

Net income / (loss) applicable to common stockholders

 

$

(24,875

)

 

$

(1,322

)

 

$

910

 

 

 

 

$

(25,287

)

Earnings (Loss) Per Common Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted net loss per Class A share applicable to common stockholders

 

$

(0.53

)

 

 

 

 

 

 

 

 

 

 

 

$

(0.54

)

Basic and diluted net loss per Class B share applicable to common stockholders

 

$

(0.53

)

 

 

 

 

 

 

 

 

 

 

 

$

(0.54

)

Class A

 

 

4,661

 

 

 

 

 

 

 

 

 

 

 

 

 

4,661

 

Class B

 

 

42,179

 

 

 

 

 

 

 

 

 

 

 

 

 

42,179

 

Class A

 

 

4,661

 

 

 

 

 

 

 

 

 

 

 

 

 

4,661

 

Class B

 

 

46,840

 

 

 

 

 

 

 

 

 

 

 

 

 

46,840

 

(1) Excludes amortization of intangibles from acquisitions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2) Components of amortization of intangibles from acquisitions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service costs

 

$

756

 

 

 

 

 

 

 

 

 

$

 

756

 

Sales and marketing

 

 

742

 

 

 

 

 

 

 

 

 

 

 

742

 

General and administrative

 

 

265

 

 

 

 

 

 

 

 

 

 

 

265

 

Total

 

$

1,763

 

 

$

 

 

$

 

 

 

 

$

1,763

 


Marchex, Inc.

Unaudited Pro Forma Consolidated Statement of Operations

Year Ended December 31, 2019

(in thousands, except per share data)

 

 

Marchex,

Inc.

Historical

 

 

Discontinued

Operations

 

 

Pro Forma

Adjustments

 

 

 

 

Marchex,

Inc.

Pro Forma

 

Revenue

 

$

106,132

 

 

$

(51,643

)

 

 

 

 

 

 

 

$

54,489

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service costs (1)

 

 

56,537

 

 

 

(37,560

)

 

 

(200

)

 

(f)

 

 

18,777

 

Sales and marketing (1)

 

 

16,651

 

 

 

(3,803

)

 

 

(100

)

 

(f)

 

 

12,748

 

Product development (1)

 

 

20,127

 

 

 

(2,675

)

 

 

(100

)

 

(f)

 

 

17,352

 

General and administrative (1)

 

 

13,516

 

 

 

(496

)

 

 

(3,100

)

 

(f)

 

 

9,920

 

Amortization of intangible assets from acquisitions (2)

 

 

6,263

 

 

 

 

 

 

 

 

 

 

 

6,263

 

Acquisition and disposition-related costs (benefit)

 

 

(447

)

 

 

 

 

 

 

 

 

 

 

(447

)

Total operating expenses

 

 

112,647

 

 

 

(44,534

)

 

 

(3,500

)

 

 

 

 

64,613

 

Impairment of goodwill

 

 

 

 

 

 

 

 

 

 

 

Impairment of intangible assets from acquisitions

 

 

 

 

 

 

 

 

 

 

 

Income / (loss) from operations

 

 

(6,515

)

 

 

(7,109

)

 

 

3,500

 

 

 

 

 

(10,124

)

Other income

 

 

(27

)

 

 

 

 

 

282

 

 

(g)

 

 

255

 

Interest income

 

 

779

 

 

 

 

 

 

 

 

 

 

 

779

 

Income / (loss) before provision for income taxes

 

 

(5,763

)

 

 

(7,109

)

 

 

3,782

 

 

 

 

 

(9,090

)

Income tax expense / (benefit)

 

 

(1,721

)

 

 

 

 

 

 

 

(h)

 

 

(1,721

)

Net income / (loss) applicable to common stockholders

 

$

(4,042

)

 

$

(7,109

)

 

$

3,782

 

 

 

 

$

(7,369

)

Loss Per Common Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted net loss per Class A share applicable to common stockholders

 

$

(0.09

)

 

 

 

 

 

 

 

 

 

 

 

$

(0.16

)

Basic and diluted net loss per Class B share applicable to common stockholders

 

$

(0.09

)

 

 

 

 

 

 

 

 

 

 

 

$

(0.16

)

Weighted average common shares outstanding for basic EPS:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

 

4,793

 

 

 

 

 

 

 

 

 

 

 

 

 

4,793

 

Class B

 

 

40,667

 

 

 

 

 

 

 

 

 

 

 

 

 

40,667

 

Class A

 

 

4,793

 

 

 

 

 

 

 

 

 

 

 

 

 

4,793

 

Class B

 

 

45,460

 

 

 

 

 

 

 

 

 

 

 

 

 

45,460

 

(1) Excludes amortization of intangibles from acquisitions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2) Components of amortization of intangibles from acquisitions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service costs

 

$

2,331

 

 

 

 

 

 

 

 

$

2,331

 

Sales and marketing

 

 

2,497

 

 

 

 

 

 

 

 

 

2,497

 

General and administrative

 

 

1,435

 

 

 

 

 

 

 

 

 

1,435

 

Total

 

$

6,263

 

 

$

 

 

$

 

 

 

 

$

6,263

 


Marchex, Inc.

Unaudited Pro Forma Consolidated Statement of Operations

Year Ended December 31, 2018

(in thousands, except per share data)

 

 

Marchex,

Inc.

Historical

 

 

Discontinued

Operations

 

 

Pro Forma

Adjustments

 

 

 

 

Marchex,

Inc.

Pro Forma

 

Revenue

 

$

85,251

 

 

$

(45,489

)

 

 

 

 

 

 

 

$

39,762

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service costs (1)

 

 

47,804

 

 

 

(33,166

)

 

 

(200

)

 

(f)

 

 

14,438

 

Sales and marketing (1)

 

 

13,788

 

 

 

(3,642

)

 

 

(100

)

 

(f)

 

 

10,046

 

Product development (1)

 

 

15,423

 

 

 

(2,090

)

 

 

(100

)

 

(f)

 

 

13,233

 

General and administrative (1)

 

 

10,881

 

 

 

 

 

 

(3,100

)

 

(f)

 

 

7,781

 

Amortization of intangible assets from acquisitions (2)

 

 

781

 

 

 

 

 

 

 

 

 

 

 

781

 

Acquisition and disposition-related costs (benefit)

 

 

462

 

 

 

 

 

 

 

 

 

 

 

462

 

Total operating expenses

 

 

89,139

 

 

 

(38,898

)

 

 

(3,500

)

 

 

 

 

46,741

 

Impairment of goodwill

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Impairment of intangible assets from acquisitions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income / (loss) from operations

 

 

(3,888

)

 

 

(6,592

)

 

 

3,500

 

 

 

 

 

(6,980

)

Other income

 

 

(20

)

 

 

 

 

 

241

 

 

(g)

 

 

221

 

Interest income

 

 

1,074

 

 

 

 

 

 

 

 

 

 

 

1,074

 

Income / (loss) before provision for income taxes

 

 

(2,834

)

 

 

(6,592

)

 

 

3,741

 

 

 

 

 

(5,685

)

Income tax expense / (benefit)

 

 

(156

)

 

 

 

 

 

 

 

(h)

 

 

(156

)

Net income / (loss) applicable to common stockholders

 

$

(2,678

)

 

$

(6,592

)

 

$

3,741

 

 

 

 

$

(5,529

)

Loss Per Common Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted net loss per Class A share applicable to common stockholders

 

$

(0.06

)

 

 

 

 

 

 

 

 

 

 

 

$

(0.13

)

Basic and diluted net loss per Class B share applicable to common stockholders

 

$

(0.06

)

 

 

 

 

 

 

 

 

 

 

 

$

(0.13

)

Weighted average common shares outstanding for basic EPS:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

 

5,056

 

 

 

 

 

 

 

 

 

 

 

 

 

5,056

 

Class B

 

 

37,390

 

 

 

 

 

 

 

 

 

 

 

 

 

37,390

 

Weighted average common shares outstanding for diluted EPS:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

 

5,056

 

 

 

 

 

 

 

 

 

 

 

 

 

5,056

 

Class B

 

 

42,446

 

 

 

 

 

 

 

 

 

 

 

 

 

42,446

 

(1) Excludes amortization of intangibles from acquisitions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2) Components of amortization of intangibles from acquisitions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service costs

 

$

302

 

 

 

 

 

 

 

 

 

 

$

302

 

Sales and marketing

 

 

295

 

 

 

 

 

 

 

 

 

 

 

295

 

General and administrative

 

 

184

 

 

 

 

 

 

 

 

 

 

 

184

 

Total

 

$

781

 

 

$

 

 

$

 

 

 

 

$

781

 


Marchex, Inc.

Notes to Unaudited Pro Forma Consolidated Condensed Financial Statements

(a)

Reflects the cash consideration received as part of Transaction closing.

(b)

The Company’s preliminary evaluation of the Transaction identified certain contingent consideration that qualifies as a derivative and that is not subject to the derivative accounting scope exception under GAAP.  Accordingly, this derivative is reflected on the pro forma consolidated balance sheet at preliminary estimate of its fair value.

(c)

Reflects Marchex’s equity interest in the Purchaser, received as part of the Transaction consideration.

(d)

Reflects costs incurred by Marchex directly attributable to the Transaction.  Such amounts are not included in the pro forma consolidated statements of operations, as these costs are considered to be nonrecurring in nature.

(e)

Reflects the equity impact of assets and liabilities recorded as the result of the Transaction.

(f)

Reflects estimated expense recovery from performing services under the Support Services Agreement, to the extent not already reflected as part of discontinued operations adjustments.  Marchex used its estimate for amounts it expects to receive for services provided to Purchaser for the first twelve months under the Support Services Agreement for purposes of the pro forma adjustment.  The following table reflects Marchex’s pro forma pre-tax income assuming it receives different amounts for services:

 

 

Marchex, Inc. pre-tax net income

 

 

 

Year ended

December 31,

2018

 

 

Year ended

December 31,

2019

 

 

Three months

ended

March 31,

2020

 

Annual Support Service Agreement Payment Amounts*

 

 

 

 

 

 

 

 

 

 

 

 

$4,500

 

 

(4,763

)

 

 

(8,168

)

 

 

(25,800

)

$3,500

 

 

(5,685

)

 

 

(9,090

)

 

 

(26,030

)

$2,500

 

 

(6,607

)

 

 

(10,012

)

 

 

(26,261

)

$1,500

 

 

(7,529

)

 

 

(10,934

)

 

 

(26,491

)

$500

 

 

(8,529

)

 

 

(11,934

)

 

 

(26,741

)

$0

 

 

(9,029

)

 

 

(12,434

)

 

 

(26,866

)

*

For services are not already reflected within discontinued operations.

(g)

Reflects Marchex’s equity interest in the net income of the Purchaser, which is part of the Transaction consideration to be received by Marchex at the closing of the Transaction.

(h)

No tax effects of pro forma adjustments have been recorded due to the extent of the Company’s tax loss carryforwards reduced by valuation allowances.


Marchex Carve Out

Unaudited Special Purpose Combined Balance Sheet

(in thousands)

 

 

 

 

As of December 31,

 

 

 

As of March 31,

 

 

 

 

2018

 

 

 

2019

 

 

 

2020

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

 

 

$

795

 

 

$

874

 

Accounts receivable, net

 

 

8,519

 

 

 

10,279

 

 

 

10,129

 

Prepaid expenses and other current assets

 

 

68

 

 

 

83

 

 

 

151

 

Total current assets

 

 

8,587

 

 

 

11,157

 

 

 

11,154

 

Property and equipment, net

 

 

73

 

 

 

80

 

 

 

77

 

Deferred income tax assets, net

 

 

1,145

 

 

 

771

 

 

 

935

 

Total assets

 

$

9,806

 

 

$

12,008

 

 

$

12,166

 

Liabilities and Marchex Net Investment

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

5,340

 

 

$

6,500

 

 

$

5,808

 

Accrued expenses and other current liabilities

 

 

476

 

 

 

659

 

 

 

555

 

Deferred revenue and deposits

 

 

248

 

 

 

310

 

 

 

231

 

Total current liabilities

 

 

6,064

 

 

 

7,469

 

 

 

6,594

 

Total liabilities

 

 

6,064

 

 

 

7,469

 

 

 

6,594

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

Marchex net investment

 

 

3,742

 

 

 

4,539

 

 

 

5,572

 

Total liabilities and Marchex net investment

 

$

9,806

 

 

$

12,008

 

 

$

12,166

 

See accompanying Notes to Special Purpose Combined Financial Statements.


Marchex Carve Out

Unaudited Special Purpose Combined Statements of Operations

(in thousands)

 

 

Years ended December 31,

 

 

Three months ended March 31,

 

 

 

2018

 

 

2019

 

 

2019

 

 

2020

 

Revenue

 

$

45,489

 

 

$

51,643

 

 

$

12,849

 

 

$

12,778

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service costs

 

 

33,468

 

 

 

37,837

 

 

 

9,402

 

 

 

9,515

 

Sales and marketing

 

 

4,299

 

 

 

4,489

 

 

 

1,142

 

 

 

1,344

 

Product development

 

 

3,629

 

 

 

4,024

 

 

 

845

 

 

 

1,184

 

General and administrative

 

 

3,643

 

 

 

4,054

 

 

 

1,034

 

 

 

1,104

 

Total operating expenses

 

 

45,039

 

 

 

50,404

 

 

 

12,423

 

 

 

13,147

 

Income / (loss) from operations

 

 

450

 

 

 

1,239

 

 

 

426

 

 

 

(369

)

Income / (loss) before provision for income taxes

 

 

450

 

 

 

1,239

 

 

 

426

 

 

 

(369

)

Income tax (benefit) / expense

 

 

257

 

 

 

391

 

 

 

133

 

 

 

(164

)

Net income / (loss)

 

$

193

 

 

$

848

 

 

$

293

 

 

$

(205

)

See accompanying Notes to Special Purpose Combined Financial Statements.


Marchex Carve Out

Unaudited Special Purpose Combined Statement of Cash Flows

(in thousands)

 

 

Years ended December 31,

 

 

Three months ended March 31,

 

 

 

2018

 

 

2019

 

 

 

2019

 

 

2020

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income / (loss)

 

$

193

 

$

848

 

 

$

293

 

$

(205)

Adjustments to reconcile net income / (loss) to net cash provided by / (used in) operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation

 

 

70

 

 

51

 

 

 

10

 

 

15

Shared asset usage charge

 

 

440

 

 

365

 

 

 

88

 

 

101

Allowance for doubtful accounts and advertiser credits

 

 

21

 

 

142

 

 

 

61

 

 

200

Deferred income taxes

 

 

243

 

 

374

 

 

 

128

 

 

(164)

Stock-based compensation

 

 

1,064

 

 

976

 

 

 

169

 

 

338

Change in certain assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable, net

 

 

1,268

 

 

(1,901)

 

 

 

985

 

 

(51)

Prepaid expenses, other current assets, and other assets

 

 

(1)

 

 

(15)

 

 

 

(91)

 

 

(67)

Accounts payable

 

 

830

 

 

1,160

 

 

 

646

 

 

(691)

Accrued expenses and other current liabilities

 

 

(33)

 

 

183

 

 

 

108

 

 

(105)

Deferred revenue and deposits

 

 

10

 

 

62

 

 

 

2,129

 

 

(79)

Net cash provided by / (used in) operating activities

 

 

4,105

 

 

2,245

 

 

 

4,526

 

 

(708)

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of property and equipment

 

 

(38)

 

 

(58)

 

 

 

(4)

 

 

(12)

Net cash used in investing activities

 

 

(38)

 

 

(58)

 

 

 

(4)

 

 

(12)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Contributions from (distributions to) Marchex, net

 

 

(4,067)

 

 

(1,392)

 

 

 

(4,098)

 

 

799

Net cash provided by / (used in) financing activities

 

 

(4,067)

 

 

(1,392)

 

 

 

(4,098)

 

 

799

Net change in cash and cash equivalents

 

 

 

 

795

 

 

 

424

 

 

79

Cash and cash equivalents at beginning of period

 

 

 

 

 

 

 

 

 

795

Cash and cash equivalents at end of period

 

$

 

$

795

 

 

$

424

 

$

874

See accompanying Notes to Special Purpose Combined Financial Statements.


Marchex Carve Out

Notes to Unaudited Special Purpose Combined Financial Statements

(1) Description of Business and Basis of Presentation

(a) Description of Business

Marchex, Inc. (“Marchex” or the “Company”) is a call analytics company that helps businesses connect, drive, measure, and convert callers into customers. Marchex provides products and services for businesses of all sizes that depend on consumer phone calls or texts to drive sales. Marchex also delivers performance-based, pay-for-call advertising across numerous mobile and online publishers to connect consumers with businesses over the phone.

On August 7, 2020 Marchex entered into a definitive agreement to divest to a related party group (the “Transaction”) its Local Leads Platform, Call Marketplace and other assets and operations not related to core conversational analytics (the “Marchex Carve Out”).  Consideration receivable at close consists of cash and non-cash components, including a minority equity interest in the company acquiring the assets and operations (the “Purchaser”).  The Transaction also includes contingent consideration, whereby Marchex would receive additional payments based on achievement of future outcomes.  The Transaction is subject to stockholder approval and other closing conditions.  Should these closing conditions be satisfied, Marchex expects the Transaction to close in Q4 2020.

These special purpose combined financial statements represent the combined financial position, results of operations and cash flows of the Marchex Carve Out.

(b) Basis of Presentation

The special purpose combined financial statements of the Marchex Carve Out are presented in accordance with U.S. generally accepted accounting principles (“GAAP”). The Marchex Carve Out represents integrated assets, liabilities and operations of Marchex and does not represent a stand-alone entity. The financial information included herein was derived from the consolidated financial statements and accounting records of Marchex and may not necessarily reflect the combined financial position, results of operations and cash flows of the Marchex Carve Out in the future or what they would have been had the Marchex Carve Out operated as a separate, stand-alone entity during the periods presented. The special purpose combined financial statements of the Marchex Carve Out include all of the assets, liabilities, revenue, expenses and cash flows of the Marchex Carve Out, as well as expense allocations deemed reasonable by management, to present the combined financial position, results of operations and cash flows of the Marchex Carve Out on a stand-alone basis. The special purpose combined financial statements only include assets and liabilities that are specifically attributable to the Marchex Carve Out. Management believes expense allocations are reasonable; however, they may not be indicative of the actual level of expense that would have been incurred by the Marchex Carve Out if such operations had operated as a separate, standalone entity or of the costs expected to be incurred in the future. Refer to Note 8 for further information related to expense allocation methodologies.

All intercompany accounts and transactions have been eliminated in preparing the special purpose combined financial statements of Marchex Carve Out. The Marchex Carve Out operates within multiple Marchex legal entities, and transactions among and between Marchex legal entities (i) include certain transactions unrelated to Marchex Carve Out; and (ii) for those transactions that do relate to Marchex Carve Out, do not always capture results for Marchex Carve Out on a stand-alone basis.  


(c) The Impact of COVID-19 on Marchex Carve Out’s Results of Operations

In late 2019, an outbreak of COVID-19 emerged and by March 11, 2020 was declared a global pandemic by the World Health Organization. Across the United States and the world, governments and municipalities instituted measures in an effort to control the spread of COVID-19, including quarantines, shelter-in-place orders, school closings, travel restrictions and the closure of non-essential businesses. By the end of March, the macroeconomic impacts became significant, exhibited by, among other things, a rise in unemployment and market volatility.

For most of the quarter ended March 31, 2020, Marchex Carve Out’s results reflect historical trends and seasonality. However, in March 2020, a decline in revenues occurred due to the impact of COVID-19 and the related reductions in global economic activity and reduced spending by its customers in response to the macroeconomic impact. The realized and potential credit deterioration of its customers due to changes in the macroeconomic environment was also assessed, which has been reflected in an increase in its allowance for credit losses for accounts receivable.  

(2) Significant Accounting Policies

a)

Cash and Cash Equivalents

Marchex Carve-Out considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents. Refer to Note 8 for further information related to cash management.

b)

Accounts Receivable

Accounts receivable are recorded at the invoiced amount and do not bear interest. Accounts receivable balances are presented net of allowance for doubtful accounts and allowance for advertiser credits.

Allowance for Doubtful Accounts

The allowance for doubtful accounts reflects the best estimate of the amount of probable credit losses in existing accounts receivable. The allowance is based on analysis of historical bad debts, advertiser concentrations, advertiser credit-worthiness and current economic trends. Past due balances over 90 days and specific other balances are reviewed individually for collectability. The allowance is reviewed for collectability quarterly. Account balances are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

The allowance for doubtful accounts activity for the periods indicated is as follows (in thousands):

 

 

Balance at

beginning

of period

 

 

Charge /

(benefit) to

expenses

 

 

Write-offs,

net of

recoveries

 

 

Balance at

end of

period

 

December 31, 2018

 

 

256

 

 

 

(16)

 

 

 

8

 

 

 

232

 

December 31, 2019

 

 

232

 

 

 

18  

 

 

 

43

 

 

 

207

 

March 31, 2020

 

 

207

 

 

 

85

 

 

 

(1)

 

 

 

293

 


Allowance for Advertiser Credits

The allowance for advertiser credits reflects the best estimate of the amount of expected future reductions in advertisers’ payment obligations related to delivered services. The allowance for advertiser credits is based on analysis of historical credits.

The allowance for advertiser credits activity for the periods indicated is as follows (in thousands):

 

 

Balance at

beginning

of period

 

 

Additions

charged

against

revenue

 

 

Credits

processed

and other

 

 

Balance at

end of

period

 

December 31, 2018

 

 

72

 

 

 

37

 

 

 

81

 

 

 

28

 

December 31, 2019

 

 

28

 

 

 

124

 

 

 

152

 

 

 

 

March 31, 2020

 

 

 

 

 

115

 

 

 

35

 

 

 

80

 

c)

Property and Equipment

Property and equipment are stated at cost. Depreciation on computers and other related equipment, purchased and internally developed software, and furniture and fixtures is calculated on the straight-line method over the estimated useful lives of the assets, generally averaging three years.  Leasehold improvements are amortized straight-line over the shorter of the lease term or estimated useful lives of the assets generally ranging from five to eight years.

d)

Revenue Recognition

The majority of revenue is generated from advertisers who use Marchex Carve Out’s pay-for-call advertising products and services. Revenue also consists of payments from reseller partners for use of Marchex Carve Out’s local leads platform and marketing services, which they offer to their small business customers. Customers typically receive the benefit of Marchex Carve Out’s services as they are performed and substantially all of our revenue is recognized over time as the services are performed.

Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers, (ASC 606) was adopted on January 1, 2018 using the modified retrospective approach for all contracts not completed as of the date of initial application, referred to as open contracts.

Marchex Carve Out’s call marketplace services offer advertisers and advertising service providers’ ad placements across our distribution network. Advertisers or advertising service providers are charged on a pay-for-call or cost-per-action basis. For pay-for-call advertising, revenue is recorded upon delivery of qualified and reported phone calls or other action to advertisers or advertising service providers’ listings, which occurs when a mobile, online or offline user makes a phone call, clicks, or completes a specified action on any of their advertisements after it has been placed by Marchex Carve Out or a distribution partner. Each qualified phone call or specified action on an advertisement listing represents a completed transaction. For cost-per-action services,  revenue is recognized when a user makes a phone call from an applicable advertiser’s listing or is redirected from a Marchex Carve Out website or a third-party website in Marchex Carve Out’s distribution network to an advertiser website and completes the specified action.

Revenue is also recognized from reseller partners utilizing the local leads platform.  Account fees and/or agency fees for the local leads platform are generated based on a percentage of the cost of every call or click delivered to advertisers. The reseller partners engage the advertisers and are the principal for the transaction, and Marchex, on behalf of Marchex Carve Out, in certain instances is only financially liable to the publishers in the capacity as a collection agency for the amount collected from the advertisers. Revenue is recognized for these fees under the net revenue recognition method. In limited arrangements where resellers pay a fee for fulfilling an advertiser’s campaign in its distribution network, Marchex Carve Out acts as the principal and recognizes revenue for these fees under the gross revenue recognition method.


For the years ended December 31, 2018 and 2019, revenues disaggregated by service type were $38.9 million  and $47.5 million, respectively for performance based advertising services and $6.6 million and $4.1 million, respectively, for local leads services.  For the three months ended March 31, 2019 and 2020, revenues disaggregated by service type were $11.6 million and $12.0 million, respectively, for performance based advertising services and $1.2 million and $800,000, respectively, for local leads services.

The majority of Marchex Carve Out customers are invoiced on a monthly basis following the month of the delivery of services and are required to make payments under standard credit terms. A customer refund liability accrual is established, which is included in accrued expenses and other current liabilities in the balance sheet, to reflect the estimated amount of expected future reductions in advertisers’ payment obligations related to delivered services based on analysis of historical credits. The balance associated with the customer refund liability accrual in Marchex Carve Out consolidated balance sheet was $52,000, and $97,000 as of December 31, 2018 and 2019, respectively, and $82,000 as of March 31, 2020. Customer payments received in advance of revenue recognition are also contract liabilities and are recorded as deferred revenue and deposits. The deferred revenue and deposit balance in Marchex Carve Out’s special purpose combined balance sheet as of December 31, 2018 and 2019 was $248,000 and $310,000, respectively, and as of March 31, 2020 was $231,000.

Marchex, on behalf of Marchex Carve Out, has entered into agreements with various third-party distribution partners in order to expand Marchex Carve Out’s distribution network, which includes third-party mobile and online search engines and applications, mobile carriers, directories, destination sites, shopping engines, Internet domains or web sites, other targeted web-based content, and offline sources. These partners provide distribution for pay-for-call advertisement listings, which contain all tracking numbers and/or URL strings. Marchex Carve Out generally compensates these distribution partners based on a percentage of revenue or a fixed amount per phone call or other action on these listings. Marchex Carve Out acts as the principal, and is responsible for providing customer and administrative services to the advertiser. The revenue derived from advertisers who receive paid introductions through Marchex Carve Out as supplied by distribution partners is reported gross based upon the amounts received from the advertiser. Certain revenue for certain agency or reseller contracts with advertisers is recognized under the net revenue recognition method. Under these specific agreements, listings on behalf of advertisers are purchased by Marchex Carve Out from its distribution network. Marchex Carve Out earns account fees and also agency fees based on the total amount of the purchase made on behalf of these advertisers. Under these agreements, Marchex Carve Out’s advertisers are primarily responsible for choosing the publisher and determining pricing, and Marchex, acting on behalf of Marchex Carve out, in certain instances is only financially liable to the publisher for the amount collected from its advertisers. This creates a sequential liability for media purchases made on behalf of advertisers. In certain instances, the web publishers engage the advertisers directly and an agency fee is earned based on the total amount of the purchase made by the advertiser. In limited arrangements, fees are earned from resellers for fulfilling an advertiser’s campaign in Marchex Carve Out’s distribution network and Marchex Carve Out act as the primary obligor. Marchex Carve Out  recognizes revenue for these fees under the gross revenue recognition method.

For arrangements that include multiple performance obligations, the transaction price from the arrangement is allocated to each respective performance obligation based on its relative standalone selling price and recognized when revenue recognition criteria for each performance obligation are met. The standalone selling price for each performance obligation is established based on the sales price at which Marchex Carve Out would sell a promised good or service separately to a customer or the estimated standalone selling price.

In certain cases, revenue is recorded based on available and reported preliminary information from third parties. Collection on the related receivables may vary from reported information based upon third-party refinement of the estimated and reported amounts owed that occurs subsequent to period ends.

e)

Service Costs

The largest component of service costs consists of fees payable to distribution partners for access to their mobile, online, offline, or other user traffic. Marchex, on behalf of Marchex Carve Out, enters into agreements of varying durations with distribution partners that integrate Marchex Carve Out services into their web sites, indexes or other sources of user traffic. The primary economic structure of the distribution partner agreements is a variable payment based on a specified percentage of revenue. These variable payments are often subject to minimum payment amounts per phone call or other action. Other payment structures that to a lesser degree exist include: 1) variable


payments based on a specified metric, such as number of paid calls/texts or other actions, 2) fixed payments, based on a guaranteed minimum amount of usage delivered, and 3) a combination arrangement with both fixed and variable amounts that may be paid in advance.

Fees payable to distribution partners are expensed based on whether the agreement provides for variable or fixed payments. Agreements with variable payments based on a percentage of revenue, number of paid phone calls/texts or other metrics are expensed as incurred based on the volume of the underlying activity or revenue multiplied by the agreed-upon price or rate. Agreements with fixed payments and with minimum guaranteed amounts of usage are expensed as the greater of the pro-rata amount over the term of arrangement or the actual usage delivered to date based on the contractual revenue share.

Service costs also include network operations and customer service costs that consist primarily of costs associated with providing performance based advertising and marketing services. These costs include telecommunication costs, including the use of phone numbers for providing call based advertising services, colocation service charges and depreciation of network equipment and software, bandwidth and software license fees, payroll and expenses of related personnel, and stock-based compensation. Other service costs include license and content fees, costs to maintain our websites, credit card processing fees and domain name and related renewal and registration costs.

f)

Advertising Expenses

Advertising costs are expensed as incurred and include mobile and online advertising and related outside marketing activities, including sponsorships and trade shows. Such costs are included in sales and marketing. Advertising costs were approximately $485,000 and $490,000 for the years ended December 31, 2018 and 2019, respectively, and were approximately $102,000 and $107,000 for the three months ended March 31, 2019 and 2020, respectively.

g)

Product Development

Product development costs consist primarily of expenses incurred in the research and development, creation, and enhancement of the products and services. Research and development costs are expensed as incurred and include compensation and related expenses, costs of computer hardware and software, and costs incurred in developing features and functionality of the services. For the periods presented, substantially all of the product development expenses are research and development. Product development costs are expensed as incurred or capitalized into property and equipment in accordance with FASB ASC Topic 350, Intangibles – Goodwill and Other. FASB ASC Topic 350 requires that cost incurred in the preliminary project and post-implementation stages of an internal use software project be expensed as incurred and that certain costs incurred in the application development stage of a project be capitalized.

h)

Income Taxes

Income taxes are provided using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred income taxes reflect the tax effect of net operating losses and the net tax effects of temporary differences and are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law is recognized in results of operations in the period that includes the enactment date. Valuation allowances are established when management determines that it is more likely than not that some portion or the entire deferred tax asset will not be realized.


Marchex Carve Out’s results of operations have historically been included in the consolidated U.S. federal income tax returns of Marchex and applicable state income tax returns. The income tax amounts reflected in the special purpose combined financial statements have been determined as if Marchex Carve Out filed a separate income tax return for both U.S. federal and applicable states (the “separate return method”). Marchex Carve Out’s current income tax liabilities related to these separate income tax returns, including any applicable penalties and interest, are treated as being settled with Marchex without payment as of the end of each year.

From time to time, transactions occur in which the tax consequences may be subject to uncertainty. Significant judgment is required in assessing and estimating the tax consequences of these transactions. In evaluating the exposure associated with various tax filing positions, accrued charges for uncertain positions are established. Resolution of uncertain tax positions will impact the effective tax rate when settled. No significant interest or penalty accruals currently exist. The provision for income taxes includes the impact of contingency provisions and changes to contingencies that are considered appropriate.

i)

Stock-Based Compensation

Stock-based compensation cost is measured at the grant date based on the fair value of the award and recognized as expense, over the vesting or service period, as applicable, of the stock award using the straight-line method.  Forfeitures are accounted for as they occur.

j)

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates relate to several financial statement amounts within these special purpose combined financial statements, including revenues, allowance for doubtful accounts, allowance for advertiser credits, useful lives for property and equipment the fair value of and stock option awards, the valuation allowance for deferred tax assets, and the allocation of charges for corporate shared support functions and shared asset usage. Actual results could differ from those estimates.

k)

Concentrations

The advertisers representing more than 10% of revenue are as follows:

 

Years ended December 31,

 

Three months ended March 31,

 

2018

 

2019

 

2019

 

2020

Advertiser A

38%

 

43%

 

44%

 

43%

Advertiser B

36%

 

30%

 

31%

 

32%

Advertiser A is also a distribution partner.

The outstanding receivable balance for each advertiser representing more than 10% of accounts receivable is as follows:  

 

At December 31,

 

At March 31,

2018

 

2019

 

2020

Advertiser A

26%

 

14%

 

18%

Advertiser B

58%

 

71%

 

65%


In certain cases, Marchex Carve Out may engage directly with one or more advertising agencies who act on an advertiser’s behalf.  In addition, an advertising agency may represent more than one advertiser that utilizes the Marchex Carve Out’s products and services. One advertising agency represented 26% of revenue for both of the years ended December 31, 2018 and 2019, and 26% and 30% for the three month periods ended March 31, 2019 and 2020, respectively. This same advertising agency represented 43% and 64% of accounts receivable as of December 31, 2018 and 2019, respectively, and 63% of accounts receivable as of March 31, 2020.

A significant amount of revenue earned from advertisers is generated through arrangements with distribution partners. Any or all of these arrangements may not be successfully renewed, or, if they are renewed, they may not be on terms as favorable as current arrangements. Marchex Carve Out may not be successful in entering into agreements with new distribution partners or advertisers on commercially acceptable terms. In addition, several of these distribution partners or advertisers may be considered potential competitors. There were no distribution partners for which costs exceeded 10% of revenue for the year ended December 31, 2018.  For the year ended December 31, 2019, Marchex Carve Out incurred costs for one distribution partner of 11% of revenue. For the three months ended March 31, 2019, Marchex Carve Out incurred costs from one distribution partner of 13% of revenue. There were no distribution partners for which costs exceeded 10% of revenue for the three months ended March 31, 2020.

l)

Guarantees

FASB ASC Topic 460, Guarantees provides accounting guidance surrounding liability recognition and disclosure requirements related to guarantees. In the ordinary course of business, Marchex, acting on behalf of Marchex Carve Out, is not subject to the potential obligations under guarantees that fall within the scope of FASB ASC Topic 460 except for standard indemnification provisions that are contained within many advertiser and distribution partner agreements.  These provisions give rise only to the disclosure requirements prescribed by FASB ASC Topic 460.

(3) Geographic Revenue Information

Revenues from advertisers by geographical areas are tracked on the basis of the location of the advertiser. The vast majority of Marchex Carve Out revenue and accounts receivable are derived from domestic sales to advertisers engaged in various mobile, online and other activities. For all periods presented, revenues from countries other than the United States are less than 1% of revenue.

(4) Property and Equipment

Property and equipment consisted of the following (in thousands):

 

At December 31,

 

At March 31,

2018

 

2019

 

2020

Computer and other related equipment

$

145  

 

$

146  

 

 

144  

Less: Accumulated depreciation

 

(72)  

 

 

(66)  

 

 

(67)  

Property and equipment, net

$

73  

 

$

80  

 

$

77  

Depreciation expense related to property and equipment was approximately $70,000 and $51,000 for the years ended December 31, 2018 and 2019, respectively, and $10,000 and $15,000 for the three months ended March 31, 2019 and 2020, respectively.  Shared asset charges for Marchex Carve Out’s use of Marchex’s property and equipment is discussed further in Note 8.  


(5) Stock-Based Compensation

Marchex grants stock-based awards, including stock options, restricted stock awards, and restricted stock units to certain employees, including those of Marchex Carve Out and other employees that provide services to Marchex Carve Out. Stock-based compensation cost is measured at the grant date based on the fair value of the award and recognized as expense over the vesting or service period, as applicable, of the stock-based award using the straight-line method. Forfeitures are accounted for as they occur.

Stock-based compensation expense was included in the following operating expense categories as follows (in thousands):

 

 

Years ended December 31,

 

 

Three months ended March 31,

 

 

 

2018

 

 

2019

 

 

2019

 

 

2020

 

Service costs

 

$

152

 

 

$

44

 

 

$

18

 

 

$

7

 

Sales and marketing

 

 

197

 

 

 

222

 

 

 

55

 

 

 

101

 

Product development

 

 

125

 

 

 

90

 

 

 

24

 

 

 

30

 

General and administrative

 

 

590

 

 

 

620

 

 

 

72

 

 

 

200

 

Total stock-based compensation

 

$

1,064

 

 

$

976

 

 

$

169

 

 

$

338

 

The Black-Scholes option pricing model is used to estimate the per share fair value of stock option grants with time-based vesting. The Black-Scholes model relies on a number of key assumptions to calculate estimated fair values. The various inputs and are specific to Marchex and are not necessarily representative of what the inputs for Marchex Carve Out would be if it had been a stand-alone company.

(6) Commitments and Contingencies

(a) Commitments

Marchex Carve Out has commitments for future payments related to certain contractual obligations that relate to minimum contractual payments due to outside service providers. Future minimum payments as of March 31, 2020 are approximately $154,000 and are scheduled to occur in the remainder of 2020.

(b) Contingencies

Marchex, on behalf of Marchex Carve Out, from time to time is a party to disputes and legal and administrative proceedings arising from the ordinary course of business. In some agreements to which it is a party, Marchex, on behalf of Marchex Carve Out, has agreed to indemnification provisions of varying scope and terms with advertisers, vendors and other parties with respect to certain matters, including, but not limited to, losses arising out of breach of agreements or representations and warranties made by Marchex, services to be provided by Marchex Carve Out and intellectual property infringement claims made by third parties. As a result of these provisions, Marchex, on behalf of Marchex Carve Out, may from time to time provide certain levels of financial support to its contract parties to seek to minimize the impact of any associated litigation in which they may be involved. To date, there have been no known events or circumstances that have resulted in any material costs related to these indemnification provisions and no liabilities therefore have been recorded in the accompanying special purpose combined financial statements. However, the maximum potential amount of the future payments we could be required to make under these indemnification provisions could be material.

While any litigation contains an element of uncertainty, no known legal proceedings or pending claims exist that, based on current knowledge, are expected to have, individually or taken together, a material adverse effect on Marchex Carve Out’s financial condition, results of operations or liquidity.


(7)  Income Taxes

The components of income from operations before provision for income taxes consist of the following (in thousands):

 

 

Years ended December 31,

 

 

Three months ended March 31,

 

 

 

2018

 

 

2019

 

 

2019

 

 

2020

 

United States

 

$

450

 

 

$

1,239

 

 

$

426

 

 

$

(369

)

Foreign

 

 

 

 

 

 

 

 

 

 

 

 

Income / (loss) before provision for income taxes

 

$

450

 

 

$

1,239

 

 

$

426

 

 

$

(369

)

The current and deferred income tax provision for the years ended December 31, 2018 and 2019 consisted of the following (in thousands):

 

 

Years ended December 31,

 

 

Three months ended March 31,

 

 

 

2018

 

 

2019

 

 

2019

 

 

2020

 

Current provision

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

 

 

$

 

 

$

 

 

$

 

State

 

 

16

 

 

 

16

 

 

 

5

 

 

 

Deferred provision / (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

158

 

 

 

257

 

 

 

88

 

 

 

(99

)

State

 

 

83

 

 

 

118

 

 

 

40

 

 

 

(65

)

Total income tax expense / (benefit)

 

$

257

 

 

$

391

 

 

$

133

 

 

$

(164

)

The differences between income tax provision expected at the U.S. federal statutory income tax rate and income tax provision provided for the years ended December 31, 2018 and 2019 consisted of the following (in thousands):

 

 

Years ended December 31,

 

 

Three months ended March 31,

 

 

 

2018

 

 

2019

 

 

2019

 

 

2020

 

Income tax expense / (benefit) at U.S. federal statutory rate

 

$

95

 

 

$

260

 

 

$

90

 

 

$

(77

)

State taxes

 

 

80

 

 

 

106

 

 

 

35

 

 

 

(49

)

Stock based compensation

 

 

65

 

 

 

10

 

 

 

3

 

 

 

(24

)

Meals and entertainment and employee transportation

 

 

17

 

 

 

15

 

 

 

5

 

 

 

(14

)

Total income tax expense / (benefit)

 

$

257

 

 

$

391

 

 

$

133

 

 

$

(164

)


Significant components of deferred income tax liabilities, net, as of December 31, 2018 and 2019 consisted of the following (in thousands):

 

 

As of December 31,

 

 

As of March 31,

 

 

 

2018

 

 

2019

 

 

2020

 

Deferred tax assets:

 

 

 

 

 

 

 

 

 

 

 

 

Federal and state net operating losses

 

$

647

 

 

$

261

 

 

$

425

 

Deferred revenue

 

 

75

 

 

 

94

 

 

 

94

 

Reserves and accruals

 

 

223

 

 

 

179

 

 

 

179

 

Stock based compensation

 

 

290

 

 

 

302

 

 

 

302

 

Gross deferred tax assets

 

 

1,235

 

 

 

836

 

 

 

1,000

 

Valuation allowance

 

 

 

 

 

 

 

 

��

 

Net deferred tax assets

 

$

1,235

 

 

$

836

 

 

$

1,000

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Deferred state income tax

 

 

(90

)

 

 

(65

)

 

 

(65

)

Deferred tax assets, net

 

$

1,145

 

 

$

771

 

 

$

935

 

Marchex Carve Out’s opening balance sheet as of January 1, 2018 included deferred tax assets related to previously acquired net operating losses. For purposes of calculating the opening deferred tax asset balance, the net operating loss reflects only the amount expected to be realized based on limitations from historical and expected change of control transactions.

Marchex Carve Out recognizes income tax benefits for those income tax positions determined more likely than not to be sustained upon examination, based on the technical merits of the position. Any reserve for uncertain income tax positions is recorded as an offset to net deferred tax assets on the special purpose combined balance sheet. The impact of the temporary differences and tax attributes are considered when calculating accruals for interest and penalties associated with reserve for uncertain tax positions. Marchex Carve Out does not have any uncertain tax benefits recorded for the periods presented and we do not anticipate any significant changes to unrecognized tax benefits over the next 12 months.

(8) Related Party Transactions

Marchex Carve Out has received certain management and administrative services from Marchex (referred to as “shared support functions”) including, but not limited to, accounting and finance, information technology, executive management, legal, human resources, technology and data center operations and product management.  Furthermore, Marchex Carve Out uses assets owned by Marchex as part of its operations (referred to as “shared assets”) including, but not limited to, computer equipment, purchased software, furniture and fixtures, and leasehold improvements.  The operating costs and expenses associated with these services and assets have been allocated to Marchex Carve Out on the basis of direct usage when identifiable, with the remainder allocated pro rata based on relative call volume and employee counts. The Marchex Carve Out recognized allocations for shared support functions and shared assets for the years ended December 31, 2018 and 2019, and for the three months ended March 31, 2019 and 2020, all of which are included in the special purpose combined statement of operations for Marchex Carve Out as follows (in thousands):

 

 

Years ended December 31,

 

 

Three months ended March 31,

 

 

 

2018

 

 

2019

 

 

2019

 

 

2020

 

Service costs

 

$

302

 

 

$

278

 

 

$

70

 

 

$

74

 

Sales and marketing

 

 

657

 

 

 

687

 

 

 

138

 

 

 

306

 

Product development

 

 

1,531

 

 

 

1,349

 

 

 

349

 

 

 

377

 

General and administrative

 

 

3,651

 

 

 

3,556

 

 

 

875

 

 

 

932

 

Total operating expenses

 

$

6,141

 

 

$

5,870

 

 

$

1,432

 

 

$

1,689

 


Additionally, Marchex primarily uses a centralized approach to cash management and financing of its operations with related activity between the Marchex Carve Out and Marchex reflected in “Marchex net investment” in the special purpose combined balance sheet.  Such transactions include (a) cash deposits from customer payments and other cash receipts that are transferred to Marchex on a regular basis, (b) cash contributions from Marchex to fund the Marchex Carve Out and make capital expenditures, and (c) allocation of Marchex’s shared support functions and shared assets use. Cash and cash equivalents of $795,000 and $874,000 reported as of December 31, 2019 and March 31, 2020, respectively, reflects cash that remained outside of the centralized cash management program for purposes of certain aspects of the Marchex Carve Out’s operations.


ANNEX A

MARCHEX, INC.ASSET PURCHASE AGREEMENT

2012 STOCK INCENTIVE PLAN

Asset Purchase Agreement

by and among

Marchex, Inc.

and

Archenia, Inc.

dated as of August 7, 2020


Table of Contents

Page

 

1.ARTICLE I DEFINITIONS

Establishment, PurposeA-3

SECTION 1.1

Definitions

A-3

SECTION 1.2

Accounting Terms

A-5

ARTICLE II PURCHASE AND SALE

A-6

SECTION 2.1

Agreement to Purchase and TypesSell

A-6

SECTION 2.2

Excluded Assets

A-6

SECTION 2.3

Assumed Liabilities

A-7

SECTION 2.4

Excluded Liabilities

A-7

ARTICLE III PURCHASE PRICE; CONTINGENT CONSIDERATION; ALLOCATIONS

A-8

SECTION 3.1

Purchase Price

A-8

SECTION 3.2

Payment

A-8

SECTION 3.3

Contingent Consideration

A-8

SECTION 3.4

Allocation of AwardsPurchase Price

A-10

ARTICLE IV REPRESENTATIONS AND WARRANTIES OF SELLER

A-10

SECTION 4.1

Organization

A-10

SECTION 4.2

Authorization

A-10

SECTION 4.3

Absence of Restrictions and Conflicts

A-10

SECTION 4.4

Legal Proceedings

A-10

SECTION 4.5

Compliance with Law

A-10

SECTION 4.6

Assumed Contracts

A-10

SECTION 4.7

Title to Tangible Personal Property; Sufficiency of Assets

A-10

SECTION 4.8

Tax Returns; Taxes

A-11

SECTION 4.9

Proxy Statement

A-11

ARTICLE V REPRESENTATIONS AND WARRANTIES OF PURCHASER

A-11

SECTION 5.1

Organization

A-11

SECTION 5.2

Authorization

A-11

SECTION 5.3

Access to Data

A-11

SECTION 5.4

Acknowledgment

A-11

ARTICLE VI CERTAIN COVENANTS AND AGREEMENTS

A-11

SECTION 6.1

No Solicitation of Transactions

A-11

SECTION 6.2

Transfer Taxes

A-12

SECTION 6.3

Restrictive Covenants

A-12

SECTION 6.4

Proxy Statement; Seller Stockholders’ Meeting.

A-12

SECTION 6.5

Public Announcements.

A-13

SECTION 6.6

Employees

A-13

SECTION 6.7

Consents

A-14

ARTICLE VII CONDITIONS TO CLOSING

A-14

SECTION 7.1

Conditions to Obligations of Purchaser

A-14

SECTION 7.2

Conditions to Obligations of Seller

A-15

ARTICLE VIII CLOSING

A-16

ARTICLE IX TERMINATION

A-16

SECTION 9.1

Termination

A-16

SECTION 9.2

Effect of Termination

A-16

ARTICLE X INDEMNIFICATION

A-16

SECTION 10.1

Indemnification Obligations of Parties

A-16

SECTION 10.2

Claims Period

A-16

SECTION 10.3

Limitations on Indemnification.

A-16

SECTION 10.4

Liability Limits

A-17

SECTION 10.5

Exclusive Remedy

A-17

ARTICLE XI MISCELLANEOUS PROVISIONS

A-17

SECTION 11.1

Notices

A-17

SECTION 11.2

Controlling Law; Amendment

A-18

SECTION 11.3

Consent to Jurisdiction

A-18

A-i


SECTION 11.4

Severability

A-18

SECTION 11.5

Counterparts

A-18

SECTION 11.6

Integration

A-18

SECTION 11.7

Compliance with Bulk Sales Laws

A-18

SECTION 11.8

Cooperation Following the Closing

A-18

SECTION 11.9

Transaction Costs

A-19

SECTION 11.10

Waiver

A-19

SECTION 11.11

Waiver of Jury Trial

A-19

* * * * *

A-ii


The following is a list of all exhibits and schedules to this Agreement.  Except for Exhibit A, Seller has omitted all exhibits and schedules to this Agreement, and Seller agrees to furnish them supplementally to the Securities and Exchange Commission upon request.

Exhibits

Exhibit AForm of Support Services Agreement

Exhibit B Form of Subscription Agreement

Exhibit CForm of Bill of Sale

Exhibit D Form of Assignment and Assumption Agreement

Exhibit EForm of Domain Name Assignments

Exhibit FForm of Trademark Assignments

Exhibit GForm of Patent Assignments

Schedules

Schedule 1Assumed Contracts

Schedule 2Intellectual Property Assets

Schedule 3Schedule of Terminated Options

Schedule 4Third Party Consents

* * * * *


ASSET PURCHASE AGREEMENT

THIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of August 7, 2020, is made and entered into by and between Marchex, Inc., a Delaware corporation (the “(“CompanySeller”), hereby establishesand Archenia, Inc., a Delaware corporation (“Purchaser”). Seller and Purchaser are sometimes individually referred to herein as a “Party” and collectively as the MARCHEX, INC. 2012 STOCK INCENTIVE PLAN“Parties.”

WHEREAS, in connection with its business, among other things Seller (i) provides a mobile advertising network for businesses that depend on inbound phone calls to drive sales (the “PlanCall Marketplace Product”). The purpose, (ii) provides a white-labeled full service advertising solution for small business resellers to sell call advertising, search marketing and other lead generation products through their existing sales channels to their small business advertisers (the “Local Leads Product”), and (iii) owns and operates other assets and product areas (other than Seller’s core analytics products and assets (the “Core Analytics Product”), and an equity interest in Uproar.car Corporation, a Delaware corporation (“Uproar”)) ((i), (ii) and (iii) collectively, the “Business”);

WHEREAS, the Parties desire to enter into this Agreement pursuant to which Seller proposes to sell to Purchaser, and Purchaser proposes to purchase from Seller (the “Transaction”), the Assets (as defined in Section 2.1 below), and Purchaser proposes to assume the Assumed Liabilities (as defined in Section 2.3 below), upon the terms and conditions of this Agreement;

WHEREAS, at the Closing, a portion of the Plan isPurchase Price will be paid by issuing the Equity Consideration to promoteSeller, all on the long-term growthterms and profitabilitysubject to the conditions set forth in this Agreement and the Subscription Agreement;

WHEREAS, in connection with the Transaction, the Parties desire to enter into a support services agreement whereby Seller will provide various services to Purchaser in exchange for certain payments, all on the terms and subject to the conditions set forth in the Support Services Agreement (as further defined herein).

WHEREAS, the Parties desire to make certain representations, warranties and agreements in connection with the Transaction; and

WHEREAS, capitalized terms used but not defined elsewhere in this Agreement shall have the meanings set forth in Section 1.1.

NOW, THEREFORE, in consideration of the Company by (i) providing key people with incentivesforegoing and the respective representations, warranties, covenants, agreements and conditions hereinafter set forth, and intending to improve stockholder value and to contribute to the growth and financial success of the Company through their future services, and (ii) enabling the Company to attract, retain and reward the best-available personnel.be legally bound hereby, each Party hereby agrees as follows:


Article I
DEFINITIONS

After December 31, 2012, no further awards will be made under the Company’s 2003 Amended and Restated Stock Incentive Plan (the “Section 1.12003 Plan”).

Definitions. The Plan permits the granting of stock options (including incentive stock options qualifying under Code section 422 and nonstatutory stock options), stock appreciation rights, restricted or unrestricted stock awards, restricted stock units, performance awards, other stock-based awards, or any combination of the foregoing.

2.

Definitions

Under this Plan, except where the context otherwise indicates,following terms, as used herein, have the following definitions apply:meanings:

(a) “Administrator” means the Board or the committee(s) or officer(s) appointed by the Board that have authority to administer the Plan as provided in Section 3 hereof.

(b) Affiliate”Affiliate” of a Party means any entity whether now or hereafter existing, which controls, is controlled by, controlling or is under common control with such Party where “control” in any of the Company (including, but not limitedforegoing forms means ownership, either direct or indirect, of more than 50% of the equity interest entitled to joint ventures, limited liability companies, and partnerships). For this purpose, vote for the election of directors or equivalent governing body.  An entity shall be considered an Affiliate only so long as such entity continues to meet the foregoing definition.

controlBase Cash Payment Amountshall mean ownership of 50%means $2,250,000.

Benefit Plan” means any material benefit, retirement, employment, consulting, compensation, incentive, bonus, stock option, restricted stock, stock appreciation right, phantom equity, change in control, severance, vacation, paid time off, welfare and fringe-benefit agreement, plan, policy and program in effect and covering one or more employees, former employees of the total combined voting powerBusiness, current or value of all classes of stock or interestsformer directors of the entity,Business or the beneficiaries or dependents of any such Persons, and is maintained, sponsored, contributed to, or required to be contributed to by Seller, or under which Seller has any material liability for premiums or benefits.

Business Day” means any day except Saturday, Sunday or any day on which banks are generally not open for business in Seattle, Washington.

Claims Period” means the period during which a claim for indemnification may be asserted hereunder by an indemnified party.

Closing” means the consummation of the transactions contemplated by Article VIII.

Closing Date” means the date on which the Closing occurs.

Code” means the United States Internal Revenue Code of 1986, as amended.

Confidential Business Information” means data or information (including trade secrets) that is valuable to the operation of the Business and not generally known to the public or competitors.

Confidential Information” means (a) any Confidential Business Information and (b) any data or information (including trade secrets) (i) of Purchaser or its Affiliates, including any data or information that is valuable to the operation of Purchaser’s or an Affiliate’s respective businesses and (ii) that is not generally known to the public or competitors.

Control” means, when used with respect to any specified Person, the power to direct the management and policies of such Person, directly or indirectly, whether through the entity,ownership of voting securities, by contract or otherwise.

(c) “Award” Equity Considerationmeans any stock option, stock appreciation right, stock award, restricted stock unit award, performance award, or other stock-based award.

(d) “Board”means the Boardamount of Directorsshares of Class B Common Stock of Purchaser equal to 10% of the Company.total outstanding shares of capital stock on a fully-diluted basis of Purchaser at Closing, to be issued by Purchaser to Seller subject to the terms and conditions of the Subscription Agreement.

(e) Change in ControlGAAP” means generally accepted accounting principles as applied in the occurrenceUnited States.


Governmental Authority” means any federal, state or local or foreign government, any political subdivision thereof or any court, administrative or regulatory agency, department, instrumentality, body or commission, publicly chartered, publicly managed or public benefit corporation or other governmental or quasi-governmental authority or agency, domestic or foreign, including any tax authority.

Intellectual Property” means any and all of the following arising pursuant to the Laws of any jurisdiction throughout the world: (a) trademarks, service marks, trade names, and similar indicia of source of origin, all registrations and applications for registration thereof, and the goodwill connected with the use of and symbolized by the foregoing; (b) copyrights and all registrations and applications for registration thereof; (c) trade secrets and know-how; (d) patents and patent applications; (e) internet domain name registrations; and (f) other intellectual property and related proprietary rights.

Intellectual Property Assets” means all Intellectual Property that is owned by Seller and primarily used in connection with the Business, including the Intellectual Property Registrations.

Intellectual Property Registrations” means all Intellectual Property Assets that are subject to any issuance, registration, application or other filing by, to or with any Governmental Authority or authorized private registrar in any jurisdiction, including registered trademarks, domain names, and copyrights, issued and reissued patents and pending applications for any of the following events:foregoing.

(i) an acquisition (other than directly fromLaws” means all statutes, rules, codes, regulations, restrictions, ordinances, orders, decrees, approvals, directives, judgments, injunctions, writs, awards and decrees of, or issued by, all Governmental Authorities.

Material Adverse Effect” means any state of facts, change, event, effect or occurrence (when taken together with all other states of fact, changes, events, effects or occurrences) that is or may be reasonably likely to be materially adverse to the Company)financial condition, results of any voting securitiesoperations, properties, assets or liabilities or prospects of the Company (the “Business or the Assets taken as a whole; Voting Securities provided“) by, however, that the foregoing “Material Adverse Effect” shall not include any “Person”state of facts, change, event, effect or “Group” (as such terms are used foroccurrence, directly or indirectly, arising out of or attributable to: (a) general economic or political conditions; (b) conditions generally affecting the purposesindustries in which the Business operates; (c) any changes in financial or securities markets in general; (d) acts of Section 13(d)war (whether or 14(d)not declared), armed hostilities or terrorism, or the escalation or worsening thereof; (e) any changes in applicable Laws or accounting rules, including GAAP; or (f) the public announcement, pendency or completion of the Securities Exchange Act of 1934, as amended (the “transactions contemplated by this Agreement; Exchange Act”)) immediately after which such Person or Group has Beneficial Ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of fifty percent (50%) or more of the combined voting power of the Company’s then-outstanding Voting Securities; provided however, in determining whether or not a Change in Control has occurred, Voting Securities which are acquired in a “Non-Control Acquisition” (as hereinafter defined) shall not constitute an acquisition which would constitute a Change in Control. A “furtherNon-Control Acquisition” shall mean an acquisition by (i) any employee benefit plan (or related trust) sponsored or maintained by the Company or any affiliate of the Company, (ii) the Company, (iii) any Person in connection with a Non-Control Transaction (as hereinafter defined), or (iv) any holder of the Company’s Class A Common Stock as of the date hereof;

(ii) individuals who, as of the date hereof, constitute the Board (the “Incumbent Boardhowever”) cease for any reason to constitute at least a majority of the Board; provided, however,, that any individual becoming a director subsequent to the date hereof whose election, or nomination for election by the Company’s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the electionforegoing clauses (a) through (e), such matter shall only be excluded so long as, and to the extent that, such matter does not have a materially disproportionate effect on the Business, taken as a whole, relative to other comparable businesses operating in the industry in which the Business operates and that serve similar customers as the Business.

Net Revenue” means Purchaser’s Revenue adjusted by (i) chargebacks, refunds and other GAAP related adjustments to revenue such as customer discounts, advertiser incentives or removal of directorssimilar price concessions and (ii) credit card charges, agency fees and expenses to distribution partners as well as reporting and tracking costs, all recorded as determined in accordance with GAAP and the Purchaser’s historical methodologies.

Permits” means all permits, licenses, franchises, approvals, authorizations and consents required to be obtained from Governmental Authorities.

Person” means any individual, corporation, partnership, joint venture, limited liability company, trust, unincorporated organization or Governmental Authority.

Purchaser Ancillary Documents” means the Support Services Agreement, Subscription Agreement and any certificate, agreement, document or other actual or threatened solicitation of proxies or consents by or on behalf of a Personinstrument, other than this Agreement, to be executed and delivered by Purchaser in connection with the Board; ortransactions contemplated hereby.

(iii) the consummation of:

(a) A merger, consolidation or reorganization with or into the Company or in which securities of the Company are issued, unless such merger, consolidation or reorganization is a “Non-Control Transaction.” A Non-Control TransactionPurchaser Businessis a merger, consolidation or reorganizationmeans the business of advertising marketing services and lead generation, and with or into the Company or in which securities of the Company are issued where:respect to Uproar, auto warranty and service packages (including marketed offerings).


A.Restricted Period” means the shareholdersperiod beginning on the Closing Date and ending on the date that is five years after the Closing Date.

Revenue” means Purchaser’s recognized revenue (not presented on a net basis) as determined in accordance with GAAP and the Purchaser’s historical methodologies.

Sale Transaction” means a transaction or series of related transactions involving (i) the Company immediately before such merger, consolidation or reorganization, own, directly or indirectly, at least fifty-one percent (51%)merger of the combined voting power of the outstanding voting securities of the corporation resulting from such merger, consolidation or reorganization (the “Surviving Corporation”) in substantially the same proportion as their ownership of the Voting Securities immediately before such merger, consolidation or reorganization,

B. the individuals who were members of the Incumbent Board immediately prior to the execution of the agreement providing for such merger, consolidation or reorganization constitute at leastPurchaser with another Person, (ii) a majority of the members of the board of directors of the Surviving Corporation or a corporation owning directly or indirectly fifty-one percent (51%) or more of the Voting Securities of the Surviving Corporation, and

C. no Person or Group, other than (i) the Company, (ii) any subsidiary of the Company, (iii) any employee benefit plan (or any trust forming a part thereof) maintained by the Company immediately prior to such merger, consolidation, or reorganization, or (iv) any holder of the Company’s Class A Common Stock as of the date hereof, owns twenty percent (20%) or more of the combined voting power of the Surviving Corporation’s then-outstanding voting securities; or

(b) a complete liquidation or dissolution of the Company; or

(c) the sale or disposition of all or substantially all of the assets of Purchaser, (iii) a purchase, tender or exchange offer that is accepted by the Company to any Person.

Notwithstanding the foregoing, a Change in Control shall not be deemed to occur solely because any Person (the “Subject Person”) acquired Beneficial Ownershipholders of more than the permitted amount ofall or substantially all the outstanding Voting Securities as a result of the acquisition of Voting Securities by the Company which, by reducing the number of Voting Securities outstanding, increases the proportional number of shares Beneficially Owned by the Subject Person provided that if a Change in Control would occur (but for the operation of this sentence) and after such acquisition of Voting Securities by the Company, the Subject Person becomes the Beneficial Owner of any additional Voting Securities, then a Change in Control shall occur.

(f) “Code” means the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder.

(g) “Common Stock” means shares of Class B common stock of the Company, par value of $0.01 per share.

(h) “Fair Market Value” means, with respect to the Common Stock, as of any date:

(i) if the principal market for the Common Stock (as determined by the Administrator if the Common Stock is listed or admitted to trading on more than one exchange or market) is a national securities exchange or an established securities market, the official closing price per share of Common Stock for the regular market session on that date on the principal exchange or market on which the Common Stock is then listed or admitted to trading or, if no sale is reported for that date, on the last preceding day on which a sale was reported;

(ii) if the principal market for the Common Stock is not a national securities exchange or an established securities market, the average of the highest bid and lowest asked prices for the Common Stock on that date as reported on a national quotation system or, if no prices are reported for that date, on the last preceding day on which prices were reported; or

(iii) if the Common Stock is neither listed or admitted to trading on a national securities exchange or an established securities market, nor quoted by a national quotation system, the value determined by the Administrator in good faith by the reasonable application of a reasonable valuation method.

(i) “Grant Agreement” means a written document, including an electronic writing acceptable to the Administrator, memorializing the terms and conditions of an Award granted pursuant to the Plan and which shall incorporate the terms of the Plan.

(j) “Performance Measures” mean criteria established by the Administrator relating to any of the following, as it may apply to an individual, one or more business units, divisions or subsidiaries, or on a Company-wide basis, and in either absolute terms or relative to the performance of one or more comparable companies or an index covering multiple companies:

(i) Earnings or Profitability Metrics: earnings/loss (gross, operating, net, or adjusted); earnings/loss before interest and taxes (“EBIT”); operating income before amortization (“OIBA”) and adjusted OIBA; earnings/loss before interest, taxes, depreciation and amortization (“EBITDA”) and adjusted EBITDA; profit margins; expense levels or ratios; as may be adjusted to eliminate the effect of any one or more of the following: interest expense, asset impairments, early extinguishment of debt, stock-based compensation expense, amortization of intangible assets from acquisitions, acquisition related costs, gain/loss on sales and disposals of intangible assets, lease incentives, costs to exit activities and other non-GAAP financial measures under Regulation G promulgated by the Securities and Exchange Commission;

(ii) Return Metrics: return on investment, assets, equity or capital (total or invested);


(iii) Cash Flow Metrics: operating cash flow; cash flow sufficient to achieve financial ratios or a specified cash balance; free cash flow; cash flow return on capital; net cash provided by operating activities; cash flow per share; working capital;

(iv) Liquidity Metrics: capital raising; debt reduction; extension of maturity dates of outstanding debt; debt leverage (debt to capital, net debt-to-capital, debt-to-EBITDA or other liquidity ratios) or access to capital; debt ratings; total or net debt; other similar measures approved by the Administrator;

(v) Stock Price and Equity Metrics: return on stockholders’ equity; total stockholder return; stock price; stock price appreciation; market capitalization; earnings/loss per share (basic or diluted) (before or after taxes); price-to-earnings ratio;

(vi) Strategic and Operating Metrics: geographic footprint; revenue (gross, operating or net); new business or customer wins; market share; market penetration; growth in assets; key hires; management of employment practices and employee benefits; effective income tax rates; business expansion; acquisitions, divestitures, collaborations, licensing or joint ventures; financing; covenant compliance; resolution of significant litigation; and legal compliance or risk reduction; and

(vii) Other Performance Measures: as may be established by the Administrator from time to time.

3.

Administration

(a) Administration of the Plan. The Plan shall be administered by the Board or by such committee or committees as may be appointed by the Board from time to time. To the extent allowed by applicable state law, the Board by resolution may authorize an officer or officers to grant Awards (other than Stock Awards) to other officers and employees of the Company and its Affiliates, and, to the extent of such authorization, such officer or officers shall be the Administrator.

(b) Powers of the Administrator. The Administrator shall have all the powers vested in it by the terms of the Plan, such powers to include authority, in its sole and absolute discretion, to grant Awards under the Plan, prescribe Grant Agreements evidencing such Awards and establish programs for granting Awards.

The Administrator shall have full power and authority to take all other actions necessary to carry out the purpose and intent of the Plan, including, but not limited to, the authority to: (i) determine the eligible persons to whom, and the time or times at which Awards shall be granted; (ii) determine the types of Awards to be granted; (iii) determine the number of shares to be covered by or used for reference purposes for each Award; (iv) impose such terms, limitations, restrictions and conditions upon any such Award as the Administrator shall deem appropriate; (v) modify, amend, extend or renew outstanding Awards, or accept the surrender of outstanding Awards and substitute new Awards (provided however, that, except as provided in Section 6 or 7(d) of the Plan, any modification that would materially adversely affect any outstanding Award shall not be made without the consent of the holder and no such modification, amendment or substitution that results in repricing the Award, shall be made without prior stockholder approval); (vi) accelerate or otherwise change the time in which an Award may be exercised or becomes payable and to waive or accelerate the lapse, in whole or in part, of any restriction or condition with respect to such Award, including, but not limited to, any restriction or condition with respect to the vesting or exercisability of an Award following termination of any grantee’s employment or other relationship with the Company; provided, however, that no such waiver or acceleration of lapse restrictions shall be made with respect to a performance-based stock award granted to an executive officer of the Company if such waiver or acceleration is inconsistent with Code section 162(m); (vii) establish objectives and conditions, if any, for earning Awards and determining whether Awards will be paid with respect to a performance period; and (viii) for any purpose, including but not limited to, qualifying for preferred tax treatment under foreign tax laws or otherwise complying with the regulatory requirements of local or foreign jurisdictions, to establish, amend, modify, administer or terminate sub-plans, and prescribe, amend and rescind rules and regulations relating to such sub-plans.

The Administrator shall have full power and authority, in its sole and absolute discretion, to administer, construe and interpret the Plan, Grant Agreements and all other documents relevant to the Plan and Awards issued thereunder, to establish, amend, rescind and interpret such rules, regulations, agreements, guidelines and instruments for the administration of the Plan and for the conduct of its business as the Administrator deems necessary or advisable, and to correct any defect, supply any omission or reconcile any inconsistency in the Plan or in any Award in the manner and to the extent the Administrator shall deem it desirable to carry it into effect.

(c) Non-Uniform Determinations. The Administrator’s determinations under the Plan (including without limitation, determinations of the persons to receive Awards, the form, amount and timing of such Awards, the terms and provisions of such Awards, and the Grant Agreements evidencing such Awards, and the ramifications of a Change in Control upon outstanding Awards) need not be uniform and may be made by the Administrator selectively among Awards or persons who receive, or are eligible to receive, Awards under the Plan, whether or not such persons are similarly situated.

(d) Limited Liability. To the maximum extent permitted by law, no member of the Administrator shall be liable for any action taken or decision made in good faith relating to the Plan or any Award thereunder.


(e) Indemnification. To the maximum extent permitted by law and by the Company’s charter and by-laws, the members of the Administrator shall be indemnified by the Company in respect of all their activities under the Plan.

(f) Effect of Administrator’s Decision. All actions taken and decisions and determinations made by the Administrator on all matters relating to the Plan pursuant to the powers vested in it hereunder shall be in the Administrator’s sole and absolute discretion and shall be conclusive and binding on all parties concerned, including the Company, its stockholders, any participants in the Plan and any other employee, consultant, or director of the Company, and their respective successors in interest.

4.

Shares Available for the Plan; Maximum Awards

Subject to adjustments as provided in Section 7(d) of the Plan, the total number of shares of Common Stock that may be issued with respect to Awards granted under the Plan shall be 3,500,000, plus an automatic annual increase to be added on January 1 of each year equal to five percent (5%) of the total shares of Common Stock outstanding on such date (including for this purpose any shares of Common Stock issuable upon conversion of any outstanding capital stock of Purchaser, or (iv) the Company). Subject to adjustments as provided in Section 7(d) of the Plan, the total number of shares of Common Stock available for granting incentive stock options intended to qualify under Code section 422 under the Plan shall be 3,500,000, plus an automatic annual increase to be added on January 1 of each year beginning in 2013 and ending in 2022, equal to the lesser of (i) 2,000,000 shares of Common Stock or (ii) five percent (5%) of the total shares of Common Stock outstanding on such date (including for this purpose any shares of Common Stock issuable upon conversion of any outstanding capital stock of the Company) or (iii) such lesser number as determined by the Board.

The Company shall reserve such number of shares for Awards under the Plan, subject to adjustments as provided in Section 7(d) of the Plan. If any Award, or portion of an Award, under the Plan or 2003 Plan expires or terminates unexercised, becomes unexercisable, is settled in cash without delivery of shares of Common Stock, or is forfeited or otherwise terminated, surrendered or canceled as to any shares, or if any shares of Common Stock are repurchased by or surrendered to the Company in connection with any Award (whether or not such surrendered shares were acquired pursuant to any Award) under this Plan or the 2003 Plan, or if any shares are withheld by the Company, the shares subject to such Award and the repurchased, surrendered and withheld shares shall thereafter be available for further Awards under the Plan; provided, however, that any such shares that are surrendered to or repurchased or withheld by the Company in connection with any Award under this Plan or the 2003 Plan or that are otherwise forfeited after issuance shall not be available for purchase pursuant to incentive stock options intended to qualify under Code section 422.

Subject to adjustments as provided in Section 7(d) of the Plan, the maximum number of shares of Common Stock subject to Awards of any combination that may be granted during any one fiscal year of the Company to any one individual under this Plan shall be limited to 4,000,000 shares. Such per-individual limit shall not be adjusted to effect a restoration of shares of Common Stock with respect to which the related Award is terminated, surrendered or canceled.

5.

Participation

Participation in the Plan shall be open to all employees, officers, and directors of, and other individuals providing bona fide services to or for, the Company, or of any Affiliate of the Company, as may be selected by the Administrator from time to time. The Administrator may also grant Awards to individuals in connection with hiring, recruiting or otherwise, prior to the date the individual first performs services for the Company or an Affiliate, provided that such Awards shall not become vested or exercisable, and no shares shall be issued to such individual, prior to the date the individual first commences performance of such services.

6.

Awards

The Administrator, in its sole discretion, establishes the terms of all Awards granted under the Plan. Awards may be granted individually or in tandem with other types of Awards, concurrently with or with respect to outstanding Awards. All Awards are subject to the terms and conditions provided in the Grant Agreement.

(a) Stock Options. The Administrator may from time to time grant to eligible participants Awards of incentive stock options as that term is defined in Code section 422 or nonstatutory stock options; provided, however, that Awards of incentive stock options shall be limited to employees of the Company or of any current or hereafter existing “parent corporation” or “subsidiary corporation,” as defined in Code sections 424(e) and (f), respectively, of the Company and any other individuals who are eligible to receive incentive stock options under the provisions of Code section 422. Options must have an exercise price at least equal to Fair Market Value as of the date of grant and may not have a term in excess of ten years’ duration. No stock option shall be an incentive stock option unless so designated by the Administrator at the time of grant or in the Grant Agreement evidencing such stock option.



(b) Stock Appreciation Rights. The Administrator may from time to time grant to eligible participants Awards of Stock Appreciation Rights (“SAR”). An SAR entitles the grantee to receive, subject to the provisions of the Plan and the Grant Agreement, a payment having an aggregate value equal to the product of (i) the excess of (A) the Fair Market Value on the exercise date of one share of Common Stock over (B) the base price per share specified in the Grant Agreement, times (ii) the number of shares specified by the SAR, or portion thereof, which is exercised. The base price per share specified in the Grant Agreement shall not be less than the lower of the Fair Market Value on the grant date or the exercise price of any tandem stock option Award to which the SAR is related. No SAR shall have a term longer than ten years’ duration. Payment by the Company of the amount receivable upon any exercise of an SAR may be made by the delivery of Common Stock or cash, or any combination of Common Stock and cash, as determined in the sole discretion of the Administrator. If upon settlement of the exercise of an SAR a grantee is to receive a portion of such payment in shares of Common Stock, the number of shares shall be determined by dividing such portion by the Fair Market Value of a share of Common Stock on the exercise date. No fractional shares shall be used for such payment and the Administrator shall determine whether cash shall be given in lieu of such fractional shares or whether such fractional shares shall be eliminated.

(c) Stock Awards.

(i) The Administrator may from time to time grant stock awards to eligible participants in such amounts, on such terms and conditions, and for such consideration, including no consideration or such minimum consideration as may be required by law, as it shall determine. A stock award may be denominated in Common Stock or other securities, stock-equivalent units or restricted stock units, securities or debentures convertible into Common Stock, or any combination of the foregoing and may be paid in Common Stock or other securities, in cash, or in a combination of Common Stock or other securities and cash, all as determined in the sole discretion of the Administrator.

(ii) The Administrator may grant stock awards in a manner constituting “qualified performance-based compensation” within the meaning of Code section 162(m). The grant of, or lapse of restrictions with respect to, such performance-based stock awards shall be based upon one or more Performance Measures and objective performance targets to be attained relative to those Performance Measures, all as determined by the Administrator. Performance targets may include minimum, maximum, intermediate and target levels of performance, with the size of the performance-based stock award or the lapse of restrictions with respect thereto based on the level attained. A performance target may be stated as an absolute value or as a value determined relative to prior performance, one or more indices, budget, one or more peer group companies, any other standard selected by the Administrator, or any combination thereof. The Administrator shall be authorized to make adjustments in the method of calculating attainment of Performance Measures and performance targets in recognition of: (A) extraordinary or non-recurring items; (B) changes in tax laws; (C) changes in generally accepted accounting principles or changes in accounting policies; (D) charges related to restructured or discontinued operations; (E) restatement of prior period financial results; and (F) any other unusual, non-recurring gain or loss that is separately identified and quantified in the Company’s financial statements; provided that the Administrator’s decision as to whether such adjustments will be made with respect to any Covered Employee, within the meaning of Code section 162(m), is determined when the performance targets are established for the applicable performance period. Notwithstanding the foregoing, the Administrator may, at its sole discretion, modify the performance results upon which Awards are based under the Plan to offset any unintended results arising from events not anticipated when the Performance Measures and performance targets were established; provided, that such modifications may be made with respect to an Award granted to any Covered Employee, within the meaning of Code section 162(m), only to the extent permitted by Code section 162(m) if the Award was intended to constitute “qualified performance-based compensation” within the meaning of Code section 162(m). Notwithstanding anything in the Plan to the contrary, the Administrator is not authorized to waive or accelerate the lapse of restrictions on a performance-based stock award granted to any Covered Employee, within the meaning of Code section 162(m) except upon death, disability or a change of ownership or control of the Company. In the event that a Change in Control occurs after a performance-based stock award has been granted but before completion of the applicable performance period, a pro rata portion of such Award shall become payable (or a pro rata portion of the lapse restrictions shall lapse, as applicable) as of the date of the Change in Control to the extent otherwise earned on the basis of achievement of the pro rata portion of the Performance Measures and performance targets relating to the portion of the performance period completed as of the date of the Change in Control.

7.

Miscellaneous

(a) Withholding of Taxes. Grantees and holders of Awards shall pay to the Company or its Affiliate, or make provision satisfactory to the Administrator for payment of, any taxes required to be withheld in respect of Awards under the Plan no later than the date of the event creating the tax liability. The Company or its Affiliate may, to the extent permitted by law, deduct any such tax obligations from any payment of any kind otherwise due to the grantee or holder of an Award. In the event that payment to the Company or its Affiliate of such tax obligations is made in shares of Common Stock, such shares shall be valued at Fair Market Value on the applicable date for such purposes and shall not exceed in amount the minimum statutory tax withholding obligation.


(b) Loans. To the extent otherwise permitted by law, the Company or its Affiliate may make or guarantee loans to grantees to assist grantees in exercising Awards and satisfying any withholding tax obligations.

(c) Transferability. Except as otherwise determined by the Administrator, and in any event in the case of an incentive stock option or a stock appreciation right granted with respect to an incentive stock option, no Award granted under the Plan shall be transferable by a grantee otherwise than by will or the laws of descent and distribution. Unless otherwise determined by the Administrator in accord with the provisions of the immediately preceding sentence, an Award may be exercised during the lifetime of the grantee, only by the grantee or, during the period the grantee is under a legal disability, by the grantee’s guardian or legal representative.

(d) Adjustments for Corporate Transactions and Other Events.

(i) Stock Dividend, Stock Split and Reverse Stock Split. In the eventconsummation of a stock dividend of,purchase agreement or stock split or reverse stock split affecting, the Common Stock, (A) the maximum number of shares ofother business combination with another Person whereby such Common Stock as to which Awards may be granted under this Plan and the maximum number of shares with respect to which Awards may be granted during any one fiscal year of the Company to any individual, as provided in Section 4 of the Plan, and (B) the number of shares covered by and the exercise price and other terms of outstanding Awards, shall, without further action of the Board, be adjusted to reflect such event. The Administrator may make adjustments, in its discretion, to address the treatment of fractional shares and fractional cents that arise with respect to outstanding Awards as a result of the stock dividend, stock split or reverse stock split.

(ii) Non-Change in Control Transactions. Except with respect to the transactions set forth in Section 7(d)(i), in the event of any change affecting the Common Stock, the Company or its capitalization, by reason of a spin-off, split-up, dividend, recapitalization, merger, consolidation or share exchange, other than any such change that is part of a transaction resulting in a Change in Control of the Company, the Administrator, in its discretion and without the consent of the holders of the Awards, shall make (A) appropriate adjustments to the maximum number and kind of shares reserved for issuance or with respect to which Awards may be granted under the Plan, in the aggregate and with respect to any individual during any one fiscal year of the Company, as provided in Section 4 of the Plan; and (B) any adjustments in outstanding Awards, including but not limited to modifying the number, kind and price of securities subject to Awards, as the Administrator determines to be appropriate and equitable.

(iii) Change in Control Transactions. In the event of any transaction resulting in a Change in Control of the Company or if the Company is to be consolidated with or acquired by another entity in a merger, consolidation, private sale or sale ofPerson acquires all or substantially all of the Company’s assetsoutstanding capital stock of Purchaser.

Seller Ancillary Documents” means the Support Services Agreement, Subscription Agreement and any certificate, agreement, document or otherwise (any of the foregoing, an “Acquisition”), the Administrator or the board of directors of any entity assuming the obligations of the Company hereunder (the “Successor Board”), shall, asother instrument, other than this Agreement, to outstanding stock options, either (i) make appropriate provision for the continuation of such stock optionsbe executed and delivered by substituting on an equitable basis for the shares of Common Stock then subject to such stock options either the consideration payable with respect to the outstanding shares of Common StockSeller in connection with the Acquisition or securitiestransactions contemplated hereby.

Support Services Agreement” means that certain Support Services Agreement dated as of any successor or acquiring entity; or (ii) upon written noticethe Closing Date between Purchaser and Seller, whereby Seller will provide various services to the holders, provide that all options must be exercised (to the extent then exercisable after taking into account any applicable acceleration of vesting) at the end of which period the options shall terminate; or (iii) terminate all optionsPurchaser in exchange for a cash payment equal tocertain payments, in substantially the excessform attached hereto as Exhibit A.

Subscription Agreement” means that certain Subscription Agreement dated as of the Fair Market ValueClosing Date between Purchaser and Seller, in substantially the form attached hereto as Exhibit B, pursuant to which Purchaser has agreed to issue, at the Closing, the Equity Consideration to Seller as part of the shares subject to such options (to the extent then exercisable after taking into accountPurchase Price.

Taxes” means all federal, state, local, foreign and other income, gross receipts, sales, use, production, ad valorem, transfer, franchise, registration, profits, license, lease, service, service use, withholding, payroll, employment, unemployment, estimated, excise, severance, environmental, stamp, occupation, premium, property (real or personal), real property gains, windfall profits, customs, duties or other taxes, fees, assessments or charges of any applicable acceleration of vesting) over the exercise price thereof. Withkind whatsoever, together with any interest, additions or penalties with respect to outstanding Awards other than stock options, the Administrator or the Successor Board, shall either (x) make appropriate provisions for the continuationthereto and any interest in respect of such Awards by substituting on an equitable basisadditions or penalties.

Tax Return” means any return, declaration, report, claim for the shares then subjectrefund, information return or state or other document required to such Awards either the consideration payablebe filed with respect to Taxes, including any schedule or attachment thereto, and including any amendment thereof.

Termination Date” means the outstanding shares of Common Stock in connection with the Acquisition or securities of any successor or acquiring entity; or (y) upon written noticedate prior to the holders, provide that all such Awards must be accepted (to the extent then subject to acceptance) within a specified number of days of the date of such notice, at the end of which period the offer of the Awards shall terminate;Closing when this Agreement is terminated in accordance with Article IX.

Territory” means worldwide.

Transfer Taxes” means any sales tax, use tax, transfer tax, documentary stamp tax or (z) terminate all such other Awards in exchange for a cash payment equal to the excess of the Fair Market Value of the shares subject to such Awards (to the extent then vested after taking into accountsimilar tax (but excluding any applicable acceleration of vesting) overbulk sales Law) attributable to or based on the base or purchase price thereof, if any. In addition,Transaction.

Treasury Regulations” means the income tax regulations, including temporary regulations, promulgated under the Code.

Section 1.2Accounting Terms. All accounting terms not specifically defined herein shall be construed in the event of an Acquisition, the Administrator may waive any or all Company repurchase rightsaccordance with respectGAAP.


Article II
PURCHASE AND SALE

Section 2.1Agreement to outstanding Awards.

(iv) Unusual or Nonrecurring Events. The Administrator is authorizedPurchase and Sell. Subject to make, in its discretion and without the consent of holders of Awards, adjustments in the terms and conditions of,hereof, at the Closing, Seller shall grant, sell, assign, transfer, convey and deliver to Purchaser (or, in the criteria included in, Awards in recognition of unusual or nonrecurring events affecting the Company, or the financial statementscase of the Company or any Affiliate, orUproar Shares (as defined below), cause to grant, sell, assign, transfer, convey and deliver to Purchaser), and Purchaser shall purchase and acquire from Seller, all of changesSeller’s right, title and interest in, applicable laws, regulations, or accounting principles, wheneverto and under (i) the Administrator determinesfollowing assets, properties and rights of Seller, to the extent that such adjustments are appropriate in order to prevent dilution or enlargementassets, properties and rights exist as of the benefits or potential benefits intendedClosing Date and primarily relate to be made available under the Plan.


Business, and (ii) 3,500,000 shares of Series A Preferred Stock held by Seller in Uproar (the “Uproar Shares”), with Seller retaining an equity interest in Uproar equal to 10% of Uproar’s outstanding capital stock (the “Retained Uproar Equity”) (collectively, the “Assets”), free and clear of all liens, claims, pledges, mortgages, restrictions, security interests and encumbrances of any kind, nature and description (“Liens”):


(a)

all accounts or notes receivable of the Business;

(b)

all inventory, including office and other supplies of the Business;

(c)

all contracts set forth on Schedule 1 (the “Assumed Contracts”);

(d)

all Intellectual Property Assets set forth on Schedule 2 (the “Intellectual Property Assets”) and Intellectual Property primarily related to the Business;

(e)

all fixed assets, equipment, furnishings, computer hardware, fixtures and other tangible personal property (the “Tangible Personal Property”);

(f)

all Permits of the Business;

(g)

all prepaid expenses, credits, advance payments, security, deposits, charges, sums and fees to the extent related to any of the Assets;

(h)

all of Seller’s rights under warranties, indemnities and all similar rights against third parties to the extent related to any of the Assets;

(i)

originals, or where not available, copies, of all books and records, including books of account ledgers and general, financial and accounting records, equipment maintenance files, customer lists, customer purchasing histories, price lists, distribution lists, supplier lists, production data, quality control records and procedures, customer complaints and inquiry files, research and development files, records and data (including all correspondence with any Governmental Authority), sales material and records, strategic plans, internal financial statements and marketing and promotional surveys, material and research, that relate to the Business or the Assets;

(j)

all goodwill associated with any of the assets described in the foregoing clauses;

(k)

all shares of capital stock held by Seller in Jingle Networks, Inc., a Delaware corporation; and

(l)

the Uproar bank account held by Seller.

Section 2.2(e) Substitution of Awards in MergersExcluded Assets. Other than the Assets subject to Section 2.1, Purchaser expressly understands and Acquisitions. Awards may be granted under the Plan from time to time in substitution for awards held by employees, officers, consultantsagrees that it is not purchasing or directors of entities who becomeacquiring, and Seller is not selling or are about to become employees, officers, consultants or directors of the Company or an Affiliate as the result of a merger or consolidation of the employing entity with the Company or an Affiliate, or the acquisition by the Company or an Affiliate of theassigning, any other assets or stockproperties of Seller, and all such other assets and properties shall be excluded from the employing entity. The termsAssets (the “Excluded Assets”). Excluded Assets include the following assets and conditionsproperties of any substitute Awards so granted may varySeller:

(a)

all cash and cash equivalents, bank accounts and securities of Seller (including the remaining shares held by Seller in Uproar);

(b)

all contracts that are not Assumed Contracts and not related to the Business;

(c)

all Intellectual Property other than the Intellectual Property Assets;


(d)

the corporate seals, organizational documents, minute books, stock books, Tax Returns, books of account or other records having to do with the corporate organization of Seller, all employee-related or employee benefit-related files or records, and any other books and records which Seller is prohibited from disclosing or transferring to Purchaser under applicable Law and is required by applicable Law to retain;

(e)

all insurance policies of Seller and all rights to applicable claims and proceeds thereunder;

(f)

all Benefit Plans and trusts or other assets attributable thereto;

(g)

all Tax assets (including duty and Tax refunds and prepayments) of Seller or any of its Affiliates unless they specifically relate to the Business;

(h)

all rights to any action, suit or claim of any nature available to or being pursued by Seller, whether arising by way of counterclaim or otherwise;

(i)

all assets, properties and rights primarily used by Seller in its business other than the Business; and

(j)

the rights which accrue or will accrue to Seller under this Agreement.

Section 2.3Assumed Liabilities. Subject to the terms and conditions set forth herein, Purchaser shall assume and agree to pay, perform and discharge when due any and all liabilities and obligations of Seller arising out of or relating to the Business or the Assets on or after the Closing, other than the Excluded Liabilities (collectively, the “Assumed Liabilities”), including, without limitation, the following:

(a)

all trade accounts payable of Seller to third parties in connection with the Business that remain unpaid as of the Closing Date;

(b)

all liabilities and obligations arising under or related to the Assumed Contracts on or after the Closing;

(c)

all liabilities and obligations for Taxes related to the Business, the Assets or the Assumed Liabilities for any taxable period ending after the Closing Date; and

(d)

all other liabilities and obligations arising out of or relating to Purchaser’s ownership or operation of the Business and the Assets on or after the Closing.

Section 2.4Excluded Liabilities Purchaser shall not assume and shall not be responsible to pay, perform or discharge any of the following liabilities or obligations of Seller (collectively, the “Excluded Liabilities”):

(a)

any liabilities or obligations arising out of or relating to Seller’s ownership or operation of the Business and the Assets prior to the Closing Date;

(b)

any liabilities or obligations relating to or arising out of the Excluded Assets; and

(c)

any liabilities or obligations for (i) Taxes related to the Business, the Assets or the Assumed Liabilities for any taxable period ending on or prior to the Closing Date and (ii) any other Taxes of Seller for any taxable period.


Article III
PURCHASE PRICE; CONTINGENT CONSIDERATION; ALLOCATIONS

Section 3.1Purchase Price. The aggregate amount to be paid for the Assets (the “Purchase Price”) shall be an amount equal to (a) the Base Cash Payment Amount plus (b) the Equity Consideration plus (c) the contingent consideration (if any) pursuant to Section 3.3 below plus (d) the assumption of the Assumed Liabilities plus (e) the termination by Seller of the options held by (i) Russell Horowitz, and (ii) Michael Arends, to purchase shares of capital stock of Seller, as set forth on Schedule 3 (“Schedule of Terminated Options”).

Section 3.2Payment.

(a)

On the Closing Date:

(i)

Purchaser shall pay to Seller an amount equal to the Base Cash Payment Amount;

(ii)

Pursuant to the terms and conditions of the Subscription Agreement, Purchaser will issue to Seller the Equity Consideration; and

(iii)

Seller will terminate the options held by (i) Russell Horowitz, and (ii) Michael Arends, to purchase shares of capital stock of Seller, as set forth on the Schedule of Terminated Options.

(b)

The Base Cash Payment Amount shall be made in cash by wire transfer of immediately available funds to a bank account designated in writing by Seller at least two Business Days prior to the Closing Date.

Section 3.3Contingent Consideration.

(a)

Revenue-Based Contingent Consideration.

(i)

Call Marketplace Revenue. If, at any time following the Closing Date, Purchaser’s cumulative Revenue from the Call Marketplace Product exceeds One Hundred and Forty Million Dollars ($140,000,000) (the “Call Marketplace Threshold Amount”), then Purchaser shall pay to Seller an amount equal to 2.5% of all of Purchaser’s Net Revenue generated from such Revenue exceeding the Call Marketplace Threshold Amount beginning on the date the Call Marketplace Threshold Amount is achieved and ending on the date that is two years following such date (the “Call Marketplace Contingent Consideration”).

(ii)

Local Leads Revenue. If, at any time following the Closing Date, Purchaser’s cumulative Revenue of the Local Leads Product exceeds Six Million Dollars ($6,000,000) (the “Local Leads Threshold Amount”), then Purchaser shall pay to Seller 15% of all of Purchaser’s Net Revenue generated from such Revenue exceeding the Local Leads Threshold Amount beginning on the date the Local Leads Threshold Amount is achieved and continuing for so long as the Local Leads Product may be sold (the “Local Leads Contingent Consideration”).

(iii)

Purchaser’s Aggregate Revenue.  If Purchaser’s aggregate Revenue exceeds Fifty-Three Million Dollars ($53,000,000) (the “Aggregate Revenue Threshold Amount”) in any of the calendar years 2021, 2022, or 2023, then Purchaser shall pay to Seller an amount equal to 0.25% of all of Purchaser’s Revenue exceeding the Aggregate Revenue Threshold Amount for such calendar year (the “Aggregate Revenue Contingent Consideration”).

(b)

Notice; Calculation of Revenue-Based Contingent Consideration. Starting as soon as practicable on the date that Purchaser achieves the Call Marketplace Threshold Amount, the Local Leads Threshold Amount or the Aggregate Revenue Threshold Amount, and thereafter within 30 days following the end of each fiscal quarter of Seller, Purchaser shall deliver a written notice (a “Contingent Payment Notice”) to Seller setting forth Purchaser’s calculation of (i) Purchaser’s


aggregate Revenue for such fiscal quarter, (ii) Purchaser’s Revenue and Net Revenue for each of the Call Marketplace Product and the Local Leads Product for such fiscal quarter, and (iii) the contingent payment amount applicable to such fiscal quarter ((i) through (iii), collectively, the “Revenue / CP Amounts”), if any, payable to Seller (as determined in accordance with this Section 3.3).  In addition, Purchaser will deliver to Seller any additional information reasonably requested by Seller to assist it in accounting for the Call Marketplace Contingent Consideration, Local Leads Contingent Consideration, or the Aggregate Revenue Contingent Consideration.

(c)

Review Procedures for Revenue-Based Contingent Consideration. If the Seller disagrees with Purchaser’s calculation of the Revenue / CP Amounts for a particular period set forth in the applicable Contingent Payment Notice, Seller must deliver to Purchaser, within 30 days after the date Purchaser delivered such Contingent Payment Notice to the Seller, a written description of such disagreement in reasonable detail setting forth the amounts in dispute and the bases for such disagreement. If the Seller does not timely deliver to Purchaser a written notice objecting to the calculation of the Revenue / CP Amounts set forth in such Contingent Payment Notice in such 30-day period, then the calculation of the Revenue / CP Amounts shall be deemed final and binding on the Parties. Purchaser and the Seller will negotiate in good faith, as promptly as possible, to resolve any disagreements noted by the Seller in its timely-delivered written dispute notice. If, after a period of 15 days following the date on which such written description is timely delivered, Purchaser and the Seller have not resolved such disagreement, then either Purchaser or the Seller will be entitled to submit such disagreements to a mutually agreed-upon accounting firm (the “Accounting Firm”). Purchaser will grant to the Accounting Firm reasonable access to review Purchaser’s books and records and to discuss the preparation of the Contingent Payment Notice and Revenue / CP Amounts. The Accounting Firm shall be instructed to resolve the disagreements utilizing the relevant definitions and terms set forth in this Section 3.3. The Accounting Firm will review and comment only on items in dispute, it being understood that the resolution of the contingent payment amount by the Accounting Firm may not be an amount less than Purchaser’s calculation set forth on the Contingent Payment Notice nor more than the Seller’s calculation set forth in the Seller’s dispute notice. The Accounting Firm shall use commercially reasonable efforts to complete its work within 30 days following its engagement. Such resolution by the Accounting Firm shall be final and binding on the Parties.  The expenses of the Accounting Firm shall be shared equally by Seller and Purchaser. Purchaser’s obligation to remit any disputed contingent payment amount (if any) to Seller shall be suspended until the Revenue / CP Amounts are finally resolved either by agreement between Purchaser and the Seller or by the Accounting Firm.

(d)

Payment of Revenue-Based Contingent Consideration. Within sixty (60) days after the final determination of the Revenue / CP Amounts (or, if the same are subject to a timely-noticed disagreement under Section 3.3(c), ten (10) days following final resolution of such disagreement by agreement between Purchaser and the Seller or by the Accounting Firm), Purchaser shall pay to Seller an amount equal to the contingent payment amount applicable to such calendar year (if any). For the avoidance of doubt, any amounts in respect of any contingent consideration to which Seller becomes entitled pursuant to this Section 3.3 shall be deemed an adjustment to the Purchase Price.

(e)

Sale Transaction Contingent Consideration. If (i) Purchaser undergoes a Sale Transaction within twenty-four (24) months following the Closing Date, and (ii) the purchase price for the Sale Transaction is in excess of Eleven Million One Hundred Eleven Thousand One Hundred Eleven Dollars ($11,111,111) (the “Sale Transaction Contingent Consideration Threshold Amount”), then, in addition to Seller’s pro rata share of the consideration paid pursuant to such Sale Transaction, Purchaser shall pay to Seller an additional amount equal to 30% of the distributable proceeds exceeding the Sale Transaction Contingent Consideration Threshold Amount pursuant to the Sale Transaction (the “Sale Transaction Contingent Consideration”). Purchaser shall pay Seller the Sale Transaction Consideration at the time the consideration paid pursuant to such Sale Transaction is


distributed.  Purchaser will deliver to Seller any additional information reasonably requested by Seller to assist it in accounting for the Sale Transaction Contingent Consideration.

Section 3.4Allocation of Purchase Price. Within 75 days after the Closing Date, Seller shall deliver a schedule allocating the Purchase Price (including any Assumed Liabilities treated as consideration for the Assets for Tax purposes) (the “Allocation Schedule”). The Allocation Schedule shall be prepared in accordance with Section 1060 of the Code.

Article IV
REPRESENTATIONS AND WARRANTIES OF SELLER

Seller hereby represents and warrants to Purchaser that the statements contained in this Article IV are true and correct as of the date hereof:

Section 4.1Organization. Seller. Seller is a corporation duly incorporated and validly existing under the Laws of the State of Delaware.

Section 4.2Authorization. Seller has full power and authority to execute and deliver this Agreement and the Seller Ancillary Documents, as the case may be, and to perform its respective obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The execution and delivery of this Agreement and the Seller Ancillary Documents by Seller, and the performance by Seller of its respective obligations hereunder and thereunder and the consummation of the transactions provided for herein and therein have been duly and validly authorized by all necessary board and stockholder action on the part of Seller (except for the stockholder approvals as provided in this Agreement).

Section 4.3Absence of Restrictions and Conflicts. The execution, delivery and performance of this Agreement and the Seller Ancillary Documents, the consummation of the transactions contemplated hereby and thereby and the fulfillment of and compliance with the terms and conditions hereof and thereof do not or shall not (as the case may be): (a) result in a violation or breach of any provision of the charter documents of Seller; (b) result in a violation or breach of any provision of any Law applicable to Seller; or (c) except as set forth on Schedule 4, require the consent, notice or other action by any Person under, conflict with, result in a violation or breach of, constitute a default under or result in the acceleration of any material agreement to which Seller is a party.

Section 4.4Legal Proceedings. To the knowledge of Seller, there is no suit, action, claim, arbitration, proceeding or investigation pending or threatened against, relating to or involving Seller, the Business or the Assets by or before any Governmental Authority.

Section 4.5Compliance with Law. Seller is in compliance in all material respects with all applicable Laws.

Section 4.6Assumed Contracts. True, correct and complete copies of all Assumed Contracts have been made available to Purchaser. The Assumed Contracts are legal, valid, binding and enforceable in accordance with their respective terms with respect to Seller and each other party to such Assumed Contracts. There is no existing default or breach of Seller under any Assumed Contract.

Section 4.7Title to Tangible Personal Property; Sufficiency of Assets

.  Seller has good and valid title to, or a valid leasehold interest in, all Tangible Personal Property included in the Assets. The Assets are sufficient for the continued conduct of the Business after the Closing in substantially the same manner as conducted prior to the Closing and constitute all of the rights, property and assets necessary to conduct the Business as currently conducted.


Section 4.8Tax Returns; Taxes. Seller has filed (taking into account any valid extensions) all Tax Returns required to be filed by Seller and has paid all Taxes shown thereon as owing. Seller is not currently the beneficiary of any extension of time within which to file any material Tax Return other than extensions of time to file Tax Returns obtained in the ordinary course of business.

Section 4.9Proxy Statement.  None of the information included or incorporated by reference in the Seller Proxy Statement (as further defined herein) will, at the date it is first mailed to the Seller’s stockholders or at the time of the Seller Stockholders’ Meeting (as further defined herein) or at the time of any amendment or supplement thereof, contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.

Article V
REPRESENTATIONS AND WARRANTIES OF PURCHASER

Purchaser hereby represents and warrants to Seller that the statements contained in this Article V are true and correct as of the date hereof:

Section 5.1Organization. Purchaser is a corporation duly incorporated and validly existing under the Laws of the State of Delaware.

Section 5.2Authorization. Purchaser has full power and authority to execute and deliver this Agreement and the Purchaser Ancillary Documents, as the case may be, and to perform its respective obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The execution and delivery of this Agreement and the Purchaser Ancillary Documents by Purchaser, and the performance by Purchaser of its respective obligations hereunder and thereunder and the consummation of the transactions provided for herein and therein have been duly and validly authorized by all necessary board and stockholder action on the part of Purchaser.

Section 5.3Access to Data.  Purchaser has received full access to all pertinent information regarding the Business and has received all information it considers necessary or appropriate for deciding whether to purchase the Assets.

Section 5.4Acknowledgment.  Seller has made no representations or warranties as to the Assets or the Business except as specifically set forth in this Agreement.

Article VI
CERTAIN COVENANTS AND AGREEMENTS

Section 6.1No Solicitation of Transactions. Seller shall not, directly or indirectly, through any officer, director, stockholder or agent, initiate, solicit or encourage (including by way of furnishing non-public information or assistance), or enter into negotiations of any type, directly or indirectly, or enter into a confidentiality agreement, letter of intent or purchase agreement, merger agreement or other similar agreement with any Person other than Purchaser with respect to a sale of all or any substantial portion of the Assets, or a merger, consolidation, business combination, sale of all or any substantial portion of the capital stock of Seller or the liquidation or similar extraordinary transaction with respect to Seller. Seller shall notify Purchaser orally (within one Business Day) and in writing (as promptly as practicable) of all relevant terms of any inquiry or proposal by a third party to do any of the foregoing that Seller or any of its respective Affiliates may receive relating to any of such matters. In the event such inquiry or proposal is in writing, Seller shall deliver to Purchaser a copy of such inquiry or proposal together with such written


notice. Notwithstanding anything to the contrary, the Parties will work together in good faith to determine an appropriate response to any such inquiry or proposal.

Section 6.2Transfer Taxes.  Any Transfer Taxes that are incurred as a result of the Transaction will be borne by the Seller. The Parties shall cooperate in the preparation, execution and filing of all returns, questionnaires, applications and other documents regarding Taxes and all transfer, recording, registration and other fees that become payable in connection with the transactions contemplated hereby that are required or permitted to be filed at or prior to the Closing.

Section 6.3Restrictive Covenants.

(a)

Confidentiality. Seller shall hold in confidence at all times following the date hereof all Confidential Information and shall not disclose, publish or make use of Confidential Information at any time following the date hereof without the prior written consent of Purchaser. In the event that Seller reasonably believes that after consultation with counsel that Seller is required by applicable law to disclose any Confidential Information, Seller may disclose only such Confidential Information as my be legally required, provided that it (i) provides the Purchaser with prompt notice before such disclosure so that Purchaser may attempt to obtain a protective order or other assurance that confidential treatment will be accorded to such Confidential Information, and (ii) cooperates with Purchaser in attempting to obtain such order or assurance.

(b)

Non-Competition. Seller hereby acknowledges that (i) Seller conducts the Business throughout the Territory and that Purchaser conducts the Purchaser Business throughout the Territory and (ii) to protect adequately the interest of Purchaser in the Business and the Purchaser Business it is essential that any noncompete covenant with respect thereto cover all of the Business, the Purchaser Business and the entire Territory. Seller shall not, during the Restricted Period, in any manner, directly or indirectly or by assisting any other Person, engage in or assist others in engaging in any business or activity that competes with the Business or the Purchaser Business in the Territory, other than holding the Retained Uproar Equity.

(c)

Non-Disparagement.  Each Party hereby covenants and agrees that during the Restricted Period neither it nor its affiliates will, directly or indirectly, make any derogatory or disparaging statement or communication regarding the other Party or any of the other Party’s affiliates or the Business or any of their respective employees.

Section 6.4Proxy Statement; Seller Stockholders’ Meeting.

(a)

By no later than August 14, 2020, the Seller shall file the preliminary proxy statement in connection with the transactions contemplated hereby (the “Seller Proxy Statement”) with the SEC.  The Seller shall not file any amendment or supplement to the Seller Proxy Statement without providing the Purchaser a reasonable opportunity to review and comment thereon (which comments shall be reasonably considered by the Seller).  Each of the Seller and the Purchaser shall use its reasonable best efforts to resolve, and each party agrees to consult and cooperate with the other parties in resolving, all SEC comments with respect to the Seller Proxy Statement as promptly as practicable after receipt thereof and to cause the Seller Proxy Statement in definitive form to be cleared by the SEC and mailed or made available to the Seller’s stockholders as promptly as reasonably practicable following filing with the SEC.  The Seller agrees to consult with the Purchaser (and reasonably consider any comments provided by the Purchaser) prior to responding to SEC comments with respect to the Seller Proxy Statement and, to the extent reasonably practicable, permit the Purchaser and its outside counsel to participate in all meetings, telephone conferences and other substantive communications with the SEC relating to the Seller Proxy Statement.  Each of the Seller and the Purchaser agrees to correct any information provided by it for use in the Seller Proxy Statement which shall have become false or misleading and the Seller shall promptly, to the


extent required by applicable law, prepare and mail or make available to its stockholders an amendment or supplement setting forth such correction.  The Seller shall as soon as reasonably practicable (i) notify the Purchaser of the receipt of any comments from the SEC with respect to the Seller Proxy Statement and any request by the SEC for any amendment to the Seller Proxy Statement or for additional information and (ii) provide the Purchaser with copies of all written correspondence between the Seller and its representatives, on the one hand, and the SEC, on the other hand, with respect to the Seller Proxy Statement or the transactions contemplated hereby.

(b)

The Seller shall, as soon as practicable following the date on which the Seller is informed that the SEC has no further comments on the preliminary Seller Proxy Statement, duly set a record date for, call, give notice of, convene and hold a stockholders’ meeting (“Seller Stockholders’ Meeting”).  The Seller shall not make any change to the recommendation by the Special Committee of Seller’s Board of Directors of the transactions contemplated hereby and use its reasonable best efforts to (i) solicit from its stockholders proxies in favor of the adoption of this Agreement and the transactions contemplated by this Agreement, and (ii) take all other action necessary or advisable to secure the Majority of the Minority Vote (as defined in Section 7.1(c)).  Promptly following the filing of the Seller Proxy Statement in definitive form, the Purchaser shall deliver to Seller the executed proxy of Russell Horowitz and Michael Arends voting all of the shares at the Seller Stockholders’ Meeting in favor of the transactions contemplated by this Agreement in the same form as is contained in the Seller Proxy Statement, which proxy shall be deemed irrevocable and coupled with an interest until the earlier of the Closing and the termination of this Agreement pursuant to its terms.  Furthermore, the Purchaser shall not take any action with the purpose of adversely affecting the Seller’s solicitation of stockholders proxies in favor of the adoption of this Agreement and the transactions contemplated by this Agreement or securing the Majority of the Minority Vote.  If, at any time following the dissemination of the Seller Proxy Statement, either the Seller or the Purchaser reasonably determines in good faith (after consulting with the other) that a quorum or the Majority of the Minority Vote is unlikely to be obtained at the Seller Stockholders’ Meeting, then the Seller shall have the right to adjourn or postpone the Seller Stockholders’ Meeting from time to time; provided that no such adjournment or postponement shall delay the Seller Stockholders’ Meeting by more than thirty (30) days from the currently scheduled date.  During any such period of adjournment or postponement, the Seller shall continue in all respects to comply with its obligations under this ‎Section 6.4.

Section 6.5Public Announcements.  Prior to and following the Closing, subject to its legal obligations (including requirements of stock exchanges and other similar regulatory bodies), each Party shall consult with the other Parties with respect to the timing and content of all announcements regarding any aspect hereof or the transactions contemplated hereby to the financial community, Governmental Authorities, employees, customers, suppliers or the general public and shall use reasonable efforts to agree upon the text of any such announcement prior to its release.

Section 6.6 Employees.  Seller shall terminate the employees related to the Business at such times as mutually agreed to by the Parties (the “Transferred Employees”), and Purchaser shall make offers of employment, on an “at-will” basis, with substantially similar base salary or hourly wage, to the Transferred Employees. The Parties shall work together and use good faith efforts to do, or cause to be done, all things necessary, proper or advisable under applicable Law to effectuate the transition of the Transferred Employees (including, but not limited to, the provision of COBRA coverage and the rollover and/or transfer of any benefits that the Transferred Employees are or may be entitled to pursuant to Seller’s benefit plans).


Section 6.7Consents.  If any Third Party Consent with respect to any Assumed Contract is not obtained prior to the Closing (each, a “Non-Assignable Contract”), Seller shall, during the remaining term of each Non-Assignable Contract, use its reasonable best efforts to (i) obtain the consent of the third parties required thereunder and otherwise transfer the Non-Assignable Contracts to Purchaser, (ii) make the benefit of such Non-Assignable Contract available to Purchaser so long as Purchaser cooperates with Seller and promptly reimburses Seller for all payments made by Seller in connection therewith, and (iii) enforce, at the request of Purchaser and at the expense and for the account of Purchaser, any right of Seller arising from such Non-Assignable Contract against the other party or parties thereto. With respect to any such Non-Assignable Contract as to which the necessary approval or consent for the assignment or transfer to Purchaser is obtained following the Closing, such Non-Assignable Contract shall be, and hereby is, automatically transferred and assigned to Purchaser without any further action required of the Parties.

Article VII
CONDITIONS TO CLOSING

Section 7.1Conditions to Obligations of Purchaser. The obligations of Purchaser to consummate the transactions contemplated hereby shall be subject to the fulfillment at or prior to the Closing of each of the following conditions:

(a)

Governmental Consents. All consents, approvals, orders or authorizations of, or registrations, declarations or filings with, all Governmental Authorities required in connection with the execution, delivery or performance hereof shall have been obtained or made, except where the failure to have obtained or made any such consent, approval, order, authorization, registration, declaration or filing would not result in a material fine or penalty payable by Purchaser or any of its Affiliates or any adverse effect on the assets, liabilities, results of operations, business or prospects of the Business following the Closing.

(b)

Performance of Obligations of Seller. Seller shall have performed in all material respects all covenants and agreements required to be performed by each of them hereunder at or prior to the Closing.

(c)

Majority of Minority Vote. Holders of a majority of the outstanding voting securities of the Seller other than those securities held by Russell Horowitz and Michael Arends approve the Transaction (the “Majority of the Minority Vote”).

(d)

Consents. Seller shall have obtained and delivered to Purchaser the written consents (or waivers with respect thereto) as described on Schedule 4 (“Third Party Consents”) (all such consents and waivers shall be in full force and effect).

(e)

Ancillary Documents. Seller shall have delivered, or caused to be delivered, to Purchaser the following:

(i)

Subscription Agreement executed by Seller;

(ii)

Support Services Agreement executed by Seller;

(iii)

an Option Termination Agreement, in a form to be mutually agreed upon by the Parties, executed by Seller, with respect to the options to be terminated as set forth on the Schedule of Terminated Options;

(iv)

executed deed, bill of sale, instrument of assignment, certificate of title and other conveyance documents, dated as of the Closing Date, transferring to Purchaser all of Seller’s right, title and interest in and to the Assets, together with possession of the Assets, including the Bill of Sale substantially in the form attached hereto as Exhibit C (the “Bill of Sale”);


(v)

document evidencing the assignment to Purchaser of all of the Assumed Contracts and the assignment of any Permits, including the Assignment and Assumption Agreement substantially in the form attached hereto as Exhibit D (the “Assignment and Assumption Agreement”);

(vi)

a Domain Name Assignment executed by Seller, in substantially the form attached hereto as Exhibit E;

(vii)

a Trademark Assignment executed by Seller, in substantially the form attached hereto as Exhibit F; and

(viii)

a Patent Assignment executed by Seller, in substantially the form attached hereto as Exhibit G.

(f)

No Material Adverse Effect.  Between the date hereof and the Closing Date, there shall not have occurred (nor shall Purchaser have become aware of) any Material Adverse Effect.

Section 7.2Conditions to Obligations of Seller. The obligations of Seller to consummate the transactions contemplated hereby shall be subject to the fulfillment at or prior to the Closing of each of the following conditions:

(a)

Governmental Consents. All consents, approvals, orders or authorizations of, or registrations, declarations or filings with, any Governmental Authority required in connection with the execution, delivery or performance hereof shall have been obtained or made, except where the failure to have obtained or made any such consent, approval, order, authorization, registration, declaration or filing would not result in a material fine or penalty payable by Seller or a material restriction on Seller’s operations.

(b)

Performance of Obligations by Purchaser. Purchaser shall have performed in all material respects all covenants and agreements required to be performed by each Party hereunder on or prior to the Closing Date.

(c)

Majority of Minority Vote.  The Majority of the Minority Vote is obtained.

(d)

Ancillary Documents. Purchaser shall have delivered, or caused to be delivered, to Seller the following:

(i)

An executed Subscription Agreement for Seller executed by Purchaser and stock certificates with respect to such Equity Consideration;

(ii)

documents evidencing the assumption of the Assumed Contracts, the acceptance of the Permits and the Assumed Liabilities, including the Assignment and Assumption Agreement;

(iii)

Support Services Agreement executed by Purchaser; and

(iv)

an Option Termination Agreement, in a form to be mutually agreed by the Parties, executed by each of Russell Horowitz and Michael Arends, with respect to the options to be terminated as set forth on the Schedule of Terminated Options.


Article VIII
CLOSING

The Closing shall take place remotely via the electronic exchange of documents and signatures on the first Business Day after all of the conditions to closing set forth in Article VII are either satisfied or waived (other than conditions which, by their nature, are to be satisfied on the Closing Date), or at such other time, date or place as Seller and Purchaser may mutually agree upon in writing.

Article IX
TERMINATION

Section 9.1Termination. This Agreement may be terminated:

(a)

in writing by mutual consent of the Parties;

(b)

by written notice from Seller to Purchaser, in the event Purchaser (i) fails to perform in any material respect any of its agreements contained herein required to be performed by it at or prior to the Closing or (ii) materially breaches any of its representations and warranties contained herein, which failure or breach is not cured within ten days following Seller having notified Purchaser of their intent to terminate this Agreement pursuant to this Section 9.1(b); or

(c)

by written notice from Purchaser to Seller, in the event Seller (i) fails to perform in any material respect any of its agreements contained herein required to be performed by it at or prior to the Closing or (ii) materially breaches any of its representations and warranties contained herein, which failure or breach is not cured within ten days following Purchaser having notified Seller of its intent to terminate this Agreement pursuant to this Section 9.1(c);

Section 9.2Effect of Termination. In the event of termination of this Agreement pursuant to this Article IX, this Agreement shall immediately become void and there shall be no liability on the part of any Party or its officers, directors or stockholders, except for obligations under Section 6.5 (Public Announcements), Section 11.1 (Notices), Section 11.2 (Controlling Law; Amendment), Section 11.3 (Consent to Jurisdiction), and Section 11.9 (Transaction Costs), all of which shall survive the Termination Date.

Article X
INDEMNIFICATION

Section 10.1 Indemnification Obligations of Parties. Each Party hereby agrees to indemnify, defend, and hold the other party harmless from, against, and in respect of, and will compensate and reimburse the other party for, any and all losses (“Losses”) incurred, arising out of or relating to (i) any breach or inaccuracy of any representation or warranty made by such Party in this Agreement, or (ii) any breach of any covenant, agreement or undertaking made by such Party in this Agreement.

Section 10.2Claims Period. The Parties, intending to contractually modify the applicable statutes of limitation, agree that the Claims Period for any losses arising hereunder shall expire on the date that is 12 months following the Closing Date.

Section 10.3Limitations on Indemnification.

(a)

Losses in respect of a claim for indemnification under Article X shall be reduced by the amount of any insurance proceeds actually received by the indemnified party with respect to such matter.

(b)

An indemnified party shall act in good faith and in a commercially reasonable manner to mitigate any Losses they may suffer as a result of an allowable claim under Article X.


Section 10.4Liability Limits.  Neither Party shall be required to pay an aggregate amount in excess of the Base Cash Payment Amount in respect of any Losses suffered by the other party.

Section 10.5Exclusive Remedy.  Each Party acknowledges and agrees that its respective sole and exclusive remedy with respect to any and all claims under this Agreement shall be pursuant to the indemnification provisions set forth in this Article X; provided, however, that nothing in this Section 10.5 shall be deemed a waiver by any Party of any right to specific performance, injunctive or other equitable relief or any right to seek any remedy on account of any Party’s fraudulent, criminal or intentional misconduct.

Article XI
MISCELLANEOUS PROVISIONS

Section 11.1Notices. All notices, requests, claims, demands, waivers and other communications under this Agreement shall be in writing and shall be deemed given (a) five Business Days following sending by registered or certified mail, postage prepaid, (b) when sent, if sent by email, unless not sent during business hours, in which case it shall be deemed delivered on the next Business Day, in each case, provided no failure of delivery or out of office notice is generated or otherwise received by the sender; (c) when delivered, if delivered personally to the intended recipient, and (d) when received by the addressee if sent by an internationally recognized two-day courier (receipt requested), in each case, addressed to a Party at the following address for such Party:

(a)If to Purchaser to:

Archenia, Inc.

Attn: Russell C. Horowitz

E-mail: [***]

(b)If to Seller to:

Marchex, Inc.

520 Pike Street, Suite 200

Seattle, WA 98101

Attn: Don Cogsville

Email: [***]

with a copy to (which shall not constitute notice):

DLA Piper LLP (US)

701 Fifth Avenue, Suite 6900

Seattle, WA 98104

Attn: Andrew Ledbetter

E-mail: Andrew.ledbetter@us.dlapiper.com

or to such other address(es) as shall be furnished in writing by any such Party to the other Parties hereto in accordance with the provisions of this Section 11.1. The Parties agree that the attorney for a Party shall have the authority to deliver notices on such Party’s behalf to the other Parties hereto.


Section 11.2Controlling Law; Amendment. This Agreement shall be governed by and construed and enforced in accordance with the internal Laws of the State of Delaware without reference to its choice of Law rules. This Agreement may not be amended, modified or supplemented except by written agreement of the Parties.

Section 11.3Consent to Jurisdiction. Each Party hereby irrevocably agrees that any legal dispute shall be brought only to the exclusive jurisdiction of the courts of the State of Delaware or the federal courts located in the State of Delaware, and each Party hereby consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by Law, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding that is brought in any such court has been brought in an inconvenient forum. During the period a legal dispute that is filed in accordance with this Section 11.3 is pending before a court, all actions, suits or proceedings with respect to such legal dispute or any other legal dispute, including any counterclaim, cross-claim or interpleader, shall be subject to the exclusive jurisdiction of such court. Each Party hereby waives, and shall not assert as a defense in any legal dispute, that (a) such Party is not subject thereto, (b) such action, suit or proceeding may not be brought or is not maintainable in such court, (c) such Party’s property is exempt or immune from execution, (d) such action, suit or proceeding is brought in an inconvenient forum, or (e) the venue of such action, suit or proceeding is improper. A final judgment in any action, suit or proceeding described in this Section 11.3 following the expiration of any period permitted for appeal and subject to any stay during appeal shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Laws.

Section 11.4Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule or Law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any Party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible to the end that the transactions are fulfilled to the extent possible.

Section 11.5Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all of which shall be considered one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by facsimile or email shall be as effective as delivery of a manually executed counterpart of this Agreement.

Section 11.6Integration. This Agreement, together with the schedules attached hereto, and the documents executed pursuant hereto supersede all negotiations, agreements and understandings among the Parties with respect to the subject matter hereof and constitute the entire agreement among the Parties with respect thereto.

Section 11.7Compliance with Bulk Sales Laws. Each Party hereby waives compliance by the Parties with the “bulk sales,” “bulk transfers” or similar Laws and all other similar Laws in all applicable jurisdictions in respect of the transactions contemplated by this Agreement.

Section 11.8Cooperation Following the Closing. Following the Closing, each Party shall deliver to the other Parties such further information and documents and shall execute and deliver to the other Parties such further instruments and agreements as any other Party shall reasonably request to consummate or confirm the transactions provided for herein, to accomplish the purpose hereof or to assure to any other Party the benefits hereof.


Section 11.9Transaction Costs. Except as provided above or as otherwise expressly provided herein, (a) the Purchaser shall pay its own fees, costs and expenses incurred in connection herewith and the transactions contemplated hereby, including the fees, costs and expenses of its financial advisors, accountants and counsel, and (b) the Seller shall pay its fees, costs and expenses incurred in connection herewith and the transactions contemplated hereby, including the fees, costs and expenses of its financial advisors, accountants and counsel.

Section 11.10Waiver.  Any agreement on the part of a Party to any extension or waiver of any provision hereof shall be valid only if set forth in an instrument in writing signed on behalf of such Party. A waiver by a Party of the performance of any covenant, agreement, obligation, condition, representation or warranty shall not be construed as a waiver of any other covenant, agreement, obligation, condition, representation or warranty. A waiver by any Party of the performance of any act shall not constitute a waiver of the performance of any other act or an identical act required to be performed at a later time.

Section 11.11Waiver of Jury Trial. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW THAT CANNOT BE WAIVED, THE PARTIES HEREBY WAIVE, AND COVENANT THAT THEY WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE), ANY RIGHT TO TRIAL BY JURY IN ANY ACTION ARISING IN WHOLE OR IN PART UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE. THE PARTIES AGREE THAT ANY OF THEM MAY FILE A COPY OF THIS PARAGRAPH WITH ANY COURT AS WRITTEN EVIDENCE OF THE KNOWING, VOLUNTARY AND BARGAINED-FOR AGREEMENT AMONG THE PARTIES IRREVOCABLY TO WAIVE ITS RIGHT TO TRIAL BY JURY IN ANY PROCEEDING WHATSOEVER BETWEEN THEM RELATING TO THIS AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT AND THAT SUCH PROCEEDING WILL INSTEAD BE TRIED IN A COURT OF COMPETENT JURISDICTION BY A JUDGE SITTING WITHOUT A JURY.

[Signature page immediately follows]


In Witness Whereof, the Parties have caused this Agreement to be duly executed, as of the date first above written.

PURCHASER:

Archenia, Inc.

By:

/s/ Russell C. Horowitz

Name:

Russell C. Horowitz

Title:

Director


Seller:

Marchex, Inc.

By:

/s/  Don Cogsville

Name:

Don Cogsville

Title:

Director


EXHIBIT A

Form of Support Services Agreement



SUPPORT SERVICES AGREEMENT

Marchex, Inc.Archenia, Inc.

THIS SUPPORT SERVICES AGREEMENT (“Agreement”), with an effective date of [Date] (“Effective Date”), is entered into by and between Marchex, Inc. (“Service Provider”), a Delaware corporation and Archenia, Inc. (“Service Recipient”), a Delaware corporation (collectively as “Parties” and individually as “Party”).

RECITALS

WHEREAS, Service Provider has represented to Service Recipient that it has the facilities, personnel and expertise to effectively provide Support Services (as such term is defined below);

WHEREAS, Service Recipient desires Service Provider to provide such Support Services; and

WHEREAS, the Parties wish to define the scope and nature of Support Services to be undertaken by Service Provider.

NOW, THEREFORE, in consideration of the premises and the mutual promises hereinafter set forth, the Parties hereto agree as follows:


DEFINITIONS

For purposes of this Agreement, the following definitions shall apply to the terms set forth below wherever they appear:

Affiliate.  “Affiliate” of a Party means any entity controlled by, controlling or under common control with such Party where “control” in any of the foregoing forms means ownership, either direct or indirect, of more than 50% of the equity interest entitled to vote for the election of directors or equivalent governing body.  An entity shall be considered an Affiliate only so long as such entity continues to meet the foregoing definition.

Direct Costs.  “Direct Costs” means and includes all of Service Provider’s costs, determined under United States generally accepted accounting principles (“GAAP”), including wages, fringe benefits, employer taxes and contributions, office space, stock-based compensation (if any intrinsic value based compensation expenses are appropriate under Accounting Standards Codification Topic 718), equipment, materials, and third party services that are specifically attributable to the Support Services provided by Service Provider under this Agreement, including allowances for the depreciation of equipment and other capital assets used in the provision of Support Services, as reported in Service Provider’s records of account, computed under GAAP, but shall not include financing expenses (which means interest income or expense, all exchange gains or losses and other financial costs), taxes based on income or extraordinary, unusual or other non-operating expenses (other than those incurred at the request of Service Recipient), including but not limited to material changes to workforce or operations.

Fiscal Quarterly Close Date.  “Fiscal Quarterly Close Date” means March 31, June 30, September 30 and December 31 or equivalent dates corresponding to the last day of the third, sixth, ninth and twelfth months of Service Provider’s fiscal year.

Fiscal Year.  “Fiscal Year” shall mean each Party’s fiscal year.


Indirect Costs.  “Indirect Costs” means that portion of Service Provider’s general and administrative expenses that are specifically allocated to the Support Services under this Agreement under any reasonable method agreed to by the Parties.

Representative(s).  “Representative(s)” means and includes any and all employees, managers, officers, directors, partners, consultants, independent contractors, licensees, successors, assigns and agents of either Party.

Support Services.  “Support Services” means the services provided by Service Provider to Service Recipient as described in Article 3.

Reverse Services.  “Reverse Services” means any services provided by the Service Recipient to the Service Provider pursuant to a separate agreement entered into between the parties.

Support Services Costs.  “Support Services Costs” means the sum of Direct Costs and Indirect Costs incurred in the performance of Support Services under the terms of this Agreement.

Third Party.  “Third Party” means and includes any individual, corporation, trust, estate, partnership, joint venture, company, association, league, governmental bureau or agency, or any other entity regardless of the type or nature, which is not a Party or an Affiliate.


AGREEMENT TO PROVIDE SUPPORT SERVICES

Provision of Support Services.  Upon request by Service Recipient, Service Provider shall perform Support Services for the benefit of Service Recipient pursuant to the terms and conditions set forth herein.

Service Provider shall determine whether itself or one of its subsidiaries will render the corporate facilities to be used in rendering the Support Services and the individuals who will render such Support Services.

Nothing herein shall be deemed to restrict Service Provider or its directors, officers or employees from engaging in any business or from contracting with Third Parties or other parties for similar or different services.

Progress Reports.  Service Provider shall, upon request and based on its actual knowledge thereof, provide reasonably prompt notice to Service Recipient of the status and progress of Support Services being provided under this Agreement.


SUPPORT SERVICES

Support Services.  The Support Services to be covered in this Agreement shall include, but not be limited to:

(a) information technology, human resources, accounting, legal, technology operations (comprising physical and logical monitoring and maintenance of data centers) and contracts administration, to the extent not covered in a separate agreement between or among the Parties; such other general and administrative services that Service Recipient may need from time to time.

License of Marchex branding and historical marketing efforts. Service provider grants Service Recipient a license to Marchex branding, trademarks and other intellectual property, as well as historical marketing efforts and materials relevant to Service Recipient’s business.  The license shall be in effect until the later


of: (i) three (3) years from the Effective Date, and (ii) one (1) year following any nonrenewal or termination of this Agreement.

Legal Title.  Legal title to any work product (“Work Product”) resulting from the Support Services shall be vested in Service Recipient, to exploit fully or assign anywhere in the world.  Work Product may include, among others, reports, memoranda, compilations, presentations and e-mails.  All Work Product shall constitute Confidential Information (as defined in Article 5).

Assignment of Rights.  To the extent as may be required or appropriate to establish legal title to the Work Product to Service Recipient, Service Provider hereby irrevocably assigns all its rights, title and interest to the Work Product to Service Recipient and will execute and provide to Service Recipient documents and instruments of conveyance respecting the Work Product as may be appropriate to perfect Service Recipient’s title thereto.  The absence of such written documentation shall not limit the rights of Service Recipient in the Work Product.  To the extent any of the rights, title and interest in and to the Work Product cannot be assigned by Service Provider to Service Recipient, Service Provider hereby grants to Service Recipient under the arm’s length standard an exclusive, royalty-free, transferable, perpetual, irrevocable, unrestricted, worldwide license (with rights to sublicense through one or more tiers of sublicensees) under such non-assignable Work Product.  To the extent any of the Work Product can be neither assigned nor licensed by Service Provider to Service Recipient, Service Provider hereby irrevocably waives and agrees never to assert its rights in any such non-assignable and non-licensable Work Product against Service Recipient, Service Recipient’s Affiliates, Service Recipient’s licensees or Service Recipient’s successors, or its and their respective customers.

General Conduct.  Service Provider shall use reasonable efforts to provide Support Services for Service Recipient.  Service Provider agrees that it shall at all times adhere to the instructions, requests and policies of Service Recipient regarding any activities relating to the performance of Support Services under this Agreement, provided that such instructions, requests and policies are commercially reasonable.  Service Provider shall conduct its activities under this Agreement in a lawful manner and in accordance with high standards of fair trade, fair competition and business ethics and shall cause all of its Representatives to do the same.

Personnel and Facilities.  Service Provider represents and warrants that it shall occupy and maintain personnel and facilities adequate to provide Support Services and perform its other obligations under this Agreement.  Service Provider shall retain and have at its disposal at all times an adequate staff of trained and qualified personnel to perform its obligations under this Agreement.  

Independent Service Provider Relationship.  The relationship of the Parties established by this Agreement is that of independent service providers, and nothing in this Agreement shall be construed: (a) to give either Party the right or power to direct or control the daily activities of the other Party; (b) to constitute the Parties as principal and agent, employer and employee, partners, joint venturers, co-owners or otherwise as participants in a joint undertaking or (c) to allow either Party to (i) create or assume any obligation on behalf of the other Party for any purpose whatsoever or (ii) represent to any person that such Party has any right or power to enter into any binding obligation on the other Party’s behalf.



COMPENSATION

Compensation of Service Provider.  As compensation for the Support Services provided under the terms of this Agreement, Service Recipient shall pay Service Provider a fee (“Support Services Fee”) as detailed in Exhibit A.  The Parties shall periodically review such Support Services Fee and adjust it as necessary to ensure that it continues to satisfy arm’s length principles.  Exhibit A also includes other compensation payable by Service Recipient to Service Provider pursuant to this Agreement.

Quarterly Report and Invoice.  Upon request, for each of Service Provider’s Fiscal Quarterly Close Dates, Service Provider shall issue Service Recipient an invoice listing the Support Services Costs that Service Provider has incurred pursuant to this Agreement during such fiscal quarter (“Quarterly Invoice”), or more frequently as needed.  Each Quarterly Invoice shall be provided no later than the thirtieth (30th) day following the end of each Fiscal Quarterly Close Date, and shall include a listing of the Support Services Costs incurred by Service Provider.

Reasonableness of Expenses. All costs and expenses reported by Service Provider to Service Recipient pursuant to this Agreement shall be reasonable and necessary costs and expenses incurred by Service Provider in the performance of Support Services under this Agreement.

Payment.  Service Recipient shall pay the Support Services Fee payable under this Article 4 within forty-five (45) days of receipt of the Quarterly Invoice from Service Provider or, if a Quarterly Invoice is not furnished within forty-five (75) days of the respective Fiscal Quarterly Close Date, an amount equal to the communicated Support Services Fee.  Payment shall be made by Service Recipient in the form of a bank draft, wire transfer or other form of payment as may be determined by mutual agreement of the Parties.  Unpaid amounts shall bear interest based upon the short-term U.S. Applicable Federal Rate (published monthly by the Internal Revenue Service), provided that Service Provider may charge default interest of 6% per annum on unpaid amounts after 60 days from the date of the Quarterly Invoice.

Examination of Books and Records. Service Provider shall keep accurate books and records with respect to the Support Service Costs, and Service Recipient shall be permitted to inspect such books and records with respect to such Support Services Costs upon providing ten (10) days advance written notice.

Purchased Materials and Third Party Costs.  If a Service Provider acquires materials to perform services on behalf of Service Recipient pursuant to this Agreement, such cost of materials shall be included as a Direct Cost under Section 1.2.  As between the Parties, the payment terms specified in Section 4.4 above shall apply irrespective of the payment terms or arrangements between Service Provider and the Third Party.  If a Service Provider engages a Third Party to perform services on behalf of Service Recipient, Service Recipient shall reimburse Service Provider at cost for the costs of hiring such Third Party (subject to the compensation markup detailed on Exhibit A).

Netting as Payment.  At the sole discretion of Service Recipient, netting of any amount payable under this Agreement as against existing accounts payable and accounts receivable shall be acceptable payment, effective as of the date of the netting on the books of Service Provider and Service Recipient.

True-up.  Within sixty (60) days of completion by Service Provider of its audited year-end financial statements, if Service Provider determines that the aggregate Support Services Fee paid by Service Recipient for the previous year either overstates or understates the proper amount as determined by the year-end audit, Service Provider shall invoice or credit, as the case may be, Service Recipient for the amount of such variance, or the excess Support Services Fee shall be netted as provided in Section 4.7.


CONFIDENTIAL INFORMATION

Definition of Confidential Information.  The Parties acknowledge that, from time to time, one Party (the “Discloser”) may disclose to the other Party (the “Recipient”) information: (a) which is marked with “confidential” or a similar legend; (b) which is described orally and designated as confidential or (c) which would, under the circumstances, be understood by a reasonable person to be confidential (“Confidential Information”).  Any unmarked or oral information between employees of the Parties discussing Confidential Information will be Confidential Information by default whether or not declared confidential and whether or not it is subsequently described in writing.  Upon subsequent disclosure of previously disclosed Confidential Information to Recipient by Discloser, the information will remain Confidential Information even if not identified as confidential information at the subsequent disclosure.

Confidentiality Obligations.  Recipient shall retain such Confidential Information in confidence, and shall not disclose it to any Third Party or use it for other than the purposes of this Agreement without Discloser’s prior written consent.  Recipient may disclose such Confidential Information to any other Party, provided such other Party has a need to know it for the purposes of this Agreement and is bound under confidentiality obligations at least as stringent as those of this Section 5.2 with respect to such Confidential Information.  Each Party shall use at least the same procedures and degree of care with respect to such Confidential Information which it uses to protect its own confidential information of like importance, and in no event less than reasonable care.  Recipient will immediately give written notice to Discloser of any unauthorized use or disclosure of Discloser’s Confidential Information, and Recipient will assist Discloser in remedying such unauthorized use or disclosure.

Period of Confidentiality Obligations.  With respect to each item of Confidential Information, other than any source code, disclosed under this Agreement, the provisions of this Article 5 shall apply for a period of five (5) years from the date of first receipt by Recipient of such item of Confidential Information.  With respect to any source code, in whole or in part, disclosed under this Agreement, the provisions of this Article 5 shall remain in effect until such time as Recipient can demonstrate, using only legally admissible evidence, that such source code is publicly known or was made generally available through no action or inaction of Recipient.

Compelled Disclosure.  In the event that Recipient or any of its Affiliates or Representatives is requested or required (by oral questions, interrogatories requests for information or documents in legal proceedings, subpoenas, civil investigative demands or other similar processes) to disclose any of Discloser’s Confidential Information, Recipient shall provide Discloser with prompt written notice of any such request or requirement sufficiently timely to allow Discloser adequate time to seek a protective order or other appropriate remedy and/or waive compliance with the provisions of this Agreement.

Third Party Contracts.  Prior to Recipient’s disclosure of any of Discloser’s Confidential Information to any Third Party, Recipient must require the Third Party to enter into a nondisclosure agreement (“NDA”) provided by Discloser.  The NDA will take precedence over the Third Party agreement.

Ownership of Materials.  Each Recipient agrees that all Confidential Information received is and will remain the property of Discloser and shall not be copied or reproduced without the express permission of Discloser, except for such copies as may be reasonably necessary in order to accomplish the purpose of this Agreement.  Upon written request of Discloser, Recipient shall immediately discontinue use of all Confidential Information of Discloser and shall, at Discloser’s option, either destroy or return to Discloser all hard copies in its possession of such Confidential Information and any derivatives thereof (including all hard copies of any translation, modification, compilation, abridgement or other form in which the Confidential Information has been recast, transformed or adapted), and to delete all online electronic copies thereof; provided, however, that Recipient may retain one (1) archival copy of the Confidential Information,


which shall be used only in case of a dispute concerning this Agreement.  Notwithstanding the foregoing, neither Party shall be required to destroy or alter any computer-based back-up files generated in the normal course of its business, provided that such files are maintained confidential in accordance with the terms of this Agreement for the full period provided for in Section 5.3.

Exceptions to Confidentiality Obligations.  Confidential Information will not include information to the extent that such information:

was generally available to the Administrator deems appropriatepublic at the time of grantits disclosure to conformRecipient hereunder;

became generally available to the substitute Awardspublic after its disclosure other than through an act or omission of Recipient in breach of this Agreement; or

was subsequently lawfully and independently disclosed to Recipient by a person, other than Discloser, without an obligation of confidentiality.

In the event that Recipient intends to disclose to a Third Party any of Discloser’s Confidential Information under the exceptions (a), (b) or (c) above, Recipient must first obtain Discloser’s written permission to do so, which approval will be at Discloser’s sole discretion.

Equitable Remedies.  Since unauthorized use or disclosure of Discloser’s Confidential Information will diminish the value to Discloser of its proprietary interests in the Confidential Information, if Recipient breaches any of its obligations under this Article 5, Discloser shall be entitled to equitable relief to protect its interests therein, including, but not limited to, injunctive relief, as well as money damages.

Confidentiality Obligations Survival.  With respect to each item of Confidential Information, transferred under this Agreement, the provisions of the awards for which they are substituted.this Article 5 shall remain in effect until such time as Recipient can demonstrate, using only legally admissible evidence, that such item of Confidential Information is publicly known or was made generally available through no action or inaction of Recipient.

(f) 
INDEMNIFICATION AND LIABILITY LIMITATIONS

Termination, Amendment and Modification of the PlanGeneral Indemnity.  The Board may terminate, amendService Provider shall hold Service Recipient harmless and shall defend and indemnify Service Recipient from and against any loss, cost or modify the Plan or any portion thereof at any time. Except as otherwise determined by the Board, termination of the Plan shall not affect the Administrator’s ability to exercise the powers granted to it hereunderexpense, including reasonable attorney fees, with respect to Awards grantedany Third Party claim arising out of any act or omission of Service Provider in connection with the performance of its duties under this Agreement.

Limitation on Damages.  In no event will Service Provider have any liability to Service Recipient for any indirect, incidental, special or consequential damages arising out of or related to this Agreement, however caused and on any theory of liability, whether for breach of contract, tort or otherwise, including, but not limited to, loss of anticipated profits, loss of data or loss of use, even if Service Provider has been advised of the Planpossibility of such damages.

No Warranty.  The Support Services and information are provided “as is”.  Service Provider makes no express or implied representations, warranties or guarantees relating to the Support Services or the quality or results of the Support Services to be performed under this Agreement and expressly disclaims all such representations, warranties and guarantees, including, without limitation, any implied warranties of merchantability, non-infringement and fitness for a particular purpose.

Reasonable Efforts.  Notwithstanding and without limitation of the provisions of Section 6.3, Service Provider will use reasonable efforts to make the Support Services available with substantially the same


degree of care as it employs in performing similar activities for its own operations.  Service Provider shall not be liable to Service Recipient for any loss, damage or expense that may result therefrom or from any change in the manner in which Service Provider renders the Support Services so long as Service Provider deems such change necessary or desirable in the conduct of its own operations.  Under no circumstance shall Service Provider be liable to Service Recipient for any consequences, damages or liabilities arising from or related to any failure or delay by Service Provider in performing any of Service Provider’s obligations under this Agreement other than for damages arising from Service Provider’s willful or reckless misconduct.

Officers and Employees.  Officers and employees of Service Provider who provide Support Services to Service Recipient shall not be liable to Service Recipient for any claims, damages or expenses relating to the Support Services provided pursuant to this Agreement and Service Recipient shall have the ultimate responsibility for all Support Services provided herein.


TERM AND TERMINATION

Term.  This Agreement shall enter into effect on the Effective Date and shall remain in full force and effect for two (2) years from the Effective Date, and shall automatically renew for successive one (1) year terms unless written notice of nonrenewal is provided by a Party at least six (6) months prior to a renewal date or unless terminated in accordance with this Article 7.

Modification of Scope:  Service Recipient shall have the right to reduce the scope of Support Services to be performed under this Agreement or to reduce or eliminate the technology operations services by providing at least ninety (90) days prior written notice to Service Provider of such election, provided such right may not reduce the Minimum Amounts (as defined in Exhibit A).

Termination for Cause.  This Agreement may be terminated by any Party with respect to the other Party (“Breaching Party”), if Breaching Party is in material breach of this Agreement and fails to cure such breach within thirty (30) days following receipt of notice of such breach.

Rights and Obligations Upon Termination.  Upon termination of this Agreement for any reason whatsoever, Service Provider shall immediately cease all activities related to the provision of Support Services as provided under this Agreement and, within thirty (30) days of termination and at the option of Service Recipient, comply with the provisions of Section 5.6.

Final Payment.  Upon any termination pursuant to Section 7.2 or Section 7.3, the date of such termination.

(g) Non-Guarantee of Employment or Service. Nothing in the Plan or in any Grant Agreement thereunder shall confer any right on an individual to continue in the service of the Company or shall interfere in any way with the right of the Company to terminate such service at any time with or without cause or notice and whether or not such termination results in (i) the failure of any Award to vest; (ii) the forfeiture of any unvested or vested portion of any Award; and/or (iii) any other adverse effect on the individual’s interests under the Plan.

(h) Compliance with Securities Laws; Listing and Registration. If at any time the Administrator determines that the delivery of Common Stock under the Plan is or may be unlawful under the laws of any applicable jurisdiction, or Federal, state or foreign securities laws, the right to exercise an Award or receive shares of Common Stock pursuant to an Award shall be suspended untiltreated as the Administrator determines that such delivery is lawful. If at any timefinal “Fiscal Quarterly Close Date”.  Service Provider shall prepare a final Quarterly Report to serve as the Administrator determines thatfinal Quarterly Invoice.  Service Recipient shall pay the deliveryfinal Quarterly Invoice within thirty (45) days thereafter in accordance with Section 4.4.

Waiver of Common Stock under the Plan is or may violate the rulesTermination Compensation.  Upon termination of the national exchange on which the shares are then listedthis Agreement, Service Recipient shall not be liable for, trade, the rightand Service Provider hereby waives, all rights to exercise an Award or receive shares of Common Stock pursuant to an Award shall be suspended until the Administrator determines that such delivery would not violate such rules. The Company shall have no obligation to effect any registration or qualification of the Common Stock under Federal, state or foreign laws.

The Company may require that a grantee, as a condition to exercise of an Award,compensation and as a condition to the delivery of any share certificate, make such written representations (including representations to the effect that such person will not dispose of the Common Stock so acquired in violation of Federal, state or foreign securities laws) and furnish such information as may, in the opinion of counsel for the Company, be appropriate to permit the Company to issue the Common Stock in compliance with applicable Federal, state or foreign securities laws. The stock certificates for any shares of Common Stock issued pursuant to this Plan may bear a legend restricting transferability of the shares of Common Stock unless such shares are registered or an exemption from registration is available under the Securities Act of 1933, as amended, and applicable state or foreign securities laws.

(i) No Trust or Fund Created. Neither the Plan nor any Award shall create or be construed to create a trust or separate fundall claims of any kind whether on account of the loss by Service Provider of present or a fiduciary relationship between the Company and a granteeprospective profits, anticipated orders, expenditures, investments or commitments made in connection with this Agreement or goodwill created or on account of any other person. Tocause whatsoever.

Survival.  In the extent thatevent of the termination of this Agreement for any granteereason whatsoever, Article 1, Article 4, Article 5, Article 6, Article 8, Article 9, Section 3.2, Section 3.3, Section 7.4, Section 7.5, Section 7.6 and this Section 7.7 of this Agreement shall survive for as long as necessary to effectuate their purposes and shall bind the Parties, their Affiliates and their Representatives.



ENFORCEMENT OF AGREEMENT

Governing Law and Jurisdiction.  Any questions, claims, disputes or other person acquires a right to receive paymentslitigation concerning or arising from the Company pursuant to an Award, such rightAgreement shall be no greater than the right of any unsecured general creditor of the Company.

(j) Governing Law. The validity, construction and effect of the Plan, of Grant Agreements entered into pursuant to the Plan, and of any rules, regulations, determinations or decisions madegoverned by the Administrator relating to the Plan or such Grant Agreements, and the rights of any and all persons having or claiming to have any interest therein or thereunder, shall be determined exclusively in accordance with applicable federal laws and the laws of the State of Delaware without regard(as it applies to its conflict of laws principles.

(k) 409A Savings Clausean agreement between Delaware residents).  The Plan and all Awards granted hereunder are intendedparties agree that any action brought by either party to comply with,interpret or otherwise be exempt from, Code section 409A. The Plan and all Awards granted under the Planenforce any provision of this Agreement shall be administered, interpreted,brought in, and construedeach party agrees to, and does hereby, submit to the jurisdiction and venue of, the appropriate state or federal court for the district encompassing Service Recipient’s principal place of business.

Litigation.  A Party may not bring a lawsuit or other action upon a cause of action under this Agreement more than one year after the occurrence of the event giving rise to the cause of action.

Remedies Cumulative.  A Party’s remedies under this Agreement are cumulative and shall not exclude any other remedy to which the Party may be entitled.  Termination of this Agreement by a Party shall not adversely affect or impair such Party’s right to pursue any other remedy including, without limitation, the right to recover damages for all harm suffered as a result of the other Party’s breach or default.

Severability.  If any provision in a manner consistent with Code section 409Athis Agreement shall be found or be held to be invalid or unenforceable, then the meaning of said provision shall be construed, to the extent necessaryfeasible, so as to avoidrender the impositionprovision enforceable, and if no feasible interpretation would save such provision, it shall be severed from the remainder of additional taxesthis Agreement which shall remain in full force and effect unless the severed provision is essential and material to the rights or benefits received by any Party.  In such event, the Parties shall use good faith efforts to negotiate a substitute, valid and enforceable provision or agreement that most nearly affects the Parties’ intent in entering into this Agreement.

Waiver.  Any waiver of the provisions of this Agreement or of a Party’s rights or remedies under Code section 409A(a)(1)(B). Shouldthis Agreement must be in writing to be effective.  Failure, neglect or delay by a Party to enforce the provisions of this Agreement or its rights or remedies at any time will not be construed and will not be deemed to be a waiver of such Party’s rights under this Agreement and will not in any way affect the validity of the whole or any part of this Agreement or prejudice such Party’s right to take subsequent action.  Any waiver, amendment or other modification of any provision of the Plan, any Awardthis Agreement or any other agreement or arrangement contemplatedwill be effective only if in writing and signed by the PlanParties.


GENERAL PROVISIONS

Amendments and Supplements.  This Agreement may be found notamended or supplemented by additional written agreements, sections or certificates, as may be mutually determined in writing by the Parties from time to comply with, or otherwise be exempt from, the provisions of Code section 409A, such provision shall be modified and given effect (retroactively if necessary), in the sole discretion of the Administrator, and without the consent of the holder of the Award, in such manner as the Administrator determinestime to be necessary, appropriate or appropriatedesirable to comply with,further the purpose hereof, to clarify the intention of the Parties, or to effectuate an exemption from, Code section 409A. Notwithstanding anythingadd to or modify the covenants, terms or conditions hereof or thereof.

Assignment.  Neither Party may assign this Agreement, its rights or responsibilities hereunder without the prior written authorization of the other Party.  Any assignment in derogation of the Planforegoing shall be void.

Attorney Fees.  Subject to the contrary,limitation set forth in no eventSection 6.2, the prevailing Party shall be entitled to recover from the Administratorlosing Party the prevailing Party’s attorney fees and costs incurred in any lawsuit or other action with respect to any claim arising from the facts or obligations set forth in this Agreement.


Computation of Time.  Whenever the last day for the exercise of any privilege or the discharge of any duty hereunder shall fall on a Saturday, Sunday or any public or legal holiday, whether local or national, the person having such privilege or duty shall have until midnight local time on the next succeeding business day to exercise such privilege, or to discharge such duty.

Counterparts.  This Agreement may be signed in any number of counterparts and by the Parties on separate counterparts, each of which when so executed shall be an original, but all counterparts shall together constitute one and the same document.

Disclosure in Compliance with Applicable Laws.  Notwithstanding any other statement in this Agreement, the Parties may disclose this Agreement and/or its discretion to accelerate the payment or settlement of an Award where such payment or settlement constitutes deferred compensation within the meaning of Code section 409A unless,terms and solelyconditions to the extent that such accelerated paymentdisclosure is necessary to comply with federal and state securities and other applicable laws.  Without limiting the generality of this Section 9.6, each Party shall obtain and shall maintain in full force and effect throughout the continuance of this Agreement all licenses, permits, authorizations, approvals, government filings and registrations necessary or settlementappropriate for the exercise of its rights and the performance of its obligations hereunder and shall provide copies of all such documents to the other Party at its request.

Entire Agreement.  This Agreement (including its exhibits and any amendments) contains the entire agreement of the Parties with respect to the subject matter of this Agreement, except for agreements referenced in this Agreement, and supersedes all previous communications, representations, understandings and agreements, either oral or written, between the Parties with respect to the subject matter hereof.

Force Majeure.  Neither Party will be liable to the other Party for failure or delay in the performance of any obligations under this Agreement for the time and to the extent such failure or delay is permissiblecaused by reasons of acts of God or other cause beyond its reasonable control; provided, however, that should a force majeure event continue to affect a Party for longer than one year, the other Party may terminate this Agreement effective upon written notice.

Headings.  The headings in this Agreement are for convenience only and will not be construed to affect the meaning of any provision of this Agreement.  Any use of “including” shall also be deemed to mean “including without limitation”.

Mutual Drafting.  This Agreement is the joint product of the Parties hereto and their respective counsel, and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such Parties and counsel, and shall not be construed for or against either Party hereto on the basis of authorship thereof.


Notices.  Any notice required or permitted to be given under Treasury Regulation section 1.409A-3(j)(4)this Agreement shall be given to the other Party in writing and delivered by overnight courier, signature of receipt required, and shall be deemed delivered upon written confirmation of delivery by the courier, if sent to the following respective addresses or such new addresses as may from time to time be supplied hereunder.

If to Service Recipient:

Archenia, Inc.

If to Service Provider:

Marchex, Inc.

520 Pike Street, Suite 2000

Seattle, WA 98101

Chief Financial Officer

Sufficiency of Consideration.  The Parties jointly and severally represent, warrant and covenant that each has received full and sufficient consideration for all assignments, licenses and other grants made, and obligations undertaken, in this Agreement.

Taxes. Each Party hereto shall be responsible for any successor provision.and all taxes levied as a result of the performance of each Party’s respective activities under this Agreement.

By their signatures, the authorized Representatives of the Parties acknowledge the Parties’ acceptance of this Agreement:

Marchex, Inc.

Archenia, Inc.

By:

By:

Name:   

Name:

Title:   

Title:   

 



(l) EXHIBIT A

SUPPORT SERVICES FEE AND OTHER COMPENSATION

Pursuant to Effective Date; Termination DateArticle 4, the compensation markup on qualifying Support Services shall be the amount of Support Services Costs, plus a markup of five percent (5%), or other fee as mutually agreed to in writing by the Parties.

Reverse Services may be netted against Support Services Fees for purposes of invoicing a net Support Services Fee.

For the first twelve months of the Term, the minimum Support Services Fee shall be $3,500,000 (the “Year 1 Minimum”), and for the second twelve months of the Term the minimum Support Services Fee shall be $1,500,000 provided Service Recipient’s revenues for such second twelve months shall be at least $38,000,000 (the “Year 2 Minimum” and together with the Year 1 Minimum, the “Minimum Amounts”).  Any adjustment for billing, if applicable, for such minimum Support Services Fee shall be adjusted for at the quarter end of the quarter in which the 365th day falls from commencement of the Agreement.

Additionally, for customer or distribution partner or other vendor relationship contracts associated with Service Recipient’s business that have not yet been assigned to Service Recipient by Service Provider, Service Provider shall remit payments (after any surcharges or withholdings) received from customers and make disbursements for approved distribution partner invoices (after any surcharges or withholdings).  The Plan is effective ascompensation for these administrative services shall be 0.1% of the date on which the Plan is adopted by the Board, subjectabsolute value of customer receipts remitted to approvalService Recipient plus 0.1% of the stockholders within twelve months before or after such date. No Award shall be granted under the Plan after the closeabsolute value of businessdisbursements made on the day immediately preceding the tenth anniversarybehalf of the effective date of the Plan, or if earlier, the tenth anniversary of the date this Plan is approved by the stockholders. Subject to other applicable provisions of the Plan, all Awards made under the Plan prior to such termination of the Plan shall remain in effect until such Awards have been satisfied or terminated in accordance with the Plan and the terms of such Awards.Service Recipient.  

 

 


ANNEX B

. MARCHEX, INC.   IMPORTANT ANNUAL MEETING INFORMATION   Electronic Voting Instructions Available 24 hours a day,OPINION OF OUR FINANCIAL ADVISOR

August 7, days a week!   Instead of mailing your proxy, you may choose one2020

Special Committee of the voting methods outlined belowBoard of Directors

Marchex, Inc.

520 Pike Street, Suite 2000

Seattle, WA 98101

Members of the Special Committee:

ROTH Capital Partners, LLC (“we” or “ROTH”) understands that Marchex, Inc., a Delaware corporation (“Seller”) and Archenia, Inc., a Delaware corporation (“Purchaser”) will enter an asset purchase agreement (the “Agreement”) pursuant to vote your proxy.   VALIDATION DETAILS ARE LOCATED BELOW IN THE TITLE BAR.   Proxies submittedwhich Seller proposes to sell to Purchaser, and Purchaser proposes to purchase from Seller (the “Transaction”), the Assets (as defined in the Agreement), and Purchaser proposes to assume the Assumed Liabilities (as defined in the Agreement), upon the terms and conditions of the Agreement.  The aggregate amount to be paid for the Assets (the “Purchase Price”) pursuant to the Agreement will be an amount equal to (a) $2,250,000 plus (b) an amount of shares of capital stock of Purchaser equal to 10% of the total outstanding shares on a fully-diluted basis plus (c) the contingent consideration (if any) pursuant to Section 3.3 of the Agreement plus (d) the assumption of the Assumed Liabilities plus (e) the termination by Seller of the Internet or telephone mustoptions held by (i) Russell Horowitz and (ii) Mike Arends.  Additional terms and conditions of the Transaction are more fully set forth in the Agreement.  Capitalized terms not otherwise defined herein shall have the meaning ascribed to them in the Agreement.

You have requested our opinion as to the fairness, from a financial point of view, of the Purchase Price to be received by 11:59 p.m., Eastern Time, on August 20, 2017.  Votethe Seller in the Transaction.  

For purposes of the opinion set forth herein, we have, among other things:

reviewed certain publicly available financial and other business information of the Business;

reviewed certain financial projections prepared, and furnished to us, by Internet • Gothe management of the Business (the “Financial Projections”) and conducted discussions with members of senior management concerning the Financial Projections;

discussed the past and current operations, financial condition and the prospects of the Business with senior executives of the Seller;

participated in certain discussions with representatives of the Special Committee and its legal advisors;

reviewed the Agreement;

reviewed the Support Services Agreement between Seller and Purchaser; and


performed such other analyses, including detailed financial analyses and modeling, and reviewed such other information and considered such other factors as we have deemed appropriate for purposes of evaluating the proposed Transaction and arriving at an opinion.

We have relied upon and assumed, without assuming liability or responsibility for independent verification, the accuracy and completeness of all information that was publicly available or was furnished, or otherwise made available, to www.investorvote.com/MCHX • Or scanus or discussed with or reviewed by or for us. We have further assumed that the QR code with your smartphone • Followforecasted financial information provided, including the steps outlined on the secure website Vote by telephone • Call toll free 1-800-652-VOTE (8683) within the USA, US territories & CanadaFinancial Projections, has been prepared on a touch tone telephone • Followreasonable basis in accordance with industry practice, and that management of the instructionsSeller is not aware of any information or facts that would make any information provided to us incomplete or misleading. Without limiting the generality of the foregoing, for the purpose of this opinion, we have assumed that with respect to financial forecasts, estimates and other forward-looking information reviewed by us, that such information has been reasonably prepared based on assumptions reflecting the recorded message Usingbest currently available estimates and judgments of the management of the Seller as to the expected future results of operations and financial condition of the Business. We express no opinion as to any such financial forecasts, estimates or forward-looking information or the assumptions on which they were based.  With respect to the financial forecasts provided to and examined by us, we note that projecting future results of any company, partnership, venture, or asset is inherently subject to uncertainty.

In connection with our opinion, we have assumed and relied upon, without independent verification, the accuracy and completeness of all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by us.  Our opinion does not address any legal, regulatory, tax or accounting issues.  

In arriving at our opinion, we have assumed that the executed Agreement and Support Services Agreement (collectively, the “Agreements”) will be in all material respects identical to the Agreements reviewed by us. We have relied upon and assumed, without independent verification, that (i) the representations and warranties of all parties set forth in the Agreements and all related documents and instruments that are referred to therein are true and correct in all material respects, (ii) each party to the Agreements will fully and timely perform, in all material respects, all of the covenants and agreements required to be performed by such party, (iii) the Transaction will be consummated pursuant to the terms of the Agreements without amendments thereto, and (iv) all conditions to the consummation of the Transaction will be satisfied without waiver by any party of any conditions or obligations thereunder. Additionally, we have assumed that all the necessary regulatory approvals and consents required for the Transaction, including the approval of the stockholders of the Seller, will be obtained in a black ink pen, mark your votesmanner that will not adversely affect the Seller or the contemplated benefits of the Transaction.

In arriving at our opinion, we have not performed any appraisals or valuations of any specific assets or liabilities (fixed, contingent or other) of the Seller or the Business, and have not been furnished or provided with an X as shown in this example. Please do not write outsideany such appraisals or valuations.  Without limiting the designated areas. X Annual Meeting Proxy Card • IF YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. • A Proposals — Thegenerality of the foregoing, we have undertaken no independent analysis of any pending or threatened litigation, regulatory action, possible unasserted claims or other contingent liabilities, to which the Seller or any of its affiliates is a party or may be subject, and at the direction of the Special Committee of the Board of Directors recommends a vote FORof the directors listed in Proposal 1, a vote FOR Proposals 2-4Seller and 6,with its consent, our opinion makes no assumption concerning, and a votetherefore does not consider, the possible assertion of THREE YEARS for Proposal 5.  1. To elect four directorsclaims, outcomes or damages arising out of any such matters.

This opinion is necessarily based upon the information available to serveus and facts and circumstances as they exist and are subject to evaluation on the Company’sdate hereof; events occurring after the date hereof could materially affect the assumptions used in preparing this opinion. We have not undertaken to reaffirm or revise this opinion or otherwise comment upon any events occurring after the date hereof and we expressly disclaim any undertaking or obligation to advise any person of any change in any fact or matter affecting our opinion of which we become aware after the date hereof.


We have been engaged by the Special Committee of the Board of Directors until their successorsof the Seller to act as its financial advisor in connection with this transaction and will receive a fee for our services.  Our fee for providing this opinion is not contingent upon the consummation of the Transaction.  The Seller has also agreed to indemnify us against certain liabilities and reimburse us for certain expenses in connection with our services, which indemnification and reimbursement obligations are duly electednot contingent on consummation of the Transaction.  In the ordinary course of business, we and qualified: + For Withhold For Withhold For Withhold 01 - Dennis Cline 02 - Anne Devereux-Mills 03 - Russell C. Horowitz 04 - M. Wayne Wisehart 2. To ratify the appointment of Moss Adams LLP as the For Against Abstain 3. To approve the adoption of an amendment to our amended For Against Abstain Company’s independent registered public accounting firmaffiliates may acquire, hold or sell, for our and restated bylaws to provide that the courts located within the fiscal year ending December 31, 2017. the State of Delaware will serve as the exclusive forumour affiliates’ own accounts and for the adjudicationaccounts of certaincustomers, equity, debt and other securities and financial instruments (including bank loans and other obligations) of the Seller and the other parties to the Transaction, and, accordingly, may at any time hold a long or a short position in such securities.  We have not otherwise had a material relationship with, nor otherwise received fees from, the Seller or any other parties to the Transaction during the two years preceding the date hereof. In the future, we may provide financial advisory and investment banking services to the parties to the Transaction for which we would expect to receive compensation.

Consistent with applicable legal disputes.  4. To approve,and regulatory requirements, we have adopted policies and procedures to establish and maintain the independence of our research departments and personnel. As a result, our research analysts may hold views, make statements or investment recommendations and/or publish research reports with respect to the parties to the Transaction that differ from the views of our investment banking personnel.

This opinion has been prepared for the information of the Special Committee of the Board of Directors of the Seller for its use in connection with its consideration of the Transaction and is not intended to be and does not constitute a recommendation to any stockholder of the Seller as to how such stockholder should vote on any matter relating to the Transaction or any other matter.  Except with respect to the inclusion of this opinion in proxy statement relating to the Transaction and any other filing with the U.S. Securities and Exchange Commission in accordance with our engagement letter with the Seller, this opinion shall not be disclosed, referred to or published (in whole or in part), nor shall any public references to us be made, without our prior written approval.  This opinion has been approved for issuance by ROTH’s Fairness Opinion Committee.

This opinion addresses only the fairness, from a non-binding advisory vote,financial point of view, to the Seller of the Purchase Price to be received by the Seller in the Transaction and does not address the relative merits of the Transaction or any alternatives to the Transaction, the Seller’s underlying decision to proceed with or effect the Transaction, or any other aspect of the Transaction.  This opinion does not address the fairness of the Transaction to the holders of any other class of securities, creditors or other constituencies of the Seller.  This opinion is not a valuation of the Seller or its assets or any class of its securities.  We do not express an opinion about the fairness of the amount or nature of any compensation 5. To select, by a non-binding advisory vote, the 1 Year 2 Years 3 Years Abstainpayable or to be paid to our named executive officers. frequency at which stockholders will be asked to approve the compensation paid to our named executive officers.  6. To reapprove provisionsany of the 2012 Stock Incentive Plan to 7. In accordance with the discretionofficers, directors or employees, of the proxy holders,Seller, whether or not related to actthe Transaction.

Based upon all matters incidentand subject to enable the Company to deduct in full certain plan-related the conductforegoing, it is our opinion that, as of the meeting and upon such other matters as may properly come before compensation under Section 162(m) ofdate hereof, the Internal Revenue the meeting.  Code of 1986, as amended. This Proxy, when properly executed, will be voted as specified above. IF NO SPECIFICATION IS MADE, THIS PROXY WILL BE VOTED FOR THEELECTION OF THE DIRECTORS LISTED IN PROPOSAL 1, FOR PROPOSALS 2-4 AND 6, AND THREE YEARS FOR PROPOSAL 5.   B Authorized Signatures — This section must be completed for your votePurchase Price to be counted. — Date and Sign Below NOTE: Please sign as name appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, trustee or guardian, please give full title as such.    Date (mm/dd/yyyy) — Please print date below. Signature 1 — Please keep signature withinreceived by Seller in the box. Signature 2 — Please keep signature withinTransaction is fair, from a financial point of view, to the box. 1UPX + 02MYPCSeller.

Sincerely,

/s/  ROTH Capital Partners, LLC

ROTH Capital Partners, LLC

 



  Important notice regarding the Internet availability of proxy materials for the Annual Meeting of Stockholders.   The Proxy Statement and the Annual Report to Stockholders are available at:   www.investorvote.com/MCHX.   •  IF YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. •    Proxy — MARCHEX, INC.   +    CLASS B COMMON STOCK  ANNUAL

PROXY

PROXY FOR THE SPECIAL MEETING OF STOCKHOLDERS AUGUST 21, 2017TO BE HELD ON OCTOBER 1, 2020. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF MARCHEX, INC.    

The undersigned revokes all previous proxies,hereby acknowledges receipt of the Notice of the AnnualSpecial Meeting of Stockholders and Proxy Statement of Marchex, Inc. in connection with the Special Meeting to be held August 21, 2017 and the Proxy Statement,on October 1, 2020, and appoints Michael ArendsFrancis Feeney, and Ethan Caldwell, and eachMichelle Paterniti, or either of them, proxy with power of substitution, for and in the Proxyname of the undersigned, with full powerand hereby authorizes each or either of substitution,them to represent and to vote, all the shares of Class B common stock of Marchex, Inc. (the “Company”, a Delaware corporation (“Company) which, that the undersigned iswould be entitled to vote either on his or her own behalf or on behalf of any entities, at the Annualour Special Meeting of Stockholders of the Company to be held at Marchex, Inc., 520 Pike Street, 1211 Building Conference Center, 12th Floor, Seattle, Washington,(“Special Meeting”) on August 21, 2017 at 10:00 a.m. Pacific Time,October 1, 2020 and at any adjournments or postponements thereof, withupon the same force and effectmatters set forth in the Notice of Special Meeting, hereby revoking any proxy heretofore given. The proxy holder appointed hereby is further authorized to vote in his discretion upon such other business as may properly come before the undersigned might or could do if personally present thereat. The shares represented  bySpecial Meeting. This proxy will be voted as specified. If no direction is made, this Proxy shallproxy will be voted in the manner set forth below andfavor of all proposals.

The Board (in reliance on the reverse side. recommendation from the Special Committee) recommends that you vote “FOR” the Asset Sale Proposal (Proposal One); and “FOR” the Adjournment Proposal (Proposal Two) and in the proxy holder’s best judgment as to any other matters raised at the Special Meeting.

Please mark date,your votes

as in this example using

dark ink only.

1.

The approval of a proposal to approve the Transaction, the Asset Purchase Agreement and the Related Agreements

FOR

AGAINST

ABSTAIN

2.

The approval of a proposal to adjourn or postpone the Special Meeting, if necessary or appropriate, for the purpose of soliciting additional votes for the approval of the Asset Sale Proposal

FOR

AGAINST

ABSTAIN

In their discretion, the proxy holders are authorized to vote upon such other business as may properly come before the meeting or any adjournment thereof, all as set out in the Notice and Proxy Statement relating to the Special Meeting, receipt of which are hereby acknowledged.

Please sign exactly as your name appears and return this proxy promptlycard immediately in the enclosed stamped self-addressed envelope.   (Continued and to be marked, dated and signed, on the other side)    Non-Voting Items  Change of Address — Please print new address below. Comments — Please print your comments below.  IF VOTING BY MAIL, YOU MUST COMPLETE SECTIONS A - C ON BOTH SIDES OF THIS CARD.

 

Signature(s)

Signature

 

Dated:

NOTE: Please mark, date and sign exactly as name(s) appear on this proxy and return the proxy card promptly using the enclosed envelope. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. Executors, administrators, attorneys, trustees, or guardians should state full title or capacity. Joint owners should each sign. If signer is a partnership, please sign in partnership name by authorized person.